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SYNTHETIC STUDIES ON THE PEDERIN FAMILY OF ANTITUMOUR AGENTS.
SYNTHESES OF PEDERIN, MYCALAMIDE B AND ANALOGUES
by Robert Narquizian
A general modular approach to members of the pederin family of antitumour agents, 
exemplified by syntheses of pederin (1.1), mycalamide B (1.5) and analogues (17-epi-1.5, 
2 .8 , 2.9 and 2.10), is described. The common strategy makes use of a metallated 
dihydropyran approach to couple two advanced fragments. All 6 compounds are prepared 
from 6-lithio-2,3-dimethyl-4-phenylselenomethyl--3,4“dihydro-2/7-pyran 1.59 and 2-(3- 
chloropropyl)-3,3-dimethyl-3,4-dihydro-277-pyran-4-one 2 .4 . The key steps in the 
synthesis of pederin 1.1 or its analogues are Sharpless asymmetric dihydroxylations and a 
rhodium-catalysed directed reduction of an acylimidate. The key steps in the synthesis of 
the right fragment of mycalamide B 1.5 are a P2O5-mediated formation of the trioxadecalin 
ring, a Meerwein-Pondorf-Verley reduction to install the C13-stereogenic centre, 
installation of the CIO-N bond in good yield and total stereocontrol at the CIO centre via a 
Curtius rearrangement and/or a Hofmann rearrangement, as well as Shaipless asymmetric 
dihydroxylations.
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The Pederin Family of Antitumour Agents: 
Structures, Synthesis and Biological Activity
INTRODUCTION  
1.1 Structures
In 1775 the Danish entomologist Johann Christian Fabricius (1745-1808) first 
described the genus Paederus which at that time included only two species. In the ensuing 
two centuries, over 600 species have been identified including Paederus fuscipes whose 
natural history deserves some mention.^ Paederus fuscipes (picture 1.1) is about 8 mm 
long with a black head and abdominal apex, an orange thorax and abdominal base and 
iridescent blue elytra (wing case). It inhabits riverbanks, marshes, and irrigated fields 
where it feeds mainly on insects, mites, soil nematodes, and decaying vegetable matter. 
Like most members of the genus, Paederus fuscipes is a predator of the fly population but 
it is also a pest to man. The insect doesn’t sting or bite but a toxin in its hemolymph causes 
severe dermatitis when it is crushed on the skin and the eyes are particularly sensitive 
though the palms of the hand and the soles of the feet are resistant. In addition to the 
lesions, severe symptoms such as fever, oedema, neuralgia, arthralgia, and vomiting are 
observed with erythrema persisting for several months. It has been suggested^ that both the 
affliction and its causative agent were known to Chinese medicine over 1200 years earlier. 
An insect called ch'ing yao ch'ung was described in A. D, 739 by Ch'en : "it contains a 
strong poison and when it touches the skin it causes the skin to swell up. It will take the 
skin off one's face and remove tattoo marks completely. It is used as a caustic for toxic 
boils, nasal polypi, and ringworm."
The active chemical agent responsible for the dermatitis was first isolated in 
crystalline form by Netolitzky in 1919. '^"  ^The research which eventually led to the correct 
structure began in 1952 with Pavan and Bo^ who named the toxic agent pederin and 
determined its melting point (112°C) on a sample derived from 25 million specimens (ca 
100 kg). The correct molecular formula (C25H45O9N) established by Quilico^ in 1961 led 
to detailed study of the chemical constitution of pederin and a structure, devoid of 
stereochemical definition, was proposed in 1965.^ An independent investigation by 
Matsumoto's team at Sapporo gave corroborating evidence.^’  ^With one minor exception 
(vide infra) all the conclusions drawn from the degradation and iR  NMR studies of 
Quilico^^ and Matsumoto were later confirmed by an X-ray crystallographic analysis of 
pederin di-p-bromobenzoate^^’ which also established the absolute and relative 
stereochemistry.
Single Paederus riparius specimens reared from the egg and kept for prolonged 
periods of time show that only the females are able to biosynthesise pederinri^"^^ 
Preimaginal stages efficiently store pederin transferred by the females into their eggs and 
the males' pederin content decreases slowly over time. Only males with access to eggs 
containing the substance moderately increase their pederin load. The females begin to 
accumulate the toxin a few weeks after imaginai éclosion and build up reserves for the egg 
laying period within 60 days.
Paederus fuscipes
8 mm
Picture 1.1
For many years, pederin (1.1), pseudopederin (1.2)^ and pederone (1.3)^  ^ (also 
isolated from Paederus fuscipes) were structurally unique in the realm of natural products. 
However, in 1988 routine screening for antiviral agents identified two marine natural 
products which bore a close structural resemblance to pederin. Mycalamide A (1.4) was 
isolated from a sponge of the genus Mycale found in the Otago harbour off New Zealand 
whilst onnamide A (1.6) was isolated from a sponge of the genus Theonella found in 
Okinawan waters^^. The pederin family grew to 24 members by 1995 with the isolation of 
mycalamide B (1.5)^^, a further 11 onnamides^^’ and theopederins A-E (1.7)^^. The most 
recent additions to the pederin family are icadamides A (1.8) and B (1.9) isolated from a 
sponge of the genus Leiosella?^ The significance of the mycalamides, onnamides, 
theopederins and icadamides in sponge physiology is unclear although it has been 
suggested that the occurrence of closely related compounds in such taxonomically remote 
animals as sponges and terrestrial beetles may indicate connection by a common producer, 
possibly a symbiotic micro-organism.^'^
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Scheme 1.1
1.2, Synthetic Studies
All members of the pederin family are rare, difficult to isolate, and comparatively frail; 
many of them have potent and potentially useful activity as antiviral and antitumour agents 
(see below) which has stimulated considerable interest in their total synthesis. Total 
syntheses of pederin^^'^^, mycalamide mycalamide onnamide A^^ and
theopederin have been reported as have significant syntheses of various fragments^^’ 
The parent member of the family, pederin itself, is also the simplest. It is composed 
of two tetrahydropyran rings (a left fragment and a right fragment) connected by an A-acyl 
aminal bridge as depicted in structure 1.10 (Scheme 1.2). The left fragment of all members 
of the pederin family is identical but all remaining members of the family (the 
mycalamides, onnamides, theopederins and icadamides) have a trioxadecalin right 
fragment as shown in structure 1.11. The principal site of structural variation is the side 
chain attached to C15. The common left fragment also imposes a common problem: the 
high acid lability associated with the alkene at C4 which activates the acetal function at C6 . 
A comprehensive discussion of the syntheses of members of the pederin family is beyond 
the scope of this review so we will focus on one of the most demanding challenges: the
11
construction of the iV-acyl aminal bridge linking the left and right fragments. The following 
discussion is arranged according to the bond formed in the fragment linkage strategy.
left A/'acyl am inal rigfit
fragm ent i bridge i fragm ent
trioxadecalin
fragm ent
X OMe O MeO _-O ^  :  II I H
Pederin
1.10 C l 5  s id e  ch a in
_ OMe O O J " 0
OH "
R
Core Structure of the Mycalamides, Onnamides and Theopederins
1.11
Scheme 1.2
1.2,1, The C8-N9 Connection via Imidate Ester Acylation
Matsumoto and his team reported the first total synthesis of pederin in 1982 in which the 
left and right fragments were connected by the acylation of an imidate ester (Scheme 
1.3).^^’ The crucial coupling reaction was accomplished by treatment of (+)- 
acetylpederic acid (1.12) with thionyl chloride in the presence of pyridine in 
dichloromethane followed by addition of methyl pedimidate (1.15). The reaction time had 
to be minimised owing to the instability of the acid chloride intermediate 1.13. 
Unfortunately, the highly hindered carboxylic acid was converted slowly to the acid 
chloride 1.13 under the reaction conditions thereby allowing time for the reaction of 
imidate ester 1.15 with thionyl chloride to give MM"Sulfinyl-bis(methyl pedimidate) (1.16) 
which can also serve as a substrate in the acylation of acid chloride 1.13. Thus, the 
formation of N-acyl imidate intermediate 1.17 occurred by two different paths 
concurrently. The N-acyl aminal bridge was then constructed by reduction of 1.17 with 
sodium borohydride. The synthesis was completed by hydrolysis of the benzoate and 
acetate ester protecting groups to give a mixture of pederin (1.1) and 10-ep/-pederin (1.18) 
in a ratio of 1:3 [6 8 % overall from (+)-benzoylpedamide (1.14)] with pederin being the 
minor product.
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The high acid sensitivity of the homoallylic acetal in (+)-acetylpederic acid (1.12) was a 
major obstacle to Matsumoto's first synthesis. In a subsequent refinement, the C4 alkene 
was carried through the synthesis in latent form with the troublesome alkene being 
introduced in the penultimate step of the synthesis as shown in Scheme 1.4.^ "^  However, the 
reduction of #-acyl imidate 1 .2 0  once again afforded an unfavourable mixture of N-acyl 
aminals 1,21 in 72% overall yield (dr 7:2). After chromatographic separation, the requisite 
alkene was introduced by brief thermolysis of the selenoxide derived from oxidation of the 
minor selenoether 1.23 whereupon hydrolysis of the C7 and C l3 benzoates afforded 
pederin (1.1).
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The poor stereoselectivity in the reduction of the A''-acyl imidates 1.17 and 1.20 in the 
foregoing studies was beyond repair and so isomérisation of the A^-acyl aminal in the 10- 
epi-pederin series was investigated. Transacétalisation of 10-gp/-pederin derivative 1.22 
with acetyl chloride in methanol (rt, 3 h) gave an equilibrium mixture (1.22:1.23 = 3:1 
showing that the undesired l^-epi series was the thermodynamic product. The possibility 
of selective conversion of the 10-epz-pederin derivative 1.22 into pederin derivative 1.23 
under kinetically controlled conditions was next examined, by taking into account the 
acceleration effect of the alkoxy-exchange reaction in methanol by a large alkoxy group. 
Thus, treatment of 1.22 with acetyl chloride (Scheme 1.5) in isopropanol gave 1.25 
selectively after 7 days through initial formation of the kinetically controlled product 1.24. 
Compound 1.25 was unstable and could not be isolated in a pure state but kinetically 
controlled transacétalisation of 1.25 with acetyl chloride in methanol (rt, 4.5 h, 50% 
conversion) proceeded in a stereoselective manner to give a 60% isolated yield (based on 
consumed 1.25) of 1.22 and a 14% yield of 1.26 (1.26:1.22 = 4:1). The lOa-isopropoxy 
compound was recovered in 42% yield in the form of a 6 or-methoxy compound 1.27.
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Nakata and his associates discovered that reduction of the 7-0-benzoyl analogue of N-acyl 
imidate 1.20 with NaBHz^ in a mixture of isopropanol and CH2CI2 gave 1.23 (28%) and 
1.22 (30%) (Scheme 1.6). The \0-epi derivative 1.22 was converted into 1.23 by 
reaction of 1.22 with 2-propanethiol and camphorsulfonic acid (CSA) in CH2CI2 to give 
thioacetal 1.28 which was then treated with HgCl2 in MeOH in the presence of NEt3 to 
give 1.23 in 47% yield (from 1.22) along with epimer 1.22 (36%). The completion of the 
synthesis was performed as previously described by Matsumoto.
OMe O MeO . 0 . :  It i H OBz
SePh
I frS H .C S A
CH,CU
OMe
OBz
IBz
SePh OMe
1.28 Me
HgCla, NEfe, MeOH
OMe O MeOOMe O MeO
.OBzOH
(c) UGH, MeOH
S e P h OMeOMe
1.23
( + 1 .22)
Pederin (1.1) IMeiMe
Scheme 1.6
1,2.2, The C8-N9 Connection via Aminal Acylation.
In the Matsumoto-Nakata approaches to pederin, the A-acyl aminal bridge was constructed 
by first condensing an activated carboxylic acid (e.g. acid chloride 1.13) with an imidate 
ester to give an A-acyl imidate which was reduced with sodium borohydride to generate 
the A-acyl aminal— a reaction which gave poor stereoselectivity. In the mycalamides, 
onnamides and theopederins, the incorporation of the oxygen atom of the aminal into a
15
dioxane ring makes the Matsumoto-Nakata protocol less attractive owing to the difficulty 
associated with the synthesis of the appropriate imidate ester. Therefore, the first syntheses 
of mycalamide A, mycalamide and onnamide by Kishi and Hong adapted the 
Matsumoto-Nakata protocol by condensing an aminal 1.32 with the activated carboxylic 
acid derivative 1.30 as illustrated in Scheme 1.7. The CIO aminal unit of 1.32 is 
configurationally unstable under acidic, basic, and neutral conditions, and consequently a 
1:1 mixture of adducts 1.33 and 1.34 was obtained. However, treatment of 1.34 with 
potassium fôrr-butoxide at room temperature first accomplished the transestérification of 
the carbonate group of 1.34 to the corresponding diol 1.35 which then epimerised on 
heating to yield 1.37. Owing to competing decomposition, the reaction was stopped at 
approximately 60% completion to yield the epimerised natural diastereoisomer 1.37 in 
42% yield along with the unnatural diastereoisomer 1.35 (33% yield). Nakata has also 
described a synthesis of mycalamide A in which the A-acyl aminal bridge is constructed by 
the Kishi procedure.
O H  pTsCI, DMAP
O R  CH aCk.rt
1 .2 9  R = 2,4-ditnethoxybenzyl (DMB)
OMe O OMe O
OTs NEtg, rt, 2  h
OMe
1.31 O-
OMe
‘OMe
OR
OH
1.37 R = DMB OH
1 .3 3  \ ^ P
dr 1:1 +  O
OMe O O
f-BuOK
OMe 0  0
OH
Scheme 1.7
1 3 5  O H
In 1993 Roush and co-workers described a route to the mycalamides which incorporates 
two significant ad v an ces.F irs tly , the stereochemistry of the aminal was assured by a 
Curtius rearrangement and secondly, the configuration of the aminal centre was stabilised 
as a temporary carbamate appendage. The steps leading up to the Curtius rearrangement 
are noteworthy. Reductive cleavage of the 2,2,2-trichloroethyl carbonate 1.38 (Scheme 
1.8) with Zn released an alkoxide which performed a nucleophilic attack on the 
neighbouring oxirane to give a cyclic diol which was selectively protected as its mono-tert-
16
butyldiphenylsilyl ether 1.39.^® After closure of the 1,3-dioxane ring, the tert- 
butyldiphenylsilyl ether was cleaved and the resultant alcohol oxidised to the 
corresponding carboxylic acid 1.40. The key Curtius rearrangement was performed by 
treatment of acid 1.40 with diphenylphosphoryl azide at 65 °C. The intermediate acyl azide 
1.41 underwent the desired Curtius rearrangement with clean retention of configuration to 
the isocyanate 1.42 which was trapped with 2-trimethylsilylethanol to give the carbamate 
1,43 as a single diastereoisomer. Hoffmann published an approach to the trioxadecalin ring 
system of the mycalamides in 1993 which was similar to that of Roush, in that it included a 
Curtius reaiTangement to form the ClO-aminal diastereoselectively.'^^
HO , .O HOH
,OMeHO. .OMe
(a) 2h ,H O A c,50°C
(b) f-BuPhgSICI 
imidazole, DMF, rt
78%
1.30
.OMe ,OMeHN-
1.421.43
H °
(a)P2Qi,CH2(OMe)g 6 h
(b)TBAF,HO Ac,THF
0 -1  1.40 A ,
(PhO)2P(0)N3,NEt3 
MeaSCHaCHaOH.THF, A
Curtius 
rea range ment
OMe
Scheme 1.8
Roush and co-workers later published a very brief route to the pederic acid derivatives 
1.44, 1,45 and 1.30 and they achieved some success in the construction of A^-acyl aminal 
bridges with model systems but the high steric hindrance of the carboxyl group in the left 
fragments once again thwarted condensation with the carbamate 1,43 (Scheme 1.9) under a 
wide variety of conditions and none of the desired adduct 1.46 was observed.^
^  OM e 0
X
ODMB
1.44 X = CI1.45 X = F  
1.30 X = OTs
,OMe.OMeHN OR+
1461.43
Scheme 1.9
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1.2.3. The C7-C8 Connection.
In 1996 Hoffmann proposed an original strategy to the construction of the N-acyl aminal 
bridge of mycalamide B based on union of the ester 1.47 with the acyl anion 1.48 to forge 
the C7-C8 bond (Scheme 1.10).^^ Once again, the stereochemistry of the aminal is to be 
controlled by a Curtius rearrangement.
OMe
OMe
O 0 ^ 0
1,47 OTSS
Scheme 1.10
OMe O 0 ^ 0Os It I H I O^Me
OTBS
Model studies for the novel coupling step were carried out with the commercially available 
isocyanate 1.50 as a suiTogate for the right fragment. The acylstannane 1.51 (Scheme 1.11) 
protected as its 2-(trimethylsilyl)ethoxymethoxy (SEM) derivative was easily prepared by 
addition of BugSnLi to the isocyanate 1.50 followed by N-alkylation with 2- 
(trimethylsilyl)ethoxymethyl chloride. The use of SEM protection for the N-atom was a 
judicious choice whose purpose was stabilisation of the highly labile acyllithium 1.52 
which was generated and trapped in situ by transmetallation with BuLi at -100°C. The 
desired model adduct 1.53 was obtained in 87% yield. A fortuitous and unprecedented 
reduction of the a-oxo ester accompanied the deprotection of the SEM group in adduct 
1.53 with TBAF in A,A^dimethylpropyleneurea (DMPU) to give the desired oc- 
hydroxyamide 1.54 as mixture of diastereoisomers (dr 3:1). The origin of the hydride for 
the reduction of the keto function is unknown. Progress towards implementation of the 
strategy has been reported: a synthesis of 1.55 from D-arabinose has been accomplished^^ 
but union of the fragments remains elusive.
1.50
1 . . I DBuaSnU BUoSn N O BuU
N O SEMCI J
SiMeg 1.51
.OMeHO.
OTBS1.55
OM e
O
Li IN' 'O'
SiM eg
1.52
OMe
OMe
1.47
OMe
TBAF
DMPU, 4 5 “C
Scheme 1.11
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1.2.4. The C6-C7 Connection: The Metallated Dihydropyran Approach.
In our early approaches to the synthesis of pederin, we chose the well-trodden Matsumoto- 
Nakata protocol for the construction of the N-acyl aminal bridge.^^’ ^^ -42, 44,45 were 
similarly chastened by difficulty in reconciling slow reactions with unstable reagents 
which has been a persistent feature of nearly all of the accounts reported to date. Moreover, 
the problem was compounded by the poor stereoselectivity of the subsequent reaction of 
the A -^acyl imidate adducts. In the mid-1980's we turned to a new strategy which attempted 
to alleviate the problems associated with the high steric hindrance surrounding the acetal 
centre at C6 . Our new strategy was inspired by some of the elegant degradation studies 
conducted by Quilico during their structure elucidation of pederin. Pseudopederin (1.2, 
Scheme 1.12), the hydrolysis product of pederin, undergoes an easy retroaldol reaction on 
heating in base in presence of air to give pederolactone (1.56) and meropederoic acid 
(1.57) wherein the iV-acyl aminal group is still intact. These transformations suggested an 
alternative disconnection between C6 and C7 that circumvented the cascade of problems 
which beset the closing stages of the previous syntheses. The new strategy required a 
metallated dihydropyran 1.59 functioning as an acyl anion equivalent in reaction with a 
suitably activated meropederoic acid derivative 1.58.^^’
OR O MeO .OH
OH
OMe1.2 R = H (Pseudopederin) 
1.1 R = Me (Pederin) OMe
O MeO
.OTBS
SePh
OMe
1.60
Ba(0H)2,0g
OMe
CL , 0
1.56
Pederolactone
SePh
1.99Scheme 1.12
O MeO 
1.57
M eropederoic Acid OMe
OMe
O MeO
OTBS
+
OMe
OMe1.58
Amide 1.61 was converted to the A-acylimidate 1.62 in 2 steps using standard 
transformations. The imidate ester intermediate 1.62 was prone to hydrolysis but good 
yields were obtained by working fast and with minimal purification. Reduction of the N- 
acylimidate 1.62 was achieved by using an unprecedented reaction—reduction with 
catecholborane in the presence of a catalytic amount of [PhgPjgRhCl. Under these 
conditions a 70% yield of a mixture of diastereoisomeric A-acyl aminals was obtained in 
which the desired isomer 1.64 predominated (10:1). Thus, for the first time, a metal 
hydride reduction of an A-acyl imidate in the pederin series afforded appreciable 
selectivity in favour of the desired diastereoisomer at CIO. The stereochemistry of the
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reduction was interpreted in terms of an intermediate 1.63 in which an octahedral Rh 
complex delivers a hydride intramolecularly as indicated in Scheme 1.13.
'Me
Me<
.OTBS catecholborane RhCI[PPh3]3.OTBS Mel
OMePhMe, -7 0  “C 
70%  (3 steps) .OMeOMeOMe H "/
iMe1.61 OMe 1.62 TBSO
1.63
d r(C 6 ) >20:1; dr (C7) 3:1
O Me] Me]OMe p  Me]
.OTBS.OTBS 1.59 Mel 
TMEDA
S eP h THF, -8 0  °C 54% dr (CIO) 10:1
OMe(a) LiBH(s-Bu)3 , -8 0  °C
(b) CSA, MeOH, rt
(c) BzOi, DMAP, rt
OMe1.60
•MeIMe 1.64
4 step s
70%  (3
Scheme 1.13
The key reaction of the sequence entailed addition of the metallated dihydropyran
1.59 to the methyl ester 1.64 in the presence of TMEDA at low temperature to give a 54% 
yield of the adduct 1.60. With the bulk of the pederin skeleton now constructed, 
completion of the synthesis merely required the introduction of the two adjacent 
stereogenic centres at C6 and C7 and a few functional group transformations. The 
stereogenic centre at C7 was introduced by metal hydride reduction of the enone function 
in 1.60. Use of the bulky reducing agent LiBH(5-Bu)3 afforded the desired diastereoisomer 
in modest diastereoselectivity (3:1). Addition of methanol to the dihydropyran occurred 
with excellent diastereoselectivity (> 20:1). Completion of the synthesis required 4 further 
steps which were well precedented.
The success of the metallated dihydropyran approach in the synthesis of pederin 
suggested an easy adaptation of the strategy to syntheses in the mycalamide-theopederin 
series. An initial foray published in 1996 was superseded by tactical improvements 
depicted in Scheme 1.14 for the synthesis of 18-0-methyl mycalamide which had 
been identified as the most potent of the mycalamide derivatives in assays against a series 
of human t u m o u r s ^ ( s e e  below). The construction of the 1,3-dioxane ring was 
accomplished by treatment of 1.66 with paraformaldehyde in the presence of HCl to give a 
mixture of diastereoisomeric 1,3-dioxane acetals 1.67 (dr = 6.5:1) in 8 8 % yield. Separation 
of acetals 1.67 by column chromatography was possible but useless since hydrogenolysis 
of the benzyl group gave the same mixture of hemiacetals 1.68 (dr 3:1).
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Replacement of the hydroxyl group in 1.68 by an azido group via substitution of 
the mesylate 1.69 by BU4NN3 had been reported by Hong and KishP"  ^but in our hands the 
yields ranged from 20% (typically) to 72% (rarely). We therefore developed a new method 
which, to our knowledge, is novel: the crude mesylate 1.69 derived from the mixture of 
hemiacetals 1 . 6 8  was treated with trim ethylsilyl azide in the presence of 
tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF) to give the azides 1.70 as a 
mixture of diastereoisomers in the ratio 1:1 to 2:1  depending on the reaction conditions. 
The isomers could be separated for purposes of characterisation but in practice it was best 
to caiTy the mixture of azides forward to the next stage of the synthesis. Catalytic reduction 
of the azides 1.71 gave a sensitive mixture of aminals which were acylated with methyl 
oxalyl chloride in the presence of DMAP to afford the diastereoisomeric methyl 
oxalamides (1:2) in 77% yield. The diastereoisomers were separated by column 
chromatography and the minor crystalline diastereoisomer 1.71 having the correct 
stereochemistry at CIO was added to a solution of the dihydro-2/7-pyranyllithium reagent
1.59 in the presence of excess TMEDA to give the acylated dihydro~2i7"pyran derivative 
1.72 in 64% yield. The remainder of the synthesis was conducted as described above for 
the synthesis of pederin.
The successful implementation of the metallated dihydropyran approach to 18-0- 
methyl mycalamide B (Scheme 1.14) was gratifying but the unfavourable stereochemistry 
at the CIO aminal centre was a blemish which eluded correction. Therefore, we examined 
the Roush-Hoffmann Curtius protocol as part of a synthesis of mycalamide B.^  ^Treatment 
of the carboxylic acid 1.55 (Scheme 1.15) with diphenylphosphoryl azide afforded an acyl 
azide intermediate which rearranged to an isocyanate which was trapped by 2 -
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(trimethylsilyl)ethanol to give the carbamate 1.75. However, the elevated temperatures (70 
°C) required for the rearrangement resulted in some decomposition with an overall 
reduction in yield to 56% at best with typical yields being more like 40%. A much better 
alternative was a classical Hofmann rearrangement using Ag(I)~assisted rearrangement of 
the A^-bromoamide derived from amide 1.74.®  ^The reaction occurred at room temperature 
with clean retention of configuration to give the carbamate 1.75 in 79% overall yield. The 
remaining 2-carbon fragment was installed by reaction of carbamate 1.75 with methyl 
oxalyl chloride in the presence of DMAP to yield the imide derivative 1.76. To complete 
the sequence, the carbamate function was expunged using TBAF buffered with acetic acid 
to give the A-acyl aminal intermediate 1.77 of mycalamide B. A similar strategy was used 
in the first synthesis of a member of the theopederin family, theopederin D (1.7D).^^
OMe
1.55 X = OH  1.74X=NH2 TBS
Mycalamide B I
A, Curtius re arrang amen t ( X=  OH)
(Ph0)gP(=0)Ng, MBaSiCHgCHgOH 
4Â tVB, DIPEA, PhM e, 70 ”C (40-56 %)
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NBS, A go Ac, MesSiCHgCHgOH 
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OMeHN
•OTBS
liMes 1.75 OMe
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Scheme 1.15
1.3. Biological Activity
1.3,1, The Natural Products.
Pederin is a very weak antibacterial agent but it is highly toxic to eukaryotic cells. 
Ingestion can cause severe internal damage and intravenous injection causes death at levels 
which suggest that it is more potent than cobra venom. The toxicity of pederin appears to 
be related to its inhibition of protein biosynthesis and cell division. Using human tonsil 
ribosomes, Vazquez^"^’ showed that pederin binds irreversibly to the ribosome preventing 
translation of mRNA. Inhibition occurred at the translocation step during the elongation 
cycle. The iiTeversible binding of pederin to ribosomes and its vesicant activity suggest it 
may function as an alkylating agent with the homoallylic acetal or A-acyl aminal as sites of 
potential reactivity. The biochemical and pharmacological activities are probably not 
related, however, since the hydrogenated derivative dihydropederin is not a vesicant 
though it remains a potent inhibitor of protein biosynthesis. Unfortunately there have been
22
very few attempts to evaluate the clinical potential of pederin. Pavan^^ demonstrated that 
elderly patients with chronic necrotic and purulent sores completely recovered in some 
cases after treatment with minute amounts of pederin. A Russian study has also revealed a 
therapeutic effect on eczema and neurodermatitis with no complications.^^ Potential use as 
an anti-cancer agent has been suggested based on pederin's ability to block mitosis in 
normal and tumour cells at doses of 1 ng/ml and reports that it inhibited sarcoma-180 
tumours in mice.^^
Like, pederin, the mycalamides and their derivatives induce severe dermatitis, 
Mycalamides A and B reveal potent in vitro cytotoxicity and in vivo antitumour efficacy 
against several leukemia and solid tumour model systems as well as antiviral activity. They 
inhibit in vitro replication of murine lymphoma P388 cells (IC50 3.0 ±1.3  and 0.7 ± 0.3 
ng/ml respectively and human promyelocytic (HL-60), colon (HT-29) and lung (A549) 
cells (IC50 < 5 nM).^^ Mycalamide A was also active against B16 melanoma, Lewis lung 
carcinoma, M5076 ovarian carcinoma, colon 26 carcinoma, and the human MX-1 
(mammary), CX-1 (colon), LX-1 (lung) and Burkitt's lymphoma tumour xenografts. 
Mode of action studies confirm that the mycalamides, like pederin, are protein synthesis 
inhibitors. Mycalamide A also disrupts DNA metabolism but does not intercalate into 
DNA itself. A correlation between their relative ability to inhibit protein synthesis, 
cytotoxicity and their in vivo efficacy suggests that their anti-tumour activity is a 
consequence of protein synthesis inhibition.^^
Antiviral assays on mycalamide A by the Munro g r o u p i n d i c a t e d  that the 
minimum dose that inhibited the cytopathic effect of the test viruses {Herpes simplex 
Type-1 and Polio Type-1 viruses) over a whole (17 mm) well was 5 ng/disk. No in vivo 
antiviral results on pure mycalamide A were available from the initial screen but in vitro 
assays showed that it was responsible for the in vitro activity of the crude sponge extract 
and thus probably the in vivo activity as well. A crude extract (ca 2% mycalamide A) was 
tested in mice infected with A59 coronavirus. Four mice dosed with virus and the extract at 
0.1 mg/kg survived 14 days whilst eight mice dosed with the virus only all died within 8 
days. For further data relevant to the antiviral activity of mycalamide A see section 1.3.4.
Onnamide A is approximately equivalent in potency to mycalamides A and B 
against murine P388 leukemia cells (IC50 2.4 ± 0.3 iiM) in vitro but it was inactive against 
P388 cells in vivo (15% increase in life span at 40 p.g/kg). Onnamide A is about 70-fold 
less active against HL-60, HT-29 and A549 in line with its reduced potency as an inhibitor 
of protein syn thesis .B io log ica l data for the remaining members of the onnamide sub­
family is limited to in vitro studies against P388 and the relevant data is collected in Table 
1.1. Onnamide A and 23(Z)-onnamide A (1.88, Scheme 1.16) are the most potent members 
of the family whilst onnamide E (1.85), lacking the A-acyl aminal functionality, is inactive. 
All members of the onnamide sub-family were v e sican ts .T h ere  is also very little data
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published regarding the antiviral activity of the onnamides. In their original report on the 
isolation and structure determination of onnamide A, Higa et al^^ claimed potent antiviral 
activity against Herpes simplex Type-1, vesicular stomatitis virus and coronavirus A-59.
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Theopederins A-E (1.7A -E) were markedly cytotoxic against P388 leukemia cells 
(see Table 1.1).^^ Theopederins A and B also showed promising antitumour activity
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against P388 (i.p.): T/C = 205% (0.1 mg/kg/day, treated on days 1, 2, and 4-6, i.p.) and 
T/C -  173% (0.4 mg/kg/day, treated on days 1,2 and 4-6, i.p.), respectively.
Table 1.1. IC50 values (ng/ml) in vitro for members of the pederin family against murine 
P388 leukemia cells.
Compound‘d Munro^ Fusetani'^ Fusetani^ Kobayashi^
Pederin (1.1) 0.07 — — —
Mycalamide A (1.4) 0.5 — —
Mycalamide B (1.5) 0.1
Theopederin A (1.7A) “  0.05 — —
Theopederin B (1.7B) _  n 7  — —
Theopederin C (1.7C) _  V n _  _
Theopederin D (1.7D)   ç ’o   _
Theopederin B (1.7E) q.4_________ _ 10 2.0
Onnamide A (1.6) — — 150 —
13-des-O-Methyl-onnamide A (1.78) — — 40 4.6
21.22-Dihydo-onnamide A (1.79) — — 130 —
Pseudo-onnamide A (1.80) — — 130 —
Onnamide B (1.81) — — 100 —
17-Oxo-onnamide B (1.82) ^0
Onnamide C (1.83) ~  — 20 —
Onnamide D (1.84) — ina^ive —
Onnamide E (1.85)       □ X
21.22-Dihydro-17-oxo-onnamide A (1.86)      ^
17-Oxo-onnamide A (1.87)
4(Z)-Onnamide A (1.88)
 ^For structures see Schemes 1.1 and 1.16.  ^Reference 18 and 62.  ^Reference 22.  ^Reference 
20.  ^Reference 21. Murine L1210 lymphoma cells were used.
1.3,2. Simple Derivatives o f the Natural Mycalamides.
In 1992, Munro et ai.®^  prepared 34 simple acyl, alkyl and silyl derivatives of the C7, C17 
and C l8 hydroxyl groups and the //-amido group of mycalamides A and B and their 
relative potency assayed in vitro against P388 cells. The most noteworthy conclusions 
from this study are (a) méthylation of the amide nitrogen together with the C7 hydroxyl 
group causes at least a lO^-fold reduction of activity; (b) derivatisation of the C l hydroxyl 
group causes a 10-100 fold reduction in activity; and (c) méthylation of both the C17 and 
C l8 hydroxyl groups (as found in pederin) renders the mycalamides as active as pederin. 
From these observations Munro concluded that the intact A-acyl aminal bridge is vitally 
important for the biological activity of the mycalamides.
In 1997 we studied the biological activities of 18-0-methyl mycalamide B (1.73), 
lO-epi-18-O-methyl mycalamide B and pederin, all prepared by total synthesis.'^^ The 
activities of 18-0-methyl mycalamide B and pederin were virtually indistinguishable when 
evaluated in DNA or protein synthesis assays, and in cytotoxicity assays using human
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carcinoma cell lines (IC50S 0.2-0.6 nM). In the assays, lO-e’p /-18-0-methyl mycalamide B 
was 1 0  ^ times less toxic than its diastereoisomer, demonstrating that the cytotoxicity of 18- 
0-methyl mycalamide B is inseparable from its ability to inhibit protein synthesis. Short­
term exposure of squamous carcinoma cells to 18-0-methyl mycalamide B or pederin 
caused an irreversible inhibition of cellular proliferation and induced cellular necrosis. In 
contrast, the antiproliferative effects of the compounds on human fibroblasts were 
reversible and there was no evidence of necrosis.
1.3.3. Degradation Products of the Natural Mycalamides.
An extensive programme on the chemistry of the mycalamides by the New Zealand group 
of Munro and Blunt involved treatment of mycalamide A and some of its alkyl derivatives 
with alkoxide, hydroxide, oxide bases, sodium borohydride and azide.^^ The study was 
extended to acid-catalysed degradations, acetal exchange reactions, catalytic 
hydrogenation, epoxidation and oxidation reactions.^^ The numerous derivatives and 
degradation products were then tested in vitro against P388 cells. The IC50 values in ng/ml 
are given together with the relevant structures in Scheme 1.17.
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Oxazolidinones 1.89-1.91 and the 1-0-benzyl derivatives 1.92 and 1.93 displayed poor 
activity as expected from the previous studies which had established the need for a free 
hydroxyl group at C l. The relative inactivity of the cleavage fragments 1.97-1.103  
demonstrates further that both segments of the mycalamide structure are essential to the 
biological activity. Only the reduction product 1.96 (40-fold deactivation) has a significant 
biological activity, showing that the CIO configuration was crucial for activity to be 
displayed. The moderate activity of the reduction product 1.96 is surprising since the 
aminal function is generally considered a crucial structural motif for biological activity. 
The importance of the C6 acetal is shown by the retention of activity with a C6 ethoxy 
derivative 1.106, a 20-40-fold drop in activity for a C6 hydroxy substituent as in 
compounds 1.104 and 1.105 and further losses (> 100-fold) with elimination or 
hydrogenolysis at C6 (compounds 1.107-1.110, 1.115, 1.117). Compounds involving 
derivatisation or transposition of the exocyclic double bond retained significant activity: 
thus, 4(3-dihydromycalamide A 1.111 was significantly more active than mycalamide A but 
4(3-dihydromycalamide B 1.113 had the same activity as mycalamide B but A^- 
mycalamide A 1.116 was 100-fold less active than mycalamide A. The epoxide derivatives 
1.118-1.121 were also much less active although there was an even more pronounced 
isomer effect.
Modifications at the C16 side chain were expected to be well tolerated so it was 
surprising that both A^^-normycalamide B isomers (1.122 and 1.123) were ca 100 fold less 
active than mycalamide B, However, the C17 aldehyde and alcohol derivatives (1,124 and 
1.125) were significantly more active than both mycalamide A and theopederin E (IC50 = 9 
ng/mL against P388).
1.3,4. Advanced Synthetic Analogues of Mycalamide A
In 1997 the Nakata^^ group synthesised a set of ten advanced analogues of mycalamide A 
(Scheme 1.18) in order to probe the minimum structural requirements of the left fragment 
for biological activity and to explore the possibility of replacing the right fragment with 
glucose derivatives. The cytotoxicity against HeLa cells and antiviral activity against 
Herpes simplex typel (HSV-1) and Varicella-zoster virus (VZV) were tested in vitro along 
with 5-fluorouracil and acyclovir as standards. The data are summarised in Table 1.2. For 
comparison, parallel tests were run on mycalamide A itself and its 10-epimer (1.95),
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Table 1.2. Biological Activity of Mycalamide A Analogues^'^
Compound
Cytotoxicity 
against HeLa cells
Antiviral activity 
against HSV-1
Antiviral activity 
against VZV
1C50 MIC^ 1C50" MIC" 1C5/
5-Fluorouracil 3 .0 _ _
Acyclovir --- - 1 .6 1.6 6.25 >50.0
Mycalamide A (1.4) <0.03 <0.4 <0.4 <0.4 <0.4
10-eoz-Mycalamide A (1.94) 12.5 12.5 1.6 12.5
1.126 <0.03 <0.4 <0.4 <0.4 <0.4
1.127
1.128
3.0 50.0 50.0 1.6 >50.0
0.03 3.1 3.9 <0.4 1.6
> 10.0 50.0 >50.0 3.1 >50.01.129 > 10.0 50.0 12.5 <0.4 12.51.130 > 10.0 50.0 >50.0 12.5 >50.01.131 I.O 25.0 25.0 3.1 >50.01.132 > 10.0 >50.0 >50.0 25.0 >50.01.133 3.0 50.0 >50.0 12.0 >50.0
1.134
1.135
10.0 50.0 50.0 12.5 >50.0
 ^Data taken from Nakata et a l ,  ref 72. (gg/ml), MIC (|ig/ml) Against HSV-1 cells. '^Against
vero cells.  ^Against VZV. -^Against HEL cells.
Mycalamide A, 1.126 and 1.128 showed very potent cytotoxicity against Hela cells 
hut their corresponding 10-epimers (i.e. lO-epi-mycalamide A, 1.127 and 1.129) were 100- 
fold less active suggesting that the CIO configuration is a crucial determinant for high 
cytotoxicity. As expected from the results described in the previous section, the high 
activity of compound 1.127 verifies that the presence of the C4-exo-methylene and C3- 
methyl groups are not an important factor for the potent cytotoxicity. The unnatural C7 
hydroxyl isomers 1.130 and its C 10-epimer 1.131, decreased the activity, which suggests 
that the configuration of the C7-hydroxy group is also essential for potent cytotoxicity. It is
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noteworthy that 1.132 and 1.134, in which the right fragment is replaced by glucose 
derivatives, showed nearly the same activity as 5-fluorouracil.
A compound can be judged to have significant antiviral activity if its therapeutic 
ratio (TR = IC50/MIC) is higher than that of acyclovir. The antiviral activity of 
mycalamide A, 1.126 and 1.128 against HSV-1 is very strong. However, their cytotoxicity 
(IC50) against vero cells is also very strong: TRs of all synthetic compounds tested are less 
than 1 (TR of acyclovir = 32). Although mycalamide A, 1.126 and 1.127 showed strong 
activity against VZV, their potent cytotoxicity (IC50) against HEL cells was also observed. 
10-gpLMycalamide A (1.94), 1.127, 1.129, 1.130, and 1.132 showed potent antiviral 
activity against VZV and low cytotoxicity against HEL cells: TRs of 10-gpi-mycalamide A 
(1.94), 1.127,1.129,1.130 and 1.132 are 8 , >32, >16, >32, and >16, respectively (cf. TR of 
acyclovir >8 ). Thus 7- or 10-epimeric compounds showed significant antiviral activity 
against VZV.
1.3,5. Simple Synthetic Derivatives.
None of the biological data presented thus far identifies the m inim um  structural 
requirements for cytotoxicity or antiviral activity. In 1997, Abell et al ^^evaluated the 
cytotoxicity of simple analogues (Table 1.3) of the V-acyl aminal bridge against the P388 
leukaemia cell line in vitro. In general, compounds 1.136a-i with a (l'R,25)-configuration 
(equivalent to C7 and CIO in the natural products) show significantly greater in vitro 
cytotoxicity than the coiTesponding ( 1 '5,25)-derivatives 1.136a-i. Notable exceptions were 
the parent natural products (pederin, mycalamides A and B) for which the equivalent CIO 
position is S. A  preference for a (l'R)-configuration over a (l'5)-configuration does not 
seem to be evident within the cyclic oxazolidinone series 1.138-1.143 (Scheme 1.19), 
where the (T^)- and (l'R)-compounds show similar in vitro cytotoxicity.
Table 1.3
IC50 values of 1.136 and 1.137 against P388 cells
 iÇ m W sü   ?' „
1.136 (P/e,25’) 1.137 (r.?.2.S)
a OH Ph 52 >340
b OH Me >125 > 188''c NHZ Ph 14 >188^
d NH-Ala-Z Ph 36 >125e OAc Ph 101 >313f OH E t 176 43
g NHZ Me >375 >375h
i 0C0QH4Br i-Pr 105^ 105O-camphanyl Ph 42f/
O OMe 
1,136 {VR,2Si
“ 1:1 mixtuiE ofepim ers. * 3:1 mixture o f  epimeis. 17:3 mixture o f epi mers. 
^ 9^:1 mixture o f  epimeis.
0  OMe 
1.137 {VS.2S)
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A variety of groups appear to be accommodated for the induction of in vitro 
cytotoxicity. For example, the corresponding acetates of 1.136a and 1.137a, compounds 
1.136e and 1.137e, show comparable activity. By comparison, acylation of the C7- 
hydroxyl group of mycalamide A and B (analogous to C2 in 1.136/1.137) results in 
compounds with significantly decreased activity. The (l')-epimeric pairs 1.136c,d,g and 
1.137c,d,g were designed to give the derivatives more peptide character. The most active 
compounds in this series, compounds 1.136c,d show activities comparable to, or better 
than, 1.136a. Again a preference for a (l'R)-configuration is noted (1.136c/1.137c and 
1.136d/1.137d) A change from R^ = Ph to Et appears to be tolerated, although in this case, 
contrary to the other compounds, a ( l ’5)-configuration seems to give the most potent in 
vitro bioactivity (1.1361 > 1,1371). It should be noted that 1.1371 and the parent natural 
products possess the same relative configuration at this centre (i.e. 5). The introduction of a 
methyl group at the R^ position resulted in compounds with significantly reduced activity 
(see compounds 1.136b,g, 1.137b,g). Finally, the glucosyl derivatives 1.143 and 1.144 
show less activity than the corresponding acyclic analogues 1.136 and 1.137 where R^ = Et 
and Ph.
In conclusion, the foregoing structure activity studies on the pederin family of antitumour 
agents established that the A-acyl aminal bridge is the pharmacophore. The homoallylic 
acetal array encompassing C4-C6 which is responsible for the acid lability of the natural 
products as well as their vesicant effects, is not necessary for anti tumour or antiviral 
activity. The C6  acetal function contributes to the high activity of the natural products 
though simpler analogue studies reveal that it is not essential. The presence of a free 
hydroxyl group at C l with the (5)-configuration is important for high activity. The 
configuration of the aminal centre is also very important with the (5)-configuration at CIO 
being significantly more active as an anti tumour agent than the (R)-epimer; however, 
compounds with the (R)-configuration at CIO remain potent antiviral agents. The complex 
trioxadecalin ring system characteristic of the mycalamides, onnamides and theopederins is 
not essential for high activity since pederin , with its simpler monocyclic right half, is one 
of the most active of the natural products followed closely by 18-(9-methyl-mycalaraide B,
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a simple synthetic derivative of natural mycalamide B. Finally, the side chain at C l5 
tolerates considerable variation with comparatively little impact on activity. A summary of 
the SAR data is given in Scheme 1.20.
acetal contributes to liigli 
activity but not essential
responsible for vesicanteffects but not essential for 
antitimiour activity
free NH impcstant
fiee liydroxyl in (5)-configuration important 
(5)-configuration essential
□Me O
Scheme 1.20
ring C not essential
OMe
gem-methyls not essential
OMe
Cl 5 side chain variable
Addendum, Theopederins F-J (1.146F-J, Scheme 1.21) have recently been isolated from 
Theonella swinhoeiJ^ Theopederin F was antifungal against an erg6  mutant of 
Saccharomyces cerevisiae deficient in (S')-adenosyImethionine:A^"^-methyltransferase 
involved in the biosynthesis of ergosterol. Theopederin F was also cytotoxic against 
murine P388 cells with an IC50 of 0.15 ng/ml. No biological data was reported for 
theopederins G-J. The close structural kinship between theopederins G-J and the 
onnamides suggests that the theopederins may be biosynthetic precursors of the 
onnamides.
OMe
.OMe:OH
OH
OH
Theopederin F (1.146F)
O
.OMe
OH
OH
Theopederin I (1.1461)
OHOH
.OMe.OMe
OHOH
CO2 H
OHOH
Theopederin J  (1.146J)Theopederin G (1.146G)
O
.OMe
OH
O
Theopederin H (1.146H)
Scheme 1.21
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Chapter 2 : Previous achievements in the Koeienski group and objectives
2.1 Previous achievements in the Koeienski group
2.1.1 Lithiated dihydropyran approach
During the early work on the synthesis of pederin 1.1, Jarowicki and Marczak were 
faced with the task of constructing the aminal bridge. As shown in Chap 1, Sec 2,4, they 
completed the synthesis of pederin 1 .1  using the metallated dihydropyran approach 
(Scheme 2.1) and they also optimised the installation of the stereogenic centres at C7 and 
CIO.32-75
HpN
OA MeOV1.61 OMe (a) MesOBF^(b) MeO^C-COCI OMe 0  MeO ^ oalecholborane  ^ I I RhCllPPhjlao l^"^^OMe PhMe, - 7 0  °C 70% (3 steps)1,62 OMe
OMe
Rh'A-HPhoP
MeO,./,
OMe
1.63
dr (C6 ) > 20 :1 ;dr(C 7)3:1  
OMe O MeO O MeO0  MeO
OTBS,0TB S MeO,1 5 97MEDAlePhOBz IM F,-BO 'C  
54% dr (CIO) 10:1
OMe(a)L iB uH (s-B u)3,-80°C  
b ) C a \ ,  M eOH,rt 
(c) BzCI, DMAP, rt
OMe1.60
OMe1.64OMe
4 s te p s
70% (3 steps)
Pederin
Scheme 2.1
Amide 1.61 was converted to the A^-acylimidate 1.62 in 2 steps using standard 
transformations. The imidate ester intermediate 1.62 was prone to hydrolysis but good 
yields were obtained by working fast and with minimal purification. Reduction of the N~ 
acylimidate 1.62 was achieved by using an unprecedented reaction—reduction with 
catecholborane in the presence of a catalytic amount of [PhsPlgRhCl. Under these 
conditions a 70% yield of a mixture of diastereoisomeric A-acyl aminals was obtained in 
which the desired isomer 1.64 predominated (10:1), Thus, for the first time, a metal 
hydride reduction of an A-acyl imidate in the pederin series afforded appreciable 
selectivity in favour of the desired diastereoisomer at CIO. The stereochemistry of the
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reduction was interpreted in terms of an intermediate 1.63 in which an octahedral Rh 
complex delivers a hydride intramolecularly as indicated in Scheme 1.13.
The key reaction of the sequence entailed addition of the metallated dihydropyran 
1.59 to the methyl ester 1.64 in the presence of TMEDA at low temperature to give a 54% 
yield of the adduct 1.60. W ith the bulk of the pederin skeleton now constructed, 
completion of the synthesis merely required the introduction of the two adjacent 
stereogenic centres at C6  and C7 and a few functional group transformations. The 
stereogenic centre at C7 was introduced by metal hydride reduction of the enone function 
in 1.60. Use of the bulky reducing agent LiBH(.s'-Bu)3 afforded the desired diastereoisomer 
in modest diastereoselectivity (3:1). Addition of methanol to the dihydropyran occurred 
with excellent diastereoselectivity (> 20:1). Completion of the synthesis required 4 further 
steps which were well precedented.
The success of the metallated dihydropyran approach in the synthesis of pederin 
suggested an easy adaptation of the strategy to syntheses in the mycalamide-theopederin 
series. This approach for the coupling of the two fragments has since successfully been 
applied to the synthesis of 18-0-methyl mycalamide
2.2.2 Optimised access to lactone 2.1 and enone 2,4
SePh
Figure 2.1
Unfortunately, the previous route to fragments 1.59 and 1.64 designed by Jarowicki 
and Marczak was expensive and impractical and therefore targeting the total synthesis of 
18-Omethyl-mycalamide B, Smith and Raubo developed a very efficient synthesis of both 
lactone 2.1 and enone 2.4 (figure 21)?^  Their objectives were :
• To develop syntheses of the pederin family members using the well-precedented 
metallated dihydropyran approach to bridge the two fragments (see chapter 1, sec 2.4);
• To access these critical intermediates in high yields with good stereocontrol using large 
scale reactions;
• To use cheap starting materials, and avoid column chromatography instead of 
distillations or recrystallisations as main means of purification;
• To develop a flexible route that would allow access to several members of the pederin 
family and analogues.
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Smith and Raubo had successfully applied their improved synthesis of 2.1 and 2.4  
(chapters 3 and 4) towards the synthesis of 18-0-methyl mycalamide prior to the 
launch of the investigations described herein.
2.2 Objectives of the present work
1. To apply the aforementioned approach to 2.1 and 2.4 towards the design of an
improved route towards pederin;
2. To complete and improve the total synthesis of mycalamide B.
3. To synthesise analogues of pederin in order to assess their biological activity.
However, a crucial requirement is to make use of the key aforementioned metallated 
dihydropyran approach in the synthesis of each member of the pederin family.
2.3 Synthetic strategy
As shown in scheme 2.2 the synthetic strategy for pederin 1.1, mycalamide B 1.5, 
17-epi-mycalamide B, and analogues 2.8, 2.9, 2.10 uses the lithiated dihydropyran 1.59^2 
2 ,^ which is accessed either from stannane 2.2 or 2.3. Studies on the coupling reaction 
(Chapter 3) showed that the tributylstannane 2.3 is a more efficient intermediate than its 
trimethylstannane analogue 2.2. Newly developed methodology, unpublished, has been 
used to access 2.3 by the reaction of a mixed cyano-staniiyl cuprate with the enol triflate 
derived from lactone 2.1. The key steps in the synthesis of pederin or its analogues are 
Sharpless asymmetric dihydroxylations and a rhodium-catalysed directed reduction of an 
acylimidate.The key steps in the synthesis of the right fragment of mycalamide B 1.5 are a 
P2 0 5 -mediated formation of the trioxadecalin ring, a Meerwein-Pondorf-Verley reduction 
to install the C l3-stereogenic centre, installation of the CIO-N bond in good yield and total 
stereocontrol at the CIO centre via  a Curtins rearrangement and/or a Hofmann 
rearrangement, as well as Sharpless asymmetric dihydroxylations.
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Thereby, after a brief description of the synthesis of lactone 2.1, formation and application 
of stannanes 2.2 and 2,3 to the coupling reaction will be discussed in chapter 3. Chapter 4 
is devoted to a brief description of the synthesis of enone 2.4, whereas chapters 5, 6 , and 7 
will detail the total (or formal) syntheses of pederin 1.1, mycalamide B 1.5 (and its 17- 
epimer) and analogues 2.8-2.10 respectively. Finally, Chapter 8 is concerned with the 
biological activity of certain interaiediates and synthetic members of the pederin family.
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Chapter 3 Construction of the left fragment
SePh
2 2  R = Me 
25  R = Bu
Figure 3.1
Vinyl stannane 2.2 is an intermediate, common to our synthesis of pederin 1.1 and 
mycalamide B 1.5, and has been previously synthesised by Koeienski and co-workers 
during a synthesis of pederin 1.1.^^ The synthesis was too long and expensive; therefore, 
during the years 1996-1997, renewed efforts by Dr P. Raubo and Dr C. Smith concentrated 
on a more efficient synthesis of the lactone 2.1. Lactone 2.1 was obtained in 13 steps from 
the cheap and readily available ethyl (S')-lactate (£1.60/mole) with nothing but distillations 
and recrystallisations as means of purification until reaching advanced intermediates. The 
key steps of this synthesis are a 1,4-conjugate addition of a methyl cuprate to homochiral 
enoate 3 .2  and a diastereoselective allylation of the corresponding potassium enolate of P- 
methyl ester 3.3.
3.1 Description of the synthesis of lactone 2.1
Ethyl (6")-lactate 3.1 was transformed in three simple steps to the a,P-unsaturated ester 3.2 
in 71% overall yield on a 0.26 mol scale."^  ^ A diastereoselective conjugate addition of 
lithium dimethylcuprate to the ester 3.2 in the presence of HMPA and TMSCl at -95 
afforded adduct 3.3 in 75% yield (dr 24:1). The final C-C bond forming reaction in the 
sequence was also highly diastereoselective. Alkylation of the potassium enolate of the 
ester 3.3 with allyl bromide gave the third contiguous stereogenic centre in 3.4 in 80% 
yield (dr 22 :1) (scheme 3.2).
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Ground state conformational models have been proposed to explain the 
stereoselectivity of the foregoing reactions. Yamamoto's model for the diastereoselective 
conjugate addition of various organocopper reagents to y-alkoxy-a,p-unsaturated carbonyl 
derivatives places the best electron donating group perpendicular to the plane of the n- 
system and the OTBS group in the more sterically demanding "inside p o s itio n " .T h e  
clear steric discrimination between the diastereotopic faces as indicated in structure 3.5 
accounts for the anti attack of the nucleophile giving the anti-adduct 3.3. Houk's 
"electrophilic rule" rationalises the diastereoselective alkylation of enolates with adjacent 
stereogenic c e n tre s .T h u s  the eclipsed conformation 3.6 placing the hydrogen of the 
stereogenic centre in the plane of the 7t-system again causes steric discrimination between 
the two diastereotopic faces of the enolate leading to alkylation as shown in structure 3.4. 
Con’oborating evidence for the Houk model has been presented.
Routine transformations accomplished the conversion of 3.4 to the alcohol 3.9 
(scheme 3.3) but the Mitsunobu reaction used to invert the configuration at C-2 
(mycalamide numbering) in alcohol 3.9 was plagued by a competing elimination to give 
alkene 3.11. A number of variations in carboxylic acid and azodicarboxylate ester 
eventually established that the combination of trityl as the protecting group, p- 
chlorobenzoic acid as the nucleophile, and diisopropyl azodicarboxylate as the activator 
returned the ester 3.10 in 76% yield together with only 5% of the elimination product 3.11 
which was easily separated by column chromatography— the first in the sequence. Any 
minor diastereoisomers were easily separated by crystallisation of the p-chlorobenzoate 
3.10.
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Oxidative cleavage of the alkene 3.10 (scheme 3.4) followed by acid treatment 
achieved simultaneous trityl deprotection and lactonisation to give the second crystalline 
compound of the series, the lactone 3.13 The phenylselenide group in 3.14 was introduced 
by nucleophilic substitution of the butyrolactone 3.13.^^ Saponification of the p- 
chlorobenzoate ester in the usual way using hot 2 M NaOH was accompanied by an 
unexpected side reaction: épimérisation at C-2. Although the extent of épimérisation was 
small (ca 5 %), suppressing it altogether was obtained by performing the cleavage with an 
"ate" complex derived from addition of BuLi to DIBAL-H.^^ The resultant hydroxy acid
lactonised to give 2.1 in 72% yield.,02GC6H4CI
OTr 
3.10
RuOg'SHgO.NalO.;
MeCN-CCt4-H 2 0 , rt, 7 h 
95%
•*.^ .02GGgH4G!
OTr
3.12
ÆG6H4CI
SePh
3.14
TsOH,MeOH
rl,4 h
PhSeNa
E ton, A, 1 Oh 
80%
(a) [Bu'aAI(H)Bu]U, CHjClr-THF, -78  °C
(b) H C l,r t,2 4 h
SePh
2.1
Scheme 3.4
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3.2. Syntheses of stannanes 2.2 and 2.3 from lactone 2.1
Conversion of lactone 2.1 to the trimethylstannane 2.2 had already been reported in our 
previous synthesis of pederin by a 3-step sequence (yield 70%). The conversion 
involves a Pd(0)-catalysed Stille coupling between the enol triflate intermediate 3.21 and 
the expensive and toxic hexamethylditin (£19.70/g) as shown in scheme 3.8. This approach 
was used in the synthesis of pederin, mycalamide B, and 17-epi-mycalamide B (chapters 4- 
6).
Two aspects of the coupling reaction require further comment. First, the method used here 
is inherently wasteful, since one equivalent of lithiated dihydropyran 1.59 was squandered 
in abstracting the amide proton. Attempts to improve the stoichiometry by using a 
sacrificial lithium reagent (BuLi) in model systems were foiled by rapid competing 
addition of the butyllithium to the oxalamide. Secondly, the yield of the coupling was 
variable; whilst a 40% yield is typical, >70% was also obtained in related systems (scheme
3.5). Success in this reaction was experimentally related to the amount of transmetallated 
dihydropyran (estimated by TLC) which was variable as well. Literature studies on 
transmetallation between trimethylstannanes and tributylstannanes led us to compare their 
reactivities on our substrates.
MeO,
0 \ / S n M %  (gj nBuL I{1.O aq),TH F,-70°C
(b) TMEDA
SePh
O O'
SePh 'S eP h SePh
(> 2 . 0  eq) 
1.59
Scheme 3.5
Indeed, J. M. Chong in 1998 showed that a-alkoxyorganotrimethylstannanes do not 
undergo transmetallations as well as their tributyl analogues.Schem e 3.6 exemplifies the 
difference in reactivity.
OBOM
Me^ '^ SnBug
3.15a
(a) nBuU (I.Oeq) OBOM
(b) COg FP 
92%
0 .HMe vvugi
3.16
OBOM (a) nBuU (IO eq)
M e" "SnM ea COaiH^
58%3 .15b
OBOM
M e" 'O O 2 H 
3.16
Scheme 3.6
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While tributylstannane 3.15a underwent quantitative transmetallation with 1 equivalent of 
BuLi to provide an a-alkoxyorganolithium species which could be trapped in 92% yield 
with CO2, the trimethylstannane 3.15b required 10 equivalent of BuLi in order to generate 
reasonable amounts of a-alkoxyorganolithium and still only provided 58% yield of the 
same trapped product 3.16.
In the above example, it is likely that the difference in transmetallation chemistry of 3.15a 
and 3.15b is due to the difference in stabilities (ie relative acidity) of organolithiums 
involved. In fact, McGarvey has shown that the stability of organolithiums decreases in the 
order: RiQCH^Li > RlOCH(R2)Li > MeLi >RlOCR2R3Li > nBuLi > c-HexLi (Rl = 
MOM).^  ^Based on this ranking, Chong concluded that treatment of organostannane 3.15b 
with BuLi should provide organolithium BOMOCH(Me)Li selectively rather than MeLi 
but with some degree of competition.
Although our lithiated dihydropyran 1.59 (scheme 3.5) should be more stable than a 
saturated a-alkoxyorganolithium  analogue, synthesis of tributylstannane 2,3 was 
attempted. Unfortunately, using the same Pd(0) catalysed Stille-type procedure ^2.75 
the bulky hexabutylditin occurred in very poor yield (14%). A more efficient synthesis was 
necessary. Fortunately, Tanya Wildman, a PhD student in the Koeienski group (1999- 
2002) was working on routes to vinylic stannanes from enol triflates using Lipshutz's 
mixed trialkylstaiinyl cyano cuprates^^ (unpublished results). Working on simple lactones 
such as 3.17 (scheme 3.7), she not only simplified and improved the preparation of enol 
triflates (e.g. 3.18), but she also showed on simple lactones that reacting the corresponding 
enol triflates with (Bu3Sn)Bu-CuLi-CNLi yields the corresponding vinyl tributylstannane 
(e.g. 3.19) in good yield along with a little of the corresponding destannylated 
dihydropyran (e.g. 3.20) (10-15%).
C y H is ^ O ^ O  C 7 H i5 ^ 0 ^ 0 T f  G7Hi5..^^^^^SnBu3
T H F ,-7 8 “C ,3 0 m In
(a) BuU (2.6 eq),T H F, -78°C, 5 min
CuCN
(1 3  eq) (b) BusSnH (2,8 eq), THF, -7 8 ° C, 20 m in
-78 “C. 15 m h
Bu(Bu3Sn)CuU-CNU + Hj + Bu^Sn
3.19 3 i 0
72% 9%
determined by H NMR 
(CDCI3,400MHz) on crude
Scheme 3.7
Although this methodology is being optimised, the tributylstannane 2.3 was obtained in 
good yield (62-85%) along with dihydropyran 3.14 (10-15%) as a byproduct (scheme 3.8) 
using Wildman's procedure.
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Scheme 3.8
3.3 Recycling of dihydropyran 3.14
As shown in scheme 3.5, dihydropyran 3.14 is produced as a byproduct in large quantities 
in our coupling reactions, since an excess of 2  equivalents of the precious stannanes 2 .2  
and 2.3 is used. Acid catalysed hydrolysis of dihydropyran 3.14 produced the 
corresponding lactols 3.22 in good yield (98%, dr ~ 55:45, in favour of the equatorial 
hydroxyl). Oxidation of lactols 3.22 to recover the previously described lactone 2.1 was 
foiled by competitive oxidation of the selanyl ether (scheme 3.9). Alternatively, lactols 
3.22 were readily transformed into the sulfones 3.23 by reaction with phenylsiilfinic acid in 
the presence of CaCh. Deprotonation of the resulting sulfones, followed by direct 
condensation with tributylstannyl chloride and heating in chloroform containing Hiinig's 
base, affords the vinylstannane 2.3 efficiently.^^’
2 N H C I:T H F (1:1)
r t . lO h
SePh 3.22 ^ S e P h
98% c ishrans = 5 5 :4 5
Xt
PhSC ^H (1 eq),C aC lg(2 .5eq)
CHzCIg.q
91%
O. S^OaPh
SePh
2.1 ^ S e P h
(a) nBuLi (1.05 eq), THF, -78'*C, 30  m n 
(b BugSnCI (1.05 eq), THF, -7 8  ^  - 1 0“C, 3 h
(c) evaporate to d ryness
(d) D IP E A (1 5 eq ),C H C l3 ,7 0 °C ,4 h
SnBUg
S e P h
6 2% ( 55%  from 3.14)
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Scheme 3.9
3.4 Conclusion
We have now in our hands a very efficient and economical synthetic route towards lactone 
2.1. Both stannanes 2.2 and 2.3, precursors of the lithiated dihydropyran 1.59, are now 
easily accessible from lactone 2.1. Bearing in mind that our aim is to use the same 
metallated dihydropyran approach for every member of the pederin family, we are now 
ready to compare the reactivities of 2.2 and 2.3 in this reaction. Finally, the previously 
wasted dihydropyran byproduct 3.14 is now recycled in good yield, rendering the coupling 
reaction less wasteful.
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Chapter 4 : Synthesis of Dihydropyranone 2.4
Figure 1
Dihydropyranone 2.4 is a critical intermediate in our synthetic strategy because it could, in 
principle, be converted to the simple monocyclic system of pederin as well as the more 
complex trioxadecalin ring system of the mycalamides, onnamides and theopederins. The 
3 -chloropropyl side chain in 2.4 also satisfied the need for an inert latent alkene which 
could be fashioned into any of the side chain variations of the pederin family. The 
optimised route^^ towards 2.4 is briefly described here
4.1 Creation of the ClS-stereogenic centre
Dihydropyranone 2.4 harbours a single stereogenic centre at C-15 (mycalamide 
numbering) which was constructed efficiently by two different routes. In the first route, the 
lithium enolate prepared from ethyl isobutyrate was condensed with 4-chlorobutanoyl 
chloride to give the /3-keto ester 4.2 in 93% yield (scheme 4.2). Noyori catalytic 
asym m etric hydrogenation of the j6 -keto ester 4 .2  using [{R )-{+)-2,2'- 
bis(diphenylphosphino)-1,F-binaphthyl] chloro (p-cymene) ruthenium chloride®^'^^ 
installed the requisite (T^)-configured stereogenic centre in good yield and high 
enantiomeric ratio (97:3). The reaction worked well on a 50 mmol scale but on scaleup to 
150 mmol, the reaction time was variable and occasionally it failed to go to completion. 
Moreover, the ruthenium catalyst was expensive and commercial supplies gave variable 
activity. Economy, scale, cost and reliability led us to an alternative synthesis of ^-hydroxy 
ester 4.3 using an asymmetric directed aldol reaction mediated by the scalemic borane 4.5 
according to the method of Kiyooka.^^’ Although the Kiyooka method requires 
stoichiometric amounts of the borane 4.5, it was easily prepared from cheap crystalline N- 
tosyl valine which was recovered in pure form after one recrystallisation in 90% yield. The 
directed aldol approach gave comparable yields and enantioselectivity and its ease of 
execution won our favour.
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EtCL^ OTMS
tl CKCHzkCHO
4.4
4.5, T H F ,-7 8  “G, 1.5 h
95%
" C .
4.2
RupiN A P)
Q^ ^OEt
4.3 (er 97:3)
Scheme 4.2
Cl-
Ph
[(R)-BINAP][p-cumene]RuCl2
A conformation of 4.3 is represented diagramaticaiiy in scheme 4.3 and is based on MM2 
calculations performed by Kiyooka.^^ The isopropyl group governs the position of the 
sulfonamide group and together they define the co-ordination site for the aldehyde. The 
aldehyde co-ordinates with its Si face exposed to nucleophilic attack whilst co-ordination 
exposing the Re face of the aldehyde to nucleophilic attack is disfavoured due to steric 
repulsion.
Nucleophile allaoks 
a t  Sf face
N. ' ,0
Favoured conformation 
0 1  a idehyde binding to boron
disfavoured confirmation 
of aldehyde binding to boron
Scheme 4.3
4.2 Conversion of P-hydroxy ester 4.3 to dihydropyranone 2.4
To complete the synthesis, the ring was constructed by Dieckmann cyclisation of the 
acetate 4.6 to give the highly crystalline jS-keto lactone 4.7 which could be easily obtained 
enantiopure by crystallisation (scheme 4.4). Simple 0-methylation under phase transfer 
catalysed conditions afforded the crystalline enol ether 4.8. Reduction of the remaining 
carbonyl with DIBAL-H returned the desired dihydropyranone 2.4 in 50-52% overall yield 
from ethyl isobutyrate. Note that none of the steps depicted in scheme 4.2 required column 
chromatography.
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Chapter 5 : Synthesis of Pederin
O M e O M eO
OH
OH
O M e
O M ePederin  1.1
Figure 1
5.1 A formal synthesis of pederin
Koeienski and co-workers had already described a synthesis of pederin from the metallated 
dihydropyran 2.2 and the nitrile 2.5 which was expensive and impractical.^^ The ready 
accessibility of dihydropyranone 2.4 on a large scale stimulated a fresh approach to the 
synthesis of nitrile 2.5 which is far more practical. Below, we summarise the conversion of 
dihydropyranone 2.4 to nitrile 2.5 which, together with our much improved synthesis of 
metallated dihydropyran 2 .2  reported herein, represents a new formal total synthesis of 
pederin (schemes 5.2-5.4).
5.1.1 Construction o f the C ll  centre
Conjugate addition of trimethylsilyl cyanide to dihydropyranone 2.4 catalysed by TMSOTf 
gave the nitrile 5.1 as a single isomer in 92% yield. The pseudo axial disposition of the 
cyano group was evidenced by 360 MHz NMR spectroscopy (scheme 5.2) and is the 
result of both a double stereoelectronic control in the transition state leading to its 
formation. Thus, attack via path a proceeds through the flattened chair 5.9a with additional 
stabilisation from the anti-periplanar lone pair adjacent to the newly formed bond, whilst 
attack via path b must proceed through the higher energy twist boat 5.9b which also lacks 
a suitably aligned lone pair on the pyran oxygen. Prediction of the dihydral angles between 
C13-H and both C l2 protons using MM2 calculation (Chem3D) as well as their coupling 
constants [^H NMR spectroscopy (360 Hz, CDCI3)] are in agreement with Karpins rules^^ 
(scheme 5.2). Occupation of the pseudo-axial position of the nitrile thereby confirmed the 
stereoselectivity.
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Scheme 5.2
5.1.2 Construction o f the C13 stereogenic centre
Luche reduction^^ of the carbonyl group was diastereoselective affording a quantitative 
yield of diastereoisomeric alcohols (dr 30:1) from which the pure desired isomer 5.2 
(scheme 5.3) could be obtained by crystallisation. In this reaction the stereoelectronic 
preference for axial attack was not subverted by the presence of the sterically undemanding 
axial nitrile group. Experimentally the best diastereoselectivity was obtained in the 
presence of CeCl] trihydrate at low temperature (-95 °C) adding a large excess (4 eq) of 
sodium borohydride in one batch to the reaction mixture. However the diastereomeric ratio
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was determined by NMR (360 MHz, CDCI3) spectroscopy by integration of signals 
(dd) of C ll-H  at Ô = 4.91 ppm (major) and 4.81 ppm (minor). The structure was confirmed 
after protection of the hydroxyl as its TBS ether by NMR (360 MHz, CDCI3) as shown 
in scheme 5.3
NaBUi, CeCls-7HzO Ma OH-95 tO - 6 0 ° C ,3 h NG-,
5 . 2  (dr 30:1) 
m p 71-72°G
Gl
5.1
mp 36-39 "G
TBSOTf, 2,6-lufdine
C H sC ls.O loaX !, 2 .5 h 
99%
Cl
11 13
mp 4 4 -4 6 °G
O TBS
CN
NMR (360M Hz, GDGb)
6 (ppm) coupling constants
h ] 3:67 j J ;2 = 5 :2 H z j J'I = 118 Hz
Scheme 5.3
5.1.3 Construction of the side chain
After displacement of chloride with sodium phenylselenide, the alkene was generated by 
thermolysis of a selenoxide intermediate giving terminal alkene 5.5. Experimentally, to 
avoid the side reactions or disproportionation reactions involving selenic acids 
triethylamine was added to the organic extracts immediately after the work up. This 
method has become our method of choice and was used in every syn elimination of alkyl 
selenoxides in the following chapters. Several chiral ligands for the Sharpless asymmetric 
dihydroxylation of olefin 5.5 were screened [(DHQ)2 P Y R ^ ^ \ (DHQD)2PYR, 
(DHQ)2PHAL^o^ (DHQD)2PHAL^03^ (DHQ)29-phenanthryl ether^o^^ (DHQ)2-4 -methyl- 
2 -quinoyl ether^ ®"^ , (DHQD)2PYDZ^^^ and (DHQ)2AQN^°^) but the diastereoselectivity 
was modest at best (scheme 5.4). The diastereomeric ratio was determined by integration 
of the signal (dd) derived from C ll-H  in the ^H NMR spectrum at 6  = 4.90 (5.6b) ppm and 
5  = 4 .8 6  (5.6a) ppm and the stereoconfiguration was confirmed at the next step.
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Scheme 5.4
The desired (176")-diol 5,6a was then methylated to give the crystalline nitrile 2.5 which 
was converted to pederin as described previously.
5.2 Completion of the right fragment of pederin
From the nitrile 2.5, pederin was synthesised as described previously^^ (schemes 5.5 and
5.6), with comparable results. This route deserves further comments since a similar
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strategy is applied to the synthesis of analogues of pederin (chapter 7). Nitrile 2.5 was 
converted to fragment 1.64 in four steps. Both imidate 5.12 and ester 1.62 were prone to 
hydrolysis and the yield was maximised by proceeding to 1.64 quickly with minimal 
purification of intermediates. Rhodium-mediated reduction of the N-acylimidate 1.62 
proceeded with high stereoselectivity yielding 1.64 with 30:1 selectivity after column 
chromatography (scheme 5.5). Integration of the signals (dd) arising from CIO-H at Ô = 
5.21 ppm (major) and 5 = 5.12 ppm (minor) determined the ratio of the diastereomers.
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O M e
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1.61 O M e
O M e
O T B SHN
5.12 O M e
O M e
MeOaC-COCI, py 
CHgClg, —50Tv, 10 min
O M eO
MeO. O TBS
OM e1.64
OMe
catecholborane, R h C p P h s]
PliVle.-7CFC. 20 h 
63% (3 steps)
O O M e
MeO..^^^
1.62
O T B S
O M e
O M e
Scheme 5.5
A mechanism for the reduction involving a rhodium-catalysed 1,4-hydroboration reaction 
is proposed in scheme 5.6. Previous studies have demonstrated that high levels of 
stereocontrol were achieved in the formation of the unwanted diastereomer 10-^p/-1.64 in 
accord with a preferential attack on rotamer 1.62b from the least hindered face of the N- 
acylimidate function. Consequently, stereoselective reduction in the desired sense requires 
some means for enhancing the population of rotamer 1.62a or, alternatively, a means for 
delivering hydride from the more hindered face of 1.62b. The rhodium complex 1.63c in 
which the N-acylimidate side chain serves as a bidentate ligand in the rhodium complex 
derived from oxidative addition of Rh(I) to the borane. In this complex, the 
triphenylphosphine ligand very effectively shields the Si face of the A-acylimidate thereby 
directing reduction to the desired Re face. According to models, the corresponding 
complex from rotamer 1.62a suffers from severe steric congestion with the TBS protecting 
group at C13. It has been shown that the role of the protecting group in ensuring 
preferential formation of complex 1.63c is crucial since the reduction of the A-acylimidate
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bearing an O“benzoyl function at the C l3 was much less diastereoselective (3:2 vs
>10:1)V
OMe
O M e
MeO.
MeO.Rh OM e
MeO.
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O M e
OMe
O M e
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O M e
T B S O
1.62b
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Scheme 5.6
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5.3 Coupling and completion
Transmetallation of the trimethylstannane 2.2 and reaction with ester 1.64 in the presence 
of TMEDA at low temperature gave adduct 1.60 in modest yield (47%) as shown in 
scheme 5.7. With the bulk of the pederin skeleton now constructed, completion of the 
synthesis required the introduction of the two adjacent stereogenic centres at C6  and C7 as 
well as a few functional group transformations. The reduction of the carbonyl at C l 
required the bulky reducing agent LiBH(^“Bu)3 to yield the corresponding alcohols with 
modest stereoselectivity (3:1). The diastereomeric ratio was determined by integration of
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the signal (s) derived from C7-H in the NMR spectrum (400 MHz, CDCI3) at 5 = 5.53 
(major) ppm and Ô = 5.55 (minor) ppm. Addition of methanol in the presence of 
camphorsulfonic acid followed by the protection of the hydroxyl at C7 yielded the desired 
compound 1.65 as a mixture of diastereoisomers 1.65a,b. Separation of 1.65a and 1.65b 
was accomplished easily by preparative thin layer chromatography. Pederin was finally 
obtained by elimination of the selenoxide, hydrolysis of the benzoate, and TBS 
deprotection. The NMR and NMR of pederin 1.1 were recorded in CgDg to avoid 
decomposition of this acid-sensitive compound that had been previously reported^^ using 
CDCI3 as the NMR solvent.
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Chapter 6 : Total synthesis of Mycalamide B and 17-epi-MycaIamide B
OMe O o O oO N
OH ^
)H
Mycalamide B (1.5)
Figure 6.1 
6.1 Construction of the 1,3-dioxane ring
Construction of the 1,3-dioxane ring required a 3-stage sequence of 7 steps 
comprising appendage of a 2-carbon unit to the dihydropyranone; two oxidations at CIO 
and C12; and finally ring closure.
6.1.1 Construction o f the Cll-centre
The first stage was accomplished in high yield (80%) and high diastereoselectivity (dr 
95:5) by Cu(I)-catalysed conjugate addition of vinylmagnesium bromide to 
dihydropyranone 2.4 as shown in scheme 6 .2 . The 1,4-addition of a cuprate or 
organomagnesium reagent to an a,|3-unsaturated ketone is an ineversible p r o c e s s A s  a 
consequence, the products should be governed by kinetic c o n t r o l ^ a n d  the 
stereoselectivity can be explained by the relative energies of the transition states. Indeed, 
attack via path a proceeds through a chair like enolate 2.4a whilst attack via path b must 
proceed through the higher energy boat like enolate 2.4b. The stereochemistry at the €11 
centre was confirmed by NMR spectroscopy with the coupling constants between both 
€12 protons and C ll-H  being 6.0 Hz (scheme 6.2).
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6.1.2 Construction o f the ClO-centre
Attempts to launch the second stage by substrate controlled dihydroxylation gave poor 
diastereocontrol [10(i?):10(5') 2:3] so the task was accomplished using the Sharpless 
asymmetric dihydroxylation (scheme 6.3).^^^ Using 20 mg of substrate, several ligand 
systems were screened but the diastereoselectivity was modest at best: AD-mix-a 
[10(S):10(i?) 1:2], AD-mix-(3 (2:1), (DHQ)2PYR10  ^ (1:3.5), (DHQD)2PYR (2.6:1), 
DHQD-PYDZ^^^ (1.3:1) and DHQ 4-methyR2-quinolyl ether^^"  ^ (1:7.5). Best results were 
obtained with DHQ 9-phenanthryl e t h e r w h i c h  gave a 75% yield of diols with dr > 10:1 
in favour of the desired 10(7?) derivative 6.2. The ratio between the two diastereoisomers 
was determined by iH NMR spectroscopic analysis by integration of the signals derived 
from C14-Me [^H NMR (360 MHz, CDCI3) : Ô = 1.28 ppm (minor) and 1.26 ppm 
(major)]. The diols were inseparable but the corresponding monopivalates were separable
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by simple crystallisation from ether-hexanes to afford pure 6.3 in 78% yield. The 
remaining hydroxyl group was converted to its crystalline MOM ether 6.4 which not only 
served as a protecting group, but also as an essential participant in the final ring 
construction.
HO
Sharpless AD
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dr 95:5
6.2
dr>10:1
PvCI( 2 equiv.) 
pyildine(3 equiv.) 
C H aC b .O 'C , 1 h 78% (from 6 .1)
MOMO HO
P  MOMCI, DIPEA,BU4 NI 
)PV 0  —  PhMe,^^^JC, 2 h i p v
Cl
6.4
mp 42-43 ”0 6.3mp 6 9 -7 0 °0
Scheme 6.3
6,13 Construction o f the trioxadecalin ring
The second oxidation was accomplished by simple epoxidation of the enol silane 
derivative 6.5 prepared from ketone 6.4 and TBSOTf. Two aspects of the conversion 6.5 to 
6 .6  are noteworthy. First, the epoxidation was highly diastereoselective giving virtually a 
single diastereoisomer with the desired stereochemistry at C12 (scheme 6.4). Secondly, the 
oxirane 6 .6  was surprisingly stable— e.g., it could be purified by silica gel chromatography 
without detriment though in practice, the crude product was generally used in the next step.
The very favourable stereochemistry of the epoxidation of enol silane 6.5 deserves 
comment. We had originally expected difficulty with this step because it would appear that 
epoxidation was required from the same face of the ring as the bulky and branched side 
chain at Cl l .  However, the C11 side chain can occupy a pseudo-equatorial position in the 
half chair conformation as shown in Scheme 6 .8  in which it offers comparatively little 
steric impediment to the approach of the oxidant compared with the pseudo-axial 3- 
chloropropyl side chain at C15. Indeed, an MM2 calculation (ChemSD) predicts that the 3- 
chloropropyl side chain protrudes over the ring somewhat thereby exacerbating its steric 
effect hence forcing the epoxidation to take place as shown. The favourable 
stereochemistry could be ascribed to tethered delivery of the m-chloroperbenzoic acid via a
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hydrogen-bonded intermediate but the same favourable stereochemistry was also obtained 
with dimethyldioxirane in which hydrogen bonding is precluded.
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During a synthesis of the trioxadecalin nucleus of mycalamide A, Roush^^ had prepared 
the methylene acetal in 6.10 (Scheme 6.5) by adding phosphorus pentoxide to a solution of 
diol 6 .9  in dimethoxymethane according to literature precedent.
HO . . O H
CH2(0M6)2 
23 "G
R =Bu^Me2 Si
Scheme 6.5
We found that the methylene acetal could be constructed directly by adding the oxirane 6.1 
to a solution of phosphorus pentoxide in dichloromethane containing a large excess of 
dimethoxymethane at 0 °C. An overall yield of 77% was obtained for the three steps from 
ketone 6.4 to methylene acetal 6.7 with a diastereoselectivity of 15:1. The methylene acetal 
could be obtained as a single diastereoisomer by simple crystallisation from ether-hexanes.
A possible mechanism of the formation of the ketone 6.7 is given in scheme 6 .6 .
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However, experimentally, both a lower yield (70%) and lower diastereoselectivity (ca 8:1) 
was obtained when the phosphorus pentoxide was added to a solution of the oxirane in a 
mixture of dimethoxymethane in dichloromethane. Thus another plausible mechanism for 
this reaction is given in scheme 6.7.
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6.2 Installation of the C13-centre
The reduction of the C l3 carbonyl which introduced the single remaining 
stereogenic centre on the ring was thwarted by poor stereoselectivity (scheme 6 .8 ). The 
most favourable ratio of 6.11a:6.11b (1 :1) was obtained with KBH4 and CeCl3*7 H2 0  in 
MeOH at -90  to -20  °C ; all other variants gave mixtures rich in 6.11b. BHg'THF and 
LiBH(5-Bu)3 gave exclusively 6.11b; Rhodium-catalysed hydrosilylation gave 
predominantly 6.11b. Dissolving metal reduction (Na, Sml2) gave decomposition but Mg 
in MeOH gave a 1:1 mixture with competing reduction of the chloride. Fortunately, the 
diastereoisomeric alcohols were easily separable thereby allowing a recycling process. A 
reason for the poor stereoselectivity can be gleaned from the ground state conformation of
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the ketone 6.7: formation of the desired stereoisomer 6.11a requires delivery of hydride 
from the more hindered concavity of the cï^s-fused trioxadecalin system. This recalcitrant 
reduction was the greatest obstacle to progress until a simple, convenient and effective 
solution to the problem was found in the form of a modified Meerwein-Ponndorf-Veiiey 
reduction. Thus treatment of ketone 6.7 at room temperature with a reagent prepared hy 
reaction of isopropanol with trimethylaluminium (3.8 equiv.) gave a mixture of 6.11a and 
6.11b in 6 6 % yield with a dr of 6:1 in favour of 6.11a. Starting ketone 6.7 was also 
recovered (28%) making the yield based on recovered starting material 92%. The 
reversible nature of the Meerwein-Ponndorf-Verley reduction is well known to afford the 
thermodynamic alcohol. Evidence that 6.11a is the thermodynamic product comes from 
two observations. First, the dr of the reaction was a function of time with the mol fraction 
of 6.11a increasing with time. Secondly, subjection of the pure axial alcohol 6.11b to the 
reaction conditions led to isomérisation. Attempts to drive the reduction to completion by 
removing the acetone at elevated temperature led to diminished dr. O-Méthylation of 6.11a 
gave a methyl ether 6 .1 2  whose stereochemistry was assigned based on the large coupling 
constant J i2 ,i3 10.4 Hz for C13H consistent with a trans-d\2ixidX disposition of the vicinal 
hydrogens as indicated in structure 6 .1 2 '.
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6.3 Installation of the CIS side chain
The C l5 side chain is the principal seat of structural variation in the pederin family 
and our route was designed to access as many members of the pederin family and their 
analogues as possible. The chloropropyl side chain was introduced at the outset because it 
offered opportunities for nucleophilic substitution or elimination and thence a rich vein of 
transformations. For the synthesis of mycalamide B, we required an elimination reaction. 
However, neither the chloride nor iodide would eliminate without severe decomposition. 
Therefore, we were forced to adopt a regrettable 3 step sequence involving substitution by 
phenylselenide anion to give phenylseleno ether 13 (scheme 6.9) whence thermolysis of 
the corresponding selenoxide afforded the desired alkene 6.14 in excellent overall yield 
(94%) for the 3-step sequence from 6.12.
6.12 6.13 &14
Scheme 6.9
To complete the elaboration of the C15 side chain (scheme 6.10) we performed a 
Sharpless asymmetric dihydroxylation as Hong and Kishi^'^ had done before us. The 
diastereoselectivity was poor giving a mixture of diols (dr 3:2) which was difficult to 
separate but the conesponding mono-TBS ethers were separable by chromatography and 
gave the desired alcohol 6.15a as a crystalline solid together with its C17 epimer 6.15b. 
Both compounds were converted to their respective methyl ethers 6.16a and 6.16b. As 
before the whole gamut of standard ligands used for the Sharpless asymmetric 
dihydroxylation was surveyed in the search for improved diastereoselectivity but to no 
avail. Once again DHQ 9-phenanthryl ether^^"  ^maximised the desired diastereoisomer but 
the highest diastereoselectivity (9:1) was obtained with (DHQD)2PYR^^^ with the major 
isomer being the unwanted C17 epimer 6.16a. The stereochemistry of the desired alcohol 
6.16a was established by X-ray analysis of a subsequent advanced intermediate (see 
below).
61
9T?
OPv
6.14
(a) Sharpie: 
(bjT B SC l.l
O '" .  O
OH
6 .15a
mp 32-34 “0
d r3 2
iTBS
l s s  AD 
NEtg, DMAP.CHjCIa
(c)separalG
S '^ ^ tbs
Oh
6.15b
76% MeOTf, 2 ,6 -di -f-B u-4 -M e  py rid ine P h M e ,7 0 ° C ,4 h 74%
OPv O^J ^
iTBS
OMe
6.16amp 30-32 “C
o d ^
OMe
6.16b
TBS
Scheme 6.10
6.4 Installation of the A -^acyl aminal function
The last remaining task in the synthesis of the trioxadecalin fragment entailed the 
introduction of the A -^acyl aminal function. The acid- and base-lability of the A -^acyl aminal 
together with the threat of isomérisation under basic conditions demanded a mild, and 
reliable route. Our optimised solution is depicted in scheme 6.11. Reductive cleavage of 
the pivalate ester 6.16a followed by oxidation of the primary alcohol 6.17 using the 
Sharpless protocol^ gave the carboxylic acid 1.55 which was converted to the 
corresponding primary amide 1.74 using standard procedures. A classical Hofmann 
rearrangement using Ag(I)-assisted r e a r r a n g e m e n t o f  the A-bromoamide derivative 
occurred at room temperature with clean retention of configuration to give an isocyanate 
intermediate which was trapped by 2-(trimethylsilyl)ethanol to give the carbamate 1.75 in 
79% overall yield from the alcohol 6.17. Alternatively, the Hofmann rearrangement could 
be induced by reaction of amide 1.74 with l,l-bis(trifluoroacetoxy)iodobenzene^^^’ but 
the yield was slightly lower (73%). The Curtius rearrangement of an acyl azide derived 
from acid 1.55 is a well-precedented route to the carbamate 1.75 (see below) which we also 
evaluated. However, the elevated temperatures (70 °C) required for the rearrangement 
resulted in decomposition with an overall reduction in yield to 56% at best with typical 
yields being more like 40%. Attempts to reduce the temperature by employing the
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photochemical variant of the Curtius rearrangement were rewarded with a multiplicity of 
products and so the route was abandoned in favour of the Hofmann rearrangement.
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I H IV ^ A jJ ,p .^ O M e  ^)DCC, HOBt HgNIT T hT DMF, fl,3h
CC - aC - 20 rt, 3 h
OTBS OTBS
#  NHg, 15 min 90% (from 50)
O M e
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The remaining 2-carbon fragment was installed by reaction of carbamate 1.75 with 
methyl oxalyl chloride in the presence of DMAP^^ to yield the imide derivative 1.76. 
Although the reaction required 6  days to go to completion, the yield of the imide was 
excellent (98%). To complete the sequence, the urethane function was cleaved using TBAF 
buffered with acetic acid to give the crystalline trioxadecalin fragment 1,77 in 73% yield. 
In the absence of acetic acid, the primary TBS group was also partially cleaved. The 
structure and relative stereochemistry of 1.77 was firmly established by X-ray 
crystallography (Fig. 6.1).
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Fig. 6.1 X-ray crystal structure of compound 1.77 showing the atom numbering and 20% 
probability ellipsoids for non-hydrogen atoms.
6.5 Coupling and completion of the synthesis of mycalamide B
The principal task required to complete the synthesis of mycalamide B was the 
construction of the A^-acyl aminal bridge linking the two ring systems by deploying the 
same linkage strategy as previously described. Thus addition of the trioxadecalin fragment 
1.77 (scheme 6.12) to a mixture of the lithiated dihydropyran 1.59 (2.7 equiv.) (derived 
from the trimethylstannane 2.2) and 7/TV -tetramethylethylenediamine (TMEDA) at
low temperature gave the adduct 6.18 in 41% yield.
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The acyldihydropyran adduct 6.18 harboured the entire skeleton of mycalamide B 
and completion of the synthesis now only required some functional group manipulations 
which began with reduction of the keto group with LiBH(j-Bu)3 . The crude product 
underwent acid-catalysed addition of MeOH to the dihydropyran and the remaining 
hydroxyl function was acylated with benzoyl chloride. NMR spectroscopic analysis of 
the crude reaction mixture revealed two diastereoisomeric benzoates (dr 6:1) which were 
separated by chromatography to give the pure benzoate 6.19 in 73% overall yield from
6.18. Two stereogenic centres at C6 and C7 were created in the forgoing transformations 
but the detection of only two isomers at C7 indicates that addition of MeOH had occurred 
with very high diastereoselectivity. Brief thermolysis of the selenoxide derived from 
oxidation of phenylselanyl ether 6.18 installed the hypersensitive methylene function at 
C4. Finally, hydrolysis of the benzoate ester with lithium hydroxide followed by cleavage 
of the primary TBS ether with TBAF produced mycalamide B in 78% overall yield from
6.18. By using identical procedures, 17-gpMnycalamide B was prepared from 6.16b with 
comparable overall efficiency. The ^H and NMR spectroscopic data recorded on 
natural and synthetic mycalamide B together with the data for the 17-epi diastereoisomer 
are summarised in Table 6.1. Data for the synthetic material is also given in C6D (5 owing to 
the slow deterioration of the synthetic material in CDCI3.
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Table 6 .1 .1 H and 13C NMR data  for natural and synthetic  
m ycalam ide B derivatives.
Position
M ycalam ide B 
natural (CD C b)
M ycalam ide B 
synthetic  (CD C b)
M yclamlde B 
synthetic (CaOe)
17-epl-M ycaiam ide B 
synthetic (CeDa)
5 H (J, Hz) 5C 5H (V, Hz) 5 H (d, Hz) 5C 6 H (d, Hz) 8 C
2 4.02, dq (2.8, 6 .6 ) 69.64 4.04, dq  (2.8, 6.5) 3.80, dq  (1.8, 6 .6 ) 6 8 , 1 3.82, dq  (2.6, 6 .6 ) 6 8 . 0
2 'M e 1 .2 0 , d (6 .6 ) 17.93 1 .2 1 , d (6 .6 ) 0 .81, d (6 .6 ) 16.5 0 .81, d (6 .6 ) 16.5
3 2.24, dq (2.4, 6.9) 41 .27 2 .28 . dq  (2.8, 7.1) 1.86, dq (1.7, 7.0) 40 .4 1.38, dq  (2.6, 7.1) 40.3
3-M e 1.01, d (7.1) 12.13 1.02, d (7.2) 0.92, d (7.0) 11 0.90, d (7.1) 1 2 .1
4 145.10 144.6 145.0
4=CH2 4 .85, dd  (2.0, 2.0) 1 1 1 . 0 2 4.86, b r s 4 .71, dd  (1,8, 1.8) 109.6 4 .75-4 .70 , m 109.4
5
4.72, dd  (1 .9 ,1 .9 ) 
2 ,2 2 , ddd  (2 .0 , 2 .0 , 36.43
4 .73, b r s  
2 .24, dm (13.9)
4 .66, dd (1.9, 1.9) 
2 .40, dd (1 .B , 14.0) 32.9
4 .75-4 .70 , m 
2.42, b r d  (13.9) 33.0
6
13.5)
2.36, d (13.9)
99.95
2,37, d (14.0) 2 .60, d (14.0)
99.2
2 .60, d (13.9)
99.1
6 -OM e 3.29, s 48.57 3.3, s 3.15, s 47 3.21, s 47.1
7 4.29, S 71.73 4.29, d (2.0) 4.16, s 70 .7  or 4.17, s 71.1
7-O H 3,68, d (2.1) 4.07  (br s)
70.9
4.17, s
8 171.88 171.1 171.1
NH 7 .54, b r d  (10.0) — 7.52, d (9.6) 7.58, d  (9.8) — 7.48,d  (9.9) —
1 0 5,79, dd (9.7, 9.7) 73.90 5.81, dd (9.6, 9.6) 5.83, d (9.9) 72.9 5,94, d (9.9) 72.8
1 0 - 0 - 5 .1 2 (7 .0 ) 86.49 5.12, d (7.0) 4.56, d (7.0) 85.1 4.57, d (6.9) 85,0
CH2
1 1
4 .84 (6.9)
3.79 (6.7, 9.7) 70.94 (br)
4 .86, d (6,7)
3 .79, dd  (6 .8 , 9.6)
4.53, d (6.9)
3.69, dd  (7.0, 10.0) 70 .7  or
4.54, d (6.9)
3.65, d d  (7.1, 9.7) 70.1
1 2 4.21 (6.7, 10.4) 74.44 4.22, dd  (6 .8 , 10.2) 4.24, dd  (7.0, 10.6)
70 .9
73.9 4.23, dd  (6 .9 ,1 0 .2 ) 73.8
13 3.44 (10.5) 79.27 3.44, d (10.4) 2.94, d (10.5) 77 .5  or 2,96, d (10.4) 77.8
13-O M e 3.55, s 6 1 .78 3.56, s 3 .22 , S
77.7
60 3 .32 , s 60.0
14 4 1.47 40.3 40.1
14-Meeq 0.97, S 2 3.13 0.99, s 0.80, 8 21.5 0 .83 , s 21.7
14—MOax 0.85, S 13.32 (br) 0.87, S 0.76, s 11.9 0 .77, s 1 2 .1
15 3.41 (3.3, 8.3) 7 5 .46 3.46-3.40, m 3.40, dd (5.6, 6.1) 74.4 3.51, d (9.3) 75.9
16 1.55, m 2 9.63 1.58-1.52, m 1.59-1.55, m 29.3 1.65, dd (8 .2 ,1 4 .8 ) 31.5
17
1.55, m 
3.2, m 78.84
1.58-1,52, m 
3 .23-3.16, m
1.59-1.55, m 
3 .33-3.28, m 77.5  or
1.27, ddd  (2.8, 10.0, 
14.6)
3 .27-3 .18 , m 78.3
17-O M e 3.24, S 56.64 3.25, s 3 .03, S
77.7
55.2 3 .06 , s 55.6
18 3.65 (3 .3 ,1 1 ,9 ) 63 .48 3.70-3.63, m 3.85-3 .77 , m 62 .6 3 .61-3 .55 , m 62.6
18-O H
3 .47 (5.7, 11.9) 3 .52-3.46, m 3.74-3 .68 , m 
2.33, b r s
3 .61-3 .55 , m 
1.50, b r s
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Chapter 7 : Synthesis of Pederin analogues 2.8, 2.9 and 2.10
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Figure 7.1
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7 .1  Choice of analogues
7,1,1 Summary of the SAR data of the pederin family
As described in chapter 1, sec. 3, structure activity studies on the pederin family of 
antitumour agents established that the A-acyl aminal bridge is the pharmacophore. The 
homoallylic acetal array encompassing C4~C6 which is responsible for the acid lability of 
the natural products as well as their vesicant effects, is not necessary for anti tumour or 
antiviral activity. The C6  acetal function contributes to the high activity of the natural 
products though studies of simpler analogue reveal that it is not essential. The presence of 
a free hydroxyl group at C l with the (5)-configuration is important for high activity. The 
configuration of the aminal centre is also very important with the (y)-configuration at CIO 
being significantly more active as an anti tumour agent than the (/?)-epimer; however, 
compounds with the (f?)-configuration at CIO remain potent antiviral agents. The complex 
trioxadecalin ring system characteristic of the mycalamides, onnamides and theopederins is 
not essential for high activity since pederin, with its simpler monocyclic right half, is one 
of the most active of the natural products followed closely by 18- 0-methyl-mycalamide B, 
a simple synthetic derivative of natural mycalamide B. Finally, the side chain at C15 
tolerates considerable variation with comparatively little impact on activity. A summary of 
the SAR data is given in figure 7.2.
acetal c m  Iribu tes to h igli 
activity but not essential
lesponsible for vesicant effects but not essential for 
antitiunour activity
free NH impcstant
free hydroxyl in (5)-confi^ration important 
(5)-configuration essential
OMe O
Figure 7.2
ring C not essential
OMe
gcHi-melliyls not essential
OMe 
OMe
C l5 side chain variable
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7,1,2 RGD peptides as selective vehicle delivery
In 1997, previous work in the Kocienski group^^ had shown that pederin/mycalamide 
derivatives were extremely potent cytotoxins but insufficiently selective. Therefore, 
exploitation of the high cytotoxicity of the pederin series would require a means of 
selective delivery.
7.1.2.1 Integrins as drug targets
Cell-cell and cell-matrix interactions play a major role in biology. An important class of 
surface receptors are the integrins, which exist in a number of subtypes and are involved in 
many biological processes, for examples embryonic development, blood coagulation, 
osteoporosis, cancer, and regulation of the balance between proliferation and death 
(apoptosis) of a cell. Therefore, selective inhibition of specific integrin subtypes is of great 
pharmaceutical interest.
The integrins are heterodimeric transmembrane glycoproteins which act as cell surface 
receptors. They play an important role in signal transduction leading to functional changes 
in the cell. The integrins consist of an a  and a p subunit. Eight separate P and fourteen a  
subunits are known. The ayPs integrin is highly expressed in many tumour cells where 
it binds to extracellular matrix proteins which share a common structural motif: the amino 
acid sequence arginine-glycine-aspartic acid (RGD). The result of such binding is 
angiogenesis (formation of new blood vessels) and tumour metastasis. Since tumours 
require angiogenesis to provide sufficient nutrition for rapidly proliferating cancer cells 
and provide a pathway for cancer cells to enter the blood circulation (the first step in the 
metastatic cascade), selective inhibition of the a y p 3 integrin is of great pharmaceutical 
interest for the treatment of cancer.
Specific antagonists for the a y p 3 integrin based on the RGD sequence and the NGR 
(asparagine-glycine-arginine) sequence have been identified by Ruoslahti using in vivo 
selection of phage display libraides.^^^ Although the affinity of NGR for integrins is about 
three orders of magnitude less than that of RGD peptides, the homing ratio (tumour/control 
organ) of the phage displaying the NGR motif was three times that of the RGD peptides 
suggesting the RGD and NGR peptides may bind to different sites on the avP 3 integrin.
7.1.2.2 RGD peptides as inter grin antagonists
Kessler and c o - w o r k e r s s c r e e n e d  a library of RGD-based cyclic penta- and hexa- 
peptides containing D-amino acids and discovered highly active and selective avPs
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antagonists with ICgo's in the nanomolar range. Jacobsen and c o - wor ke r s ^have  also 
described the solid phase synthesis of cyclic RGD peptides with high selectivity 
(>500,000) for the ayps integrin over the apbPs integrin involved in platelet aggregation.
The first attempt to harness the high binding affinity of RGD peptides for the selective 
delivery of a drug to a tumour was reported in 1998 by Ruoslahti and co-workers. They 
prepared a covalent conjugate of unspecified structure between doxorubicin, a common 
chemotherapeutic agent with antiangiogenic activity, and the cysteine-rich nonapeptide 
CDCRGDCFC (RGD-4C). The doxorubicin/RGD-4C conjugate was then used to treat 
mice bearing tumours derived from human MDA-MB-435 breast carcinoma cells. All of 
the mice treated with the conjugate outlived the control mice. Histopathological analysis 
revealed widespread destruction of the tumour architecture whereas tumours of mice 
treated with doxorubicin alone were minimally affected. Furthermore, the conjugate was 
less toxic to the liver and heart than free doxorubicin.
7.1.3.1 Aim
The aim of our work is to develop a drug which inhibits tumour angiogenesis and 
metathesis based on ayPs integrin antagonists. Our antagonists will consist of a cyclic 
RGD (or NGR) peptide (the delivery vehicle) to which is attached a potent cytotoxic agent 
(the warhead) based on the pederin-class of natural products such as 7.1a (figure 7.3).
O M e O M eO
.OH
cycl ic peptide
7.1a li nker
Figure 7.3
7.1.3.2 Choice o f analogues
Synthesising conjugates such as 7.1a required division of the task; whilst Catherine 
McCusker (PhD student) and Dr Fabrice Anizon (postdoctoral fellow) in the Kocienski 
group were concentrating their efforts on making cyclic peptides of the Kessler, Ruoslahti 
or Jacobsen type (7.1b, 7.1c and 7 .Id respectively, figure 7.4), synthesis and biological 
testing of non-conjugated analogues was performed as described herein.
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Bearing in mind the above mentioned summary of the SAR data of the pederin family the 
choice of analogues was driven by two factors:
• Firstly, the need to establish that the side chain variants lacking the OMe/OH groups 
(C l7 and CIS) were still highly active and could thus be used as a point of attachment
* Secondly, the need to suppress the high acid-lability due to the homoallylic acetal aiTay 
of the "pederin" part of the conjugates.
It appeared to us that analogues 2.8, 2.9 and 2.10 could fulfil the above requirements.
7.2 Synthesis of analogues 2.8, 2.9 and 2.10
OMe O MeO ,, O : I I  I H OMe O MeO ^ OMe O MeO
N" "Ph
Our syntheses of pederin analogues, uses the readily available nitrile 5.3 as well as the 
flexibility of the 3-chloropropyl-sidechain approach. The routes are similar to that of 
pederin (chapter 5) with the exception of the couplings between the left fragment and the 
right fragment which make use of the tributylstannane 2.3.
7.2,1 Synthesis of the right fragments of the analogues
Nitrile 5.3 (scheme 7.1) was hydrolysed to give amide 7.1,^^^’ which was converted 
to the chlorinated right fragment 7.5 in 3 steps including a rhodium-mediated reduction of 
the A-acylimidate 7.3 giving a diastereomeric mixture of 7.5 and 7.4 (105;lOR = 5.5:1). 
The diastereomeric ratio was determined by NMR (400 MHz, CDCI3) spectroscopy by
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integration of signals deriving from CIO-H at ô = 5.21 ppm (dd, J  9.8, 6.7, major) and 5.10 
ppm (dd, J  9.9, 3.4, minor). Separation and purification of 7.4 and 7.5 was easily achieved 
by column chromatography.
MeO
,OTBS.OTBS.OTBS HN'H^Oj.KjCOg HgN + recovered nitrile 5.3
15%65% 7 253 7.1 O
.pyMel
CH2 Ctg,0 °C, 1 0 m in(10S) 
O MeO ,
(10R) 
O MeO eO
.OTBSO TB S MeO. .OTBSM eO, catsrrlioitMrane. RtrCiptigP].
MeO-
PhMe. -7 5  ^  -7 0  °C, 2h
7.37 A7 5
46% 8%
(3 steps) (3 steps)
Scheme 7.1
7.2.2 Synthesis o f  analogue 2.8 with 10(R) stereochemistry
Previous experience had shown that the best yields in the coupling reaction of the two 
halves were achieved when 2.5-4 equivalents of the trimethylstannane 2.2 were 
transmetallated with BuLi prior to reaction with N-acylimidate. When the same protocol 
with tributylstannane 2.3 was used to create the bridge in 7.8, a minor byproduct 7.7 (37%) 
was isolated suggesting that the transmetallation step is more efficient with the 
tributylstannane 2.3 than the trimethylstannane 2.2.
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Scheme 7.2
Benzoates 7.8a,b were obtained following the previously described 3-step sequence and 
were separated by HPLC. The diastereomeric ratio of the reduction step using L-Selectride 
step (7.8a:7.8b = 64:36) was determined by NMR (400 MHz, CDCI3) spectroscopy by 
integration of signals (s) of C7-H at ô = 5.46 ppm (major) and 5.73 ppm (minor), NOe 
experiments (400 MHz, CDCI3 ) were not conclusive in the determination of the 
stereochemistry of each benzoate 7.8a and 7.8b, and although compound 7.8b is 
crystalline, its state of crystallisation ("soft" crystals in a "feather" manner) did not allow 
us to obtain X-Ray diffraction data. Comparison of the chemical shifts of C7-H in ^H 
NMR (400 MHz, CDCI3) spectroscopy and C7 in l^C NMR (400 MHz, CDCI3) 
spectroscopy with the benzoates in the pederin, mycalamides and pederin analogues series 
led us to the tentative conclusion that the stereochemistry of the major product (7.8a) was 
(75) (scheme 7,2). Unfortunately, after oxidative cleavage of phenyl selanylether, and 
deprotection of the benzoate, the TBAF deprotection step was more difficult than expected 
and yielded a complex mixture of products.
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7.2.3 Coupling o f tributylstannane 2.3 with 7.5 and synthesis o f analogues 2.8, 2.9, 2.10.
Synthesis of several analogues with the natural stereochemistry at the CIO centre were 
synthesised as described in schemes 7.3 and 7.5. It is noteworthy that the coupling reaction 
gave adduct 7.9 in good yield (62%) when 2.6 equivalents of tributylstannane 2.3 was 
used. Benzoates T.lOab were obtained with a 4:1 diastereoselectivity at the C7-centre 
(Scheme 7.3). The diastereoselectivity was determined by NMR (400 MHz, CDCI3) 
spectroscopy by integration of signals (dd) of CIO-H at 5 = 5.26 ppm (7.10a) and 5.73 ppm 
(7.10b).
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OM e O MeO ^
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Scheme 7.3
15%  (3 steps) 7 .10b
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Synthesis of pederin analogue 2.8 with a chloropropyl sidechain followed the typical 
procedures already described (scheme 7.5). Hydrogenation of the exocyclic double bond 
was more problem atic . Indeed, M unro, had already attem pted to obtain 
dihydromycalamide A 7.12 by catalytic hydrogenation.^^ He showed that if the reaction 
was carried out using Palladium-on-charcoal in methanol, the two diastereomers of 
dihydromycalamide A (a,|3) 7.12 were obtained in 45% yield, as well as two new products 
(scheme 7.4). The first one (7.13, 18%) is the result of the transposition of the exocyclic 
double bond into the ring to form tetrasubstituted double bond whereas the second one 
(7.14, 18%) had the 6 -methoxy replaced by a proton. Munro also described the reaction 
carried out with Adam's catalyst (Pt0 2  XH2O) in methanol yielding, this time, mainly the 
desired products. Studies on the effect of solvent in hydrogenation reactions have shown 
that benzene is effective as an isomérisation inhibitor whether or not it is used on its own 
or mixed with other solvents. Since our first attempt at homogeneous catalysed 
hydrogenation using Wilkinson's catalyst [(PPh3)RhCl] on 1.0 mg scale of 2.8 was not 
successful, the reaction was carried out using Adams' piatinium oxide catalyst in benzene
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to yield the two diastereoisomers 2.9 as an inseparable mixture (dr = 7:3). The 
diastereometric ratio was determined by integration of the signal derived from C7-H (IH, 
s) at <5= 3.96 ppm (major) and 4.02 ppm (minor).
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Scheme 7.4
To synthesise the benzamide analogue 2.10, the chlorine of the side chain was displaced by 
refluxing 7.10a in the presence of sodium azide in dimethyl formamide to yield the 
azidopropyl side chain. Reduction of the azide was then performed under mild condition 
using triphenylphosphine and water following a procedure described by Vaultier^^^ to 
yield the corresponding amine derivative which was then acylated with benzoyl chloride in 
the presence of pyridine to give the desired benzamide 7.11 in good yield (78% over 3 
steps). Obtaining the benzamide analogue 2.10 was achieved by using the same last four 
steps as previously described.
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^  O M e p  M eO
P h S e
O T B S
(a) N al0 4 , MeOH-HzO-CHzClz (3:1 ;1 ) 
rt, 30 mi n 
W  NEfe-PhM e (1:1), ^  5m in 
M  L D H , M eO H ,rt,30m in
TBAF'SHaO, 4Â M S,THF, rt, 15 h 
67%
a t  N aN 3,D M F ,50°C ,S m in  
b) P P h 3,H aO ,TH F, rt, 5d
(c) PhC O C I,py,C H 2 a 2 , 0 ''C
78%
^  O M e  O  M eO O M e 0  M K )
Cl
P tO „,H ,, PhH,r1, 3 h  99%
^  O M e  O  M e O,CL =
Cl
N ' P hP h S e
(a) Nal0 4 ,M e0 H-H 2 0 -C H 2Cl2 (3:1:1) 
rt, 3 0  min
(b) NEts-Ph Ms (1:1), A, 2 min 
(°! UOH , MeOH, rt 3 0  min
TBAF*3HgO, 4A MS, THF, r1 , 4 h 
67%
O M e O  M eO  , ,  , 0 .  : II I H
N P h
Scheme 7.5
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Chapter 8 : Biological activity
Samples have been submitted for biological testing at AstraZeneca (Macclesfield) and we 
are awaiting results.
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Chapter 9 ; Summary
The aim of the study was to develop a highly efficient, flexible and economical route 
towards the synthesis of pederin family members. By completing the total synthesis of 
pederin 1.1, mycalamide B 1.5, 17-epi-mycalamide B 17-epi-1.5, and some analogues of 
pederin (2.8, 2.9 and 2.10) we have shown that both lactone 2.1 and enone 2.4 with its 3- 
chloropropyl side chain were judiciously chosen intermediates which fulfilled our 
objectives. Although the construction of the C17 centre in both the synthesis of pederin 1.1 
and mycalamide B 1.5 occurred with little stereocontrol, every other challenging problems 
has been addressed. Indeed, the C l3 centre was obtained with good to high stereocontrol 
using a reduction under Luche conditions for the pederin-like compounds and under 
Meerwein-Pondorf-Verley conditions in the mycalamide series. The construction of the 
cw-2,4,7-trioxabicyclo[4.4.0]decalin ring was performed by a high yielding ring closure 
procedure using P2O 5/dimethoxymethane which occurred with high stereocontrol. The 
remaining elaboration of the difficult A-aminal bridge with its CIO centre found solution in 
the well precendented Rh-catalysed reduction of an A-acylimidate for the pederin-like 
compounds whereas Curtins and Hofmann rearrangements were used efficiently in the 
mycalamide series. Finally, the metallated dihydropyran approach to link the two 
fragments, which had been set as a requirement of every synthesis, has been improved by 
using the tributylstannane 2.3. An unprecedented and unpublished methodology using 
Lipshutz's mixed trialkylstannyl cyano cuprates was applied in the synthesis of 2.3.
A summary of the syntheses presented herein is shown in scheme 9.1.
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Chapter 10. Experimental
10.1 General Experimental Details
Reactions requiring anhydrous conditions were conducted in flame-dried apparatus under a static atmosphere 
of dry argon or nitrogen. Organic extracts were evaporated at 5-20 mm Hg using a Buchi rotary evaporator. 
Where appropriate, solvents and reagents were dried by standard m e t h o d s , i.e. by distillation from the 
usual drying agent prior to use: diethyl ether and tetrahydrofuran were distilled from Na/benzophenone and 
used fresh. Acetonitrile, pentane, pyridine, dimethylsulfoxide, dichloromethane, A,A^-dimethylformamide, 
toluene diidopropylethylamine and triethylamine were distilled from CaH2  and stored over 4 Â molecular
sieves under nitrogen or KOH. Methanol was distilled from the corresponding magnesium methoxide. 
Hexanes (bp 40-60°C) for chromatography was distilled before use. Iodine and catechol were sublimed at 0.5 
mg Hg and stored under nitrogen. For best results, copper (I) iodide was extracted with THF in a Soxhlet 
apparatus and stored in the dark. The Dess-Martin periodinane r e a g e n t w a s  prepared according to 
the literature and stored at -20°C under nitrogen. Commercial organometallies were used as supplied and 
alkyllithium reagents were titrated against 1,3-diphenylacetone p-tosylhydrazone.^^^
All reactions were magnetically stirred and were monitored by Thin Layer Chromatography (TLC) using 
Macherey-Nagel Alugram Sil G/UV2 5 4  pre-coated aluminium foil sheets, layer thickness 0.25 mm.
Compounds were visualised by UV (254 nm), 20 wt% phosphomolybdic acid (PMA) in ethanol, 
anisaldéhyde, vanallin followed by H2 SO4 , potassium permanganate with heating or Ceric sulphate. Flash
chromatography was performed on Fisher Scientific Matrex Silica 60 (35-70 micron, code No. 
S /0 6 8 3 /7 0 ).P r e p a r a tiv e  TLC were performed on Macherey-Nagel SIL 9-200 UV 2 5 4  pre-coated glass 
sheets ( 2 0  x 2 0  cm, layer thickness 2  mm).
Optical rotations were recorded on an Optical Activity AA-100 polarimeter. Melting points were measured 
on a Griffin electrothermal apparatus and are uncorrected. IR spectra were recorded on a Perkin Elmer 1600 
series FTIR spectrometer as thin films supported on sodium chloride plates. Absorptions are reported as 
values in cm"^ and weak absorptions are not reported.
^H and ^^C NMR spectra were recorded in Fourier Transform mode at the field strength specified. All 
spectra were obtained in CDCI3  or CgDg solution in 5 mm diameter tubes, and the chemical shift in p.p.m. is 
quoted relative to the residual signals of chloroform (Ôh 7.27, Ôq 77.0) or CgHg (Sj  ^ 7.10, 8q 126.7) as the 
internal standard unless otherwise specified. Multiplicities in the ^H NMR spectra are described as; s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, and app = apparent. Coupling constants 
(J) are reported in Hz. Numbers in parenthesis following the chemical shift in the ^^C NMR spectra refer to 
the number of protons attached to that carbon as revealed by the Distortionless Enhancement by Phase 
Transfer (DEPT) spectral editing technique, with secondary pulses at 90° and 135°. Signal assignments were 
based on COSY, HMQC and HMBC eoii'elations. Mycalamide numbering was used throughout in assigning 
NMR signals. Low and high resolution mass spectra were run on a JEOL MStation JMS-700 spectrometer. 
Ion mass/charge (m/z) ratios are reported as values in atomic mass units followed, in parenthesis, by the peak 
intensity relative to the base peak (100%). Mass spectra were recorded on samples judged to be >95% pure 
by ^H and ^^C NMR spectroscopy unless otherwise stated.
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Numbering of all intermediates uses the mycalamide system as shown below:
1  OMe O
nOH
OHMycalamide B 
1 . 5 OMe
10.2 Synthesis of lactone 2.1
E t h y l  ( 5 ) - 0 - ( f e r / - b u t y I d i m e t h y l s i I y l ) l a c t a t e  ( 3 . 1 ' )
COgEt
3.1
C cH, nO .
"v,„^ OTBS
COaEt
3.1'CiiHaQ)Si 
Mol. W l; 232,39
The title compound prepared in 99% yield (0.54 mol scale) from ethyl (5)-lactate by the procedure of Smith, 
Kocienski and Street gave -30.0 (c 2.5, CHCI3 ); lit. [aj^ -30.5 (c 2.1, CHClg).^^^
E t h y l  ( S ) - 4 - ( f e r f - b u t y l d i m e t h y l s i l y I o x y ) p e n t - 2 - e n o a t e  ( 3 . 2 )
—
CO2B
TBS
)TBS
COgEt
3.2
C11 H24QjSt 
Mol. Wl.; 232 3 9
CiaHæQîSt 
Mol. Wl.; 258.43
The title enoate ester 3 . 2  was prepared in 72% yield (0.175 mol scale) by the method of Annunziata et al. 
E t h y l  ( 3 i ? , 4 5 ) - 4 - ( t o t - b u t y l d i m e t h y l s i I y I o x y ) - 3 - m e t h y I p e n t a n o a t e  ( 3 . 3 )
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OTBS
COgEt
3 3C13H26O3SI 
Mol. W t.:258.43
OTBS
COaEt
3.3CmHsoC^SI 
Mol. W l; 274.47
The title ester 3 . 3  was prepared in 75% yield (71 mmol scale) by the method of Yamamoto et al,80
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Ethyl (2/f,3jR,4S)-2-allyl-4-(fe/^butyldimethylsilyIoxy)-3-raetliylpentanoate (3.4)
.OTBS .OTBS
Mo. Wl.: 274.47
COgEt
3 4
C ,,H ,,0 ,S i
Ester 3 . 3  (24.0 g, 91.6 mmol) was added dropwise via syringe to a stirred solution of potassium 
bis(trimethylsilyl)amide (23.3 g, 80%, 93.0 mmol) in THF (350 ml) at -78  °C, The reaction mixture was 
stirred at -78  °C for 30 min and then allyl bromide (40 ml, 456 mmol) was added dropwise. The reaction 
mixture was stirred at -78 °C for 3 h, quenched with saturated aqueous NH4 CI and extracted with hexanes (2 
X 100 ml). The combined organic extracts were washed with brine (100 ml), dried (Na2 S0 4 ) and 
concentrated. The residue was purified by short path distillation to give ester 3 . 4  (22.2 g, 73.4 mmol, 80%) 
as a colourless oil: bp 84-88 °C at 0.5 mm Hg as a 22:1 mixture of diastereoisomers according to integration 
of the doublets at Ô 0.06 (minor) and 0.04 (major) as revealed in the ^H NMR spectrum (CDCI3 ).
Spectroscopic data (^H NMR, NMR, IR, and [a]p) in agreement with Dr C. Smith data.^^
( 2 / ? , 3 / < ! , 4 S ) - 2 - A I I y l - 4 - 0 - ( ^ e r f - b u t y I d i m e t h y l s i l y l ) - 3 - m e t h y l - l , 4 - p e n t a n d l o l  ( 3 . 7 )
.OTBS .OTBS
c,7Hj,q,Si
Mol. Wl.: 3 1 4 5 4
C15H3 ASi 
Mol. W t: 272.50
A solution of DIBAL-H (neat, 28 ml, 156 mmol) was added dropwise to a stirred solution of ester 3 . 4  (21.0 
g, 66.9 mmol) in CH2 CI2  (30 ml) between 5-10 °C over 40 min. The reaction mixture was stirred at -5  °C
for 1 h. A mixture of water (4 ml) and acetone (40 ml) was added dropwise over 45 min. keeping the 
temperature of the reaction mixture below 20 °C. The clear solution became a white solid. Aqueous HCl 
(2M, 230 ml) was then added over 15 min. The phases were separated and the aqueous layer was extracted 
with CH2 CI2  (2 X 100 ml). The combined extracts were dried (MgS0 4 ) and concentrated. Kugelrohr
distillation afforded alcohol 3 . 7  (16.2 g, 59.6 mmol, 89%) as a colourless oil: bp 140-145 °C (bath) at 0.02 
mm Hg.
Spectroscopic data (^H NMR, NMR, IR, and [a]^)) in agreement with Dr C. Smith data.77
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(2/î,3jR,45)-2-AUyl-4-(9-(/er^butyldimethylsilyl)-3-methyl-l-0-triphenylmethyl-l,4-pentanediol (3.8)
OTBS
1^5^32 Ms®'Mol. W t: 272.50
A solution of alcohol 3 . 7  (15.0 g, 55.0 mmol), trityl chloride (17.3 g, 62.0 mmol), triethylamine (22 ml, 157 
mmol) and DMAP (610 mg, 5.0 mmol) in CH2 CI2  (50 ml) was stirred at rt for 12 h, poured onto aqueous 
saturated NaHCOg and extracted with CH2 CI2  (3 x 100 ml) and concentrated. The oily residue was dissolved 
in Et2 0  (100 ml) treated with hexanes (200 ml) and washed with water (500 ml). The organic layer was dried 
(Na2 S0 q) and concentrated. The residue was filtered through a pad of silica gel (5% Et2 0  in hexanes) to give 
trityl ether 3 . 8  (26.6 g, 51.7 mmol, 94%) as a colourless oil
Spectroscopic data (^H NMR, NMR, IR, and [a]p) in agreement with Dr C. Smith data.
( 2 R , 3 / f , 4 S ) “ 2 - A l l y l - 3 - m e t h y I - l - 0 - t r i p h e n y l m e t h y I - l , 4 - p e n t a n e d i o l  ( 3 . 9 )
,OTBS /O H
77
C->^H«îOoSi
OTr
35
A solution of TBS ether 3 . 8  (53.6 g, 104.0 mmol) and TBAF trihydrate (53.0 g, 168.0 mmol) in THE (200 
ml) was stirred at reflux for 5 h. After cooling to rt, the mixture was poured onto water (1 1) and extracted 
with Et2 0  (3 X 150 ml). The combined organic extracts were dried (Na2 S0 4 ) and concentrated to give crude
alcohol 3 . 9  (40.4 g, 100.9 mmol, 97%) as a colourless oil which was immediately used in the next step. Data 
was obtained by purification of a small sample by column chromatography (Si0 2 , 5-10% Et2 0  in hexanes).
Spectroscopic data (%  NMR, NMR, IR, and [a]g) in agreement with Dr C. Smith data.^^
( 2 R , 3 R , 4 / ? ) - 2 - A l l y l - 4 - 0 - ( 4 - c h l o r o b e i i z o y l ) - 3 - m e t h y l - l - 0 - t r i p h e i i y l m e t h y i > l , 4 - p e n t a n e d i o l  ( 3 . 1 0 )
O^gCCgH^CI
C„,H..,GIQ
A solution of diisopropyl azodicarboxylate (16.05 ml, 81.5 mmol) in THE (10 ml) was added dropwise to a 
stirred solution of alcohol 3 . 9  (18.5 g, 46.3 mmol), triphenylphosphine (21.4 g, 81.6 mmol) and p- 
chlorobenzoic acid (12.8 g, 81.7 mmol) in THE (150 ml). The temperature of the reaction mixture was 
maintained between -10  °C and 0 °C. The reaction mixture was stirred for 3 h between -1 0  “C and 0 °C. 
Water (1 ml) was added and the mixture was stirred at rt for 15 min before concentration. The residual oil 
was dissolved in Et2 0  (50 ml) and hexanes ( 1 0 0  ml) were added dropwise to cause formation of white
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crystals. The crystals (triphenylphosphine oxide) were filtered off and washed with hexanes (3 x 50 ml). The 
filtrate was extracted with 2M aqueous NaOH (2 x 30 ml), water (50 ml) and brine (50 ml), dried (Na2 SÛ4 ) 
and concentrated in vacuo. The residue was purified by column chromatography (Si0 2  0-4% Et2 0  in 
hexanes) to give the p-chlorobenzoate 3.10 as a colourless oil that crystallised on standing (19 g, 35 mmol, 
76%) and its C3 epimer (0.6 g, 1,1 mmol, 2.4%).
Spectroscopic data (^H NMR, NMR, IR, and [(%]g) in agreement with Dr C. Smith data.^  ^
( 3 R , 4 i ? , 5 i ? ) - 5 " ( 4 - C h I o r o b e n z o y l o x y ) - 4 - m e t h y l - 3 - ( t r i p l i e n y I m e t h o x y m e t h y l )  h e x a n o i c  a c i d  ( 3 . 1 2 )
OgCCgH^CI
^OTr 
3.10
Mol. wt.: 537.13
Oxidative cleavage of the olefin was accomplished by the procedure of Sharpless et al.  ^  ^  ^ NaI0 4  (18.3 g, 
85.7 mmol) was added to a stirred mixture of olefin 3 . 1 0  (11.0 g, 20,4 mmol), CCI4  (41 ml), acetonitrile (41 
ml) and water (62 ml). After 15 min RuCl3 »3 H 2 0  (270 mg, 1.0 mmol) was added and the reaction mixture
stirred vigorously for 7 h. The mixture was poured onto water (600 ml), the organic layer removed and the 
aqueous phase extracted with CH2 CI2  (3 x 150 ml). The combined organic extracts were dried (MgSOq) and 
concentrated in vacuo. The residue was purified by column chromatography (S1 0 2  200 g, 5% EtOAc in 
hexanes) to give acid 3 . 1 2  (10.8 g, 19.4 mmol, 95%) as a stable white foam, mp 55-57 °C;
77Spectroscopic data (^H NMR, NMR, IR, and [0 1 ]^) in agreement with Dr C. Smith data. 
( i î ) - 4 - [ ( 1 7 î , 2 7 î ) - 2 - ( 4 - C I i l o r o b e n z o y l o x y ) - l - m e t h y l p r o p y l ] - d i I i y d r o f u r a n - 2 ( 3 i ï ) - o n e  ( 3 . 1 3 )
..^^^^OgOCeH^GI s,^__^02CC6H4CI
x r
3 . 1 2  3 .13CMHasCIOs
Mol. W t: 557.08 Mol. W t: 296.75
A solution of acid 3 . 1 2  (10.8 g, 19.3 mmol) and p-toluenesulfonic acid (490 mg, 2.6 mmol) in MeOH (180 
ml) was stirred at rt for 4 h before concentration in vacuo. The residue was purified by column 
chromatography (Si0 2  120 g, 10-50% Et2 0  in hexanes) to give lactone 3 . 1 3  (4.0 g, 13.5 mmol, 71%) as a 
white solid. The lactone 3 . 1 3  was further purified by recrystallisation from hexanes-Et2 Û to remove the 
minor diastereoisomers: mp 69.5-70 °C (hexanes-Et2 Û).
Spectroscopic data (^H NMR, NMR, IR, and [a]p) in agreement with Dr C. Smith data.77
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(3jR,4Æ,5/?)-5-(4-Chlorobenzoyloxy)-4-methyl-3-(phenylselenylmethyl) hexanoic acid (3.14)
2 C C 6 H 4 C I  x ^ ^ X 3 2 G C g H 4 C I
^SePh
3.13 3.14
C,gH,yCIO., CziHzaCIO^Se
Mol. W».:296,75 M o l.W t:453.82
The lactone cleavage was accomplished using sodium phenyl selenide as described in the literature. 
Sodium borohydride (350 mg, 9.25 mmol) was added portionwise to a stirred yellow suspension of diphenyl 
diselenide (1.6 g, 5.15 mmol) in EtOH (5.8 ml) causing exothermic reaction and gas evolution. Lactone 3.13 
(1.0 g, 3.37 mmol) was added to the colourless solution of sodium phenyl selenide. The resulting mixture 
was stirred at reflux for 10 h. After cooling to rt, the reaction mixture was diluted with Et^O ( 8  ml) and
treated with aqueous HCl (2M, 5 ml). The layers were separated, and the aqueous phase was extracted with 
Et2 Ü (3 X 20 ml). The combined organic extracts were washed with aqueous NaHCOg (2 x 10 ml), dried 
(MgSO^.) and concentrated in vacuo. The residue was purified by column chromatography (Si0 2  20 g, 10- 
40% Et2 0  in hexanes) to give acid 3 . 1 4  as a yellow oil (1.05 g, 2.72 mmol, 80%).
Spectroscopic data (^H NMR, NMR, IR, and [aj^) in agreement with Dr C. Smith data.^^
( 2 j R , 3 R , 4 i ? ) - T e t r a h y d r o - 5 , 6 - d l m e t h y l - 4 - p h e n y l s e l e n y l m e t h y l - 2 E r - p y r a i i - 2 - o i i e  ( 2 . 1 )
P2CCCH4CI
SePh
C2 1 H23CIO4 S 0  C i^HieOgSG
M o],W t:453 .82  Mo). W l.:2 9 7 2 5
Reductive cleavage of the /?-chlorobenzoate ester was accomplished according to the procedure of Trost et 
a l . ^6 , 130 Q -ys ml, 2.32 M in hexanes, 8.7 mmol) was added dropwise to a solution of DIBAL-H 
(neat, 8.7 mmol, 1.55 ml) in CH2 CI2  (16 ml) at -5  °C. THE (32 ml) was then added, the mixture was cooled 
to -78  °C and a solution of the ester 3 . 1 4  (1.31 g, 2.9 mmol) in THE (32 ml) was added via cannula. The
mixture was allowed to warm to -20  °C over 5 min. and stirred at -20  °C for 3 h. The mixture was then 
treated with aqueous HCl (2M, 35 ml, 70 mmol), and Et2 0  (30 ml) and stirred vigorously for 24 h. The 
organic layer was removed and the aqueous phase extracted with Et2 0  (2 x 40 ml). The combined organic 
extracts were dried (MgSO^) and concentrated in vacuo. The residue was purified by column 
chromatography (Si0 2  40 g, 10-30% Et2 0  in hexanes) to give 2 . 1  as a clear colourless oil (619 mg, 2.08 
mmol, 72%).
H NMR and ^^ C NMR spectroscopic data agree with the literature.32
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(2/?,3/î,45)-3,4-Dihydro-2,3-dimethyl-4-phenylselenylmethyl-6-trimethylstannyl-2f/-pyran (2.2)
SeP h
2.2Ci4HiaC^Se 
Md, Wl.; 297,25
O S rM ea
SePh
Cl 7H2eCCsSn 
Mol. Wt.: 444.06
The conversion of lactone 2 . 1  (150 mg, 0.50 mmol) to 2 . 2  (156 mg, 0.35 mmol) was accomplished in 70% 
yield according to a reported procedure.
T r i b u t y l - [ ( 4 S , 5 7 ? , 6 / ? ) - 5 , 6 - d i m e t l i y l - 4 - p h e n y l s e l a n y I m e t h y l - 5 , 6 - d i h y d r o - 4 / / - p y r a n - 2 - y l ] - s t a n i i a n e  ( 2 , 3 )
F r o m  l a c t o n e  2 . 1
SePh
C44H1BQ2SG 
Mol. Wl,; 297.25
O SnBua
SePh
CaeH^ O^SeSn 
Mol. Wl.; 5 7 0 3 0
P r o c e d u r e
To the lactone 2 . 1  (944 mg, 3.16 mmol) in THF ( 8  ml) at -78°C was added HMPA (0.72 ml, 4.12 mmol) 
followed by LiHMDS (4.6 ml, 4.12 mmol, 0.9 M in THF). After 2 h at -78°C, PhNTf2  (1,44 g, 4.12 mmol)
was added as a solid to the reaction mixture which was then allowed to warm gradually to 0°C. After 2 h at 
0°C hexabutylditin (1.5 ml, 3.00 mmol) followed by Pd(PPhg)^ (109 mg, 0.095 mmol) and then lithium
chloride (805 mg, 19.0 mmol) were added. The pale yellow/brown solution was refluxed for 14 h and the 
resulting black solution was poured onto saturated aqueous NaHCOg (10 ml) and extracted with a 1:1 
solution of hexanes:Et2 0  (3 x 10 ml). The combined organic extracts were dried (Na2 S0 4 ) and concentrated 
in vacuo. Purification by column chromatography (deactivated AI2 O3  (5% H2 O), 1% EtgN in hexanes) gave 
252 mg (0.44 mmol, 14%) of stannane 2 . 3  as a colourless oil.
P r o c e d u r e  B  ^ ^ l
To a solution of KHMDS (4.45 ml, 2.22 mmol, 0.5 M in PhMe) in THE (4.5 ml) at -78°C was slowly added 
a solution of lactone 2 . 1  (508 mg, 1.71 mmol), PhNTf2  (672 mg, 1.88 mmol) in THF (4.5 ml) over 25 min to
form the intermediate enoltriflate 3 . 2 1 .  The formation of enoltriflate was followed by TLC.
Meanwhile, to a suspension of CuCN (200 mg, 2.22 mmol) in THF (5.6 ml) at -78°C, was added dropwise 
nBuLi (1.95 ml, 4.44 mmol, 2.27 M in hexane), The cooling bath was temporarily removed (2 min) and the 
clear pale yellow solution was then cooled again at -78'’C. After 5 min at -78°C, BugSnH (1.2 ml, 4.44 
mmol) was added dropwise (H2  evolution) and the dark yellow solution was then stirred at -78°C for another 
2 0  min.
The enoltriflate solution was then quickly transferred using a large cannula to the copper complex solution 
and the reaction mixture was then stirred at -78°C for 5 min before being poured onto a 100 ml solution
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containing 10 ml of concentrated aqueous NH 3  and 90 ml of saturated aqueous NH4 CI. After dilution with 
CH2 CI2  (10 ml) and strong shaking (5 min), the phases were separated and the blue aqueous layer was 
extracted with CH2 CI2  (3 x 30 ml). The combined extracts were dried (Na2 S 0 4 ) and concentrated in vacuo.
NMR (400MHz, CDCI3 ) spectroscopy showed a 86.4:13.5 ratio of desired stannane 2 . 3  : dihydropyran
3 . 1 4  byproduct.
Purification by column chromatography (deactivated AI2 O3  (5% H2 O), 500 g, column diameter = 8  cm, 1% 
Et3 N in hexanes) gave 837 mg (1.46 mmol, 85%) of stannane 2 . 3  as a colourless oil: -7 .4  (c 1.1,
CHCI3 ); Vj^ ax film/cm-1 2955, 2926, 2870, 2 8 5 3 ,  1596, 1579, 1476, 1462, 1437, 1080, 734, 690; 6 jj (400 
MHz, CDCI3 ): 7.43-7.35 (2H, m, Harom), 7.20-7.13 (3H, m, Harom), 4 . 3 5  (IH, tt, Jpj.n 1.7, Jh-Sii 14.4, C5- 
H), 3.84 (IH, dq, J6.5, 1.4, C2-H), 2.75 (2H, d, J 8.2, CH2 -Se), 2.67-2.60 (IH, m, C4-H), 1.80-1.72 (IH, m, 
C3-H), 1.50-1.60 (6 H, m, Sn-[CH2 -C//2 'CH2 -CH3 ]3 ), 1.29-1.16 (6 H, m ( 6  lines), Sn-[CH2 -CH2 -C//2 - 
CH3 l 3 ), 1.08 (3H, d, J 6.5, C2-Me), 0.82 (6 H, t, J 8 . 0 ,  Sn-[Œ 2 -CH2 -CH2 -CH3 l 3 ), 0.81 (9H, t, J 7.3, Sn- 
[CH2 -CPl2 -CH2 -C7 / 3 ]3 ), 0.69 (3H, d, /  6 .8 , C3-Me); 6 ^ (100 MHz, CDCI3 ) 162.6 (0, C6 ), 1 3 2 . 6  (1, 2C, 
Carom), 130.5 (0, Carom), 129.0 ( 1 ,  2C, Carom), 126.7 (1, Carom), 112.5 (1, t, Jq.su  3 0 ,  C5), 75.3 ( 1 ,  t, Jc. 
Sn 10, C2), 38.4 (1, t, /^-Sn 16, C 4 ) ,  33.9 (1, C3), 31.6 (2, CHz-Se), 29.0 (2, 3C, t, /c-Sn 10, Sn-[CH2 -CH2 - 
CH2 -CH3 J3 ), 27.1 (2, 3C, Jq.Sh ^6 , Sn-[CU2 -CU2 -C ti2 -CU2h l  1 8 . 5  (3, C2-Me), 13.7 (3, 3C, Sn-[CH2 - 
CH2 -CH2 -CH3 1 3 ), 9.6 (2, 3C, tt, /c .g„  170, 163, Sn-[CH2 ~CH2 -CH2 -CH3 ]3 ), 5.3 (3, C3-Me). m/z (Cl) 573
(92), 571 [(M+H)+, 100%], 569 (76), 415 (25), 413 (18), 308 (7), 283 (20), 281 (10); Found : (El), 
570.1587. C2 ôH4 4 0 SeSn requires M, 570.1587.
•  F r o m  d i h y d r o p y r a n  3 . 1 4
O^SOgPh O^ S^nBug
S e P h  ^ S e P h  S e P h  SePh
3.14 322a,b 323a,b  2.3
C^^H j^OgSo CggHg^G j^SSa ^26^44^^^ Sa
Mol. Wt.: 281.25 Mol. Wt.; 2 9 9 2 7  Mol. Wl.: 423,43 Mol. Wt.: 570.30
Synthesis of stannane 2 . 3  from 3 . 1 4  followed a S. Ley procedure.^^
d i h y d r o p y r a n  3 . 1 4  t o  l a c t o l s  3 . 2 2 a , b
To a solution of dihydropyran 3 . 1 4  (300 mg, 1.06 mmol) in THF (1 ml) was added 2N HCl (1 ml) and the 
reaction was stirred at room temperature. After 10 h, the reaction mixture was diluted with CH2 CI2  (10 ml) 
and then poured slowly onto ice-cooled saturated aqueous NaHCO^ (10 ml). The phases were separated and 
the aqueous phase was extracted with CH2 CI2  (3 x 10 ml). The combined organic extracts were dried 
( M g S 0 4 )  and concentrated in vacuo to give a mixture of inseparable lactols 3 . 2 2 a , b  (310 mg, 1.0 mmol,
98%) which was used directly in the next step. The diastereomeric ratio (dr = 3 . 2 2 a : 3 . 2 2 b  = 56:44) was 
determined by ^H NMR (400 MHz, CDCI3 ) spectroscopy by integration of signals (d or dd) of C6 -H at ô =
5.20 ppm (minor, OH in axial position) and 4.61 ppm (minor, OH in equatorial position).
l a c t o l s  3 . 2 2 a , b  t o  s u l f o n e s  3 . 2 3 a , b  
To the crude mixture of lactols 3 . 2 2 a , b  in CH2 CI2  (5 ml) was added CaCl2  anhydrous (255 mg, 2.5 mmol)
followed by freshly prepared benzenesulfinic acid (142 mg, 1.0 mmol). After 15 h at room temperature, the 
reaction mixture was diluted (10 ml), filtered and washed with saturated NaHCOg. The aqueous layer was 
then extracted with CH2 CI2  (3 x 10 ml) and the combined organic layers were dried (MgSO^) and 
concentrated in vacuo to give a crude mixture of inseparable diastereomeric sulfones 3 . 2 3 a , b  (404 mg, 0.96 
mmol, 96%) which was used directly in the next step.
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s u l f o n e s  3 . 2 3 a , b  t o  t r i b u t y l s t a n n a n e  2 . 3
To the crude mixture of sulfones 3.23a,b in THF (5 ml) was added dropwise at -78°C nBuLi (0.72 ml, 1.40 
M in hexanes, 1.0 mmol). After 30 min at -78°C, BugSnCl (0.27 ml, 1.0 mmol) was added slowly and the
reaction mixture was stirred at -78°C for 1 h and at -lO^C for 2 h. The solution was evaporated to dryness 
and taken up in chloroform (7 ml). DIPEA (0.19 ml, 1.5 mmol) was added and the resulting mixture was 
heated at 70°C for 4 h, then cooled to room temperature, and then concentrated in vacuo. Purification by 
column chromatography (deactivated AI2 O 3  (5% H2 O), 500 g, column diameter = 8  cm, 1% EtgN in 
hexanes) gave 373 mg (0.65 mmol, 65% over 3 steps) of stannane 2.3.
( 2 i ? , 4 / î , 5 / ? , 6 / î ) - 5 , 6 - D i m e t h y l - 4 - p h e n y l s e l a n y l m e t h y I - t e t r a h y d r o - p y r a n - 2 - o l  ( 3 . 2 2 a )  a n d  ( 2 S , 4 i ? , 5 / ? , 6 / f ) -  
5 , 6 - D i m e t l i y l - 4 - p h e n y l s e l a n y l m e t h y ! - t e t r a h y d r o - p y r a n - 2 - o I  ( 3 . 2 2 b )
.OH
■SePh■SePh
3 2 2 b3.22a
Mol, Wl,; 299 27
Data for the crude mixture of lactols 3 . 2 2 a  and 3 . 2 2 b  are reported using M for the major diastereomer 3 . 2 2 a  
and m for the minor diastereomer 3 . 2 2 b .
Vmax film/cm-1 3398, 2972, 2928, 2890, 1725, 1578, 1477, 1437, 1383; 6 ^  (400 MHz, CDCI3 ): 7.46-7.39 
(2Hjy[ and 2Hj^ ,^ m, Harom), 7,22-7.14 (3H^ and 3Hj„, m, Harom), 5.20 (IH^ ,^ d, 73.5 , C6 -H), 4.61 (IHjyf, 
dd, 7 9.4, 1.6, C6 -Hm), 4.14 (IH,^, dq, 7 6.4, 2.1, C2-H), 4.00 (IH ^, bd s, OH), 3.53 (IH ^, dq, 7 6.4, 2.1, 
C2-H), 3.18 (IH^, br, OH), 2.85-2.71 (2Hj^ and 2H,^, m, 2 x Se-CHg), 2.33-2.23 (IH,^, m, 10 lines, C4-H), 
1.91-1.80 (IHm, m, 10 lines, C4-H), 1.77 (1 H ^, app dt, 7 12.8, 2.7, C5-/7^Hg), 1.73-1.68 (IH^, m, C3-H), 
1.64-1.57 (IHj^, m, C5-77^Hg), 1.64-1.57 (IH ^, m, C3-H), 1.43 (IH, app dt, 7 13.3, 3.8, C5-H), 1.26 (IH, 
dd, 7 12.8, 6 .6 , C5-H), 1.26 (IH ^, dd, 7 12.8, 6 .6 , C5~HaHb), 1.10 (3Hm, d, 76.5, C2-Me), 1.03 (3H,^, d, 7
6.5, C2-Me), 0.73 (3H^, d, 7 7.0, C3-Me), 0.69 (3H^ ,^ d, 7 7.0, C3-Me); 5^ (100 MHz, CDCI3 ) 132.5 (1, 
2C ^ + 2Cj^, C arom), 129.3 (0, ICj^, Carom), 129.2 (0, IC^, Carom), 129.05 (1, 2Cj^, Carom), 128.99 (1, 
2C^, Carom), 126.8 (1, IC ^, Carom), 126.7 (1, IC ^, Carom), 96.2 (1, IC ^ , C6 ), 91.6 (1, IC^, C6 ), 74.4 
(1, ICm, C2), 6 7 . 6  (1, lCjy[, C2), 38.6 (1, IC ^, C 4 ) ,  35.7 (1, IC^, C3), 35.4 (1, IC ^, C3), 33.9 (2, IC ^, 
C5), 33.7 (1, lCn„ C4), 32.5 (1, IC^, Se-CHs), 31.9 (2, IC ^, Se-CH2 ), 31.0 (2, IC ^ , C 5 ) ,  18.5 (3, IC,^, 
C2-Me), 18.3 (3, IC ^, C2-Me), 5.0 (3, IC^, C3-Me), 4.0 (3, IC^, C3-Me), m/z (El) 302 (20), 301 (20),
300 [M+, 100%], 299 (10), 298 (55), 297 (20), 296 (20), 295 (5), 157 (65), 143 (80); Found : (El), 
300.0628. C 4^ H2 oC>2 ^® requires M, 300.0629.
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( 2 i ? , 3 / î , 4 i ? , 6 5 ) - 6 - B e i i z e i i e s u l f o i i y I " 2 , 3 - d i m e t l i y l - 4 - p h e n y l s e l a n y l n i e t h y I - t e t r a h y d r o - p y r a i i  ( 3 . 2 3 a )  a n d  
( 2 j R , 3 j R , 4 / f , 6 / î ) - 6 - B e n z e i i e s u l f o n y l - 2 , 3 - d i m e t h y l - 4 - p l i e n y l s e l a n y I m e t l i y l - t e t r a h y d r o - p y r a n  ( 3 . 2 3 b )
SePh SePh
Mol. W l: 423.43
NMR (400 MHz, CDCI3 ) and NMR (100 MHz, CDCI3 ) data of the mixture of sulfones 3 . 2 3 a  and 
3 . 2 3 b  are reported here describing only the best resolved and caracteristic pics M for the major diastereomer 
3 . 2 3 a  and m for the minor diastereomer 3 . 2 3 b  .
V^ax filin/cm-l 3527, 3058, 2973, 1726, 1578, 1477, 1445, 1384; 8 ^  (400 MHz, CDCI3 ): 4.63 (IH^, d, /
7.6 , C6 -H), 4.58 (IH^ ^^  dq, 7 6.5, 4.3, C2-H), 4.29 (IH ^, dd, 711.7, 2.8, C6 -H), 3.43 (11%, dq, 7 6.4, 2.0, 
C2-H), 1.04 (3Hj^, d, 7 6.5, C2-Me), 0.98 (3H,^, d, 7 6.5, C2-Me), 0.66 (3Hm, d, 7 7.0, C3-Me), 0.53 (3H^, 
d, 77.0, C3-Me); 8 ^ (100 MHz, CDCI3 ) 138-127 (24C, Carom), 91.3 (1, IC^, C6 ), 89.6 (1, ICj^, C6 ), 78.6 
(1, ICm, C2), 72.8 (1, ICm, C2), 39.3 (1, IC ^ + IC^,, C4), 35.4 (1, 1 0 ^ , C3), 34.9 (1, IC^, C3), 32.5 (2, 
ICj^, C5), 31.8 (2, ICm, C5), 24.8 (1, IC^, Se-CH2 ), 22.7 (2, IC^, Se-CHs), 1 8 . 6  (3, IC,^, C2-Me), 18.3 
(3, ICm, C2-Me), 4.8 (3, IC ^ , C3-Me), 3.9 (3, IC^, C3-Me), m/z (Cl, NH4 ) 444 (7), 443 (5), 442 
[(M+NH4 )+, 25%)] 441 (5), 440 (15), 439 (5), 438 (6 ), 286 (5), 285 (20), 284 (18), 283 (100), 282 (10), 281 
(50), 280 (20), 279 (20); Found : (El), 424.0604. C2 oH2 4 0 3 SSe requires M, 424.0612.
10.3 Synthesis of enone 2.4
E t h y l  ( / f ) - 6 - c h I o r O “3 - h y d r o x y - 2 , 2 - d i m e t h y l l i e x a n o a t e  ( 4 . 3 )
Ck. O^EtEtO^ OTMS
4.1 4.4 4.3C5H10O CgH2o02Si CloHigCIOs
Mol. W t. :a e . l3  M ol.w t.; 188.34 M oLW t: 222.71
By directed aldol condensation:
A solution of BHg'THF complex (313 ml, 1 M in THF, 313 mmol) was added dropwise to a stirred 
suspension of (5)-Af-tosylvaline^^^ (105.3 g, 388 mmol) in CH2 CI2  (1.85 1) under nitrogen at rt over 30 min. 
After 30 min, the clear solution was cooled to -70  °C and a solution of 4-chlorobutanaI^^^ (41.4 g, 388 
mmol) in CH2 CI2  (35 ml) was added over 10 min. Silyl ketene acetal 4 . 4 ^ ^ ^  (78.9 g, 419 mmol) was then 
added over 30 min maintaining the reaction temperature below -65 *^ C. After 2 h at -70  °C a solution of 
NaOH (24.5 g, 612 mmol) in 300 ml of water was added and the reaction mixture was allowed to warm to rt. 
The phases were separated, the aqueous phase was extracted with CH2 CI2  (2 x 100 ml) and the combined
organic extracts were washed with water (500 ml) and concentrated in vacuo. The residue was treated with 
water (500 ml) and extracted with Et2 Ü (4 x 200 ml). The combined organic extracts were dried (MgSO^) 
and concentrated in vacuo to give the hydroxy ester 4 . 3  (97.7 g, 370 mmol, 95%) as a yellow oil. The 
enantiomeric ratio (97:3) had been determined by integration of the ^H NMR signals at 6  1.16 (major) and 6
1.11 (minor) of the (7?)-MTPA esters prepared from 4.3 in the usual way (270 MHz, C5 D5 , referenced to 7.16
ppm).^ "^
Spectroscopic data (^H NMR, NMR, IR, and [ajj^) in agreement with Dr C. Smith data.^^
E t h y l  ( i ? ) - 3 - a c e t o x y - 6 - c h I o r o - 2 , 2 - d i m e t h y I h e x a n o a t e  ( 4 . 6 )
O^OEt 0<^ OEI
4.3 4.6C^jHgiClO^
Mol. Wl.: 222.71 Mol. W t : 264.75
To a solution of the crude hydroxy ester 4.3 (97.7 g, 370 mmol), triethylamine (76 ml, 550 mmol), and 
DMAP (233 mg, 1.9 mmol) in CH2 CI2  (300 ml) was added acetic anhydride (49 ml, 517 mmol) dropwise.
The solution was stirred overnight at rt and then diluted with hexanes (1 1), washed with water (3 x 200 ml), 
and brine (100 ml), dried (Na2 S0 4 ) and concentrated in vacuo. The crude product was filtered through a pad 
of silica gel (15 g, 10% Et2 0  in hexanes), concentrated in vacuo and the residue distilled (bp 88-96 °C, 0.01 
mm/Hg) to give acetate 4 . 6  (78.2 g, 0.295 mol, 76%) as a colourless oil.
Spectroscopic data (^H NMR, NMR, IR, and [a]]^) in agreement with Dr C. Smith data.
( / ? ) - 6 - ( 3 - C h l o r o p r o p y I ) - 5 , 5 - d i m e t h y l - d i h y d r o - p y r a n - 2 , 4 - d i o n e  ( 4 . 7 )
.OEt
AcO
77
C..H ..CIO
M ol.w t.; 264.75
BuLi (293 ml, 2.32M in hexane, 610 mmol) was added to a stirred solution of diisopropylamine (90 ml, 637 
mmol) in THE (875 ml) at 0 °C over 15 min. After stirring at 0 “C for 20 min, the solution was cooled to -74  
°C and a solution of the ester acetate 4 . 6  (78.2 g, 292 mmol) in THE (125 ml) was added dropwise over 15 
min keeping the temperature of the reaction mixture below - 6 8  °C. The yellow solution was stirred at -74  °C 
for 1.5 h before adding aqueous HCl (2 M, 750 ml). The phases were separated and the aqueous phase was 
extracted with CH2 CI2  (3 x 240 ml). The combined organic extracts were washed with brine (200 ml), dried 
(Na2 S0 4 ) and concentrated in vacuo. The residue was recrystallised twice from hexanes-Et2 0  to give the P- 
ketolactone 4 . 7  (50 g, 228 mmol, 78%) as a white solid: mp 103-105 °C.
Spectroscopic data (^H NMR, ^^ C NMR, IR, and [a]^ )^ in agreement with Dr C, Smith data,^^
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(R)-6-{3-Chloropropyï)-4-methoxy-5,5-dimethyl-5,6-dihydro-pyran-2-one (4.8)
4.7 A S^^3 C^HlgCIOgMot. Wl.:218.68 .......  ....
Potassium carbonate (4.74 g, 34.4 mniol) was added to a solution of P-ketolactone 4 . 7  (5.00 g, 22,9 mmol), 
18-crown-6 (60 mg, 0.25 mmol) and dimethyl sulfate (2.6 ml, 27.5 mmol) in CH2 CI2  (50 ml). The reaction 
mixture was vigorously stirred at rt for 20 h, filtered through a pad of Celite and concentrated in vacuo. 
Kugelrohr distillation (bp 245-250°(oven)/0.05 mm Hg) gave enol ether 4 . 8  (5.28 g, 22.7 mmol, 99%) as a 
colourless oil which formed a white solid on cooling: mp 56-57 °C.
Spectroscopic data (^H NMR, NMR, IR, and [aj^) in agreement with Dr C. Smith data.^  ^
( / f ) - 6 - ( 3 - C h l o r o p r o p y l ) - 5 , 6 - d i h y d r o - 5 , 5 - d i m e t h y I - 4 H - p y r a n - 4 - o n e  ( 2 . 4 )
0. DMe ^  .0
C11H17GIQ3 CioHisCIOgMol.wt.: 232.70 Mol. Wl: 202.68
DIBAL-H (neat, 8.7 ml, 48.6 mmol) was added dropwise to a stirred solution of lactone 4 , 8  (10.3 g, 44.2 
mmol) in CH2 CI2  (80 ml) maintaining the temperature of the reaction mixture below -70  °C. The reaction
mixture was stirred at -70  °C for 40 min and then poured onto aqueous HCl (2M, 250 ml) and vigorously 
stirred at rt for 15 min. The phases were separated and the aqueous layer was extracted with CH2 CI2  (2 x 30 
ml). The combined organic extracts were washed with saturated aqueous NaHCOg, dried (Na2 S0 ^) and 
concentrated m vacuo. The residue was distilled to give enone 2 . 4  (7.6 g, 37.4 mmol, 85%) as a colourless 
oil: bp 110-112 °C/0.8 mm Hg.
Spectroscopic data (^H NMR, NMR, IR, and [aj^) in agreement with Dr C. Smith data.^^
10.4 Synthesis of Pederin (1.1)
( 2 S , 6 / ? ) - 6 - ( 3 - C h l o r o p r o p y i ) - 2 “ C y a n o - t e t r a h y d r o - 5 , 5 - d i m e t h y l - 2 / / - p y r a n - 4 - o n e  ( 5 . 1 )
.0  NO _
01 0^1 2.4 5.1i^iNieCINOg
M ol.w t: 202.68 Md. Wt.: 229.70
Trimethylsilyl trifluoromethanesulfonate (110 pi, 0.6 mmol) was added to a stirred solution of 
dihydropyranone 2 . 4  (4.0 g, 19.7 mmol) and trimethylsilyl cyanide (2.7 ml, 21.7 mmol) in CPI2 CI2  (40 ml) at
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0 °C. The reaction mixture was stirred for 1.5 h at 0 “C and poured onto saturated aqueous NaHCOg (10 ml). 
The phases were separated and the aqueous phase was extracted with CH2 CI2  (2 x 20 ml). The combined 
organic extracts were dried (MgSO^) and concentrated in vacuo. The residue was treated with THF (10 ml)
and aqueous HCl (2M, 2 ml) and then stirred at rt for 30 min. The reaction mixture was extracted with 
CH2 CI2  (3 X 25 ml). The combined organic extracts were dried (MgSO^) and concentrated in vacuo.
Kugelrohr distillation [bp 250 °C(oven)/0.05 mm Hg] gave a colourless oil which crystallised upon cooling 
in the refrigerator. Recrystallisation from hexanes-Et2 0  gave cyano ketone 5.1 (4.15 g, 18.1 mmol, 92%) as 
a white solid: mp 36-38 °C; [a]jy^^ +120.0 (c 1.0, CHCI3 ); v^ax film/cm“l 1715; Ôg (400 MHz, CDCI3 ): 
5.18 (IH, dd, J 8.1, 1.5, C llH ), 3.79 (IH, dd, J 8 .8 , 3.7, C15H), 3.62 (2H, t, J 6 .6 , C I8 H2 ), 3.10 (IH, dd, J
15.5, 8.1, C12H^% ), 2.57 (IH, d d ,/ 15.5, 2.2, 2.12-2.01 (IH, m, C n /f^ H g), 1.93-1.82 (IH,
m, C 17H a% ), 1.77-1.70 (2H, m, CI6 H2 ), 1.16 (3H, s, C14Me), 1.12 (3H, s, C14Me); 5^ (100 MHz,
CDCI3 ): 206.4 (0, C13), 116.7 (0, CIO), 81.4 (1, C l5), 64.5 (1, C ll) , 50.1 (0, C14), 44.7 (2, C l 8 ), 40.1 (2, 
C12), 29.2 (2, C17), 26.0 (2, C l 6 ), 18.9 (3, 2C, C14Me); m/z (El): 231 (10), 229 (M+*, 30), 123 (87), 70 
(100%). Found: (M+), 229.0867. C ^H i^O i^C l requires M, 229.0870. Found: C, 57.32; H, 6.95; N, 5.96%. 
C 1 1 H 1 6 CINO2  requires C, 57.52; H, 7.02; N, 6.10.
( 2 S , 4 i ? , 6 7 ? ) - 6 - ( 3 - C h l o r o p r o p y I ) - 2 - c y a n o - t e t r a h y d r o - 5 , 5 - d i m e t h y l - 2 f f - p y r a i i - 4 - o l  ( 5 . 2 )  
a n d
( 2 5 , 4 S , 6 j R ) - 6 - ( 3 - C h l o r o p r o p y I ) - 2 - c y a n o - t e t r a l i y d r o - 5 , 5 - d i m e t h y l - 2 i / - p y r a n - 4 - o l  ( e p i - 5 . 2 )
n c ,„
'Cl 
13-«p i-52
C11H16CINO2 C^^H^qCIN0 2  C^^H-|qCIN02
M ol.wt.: 229.70 Mol. W t.:231.72 Mol. Wt.: 231.72
To a solution of ketone 5 . 1  (13 g, 56,6 mmol) and CeCl3 *7 H2 0  (10.4 g, 28.0 mmol) in MeOH (130 ml) at 
-95 °C was added in one portion sodium borohydride (6.5 g, 169.7 mmol). The reaction mixture was stirred 
for 1 h below -85 °C and was then allowed to warm to -60  °C over 1 h with stirring before pouring onto 
aqueous HCl (2 M, 150 ml) at 0 °C. The phases were separated and the aqueous phase was extracted with 
CH2 CI2  (3 X 150 ml). The combined organic extracts were washed with saturated aqueous NaHC0 3  (35 ml), 
dried (Na2 SO^) and concentrated in vacuo. The residue was filtered through a pad of Si0 2  to give a 30:1 
mixture of alcohols (13.0 g, >99%) as a white solid. Purification by column chromatography (Si0 2 , 10% 
Et2 0  in CH2 CI2 ) gave pure undesired alcohol e p i - 5 . 2  (110 mg, 0.48 mmol, 0.8%) and 12.8 g of a mixture of
5 . 2  and e p i - 5 . 2  which was recrystallised from hexanes-Et2 0  to give pure alcohol 5 . 2  (10.1 g, 43.6 mmol, 
77%) as white crystals:
( 2 S , 4 / f , 6 / f ) - 6 - ( 3 - C h l o r o p r o p y l ) - 2 - c y a n o - t e t r a h y d r o - 5 , 5 - d i m e t h y l - 2 1 T - p y r a n - 4 - o l  ( 5 . 2 )
Mol. Wt.: 231.72
mp 71-72 “C; +83.0 (c 1.0, CHCI3 ); v^ax (CCl^j/cm"! 3630, 3540; (400 MHz, CDCI3 ): 4.91
(IH, dd, J 5 . 9 ,  1.5, C llH ), 3.75 (IH, dd, /  11.0, 5.1, C13H), 3 . 6 7 - 3 . 5 3  (2H, m, C I 8 H2 ), 3.42 (IH, dd, J 10.3,
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1.5, C15H), 2.01 (IH, ddd, /  13.5, 11.7, 6.0, 0127/^% ), 194 (IH, ddd ,/ 13.5, 4.9, 1.5, CHH^T/g), 2.05-
1.90 (IH, m, C177/ aHb ), 1.73-1.87 (2H, m, CIOT/^Hb and 1.67 (IH, br s, C130H), 1.60-1.48
(IH, m, C16Ha77b), 1.02 (3H, s, C14Me), 0.88 (3H, s, C14Me); 6 ^ (100 MHz, CDCI3 ): 117.8 (0, CIO),
81.1 (1, C15), 71.9 (1, C13), 64.0 (1, C ll) , 44.9 (2, C18), 39.4 (0, C14), 32.7 (2, C12), 29.4 (2, C17), 25.7 (2, 
C16), 22.2 (3, C14Me), 12.0 (3, C14Me); m/z (Cl, NH3 ) 249 [(M+NH^l^, 100%]. Found: C, 56.87; H, 
7.70; N, 6.03; Cl 15.35%. CnH igClN 0 2  requires C, 56.97; H, 7.76; N, 6.04; Cl 15.32.
( 2 5 , 4 S , 6 7 î ) - 6 - ( 3 - c l i I o r o p r o p y l ) - 2 - c y a n o - t e t r a h y d r o - 5 , 5 - d i m e t h y I - 2 i ï - p y r a n - 4 - o l  ( 1 3 - e p i - 5 . 2 )
13.«pi-5.2CiiHisCINOg 
Md. Wt.: 231,72
The minor isomer ( e p i - 5 . 2 )  was isolated as a colourless oil: +84.2 (c 1.3, CHCI3 ); (film)/cm 1
3491, 2964; 6 ^  (400 MHz, CDCI3 ): 4.77 (IH, d, J 6.7, C llH ), 3.95 (IH, dd, J 10.7, 1.2, C15H), 3 . 6 1 - 3 . 5 4  
(3H, m, C13H and CI8 H2 ), 2.32-2.25 (2H, m, OH and 2.04-1.94 (IH, m, C17%HB), 1.89-
1.78 (2H, m, C17-I%77g), 1.70-1.61 (IH, m, C16?7^Hb), 1.50-1.39 (IH, m, C16H^//b), 0.98 (3H, s, 
C14Me), 0.90 (3H, s, C14Me); 8 ^ (100 MHz, CDCI3 ): 119.4 (0, CIO), 75.1 (I, C15), 72.2 (1, C13), 60.7 (I,
C ll) , 45.0 (2, C18), 36.9 (0, C14), 31.5 (2, C12), 29.2 (2, C17), 25.6 (2, C16), 22.7 (3, C14Me), 19.0 (3, 
C14Me); m/z (Cl, NH3 ) 249 [(M+NH^)+, 100%]. Found : (M+N%)+, 249.1368. C 1 1 H2 2 O2 N 2 CI requires 
M, 249.1370. Found: C, 56.96; H, 7.74; N, 6.01%. CnH igCiN 0 2  requires C, 56.97; H, 7.76; N, 6.04.
The isomers are easily separable on TLC (CH2 Cl2 -E t2 0  9:1) Rf (major isomer) 0.39: Rf (minor isomer) 
0.47.
( 2 5 ' , 4 / i : , 6 / î : ) - 4 - ( i e r i : - B u t y I d i m e t l i y l s i l y l o x y ) - 6 - ( 3 - c l i l o r o p r o p y l ) - 2 - c y a n o - t e t r a h y d r o - 5 , 5 - d i m e t h y l - 2 i T -  
p y r a n  ( 5 . 3 )
CiiHigClNOg 1^7^32^^
Md. wt.: 23172  Mol. W.: 345.98
ie/t-Butyldimethylsilyl trifluoromethanesulfonate (3.85 ml, 16.6 mmol) was added dropwise to a stirred 
solution of alcohol 5 . 2  (3.5 g, 15.1 mmol) and 2,6-lutidine (3.67 ml, 18.2 mmol) in dry CH2 CI2  (25 ml) at 0 
°C. The reaction mixture was stirred at 0-5 °C for 2.5 h, then poured into saturated aqueous NaHCOg (10 
ml). The phases were separated and the aqueous phase was extracted with CH2 CI2  (2 x 30 ml). The
combined organic extracts were washed with aqueous HCl (2M, 70 ml) followed by water (90 ml), dried 
(Na2 S0 ^) and concentrated in vacuo. The residue was purified by column chromatography (Si0 2 , 10% Et2 0  
in hexanes) to give silyl ether 5 . 3  as a white solid (5.20 g, 15.0 mmol, >99%): mp 44-46 °C (hexanes-Et2 0  
); [ajo^O +60.7 {c 1.84, CHCI3 ); v^ax (CCl^l/cm-l 2958, 2932, 2858, 1472, 1258, 1084, 876, 838; Sg  
(400 MHz, CDCI3 ): 4.87 (IH, dd, J 5.9, 1.5, C llH ), 3.67 (IH, dd, /  11.8, 5.2, C13H), 3.65-3.53 (2H, m, 
C I8 H2 ), 3.43 (IH, dd, J 10.3, 1.5, C15H), 2.08-1.91 (2H, m), 1.89-1.69 (3H, m), 1.60-1.44 (IH, m), 0.93
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(3H, s, C14Me), 0.90 (9H, s, ^BiiSi), 0.85 (3H, s, C14Me), 0.09 (3H s, SiMe), 0.08 (3H, s, SiMe); 5^ (100 
MHz, CDCI3 ): 117.9 (0, CIO), 81.2 (1, C15), 72.5 (1, C13), 63.9 (1, C ll) , 44.9 (2, C18), 40.0 (0, C14), 33.7 
(2, C12), 29.5 (2, C17), 26.0 (2, C16), 25.9 (3, 3C, ^BuSi), 22.8 (3, C14Me), 18.1 (0, CSi), 12.4 (3, C14Me), 
-4 .0  (3, MeSi), -4.8 (3, MeSi); m/z (CI, NH3 ) 363 [(M-i-N%)+, 100%]. Found: C, 58.97; H ,  9.24; N, 3 . 9 9 ;  
Cl 10.26%. Ci7H32ClN02Si requires C, 58.97; H, 9.26; N, 4.04; Cl 10.26.
( 2 5 , 4 j R , 6 > R ) - 4 - ( ^ e / ^ B u t y l d i m e t l i y l s i l y I o x y ) - 2 - c y a n o - 6 - ( 3 - p h e n y I s e l e n y l p r o p y l ) - 5 , 5 - d i m e t h y l " t e t r a h y d r o -  
2 J Ï - p y r a n  ( 5 . 4 )
NC„„ OTBS
'S eP h
5.3 &4
C-|yH32CIN02Si
Mol. Wt.: 345.98 Mol. Wt.: 466.59
Sodium borohydride (720 mg, 18.7 mmol) was added portionwise to a stirred suspension of diphenyl 
diselenide (2.65 g, 8.46 mmol) in dry ethanol (25 ml). The exothermic reaction resulted in a pale yellow 
solution to which was added chloride 5 . 3  (4.5 g, 13 mmol). The resulting mixture was refluxed for 1 h, 
cooled to rt and treated with aqueous NaOH (2M, 40 ml) and extracted with hexanes (3 x 20 ml). The 
combined organic extracts were dried (Na^SOq) and concentrated in vacuo. The residue was purified by 
chromatography on SiÜ2  eluting with tolueneihexanes ( 1 :1 ) until the yellow band passed and then hexanes- 
Et2 Ü (85:15) to give selenide 5 . 4  (5.5 g, 91%) as a colourless oil that crystallised on standing: mp 28-30 °C 
(hexanes-Et2 0  ); [ajc^O +3 6 . 9  (c 1.89, CHCI3 ); (CCl^)/cm-l 2958, 2932, 2858, 1595, 1472, 1258,
1084, 876, 838; ô g  (360 MHz, CDCI3 ): 7.57-7.50 (2H, m), 7.35-7.20 (3H, m), 4.85 (IH, dd, J 6.0, 1.3, 
C llH ), 3.67 (IH, dd, J 11.5, 4.6, C13H), 3.42 (IH, dd, J 10.3, 1.4, C15H), 3.02-2.90 (2H, m, CI8 H2 ). 1.99 
(IH, ddd, J  13.6, 11.6, 6.1, C12H a% ), 2.00-1.88 (IH, m), 1.85-1.64 (3H, m), 1.56-1.43 (IH, m), 0 . 9 3  (9H, 
s, ^BuSi), 0.91 (3H, s, C14Me), 0.84 (3H, s, C14Me), 0.11 and 0.10 (3H each, s, Me2 Si); ( 9 0  MHz, 
CDCI3 ): 1 3 2 . 4  (1, 2C), 130.4 (0), 129.0 (1, 2C), 126.6 (1), 117.8 (0), 81.1 (1), 72.4 (1), 63.7 (1), 39.8 (0),
33.6 ( 2 ) ,  28.5 (2), 27.5 (2), 27.0 (2), 25.8 (3, 3C), 22.6 (3), 17.9 (0), 12.3 (3), -4 .2  (3), -4 .9  (3); m/z (Cl, 
NH 3 ) 485 [(M+NH4 )+, 100%], 483 (50). Found: C, 59.29; H, 8.03; N, 2.92%. C23H37N02SeSi requires C, 
59.15; H, 7.92; N, 3.00.
( 2 S , 4 Æ , 6 7 ? ) - 4 - ( f e / Y - B u t y I d i n i e t h y l s i l y l o x y ) - 2 - c y a n o - t e t i ' a l i y d r O “ 5 , 5 - d i m e t h y I - 6 - ( p r o p - 2 - e n y i ) - 2 f f - p y r a n  
( 5 . 5 )
NC ^  OTBS OTBS
SePh
5.4
^23^37 O 2 S eS I ^17^31 ^ ^ 2 ^Mol. W t: 466.50 Mol. Wt.: 309.52
Sodium metaperiodate (2.15 g, 10 mmol) was added in one portion to a stirred solution of selenide 5 . 4  (3.15 
g, 6.75 mmol) in water (100 ml) and methanol (200 ml). The reaction mixture was stirred for 30 min, 
extracted with CH2 CI2  (3 x 50 ml). The combined organic phases were dried (Na2 S0 4 ), triethylamine (0.5
ml, 7.1 mmol) was added to the solution and the mixture then concentrated under high vacuum at rt. Toluene 
(25 ml) was added to the residue followed by the addition of triethylamine (10.5 ml, 75 mmol). The reaction
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mixture was then refluxed for 30 min. Solvent was removed in vacuo and the residue purified by column
chromatography (Si02, 10% toluene in hexanes) followed by Kugelrohr distillation [bp 200 °C (oven)/0.05 
mmHg] to give the olefin 5 . 5  (2.0 g, 6.46 mmol, 96%) as a colourless oil: [ocjp^^ +48.6 (c 1.35, CHCI3 ); 
v,^ a^x filni/cm-1 1644, 1472, 1258, 1162, 1104, 1082, 880, 838, 776; 6 ^  (400 MHz, CDCI3 ): 5.84 (IH, ddt, J 
16.8, 10.2, 6 .8 , C17H), 5.10 (IH, dq, /  16.8, 1.5, C 18H ^% ), 5.07 (IH, dq, J 10.2, 1.5, 4.87
(IH, dd, J 6.0, 1.5, C llH ), 3.68 (IH, dd, J 11.4, 4.6, C13H), 3.54 (IH, dd, J  10.0, 2.5, C15H), 2.33 (IH, 
dddt, J 15.0, 6.2, 2.5, 1.5, C16HA% ), 2.17 (IH, dddt, J 15.0, 9.8, 6 .8 , 1.3, C 16//aH b), 2.00 (IH, ddd, J
13.7, 11.6, 6.0, C12H^% ), 1.78 (IH, ddd, 7 13.7, 4.6, 1.6, C aH ^ H g), 0.94 (3H, s, C14Me), 0.90 (9H, s, 
^BuSi), 0.86 (3H, s, C14Me), 0.09 and 0.08 (3H each, s, Me2 Si); 6 ^ (90 MHz, CDCI3 ): 135.7 (1, C17),
117.9 (0, CIO), 116.6 (2, C I S ) ,  81.6 (1, C15), 72.5 (1, C13), 64.0 (1, C ll) , 40.0 (0, C14), 33.8 (2, C12), 33.5 
(2, C l 6 ), 25.9 (3, 3C, ^BuSi), 22.9 (3, C14Me), 18.1 (0, CSi), 12.6 (3, C14Me), -4 .0  (3, MeSi), -4 .8  (3, 
MeSi); m/z (Cl, NH3 ) 327 [(M+NH^)+, 100%]. Found: C, 66.15; H, 10.09; N, 4.62%. C i 7 H3 iN 0 2 Si 
requires C, 66.02; H, 10.03; N, 4.53.
A s y m m e t r i c  d i h y d r o x y l a t i o n  o f  a l k e n e  5 . 5
5.5
CizHaiNOgSi 
Mol. Wl: 309.52
NQ, OTBS
1^7^ 33^ 0^ 61
Mol. wt.; 343.53
NO,,, OTBS
l^yNasNO^Si
Md. Wt.: 3 4 3 5 3
Alkene 5 . 5  (1.4 g, 4.5 mmol) and dihydroquinine 9-phenanthryi e t h e r (113 mg, 0.225 mmol) were stirred 
in warm r-BuOH (28 ml) until the crystals of ligand dissolved completely. After cooling to rt, water (28 ml), 
KgFe(CN)g (4.5 g, 13.5 mmol) and K2 CO3  (1.90 g, 13.5 mmol) were added and the mixture was cooled to 0
°C before addition of potassium osmate dihydrate (89 mg, 0.225 mmol). The reaction mixture was stirred for 
3 h at 0 °C, then treated with saturated aqueous Na2 S0 3  (40 ml) and extracted with CH2 CI2  (80 + 2 x 40 ml). 
The combined organic extracts were washed with brine (30 ml), dried (MgSO^) and concentrated in vacuo to
give the crude diols 5 . 6 a , b  as a 1.5:1 mixture of diastereoisomers. The residue was purified by column 
chromatography on Si0 2  (70 g, 0-1.4% MeOH in CH2 CI2 ) to give pure diol 5 . 6 a  (806 mg, 2.34 mmol, 52%)
and pure diol 5 . 6 b  (402 mg, 1.2 mmol, 26%).
( 2 S , 4 / ? , 6 7 f ) - 4 - ( t o 7 - B u t y l d i n i e t h y l s i l y l o x y ) - 2 - c y a n o - 6 - [ ( 2 S ) - 2 , 3 - d i h y d r o x y p r o p y l ] - t e t r a h y d r o - 5 , 5 -  
d i i n e t h y I - 2 j H - p y r a n  ( 5 . 6 a )
.OTBS
OH
Md. Wt.: 343.53
gave mp 53-55 “C (hexanes-Et2 Û ); [a] )^^  ^+50.0 (c 2.0, CHCI3 ); film/cm  ^ 3442, 1472, 1258, 1100, 
1082, 878; 8 ^  (400 MHz, CDCI3 ): 4.90 (IH, dd, J 6.0, 0.9, C llH ), 3.96-3.90 (IH, m, C17H), 3.73-3.63 
(3H, m (10 lines), C13H + C15H + ClS/^^Hg), 3.51(1H, dd, 711.1, 6.0, C18H /,% ), 2.00 (IH, ddd,7 13.7,
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11.6, 6.1, C12H a//b), 1.81 (IH, ddd, J 13.7, 4.6, 1.3, C 12% H b), 1.78-1.64 (2H, m, ClôHg), 1.64-1.40 
(2H, br s, C170H and C180H), 0.91 (3H, s, C14Me), 0.89 (9H, s, ^Bu), 0.86 (3H, s, C14Me), 0.08 (3H, s, 
SiMe), 0.07 (3H, s, SiMe); (100 MHz, CDCI3 ): 117.6 (0, CIO), 81.0 (1, C13 or C15 or C17), 72.2 (1,
C13 or C15 or C17), 71.1 (1, C13 or C15 or C17), 65.8 (2, C18), 63.8 (1, Cl 1), 39.8 (0, C14), 33.4 (2, C16 or 
C12), 32.1 (2, C12 or C16), 25.7 (3, 3C, %uSi), 22.6 (3, C14Me), 17.9 (0, CSi), 12.3 (3, C14Me), -4 .2  (3, 
MeSi), -5 .0  (3, MeSi); m/z (Cl, NH3 ): 361 [(M+NH^)+' 100%], 343 [(M+H)+, 8 ], 329 (12), 96 (12). Found: 
(M+H)+, 344.2258. C i7 H3 4 0 ^NSi requires M, 344.2257.
( 2 S , 4 / î , 6 i î ) - 4 - ( t o / - B u t y l d i m e t h y I s U y I o x y ) - 2 - c y a n o - 6 - [ ( 2 / f ) - 2 , 3 - d i h y d r o x y p r o p y l ] - t e t r a h y d r o - 5 , 5 -  
d i m e t l i y l - 2 / f - p y r a n  ( 5 . 6 b )
.OTBS
'OH
ÔH
5.6b
M ol.wt.: 343.53
mp 36-38 °C (CHCI3 ); +5 3 . 5  (c 1.0, CHCI3 ); KBr/cm“ l 3426, 1471, 1257, 1103, 1083, 881;
5h  (400 MHz, CDCI3 ): 4.86 (IH, dd, 7 6.0, 0.9, C llH ), 3.92-3.85 (IH, m, C17H), 3.74 (IH, dd, J 10.3, 1.3, 
C15H), 3.70 (IH, dd, J 11.6, 4.7, C13H), 3.65 (IH, dd, J 11.1, 3.3, ClST/^Hg), 3.51(1H, dd, J 10.8, 7.2, 
C18H^/7b), 2.00 (IH, ddd, J 13.6, 11.6, 6.1, CnH^Tfg), 1.79 (IH, ddd, J  13.6, 4.6, 1.4, C12/7aHbX 167 
(IH, ddd, J 14.4, 8.9, 1.6, C16H^/7g), 1.67 (IH, ddd, 7 14.4, 10.3, 3.6, ClôT/^Hg), 1.60-1.40 (2H, br s,
C170H and C180H), 0.92 (3H, s, C14Me), 0.90 (9H, s, 'Bu), 0.84 (3H, s, C14Me), 0.09 (3H, s, SiMe), 0.08 
(3H, s, SiMe); 8 ^ (100 MHz, CDCI3 ): 117.7 (0, CIO), 78.1 (1, C13 or C15), 72.3 (1, C15 or C13), 69.2 (1,
C17), 6 6 . 8  (2, C l 8 ), 6 6 . 8  (1, C ll) , 39.6 (0, C14), 33.5 (2, C16 or C12), 32.2 (2, C12 or C16), 25.7 (3, 3C, 
^BuSi), 22.5 (3C, 14Me), 17.9 (0, CSi), 12.3 (3, C14Me), -4 .2  (3, MeSi), -5 .0  (3, MeSi); m/z (Cl, NH3 ) 361 
[(M+NH4 )+- 100%], 343 [(M+H)+, 15], 329 (25), 96 (62). Found : (M+H)+, 344.2258. CiyHg^O^NSi 
requires M, 344.2257.
Neither 5 . 6 a  nor 5 . 6 b  gave satisfactory microanalytical data.
( 2 S , 4 / ? , 6 J ? ) - 4 - ( ^ e / ’^ - B u t y l d i m e t h y I s i l y l o x y ) - 2 - c y a n o - 6 - [ ( 2 S ) " 2 , 3 - d i m e t h o x y p r o p y l ] - t e t r a h y d r o - 5 , 5 -  
d i m e  t h y  l - 2 H - p y  r a n  ( 2 . 5 )
OTBSNC,„ ^ .^ ^ ^ ^ O T B S
5.6a 2 5
CiyHagNO^Si CigHgyNO^Si
Md. wt.: 34353  Mol. Wt.: 371.59
NaH (310 mg, 7.7 mmol, 60% in oil) was added in one portion to diol 5 . 6 a  (870 mg, 2.53 mmol), Mel (0.79 
ml, 12.6 mmol) and 18-crown-6 (80 mg, 0.30 mmol) in THF (24 ml) at 0 °C. The ice bath was removed and 
the reaction mixture was sealed and stirred at rt for 24 h. The reaction mixture was then poured onto saturated
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aqueous NH4 CI (5 ml), extracted with CH2 CI2  (3 x 25 ml) and the combined organic extracts were dried 
(MgSO^) and concentrated in vacuo. The residue was purified by column chromatography (Si0 2 , 50 g, 20% 
Et2 0  in hexanes) to give the title compound 2 . 5  (860 mg, 2.31 mmol, 91%) as a white solid: mp 47-49 °C 
(hexanes-Et2 0  ); lit. mp 46-48
( 2 S , 4 7 ? , 6 i ? ) - 4 - ( r e / ^ " B u t y l d i m e t h y l s i l y l o x y ) - 2 - c y a n o - 6 - [ ( 2 1 ? ) - 2 , 3 - d i m e t h o x y p r o p y l ] - t e t r a h y d r o - 5 , 5 -  
d i m e t h y l - 2 i T - p y r a n  ( 5 . 7 b )
OTBS
5.6b 5.7b1^7^ 33^ 0^ 81 G^gHgyNO^Si
Mol, W t: 343 .53 Mol. W t- 371.59
By the same procedure described above, diol 5 . 6 b  (390 mg, 1.13 mmol), Mel (0.35 ml, 5.6 mmol) gave the 
dimethyl ether 5 . 7 b  (341 mg, 0.91 mmol, 81%) as a white solid: mp 72-74 °C (hexanes-Et2 0  );
+51.0 (c 1.0, CHCI3 ); KBr/cm-1 2953, 2931, 1857, 1473, 1252, 1104, 881, 839; 8 ^  (360 MHz,
CDCI3 ): 4.86 (IH, dd, J 6.1, 1.0, C llH ), 3.73 (IH, dd, J 1.4, 10.0, C15H), 3.70 (IH, dd, 7 11.6, 4.7, C13H), 
3.48-3.37 (3H, m, C17H, CI8 H2 ), 3.48 (3H, s, OMe), 3.38 (3H, s, OMe), 1.99 (IH, ddd, J 13.5, 11.6, 6.1, 
C12Hy^%), 1.78 (IH, ddd, J 13.6, 4.7, 1.3, 0127/^ % ), 1.67 (IH, ddd, J  14.4, 9.3, 1.4, ClbH^JT^), 1.49 
(IH, ddd, J 14.5, 10.3, 2.2, ClôT/^Hg), 0.91 (3H, s, C14Me), 0.90 (9H, s, ^Bu), 0.83 (3H, s, C14Me), 0.09 
(3H, s, SiMe), 0.07 (3H, s, SiMe); 5^ (90 MHz, CDCI3 ): 117.8 (0, CIO), 78.1.0 (1, C15), 76.4 (1, C17),
74.3 (2, C l 8 ), 72.4 (1, C13), 63.7 (1, C ll) , 59.3 (1, OMe), 58.5 (1, OMe), 39.4 (0, C14), 33.6 (2, C12), 32.2 
(2, C l 6 ), 25.7 (3, 3C, ^BuSi), 22.5 (3, C14Me), 17.9 (0, CSi), 12.3 (3, C14Me), -4 .2  (3, Me-Si), -5 .0  (3, 
MeSi); m/z (Cl, isobutane) 372 [(M+H)+, 100%], 340 (5), 314 (5), 287 (5), 240 (5), 213 (20). Found : 
(M+H)+, 372.2573 C^gH^gO^NSi requires M, 372.2570. Found: C, 61.56; H, 10.02; N, 3.72%. 
CiçHgyNO^Si requires C, 61.41; H, 10.04; N, 3.77.
P e d a m i d e  :
( 2 S , 4 j R ) - 4 - ^ c r / - B u t y I d i m e t h y I s i l y I o x y - 6 - [ ( S ) - 2 , 3 - d i m e t h o x y p r o p y l ] - t e t r a h y d r o - 5 , 5 - d i m e t h y l - 2 H - p y r a n -  
2 - c a r b o x a m i d e  ( 1 . 6 1 ) .
.OTBSOTBS
3Me
5Me OMe
2.5 1.61
M ol.w t.: 371.59 Mol. W t.:389.60
To a solution of nitrile 2 . 5  (800 mg, 2,15 mmol) in EtOH (18 ml), was added a solution of K2 CO3  ( 6  g, 43.4 
mmol) in water (12 ml) followed by H2 O2  ( 8  ml, 30 % aqueous solution, 52 mmol). The reaction mixture 
was stirred at room temperature for 5 h and a further portion of H2 O2  ( 8  ml, 30 % aqueous solution, 71
mmol) was added. The reaction mixture was stirred for an additional 15 h; before saturated aqueous 
Na2 S 2 Û3  (15 ml) was added dropwise until effervescence ceased. The solvent was evaporated and the 
residue extracted with CH2 CI2  (3 x 40 ml). The combined organic extracts were dried, concentrated, and
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purified by chromatography on silica gel (40 g) eluting with hexanes/AcOEt (7:3) to give amide 1.61 (728 
mg, 1.87 mmol, 87%).
NMR and NMR data in agreement with the literature^^
M e t h y l  1 3 - ( ? - ( / e / / - B u t y l d i m e t h y I s i l y l ) m e r o p e d e r o a t e  ( 1 . 6 4 )
o  MeO
MeO, OTBS
OMe)Me
1.641.61
Mol. W t: 38960  Mol. Wt.: 491.69
M e t h y l  ( 2 S , 4 R ) - 4 - t e r t - B u t y I d i m e t h y l s i l y l o x y - 6 - [ ( S ) - 2 , 3 - d i i n e t h o x y p r o p y l ] - t e t r a h y d r o - 5 , 5 - d i m e t h y l - 2 H -  
p y r a n - 2 - c a r b o x a m i d a t e  ( 1 . 6 1 )
To a solution of pedamide 1 , 6 1  (100 mg, 0.26 mmol) in CH2 CI2  (5.5 ml) was added in one portion 
MegOBF i^. (120 mg, 0.84 mmol). After 3 h at room temperature the mixture was poured onto saturated 
aqueous NaHCOg (5 ml) and extracted with CH2 CI2  ( 3 x 5  ml), dried (MgSO^) and concentrated in vacuo to 
give 5 . 1 2  as a foam which was used immediately in the following step.
M e t h y l  ( 2 5 , 4 / ? ) - 4 - / e / / - B u t y l d i m e t h y l s i l y l o x y - 6 - [ ( 5 ' ) - 2 , 3 - d i m e t h o x y p r o p y l ] - t e t r a h y d r o - N - m e t h o x a l y l ”5 , 5 -  
d i m e t h y l - 2 i F / - p y r a n - 2 - c a r b o x a m i d a t e  ( 1 . 6 2 )
To a solution of erude methyl imidate 5 . 1 2  in CH2 CI2  (5.5 ml) at ~50°C was added pyridine (50 ^1, 0.618
mmol, 2.3 eq) followed immediately by methyl oxalyl chloride (32 fi\, 0.34 mmol). After 10 min at ~50°C 
the mixture was poured into saturated aqueous NaHCOg (10 ml) and extracted with CH2 CI2  (3 x 10 ml), 
dried (MgSOq) and concentrated in vacuo to give 1 . 6 2  as a colourless oil which was used immediately in the 
next step.
M e t h y l  1 3 - 0 - ( / < ? r / - B u t y l d i m e t h y l s i l y l ) m e r o p e d e r o a t e  ( 1 . 6 4 )
To a solution of erude A-acylimidate 1 . 6 2  in toluene (4 ml) at room temperature was added RhCl[PhgP]g (12 
mg, 10 /imol). The mixture was cooled to -70°C and freshly prepared catecholborane^^^ (0.80 ml, 0.4 
mmol, 0.51 M solution in THF) was added. The reaction mixture was stirred at -70°C for 20 h and poured 
into saturated aqueous NaHCO^ (50 ml) and extracted with CH2 CI2  (3 x 10 ml). The combined organic 
extracts were dried (MgSO^), and concentrated in vacuo to give a yellow oil which was purified by column 
chromatography on silica gel (20 ml) eluting with hexanes/ethyl aeetate (9:1 —> 7:3) to give 1 . 6 4  (81 mg, 
0.165 mmol, 63.5%).
^H NMR and NMR data in agreement with the literature32
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A c y l a t i o n  o f  l i t h i a t e d  d i h y d r o p y r a n  ( 1 . 6 4 ) ;  A c y l d i h y d r o p y r a n  ( 1 , 6 0 ) .
S e P h
2.2CiyHggOSeSn
Mol. Wt.: 444.06
O M eO
SnM e3 MeO, .OTBS:
OMe
O M e
1.64
2^3^45^*^8®*Mol. W t: 491.69
O M eO
.O TB S
S e P h
OM e
O M e1.60C'seHsgNOgSeSi 
Mol. Wt.: 740.90
To a solution of dihydropyran 2 . 2  (100 mg, 0.225 mmol) in THF (1.5 ml) at -80°C was added BuLi (464 jA, 
0.487 M solution in hexane, 0.226 mmol) and the solution stirred at -80  °C for 15 min. TMEDA (34 jUl, 
0.224 mmol) was added and after 10 min at -  80 °C, a solution of ester 1 . 6 4  (40 mg, 0.081 mmol) in THF 
(2.2 ml) was added. After a further 45 min maintaining the temperature below -60°C, the mixture was treated 
with saturated aqueous NH4 CI (2 ml), and extracted with Et2 0  ( 2 x 4  ml). The combined extracts were dried
and concentrated to give a yellow oil which was purified by chromatography on silica gel ( 1 0  ml), eluting 
with hexanes/EtOAc [10:1, 5:1, 3:1] to give coupling product 1 . 6 0  (28 mg, 0.038 mmol, 47% based on the 
right half fragment) as a colorless oil..
^H NMR data in agreement with the literature^^
R e d u c t i o n  o f  a d d u c t  ( 1 . 6 0 ) ,  a d d i t i o n  m e t h a n o l ,  b e n z o y l a t i o n  : s y n t h e s i s  o f  b e n z o a t e  ( 1 . 6 5 ) .
O M e Q M eOO MeO
O T B SO T B S
S e P h O Bz
S e P h O M eO M e
1.651.60 O M eO M e
Mol. W t: 7 4090
egNO^gSeSi 
Moi.Wt.: 879.06
r e d u c t i o n
To a solution of acyldihydropyran 1 . 6 0  (21.4 mg, 0.029 mmol) in THE (1.5 ml) at -80°C was added LiBH(.y- 
Bu)g (0.032 ml, 1.0 M solution in THF, 0.032 mmol). After 10 min at -80°C the mixture was treated with 
brine (0.7 ml) and extracted with CH2 CI2  ( 2 x 4  ml). The combined organic extracts were dried (MgSO^) and 
concentrated in vacuo. The residue was dried by azeotropic distillation with toluene in vacuo ( 2 x 3  ml) to 
give the corresponding sensitive allylic alcohols.
a d d i t i o n  o f  m e t h a n o l
The alcohols were immediately dissolved in CH2 CI2  (1.3 ml) and MeOH (0.13 ml). Camphorsulfonic acid 
(2.0 mg, 0.0086 mmol) was added and the solution stirred at room temperature for 3 h. Solid K2 CO3  (16 mg,
0.11 mmol) was added slowly during 30 min after which the mixture was poured into saturated aqueous 
NaHCOg (1 ml) and extracted with CH2 CI2  ( 3 x 5  ml). The combined organic extracts were dried (MgSO^)
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and concentrated in vacuo, to give the corresponding diastereoisomeric acetals as a colourless oil which were 
used immediately in the next step.
b e n z o y l a t i o n
Benzoyl chloride (8.2 mg, 6.7 ill, 0.058 mmol) was added to a stirred solution of acetal alcohols, EI3 N (12 jul, 
0.058 mmol) and DMAP (5.7 mg, 0.046 mmol) in CH2 CI2  (1.6 ml) and the reaction mixture was stirred for
15 h at room temperature. MeOH (0.3 ml) was added and after 15 min the mixture was poured into brine (2 
ml) and extracted with CH2 CI2  ( 3 x 5  ml). The combined organic extracts were dried (MgSO^) and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel (5 g) eluting with 
hexanes/EtOAc (10-20%) to give 12.8 mg (0.015 mmol, 50% over 3 steps) of a mixture of the two 
diastereoisomers at C7 in the ratio 3:1. The mixture was purified by preparative thin layer chromatography 
eluting with hexanes/ether (1:1) to give pure diastereoisomer 1 . 6 5  (5.5 mg, 6.25 jUmol, 22%) along with a 
mixture of 1 . 6 5  and its C7-epimer (6.1 mg, 6.95 /tmol, 24%).
l y  NMR data in agreement with the literature^^
P e d e r i n  ( 1 . 1 )
O M e O M eO
.O T B S
OBz
■SePh O M e
1 .6 5 'Me
C 4 4 H0 gNO  ^g S e S i  
Mol. W t.: 8 7 9 .0 6
O M e o M eO
.OH
OH
O M e
OM e
M oi.W t.: 5 0 3 .6 3
7 - ( ? - B e i i z o y l - 1 3 - { ? - ( t o / - b u t y l d i m e t h y l s i l y l ) p e d e r i n
Sodium periodate (2.2 mg, 10 jumol) was added in one portion to a solution of the diastereoisomerically pure 
selenide 1 . 6 5  (5.5 mg, 6.26 jxmoV) in MeOH/H2 0  (3:1, 1.4 ml). After 30 min the mixture was diluted with 
Et2 0  ( 5  ml) and washed with H2 O ( 2 x 5  ml), dried (Na2 S0 ^) and concentrated in vacuo to give the 
selenoxide as a colourless oil which was dissolved in toluene (2 ml) whereupon EtgN (0.95 ml, 6.65 /tmol) 
was added. After refluxing for 2 min, the reaction mixture was poured into saturated aqueous NaHCOg (5 
ml) and extracted with Et2 0  ( 2 x 1 0  ml). The organic extracts were dried (Na2 S0 .^ ) and concentrated in 
vacuo to give a pale yellow oil which was used immediately in the next step.
1 3 - 0 - ( t o ' / - B u t y l d i n i e t h y I s i l y l ) p e d e r i n
To the residue in MeOH (1.5 ml) was added aqueous LiOH (0.15 ml, 1.0 M, 0.15 mmol). After 30 min at 
room temperature the mixture was concentrated, the residue was dissolved in Et2 0  (5 ml), washed with H2 O 
( 2 x 1  ml) and brine (1 ml), dried (Na2 S0 z^ ), and concentrated in vacuo to give the 13-0-TBS pederin as an
oil which was used immediately in the next step.
P e d e r i n  ( 1 . 1 )
To a solution of 13-0-TBS pederin in THF (0.4 ml) was added 4Â molecular sieves (100 mg, crushed and 
activated in vacuo at 180°C) and TBAF (4 mg, 15.3 ^mol). After 24 h at room temperature the reaction 
mixture was diluted with Et2 0  (5 ml) and washed with saturated aqueous NaHCOg (1 ml). The aqueous 
phase was extracted with CH2 CI2  ( 2 x 5  ml) and the combined organic layers dried (Na2 S0 ^) and 
concentrated in vacuo to give an oil which was purified by column chromatography on silica gel ( 1  g) eluting 
with hexane/AcOEt (7:3) and then with AcOEt to give pederin 1 . 1  (1.8 mg, 3.57 jumol, 57% over 4 steps).
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ÔH (400 MHz, CgDg): 7.22 (IH, d, J 10.1, N-H), 5.54 (IH, dd, J 7.9, 10.1, CIO-H), 4.74 (IH, t, 7 = 2.0, 
C4=CH^), 4.70 (IH, t, 7 = 2.0, C4=C%), 4.37 (IH, d, 7 = 2.9, C7-H), 4.14 (IH, d, 7 = 2.9, C7-0H), 3.86 
(IH, dq, 7 = 2.8, 6 .6 , C2-H), 3.82-3.77 (IH, m, C ll-H ), 3.62-3.56 (IH, m, C17-H), 3.50 (IH, dd, 7 = 3.1,
10.5, C18-Ha), 3.44 (IH, dd, 7 = 5.9, 10.4, C l 8 -% ), 3.35-3.31 (2H, m, C15-H and C13-H), 3.32 (3H, s, 
OMe), 3.27 (3H, s, OMe), 3.20 (3H, s, OMe), 3.15 (3H, s, OMe), 2.70 (IH, d, 7 =  14.2, CS-H^q), 2.56 (IH, 
dt, 7 = 2.0, 14.2, C5-Hgx), 1.97 (IH, ddd, 7 =  2.7, 4.5, 13.4, C12-H^), 1.90 (IH, dt, 7 = 2.7, 7.0, C3-H), 1.82 
(IH, ddd, 3.1, 10.4, 14.1, C16-HJ, 1.69-1.63 (IH, m, C16-Hy), 1.63-1.58 (IH, m, C12-Hy), 1.55 (IH, d ,7  = 
6.1, C13-0H), 0.94 (3H, d, 7 = 7.9, C2-Me), 0.89 (3H, d, 7 = 6 .6 , C3-Me), 0.784 (3H, s, C14-Me), 0.776 (3H, 
s, C14-Me); 6 ^ (100 MHz, CgDg): 170.8 (0, C8 ), 145.2 (0, C4), 109.1 (2, C6 ), 99.0 (0, C6 ), 78.4 (1, CIO),
77.0 (1, C17), 74.9 (1, C15), 73.5 (2, C18), 72.4 (1, C7), 71.7 (1, C il) , 70.4 (1, C13), 68.1 (1, C2), 57.6 (3, 
OMe), 55.7 (3, OMe), 54.8 (3, OMe), 47.6 (3, C6-0Me), 40.4 (1, C3), 37.3 (0, C14), 33.3 (2, C5), 29.8 (2, 
C16), 28.9 (2, C12), 21.9 (3, C14-Me), 16.5 (3, C2-Me), 12.0 (3, C14-Me), 10.9 (C3-Me).
10.5 Synthesis of Mycalamide B (1.5) and 17-epi-Mycalamide B (17-epi-1.5)
(2/?,6S)-2-(3-CliloropropyI)-3,3-dimethyI-6-vinyI-tetrahydro-pyran-4-one (6.1)
H
'C l
2.4 6.1
Mol. Wî.: 202.68 Mol. Wl.; 230.73
To a stirred solution of enone 2.4 (17.6 g, 8 6 . 8  mmol) and copper(I) iodide (1.0 g, 5.35 mmol) in THF (170 
ml) at -95 °C was added a solution of vinyl magnesium chloride (1.7 M in THF, 90 ml, 153 mmol) over 30 
min. The reaction mixture was stirred for 1.5 h at -90  °C and then allowed to warm up to -30  °C over 1.5 h. 
Saturated aqueous NH4 CI (300 ml) was added followed by concentrated ammonia solution (60 ml). The 
resulting mixture was stirred for 30 min at rt before being extracted with Et2 0  (3 x 80 ml). The combined 
organic extracts were dried (Na2 S0 4 ) and concentrated in vacuo. The residue was purified by Kugelrohr 
distillation to give vinyl ketone 6.1 (16.0 g, 63.3 mmol, 80%) as a colourless oil: bp 160-180 °C (bath) at 
0.07 mm Hg. The diastereoisomeric ratio was 95:5 according to integration of the ^H NMR spectrum signals 
(400 MHz, CDCI3 ) at 5 2.85 and 2.81 ppm (minor) and 2.67 and 2.55 ppm (major) corresponding to CI2 H2 . 
The following data was recorded on the mixture: 4-46.5 (c 1.1, CHCI3 ); film/cm"^ 1712, 1128;
ÔH (400 MHz, CDCI3 ): 5.85 (IH, ddd, J 17.2, 10.8, 4.8, ClOH), 5.26 (IH, dt, 7 7.8, 1.2, COH^T/g), 5.3 (IH, 
dt, J 17.2, 1 .2 , C9//aHb). 4.56 (IH, dtt, 76.0, 4.8, 1.4, Cl IH), 3.61 (IH, dd, 7 10.0, 3.6, C15H), 3.55 (2H, t, 
7 6.4, CI8 H2 ), 2.67 (IH, dd, 7 14.4, 5.9, C12Ha/7b). 2.55 (IH, dd. 7 14.4, 5.9, C1277aHb). 2.02-1.92 (IH, 
m, C17HaHb), 1.81-1.70 (IH, m, CnH ^H g), 1.70-1.50 (2H, m, CI6 H2 ), 1.11 (3H, s, C14Me), 1.06 (3H, s. 
C14Me); ô c  (100 MHz, CDCI3 ): 211.5 (0, C13), 137.3 (1, CIO), 117.9 (2, C9), 79.3 (1, C15), 72.6 (1, C ll) ,
49.8 (0, C14), 45.0 (2, C18), 41.5 (2, C l2), 29.3 (2, C17), 25.9 (2, C16), 22.0 (3, C14Me), 19.4 (3, C14Me); 
m/z (Cl) 248 [(M4 -NH4 )+, 100%]; Found: (M4-H)+, 230.1071. C 1 2 H 1 9 CIO2  requires M, 230.1074; Found: 
C, 62.48; H, 8.18%. C 1 2 H 1 9 CIO2  requires C,62.47; H, 8.24.
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(25,6/?)-6-(3-Chloropropyl)-2-[(/f)-l,2-dihydroxyethyl]-tetraliydro-5,5-dimethyl-2/7-pyran“4-one (6.2)
Cl 
6.1CirtHioCIOn
Mol. VA.: 264.75
The procedure of Sharpless et al. was used.^^'^ Olefin 6.1 (10.0 g, 43.5 mmol) and hydroquinine 9- 
phenanthryl ether (Aldrich, 439 mg, 0.9 mmol) were stirred in ^BuGH (260 ml) until the ligand dissolved 
completely. After cooling to rt, water (260 ml), KgFe(CN)g (43.3 g, 131.3 mmol) and K2 CO3  (18.3 g, 132.6 
mmol) were added and the mixture was cooled to 0 °C before addition of potassium osmate dihydrate (267 
mg, 0.72 mmol). The reaction mixture was stirred for 3 h at 0 °C, then treated with saturated aqueous 
Na2 S 0 3  (400 ml) and water (100 ml). After stirring at ambient temperature for 30 min the mixture was 
extracted with CH2 CI2  (400 ml + 2 x 200 ml). The combined organic extracts were dried (Na2 S0 .^ ) and 
concentrated in vacuo to give the crude diol. Filtration through silica gel (100 g, 10-40% EtOAc in Et2 0 )
afforded diol 6 . 2  (8.63 g, 32.7 mmol, 75%) as a 13:1 mixture of diastereoisomers according to integration of 
NMR signals (360 MHz, CDCI3 ) derived from the gem-dimethyl groups [ 8  1.26 ppm (major) and 1.28 
ppm (minor)] : _g.o (c 1.1, CHCI3 ); film/cm"! 3412, 1712; 8 ^  (400 MHz, CDCI3 ): 3.94 (IH,
dt, J 9.7, 4.6, C ll-H ), 3.81 (IH, ddd, J 9.8, 6.2, 3.7, ClOH), 3.77 (IH, dd, 711.9, 3.5, C15H), 3.73 (IH, dd, /
11.4, 3.6, C9HA%), 3.65 (IH, dd,7 11.3, 6.4, 0977^% ), 3.58 (2H, t,7  6.0, C I 8 H2 ), 2.80 (IH, dd, J 14.6,
9.7, C12/7^Hb), 2.38 (IH, dd, J 14.6, 4.3, 2.00-1.74 (2H, br, OH), 2.00-1.89 (IH, m,
C1777/^Hg), 1.83-1.74 (IH, m, CnH^i^g), 1.73-1.63 (IH, m, 01677^13^), 1.61-1.50 (IH, m, ClOHy^Ffg), 
1.27 (3H, s, C14Me), 1.01 (3H, s, C14Me); 8 ^ (100 MHz, CDCI3 ): 212.9 (0, C13), 81.6 (1, C15), 73.6 (1,
CIO), 71.7 (1, C ll) , 63.2 (2, C9), 49.6 (0, C14), 44.5 (2, C 1 8 ) ,  38.8 (2, C12), 28.7 (2, C17), 25.3 (2, C16),
24.2 (3, C14Me), 19.3 (3, C14Me); m/z (Cl) 248 [(M+N%)+, 100%]; Found: C, 54.50; H, 7.74; Cl, 
13.72%. C 1 2 H2 1 CIO4  requires C, 54.44; H, 7.94; Cl, 13.42.
( 2 S , 6 R ) - 2 - [ ( R ) - 2 - ( r e / 7 - B u t y l c a r b o i i y l o x y ) - l - h y d r o x y e t h y l ] - 6 - ( 3 - c h l o r o p r o p y I ) - t e t r a h y d r o - 5 , 5 - d i m e t h y I -  
2 i 7 - p y r a i i - 4 - o n e  ( 6 . 3 )
OH O
6.3 01C, yHggCIOg
Mol. wt.; 264.75 Mol. Wt.: 348 6 6
To a solution of diols 6 . 2  (dr 13:1, 4.8 g, 18.2 mmol) and pyridine (4.45 ml, 55.0 mmol) in CH2 CI2  (35 ml) at
0 °C was added pivaloyl chloride (4.6 ml, 37.5 mmol). The reaction mixture was stirred at 0 °C for 1 h, 
treated with saturated aqueous NaHCO^ and extracted with Et2 0  (3 x 70 ml). The combined extracts were 
washed with aqueous HCl (2M, 50 ml), brine (70 ml), dried (Na2 S0 4 ) and concentrated in vacuo. The 
residue was filtered through a pad of silica (50 g, 20-50% Et2 0  in hexanes) and concentrated in vacuo.
Diastereoisomerically pure monopivalate ester 6 . 3  (11.6 g, 33.5 mmol, 78%) was obtained as colourless 
needles by recrystallisation from hexanes-Et2 0 : mp 69-70 °C; [cc]d^^ -2 .0  (c 1.0, CHCI3 );
C C y cm -l 3599, 1716; 8 ^  (400 MHz, CDCI3 ) 4.27 (IH, dd, J 11.6, 3.6, 4.12 (IH, dd,7 11.6,
6.4, C977a%)> 3 . 9 6  (IH, dddd, J 14.8, 6.4, 5.6, 4.0, ClOH), 3.92 (IH, dt, J 9.8, 5 . 3 ,  C llH ), 3.80 (IH, dd, J
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MOMO
OPv O
12.0, 3.2, C15H), 3.58 (IH, ddd, J 10.9, 6.2, 1.1, C IS H ^ ^ ), 3.55 (IH, ddd, J 10.9, 6 .6 , 1.6, C18H ^% ), 
2.82 (IH, dd, J 14.8, 9.6, C n H ^ ^ ) ,  2.70-2.20 (IH, d,7 4.4, OH), 2.42 (IH, dd, J 14.8, 4.0, C12//^Hb), 
2.00-1.85 (IH, m, 1.83-1.73 (IH, m, C17HA% ), 1.73-1.61 (IH, m, Cld^r^Hg), 1.60-1.50
(IH, m, 1.29 (3H, s, C14Me), 1.22 (9H, s, %u), 1.03 (3H, s, C14Me); 8 ^ (100 MHz, CDCI3 ):
211.9 (0, C13), 179.1 (0, ester C=0), 82.1 (1, C15), 72.3 (1, CIO), 71.2 (1, C ll) , 64.9 (2, C9), 49.7 (0, C14),
44.8 (2, CIS), 39.1 (0, CMeg), 38.6 (2, C12), 28.8 (2, C17), 27.4 (3, 3C, CMe^), 25.4 (2, C16), 24.8 (3, 
C14Me), 19.5 (3, C14Me); m/z (Cl) 349 [(M+H)+, 20%]; Found: C, 58.71; H, 8.02; Cl, 10.37%. 
C 1 7 H2 9 CIO5  requires C, 58.54; H, 8.32; Cl, 10.19.
( 2 S , 6 / ? ) - 2 - [ ( / ? ) - 2 - ( ^ e / - f - B u t y l c a r b o n y l o x y ) - l - ( m e t h o x y m e t h o x y ) e t h y l ] - 6 - ( 3 - c h l o r o p r o p y l ) - t e t r a h y d r o - 5 , 5 -  
d l m e t h y l - 2 1 î - p y r a n - 4 - o n e  ( 6 . 4 )
OPV ~
CiTHjgCIOj C, gHjjCIOg
Mol. W l,:348.86 Mol. Wl; 392.91
A mixture of alcohol 6 . 3  (7.1 g, 20.0 mmol), A-ethyldiisopropylamine (10.8 ml, 62.0 mmol), 
tetabutylammonium iodide (355 rag, 0.92 mmol), chloromethyl methyl ether (4.7 ml, 62.0 mmol) and 
anhydrous toluene (55 ml) were stirred at 90 °C for 2 h. The reaction mixture was cooled to rt and treated 
with saturated aqueous NaHCO^ (30 ml). The layers were separated and the aqueous layer was extracted with 
Et2 0  (2 X 30 ml). The combined organic extracts were washed with brine (30 ml), dried (Na2 S0 ^) and 
concentrated in vacuo. The residue was purified by column chromatography (S1 0 2  50g, 10-40% Et2 0  in
hexanes) to give the desired MOM ether 6 . 4  (2.63 g, 6.7 mmol, 97%) as a white solid : mp 42-43 °C 
(hexanes-Et2 Ü); +3.4 (c 1.4, CHCI3 ); C C ^ cm -l 1732, 1716, 1154; 8 g  (400 MHz,
CDCI3 ): 4.69 (IH, d, J 6.9, OCHj^U^O), 4.61 (IH, d, 7 6.9, 4.29 (IH. dd, J 11.8, 4.3,
C9/7a%)> 3 99 (IH, dd,7 11.8, 4.9, C 9H a% ), 3.92 (IH, dt, 7 9.9, 4.6, C llH ), 3.78 (IH, q, 7 5.0, ClOH), 
3.68 (IH, dd, 7 11.7, 3.2, C15H), 3.47 (2H, t, 7 5.5, C I 8 H2 ), 3.30 (3H, s, OMe), 2.71 (IH, dd, 7 14.8, 10.0, 
C12/7aHb), 2.34 (IH, dd, 7 14.7, 4.3, Cl2Up^H^), 1.90-1.80 (IH, m, C17/7aHb). 1.74-1.62 (IH, m, 
C 17H a% ), 1.62-1.51 (IH, m, C16/7aHb), 1.50-1.40 (IH, m, C16HaHb), 1.19 (3H, s, C14Me), 1.11 (9H, 
s, ^Bu), 0.93 (3H, s, C14Me); Ôq (100 MHz, CDCI3 ): 211.3 (0, C13), 177.8 (0, ester C=0), 96.2 (2, O - 
CH2 -O), 81.5 (1, C15), 76.5 (1, CIO), 70.3 (1, C ll) , 62.4 (2, C9), 55.8 (3, OMe), 49.3 (0, C14), 44.4 (2, 
CIS), 38.7 (2, C12), 38.6 (0, CMcg), 28.4 (2, C17), 26.9 (3, 3C, CMe^), 24.9 (2, C16), 24.3 (3, C14Me), 19.1 
(3, C14Me); m/z (Cl) 393 [(M+H)+, 7%]; Found: C, 58.36; H, 8.12; Cl, 8.94%. C 1 9 H3 3 CIO6  requires C, 
58.09; H, 8.41; Cl, 9.04.
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( 2 S , 6 ^ ) - 2 - [ ( j R ) - 2 - ( ^ e ; ' f - B u t y l c a r b o n y l o x y ) - l - ( n i e t h o x y m e t h o x y ) e t h y I ] - 4 - [ ( ^ e r t - b u t y l d i m e t h y l s U y l ) o x y ] - 6 -  
( 3 - c h I o r o p r o p y l ) - 5 , 6 - d i h y d r o - 5 , 5 - d i m e t h y l - 2 H - p y r a n  ( 6 . 5 )
MOMO MOMO
C.„H^CIO
.OTBS
01
6.5
Mof. Wl.: 507.18
To a mixture of ketone 6 . 4  (17.5 g, 44.5 mmol) and triethylamine (12.1 ml, 8 6 . 6  mmol) in CH2 CI2  (70 ml) at 
0 °C was added TBSOTf (12.1 ml, 51.5 mmol) in a dropwise fashion over 5 min. After the addition was 
complete the cooling bath was removed and the reaction mixture stirred for 1.5 h at rt. Saturated aqueous 
NaHCOg (200 ml) was added and the mixture extracted with hexanes (3 x 50 ml). The combined extracts 
were dried (Na2 S0 ^) and concentrated in vacuo to give crude silyl enol ether 6 . 5 .  TBS OH was removed
under vacuum at 50 °C, 1 mm/Hg overnight to give the desired silyl enol ether 6 . 5  (19.2 g, 37.8 mmol, 85%) 
as a clear colourless oil : +iq.3 (c 1.1, CHCI3 ); V^^x film/cm-^ 1732, 1664, 1154; 5^ (400 MHz,
CDCI3 ): 4.74 (IH, d, J 3.0, C12H), 4. 72 (IH, d, /  6 .8 , OCHpJ:Ï^O), 4.66 (IH, d, J 6 .8 , O C H a% 0), 4.46 
(IH, dd, J 11.9, 2.5, 4.20 (IH, dd, 77.8, 3.0, C llH ), 4.08 (IH, dd, J 12.0, 5.7, COH^T/b)* 3.71
(IH, ddd, 7 7.9, 5.7, 2.5, ClOH), 3.65-3.53 (2H, m, ClSHg), 3 . 4 0  (IH, dd, 7 10.6, 2.1, C15H), 3.37 (3H, s, 
OMe), 2.10-2.00 (IH, m, 0177/^% )^ 1.83-1.70 (IH, m, C17H^77b), 1.70-1.59 (IH, m, 01677^^%), 1.59-
1.49 (IH, m, C16Ha77b), 1.19 (9H, s, %u), 1.01 (3H, s, C14Me), 0.93 (3H, s, C14Me), 0.92 (9H, s, ^BuSl), 
0.16 (3H, s, MeSi), 0.15 (3H, s, MeSi); 6 ^ (100 MHz. CDCI3 ): 178.2 (0, ester C=0), 156.0 (0, C13), 98.2 
(1, C12), 96.4 (2, OCH2 O), 79.0 (1, CI5), 77.3 (1, CIO), 70.0 (1, C ll) , 64.2 (2, C9), 55.8 (3, OMe), 45.2 (2, 
CIS), 38.7 (0, CMc3  or C14), 38.4 ( 0 ,  C14 or CMej), 29.6 (2, C17), 27,1 (3, 3C, ^BuC=0), 26.2 (2, C16),
25.6 (3, 3C, ^BuSi), 23.0 (3, C14Me), 19.7 (3, C14Me), 18.1 (0, CSi), -4.5 (3, MeSi), -4.8 (3, MeSi); m/z 
(Cl, NH3 ) 524 [(M+NH4 )+, 40%]; Found: (M+H)+, 507.2910. Cg^HqgClOgSi requires M, 507.2909; 
Found: C, 59.31; H, 9.01%. C2 5 H4 7 CiOgSi requires C, 59.35; H, 9.23.
( 2 7 ? , 3 5 , 4 S , 6 7 ? ) - 2 - [ ( 7 ? ) - 2 - ( 7 e / 7 - B u t y l c a r b o n y l o x y ) - l - ( m e t h o x y m e t h o x y ) e t h y l ] - 4 - [ ( r e / 7 -  
b u t y l d i m e t h y l s i l y l ) o x y ] - 6 - ( 3 - c l i l o r o p r o p y l ) - 3 , 4 - e p o x y - t e t r a h y d r o - 5 , 5 - d i m e t h y l - 2 F f “ p y r a n  ( 6 . 6 )
MOMO
^  ''9  JOTBS
MOMO
OTBS
OPv OOPv O
C«=H..GIO.SI
016.6
Mol. W l: 523.17
A solution of m-chloroperbenzoic acid (15.2 g, 57-80%) in CH2 CI2  (150 ml) was dried over Na2 S0 4 ,
filtered and stirred with sodium hydrogen orthophosphate (11.2 g, 78.7 mmol) at rt for 30 min. The mixture 
was then cooled to 0 °C and a solution of enol ether 6 . 5  (8.58 g, 17.0 mmol) in CH2 CI2  (56 ml) was added 
dropwise over 20 min. The reaction mixture was stirred for 40 min, treated with saturated aqueous Na2 S0 3
and hexanes (500 ml). The phases were separated and the organic layer was extracted with aqueous NaOH 
(2M, 2 X 70 ml), washed with water (70 ml), brine (70 mi), dried (Na2 S0 4 ) and concentrated in vacuo to 
afford crude oxirane 6 . 6  (9.58 g, 18.4 mmol, ca. 100%, single diastereoisomer) as a clear colourless oil : 
+10.0 (c 2.0, CHCI3 ); Vn^ ax film/cm-1 1732, 1152; 8 g  (360 MHz, CDCI3 ): 4.78 (IH, d, J 6.7, 
OCHa77bO), 4.74 (IH, d, J6.7, OC77^HbO), 4.54 (IH, dd, J 12.0, 1.8, C9Ha77b), 4.05 (IH, dd, 79.9, 3.2,
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C llH ), 4.01 (IH, dd, J 12.0, 4.3, C9H^E.^), 3.94 (IH, ddd, /  9.9, 4.1, 1.6, ClOH), 3.57-3.47 (2H, m, 
C I8 H2 ), 3.51 (IH, d, J  3.2, C12H), 3.43 (3H, s, OMe), 3.27 (IH, dd, J 10.3, 1.4, C15H), 2.00-1.85 (IH, m),
1.70-1.50 (2H, m), 1.40-1.30 (IH, m), 1.22 (9H, s, ^BuC=0), 1.05 (3H, s, C14Me), 0.98 (3H, s, C14Me), 
0.91 (9H, s, ^BuSi), 0.14 (3H, s, SiMe), 0.06 (3H, s, SiMe); (90 MHz, CDCI3 ): 178.5 (0), 96.3 (2), 8 6 . 6
(0), 76.0 (1), 71.7 (1), 68.9 (1), 63.6 (2), 60.4 (1), 56.2 (3), 45.3 (2), 39.1 (0), 38.9 (0), 30.1 (2), 27.4 (3, 3C),
26.9 (2), 25.8 (3, 3C), 18.7 (3), 18.0 (0), 16.8 (3), -3.1 (3), -3 .4  (3); m/z (Cl, NH3 ) 540 [(M+NH^)+, 100%]; 
Found: (M+H)+*, 522.2781. C25H47C10ySi requires M, 522.2780.
( 1 5 , 5 / î , 6 / î , 8 / f ) - 5 - ( / e r f - B u t y l c a r b o n y l o x y ) m e t h y I - 8 - ( 3 - c h l o r o p r o p y l ) - 9 , 9 - d i m e t h y l - 2 , 4 , 7 -  
t r i o x a b i c y c l o [ 4 . 4 . 0 ] d e c a n e - 1 0 - o n e  ( 6 . 7 )
MOMO H n OTBSH .'9
025^47^0,31 Ca^H^CIOgSi
Mol, Wl.; 523.17 Mol. Wt.: 493.15
A mixture of crude oxirane 6 . 6  (3.5 g, ca. 92% pure, 6.17 mmol) in CH2 CI2  (15 ml) was added via cannula 
to a solution of dimethoxymethane (30 ml) and P2 0 g (2.5 g, 8 . 8  mmol) in CH2 CI2  (15 ml) at 0 °C over 5
min. The cool bath was removed and the reaction mixture was stirred at rt for 2 h whereupon the reaction 
mixture was poured onto saturated aqueous NaHC0 3  (50 ml). The phases were separated and the aqueous 
layer was extracted with CH2 CI2  (3 x 100 ml). The combined extracts were washed with brine (100 ml), 
dried (Na2 S0 4 ) and concentrated in vacuo. A ^H NMR spectrum of the crude product showed a 15:1 ratio of 
diastereoisomers by integration of the ^H NMR signals (360 MHz, CDCI3 ) derived from gem-dimethyl
groups at S 1.06 ppm (major) and 1.32 ppm (minor)]. The crude product was purified by column 
chromatography (Si0 2  45 g, 10—40% Et2 0  in hexanes) to give ketone 6 . 7  (1.79 g, 4.75 mmol, 77%) as a 
white solid: mp 88-89 °C (hexanes-Et2 0 ); [a]o20 +166.6 (c 1.4, CHCI3 ); v^ax KBr/cm"l 1724, 1282,
1164, 1150; ÔH (400 MHz, CDCI3 ): 4.94 (IH, d, 7 7.8, C12H), 4.87 (IH, d, J 6.5, 0 0 7 ^HgO), 4.83 (IH, d, 
J 6.5, OCH^EgO), 4.50 (IH, dd, J 12.2, 1.6, C9HpJA^), 4.30 (IH, dd, J 10.9, 7.8, C llH ), 4.03 (IH, dd, J
12.2, 6.9, C9H^% ), 3.88 (IH, ddd, J 10.8, 6 . 9 ,  1.6, ClOH), 3.60 (2H, dt, 7 6 .8 , 5.1, C I8 H2 ), 3.56 (IH, dd, 7
12.4, 4.0, C15H), 2.12-2.02 (IH, m, C17/7^Hg), 1.90-1.70 (IH, m, C177/a%)> 1-70-1.61 (2H, m, CI6 H2 ),
1.22 (12H, s, tBuC=0 and C14Me), 1.08 (3H, s, C14Me); 0^ (100 MHz, CDCI3 ): 208.2 (0, C13), 178.3 (0, 
ester C=0), 89.8 (2, OCH2 O), 78.6 (1, C15), 73.3 (1, C12), 72.6 (1, CIO), 70.0 (1, C ll) , 62.8 (2, C9), 51.0 
(0, C14 or CMe3 ), 45.0 (2, CIS), 38.7 (0, CMe3  or C14), 29.4 (2, C17), 27.0 (3, 3C, %uC=0), 26.7 (2, C l 6 ),
19.0 (3, C14Me), 18.9 (3, C14Me); m/z (Cl, NH3 ) 394 [(M+NH^)^, 100%]. Found: (M+H)+, 376.1652. 
CigH 3 oC1 0 g requires M, 376.1653. Found: C, 57.37; H, 7.64; Cl, 9.46%. C 1 8 H2 9 CIO6  requires C, 57.37; H, 
7.70; Cl, 9.43.
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Reduction of ketone 6.7
•OH
OPv O,OPvOPv O.
6.7CiaHjaClOe 
Moi.Wt.: 376.87
6.11aCieHsi CIOg 
Mol. Wl.: 378.89
Cl 
6 . 1 1 b
Ci oH 3iC lOg 
Mol, Wl.1378 6 9
Two procedures were used the most selective being a modified Meerwein-Ponndoif-Verley reduction. Thus, 
trimethylaluminium (2.5 ml, 2.0 M in hexane, 5 mmol) was added to isopropanol (50 ml). The solution was 
stirred for 30 min at rt before solid ketone 6 . 7  (500 mg, 1.325 mmol) was added. The reaction mixture was 
stirred for 24 h at rt, then concentrated in vacuo. The residue was diluted with EtOAc (50 ml) and treated
with HCl (0.5M, 25 ml). The phases were separated and the aqueous phase was extracted with EtOAc (2 x 25 
ml). The combined organic extracts were dried (MgS0 4 ) and concentrated in vacuo to give a mixture of the
ketone 6 . 7 ,  the alcohol 6 . 1 1 a ,  and the undesired alcohol 6 . 1 1 b  as a colourless oil. Separation by column 
chromatography (SiO^, 1 0  g, 30-50% Et2 0  in hexanes) gave ketone 6 . 7  (140 mg, 0.371 mg, 28%), and a
mixture of alcohols 6 . 7 a  and 6 . 7 b  (332 mg, 0.878 mmol, 6 6 %, or 92% based on recovered starting material) 
in the ratio 6:1 (major product is the desired one). The alcohols were then separated by a second column 
chromatography (Si0 2 , 10 g, 10-50% Et2 Û in hexanes) to give alcohols 6 . 7 a  and 6 . 7 b  as colourless oils.
( l S , 5 R , 6 j R , 8 / f , 1 0 S ) - 5 - ( / e / * r - B u t y I c a r b o n y l o x y ) m e t h y l - 8 - ( 3 - e h I o r o p r o p y l ) - 9 , 9 " d i m e t h y I - 2 , 4 , 7 -  
t r i o x a b i c y c l o [ 4 . 4 . 0 ] d e c a i i - 1 0 - o l  ( 6 . 1 1 a )
O 'O ' O
1 H 1
\ TATOPv
6.11a
^18^3, CIOg
Mol, WL: 378.89
[a]j^ 2 0  +87.0 (c 2.0, CHCI3 ); Vniax film/cm-1 3486, 1740, 1728; d y  (400 MHz, CDCI3 ): 4.94 (IH, d, J
6.4, OCH^HbO), 4.80 (IH, d, J 6 .8 , OCHj^R^O), 4.49 (IH, dd, J 12.0, 2.0, C 9H ^% ), 4.16 (IH, ddd, J
10.4, 6 .8 , 1.6, ClOH), 4.06 (IH, dd, J  10.4, 6.4, C llH ), 4.03-3.94 (3H, m), 3.65-3.50 (2H, m, CI8 H2 ), 3.26 
(IH, dd, J  10.4, 1.6, C15H), 2.24 (IH, br, OH), 2.10-1.90 (IH, m), 1.80-1.60 (2H, m), 1.50-1.37 (IH, m),
1.23 (9H, s, tBuCOO), 1.04 (3H, s, C14Me), 0.93 (3H, s, C14Me); 8 ^ (100 MHz, CDCI3 ): 178.6 (0), 86.7
(2), 78.1 (1), 72.8 (1), 71.4 (1), 69.4 (1), 67.4 (1), 63.8 (2), 45.4 (2), 40.8 (0), 39.0 (0), 29.7 (2), 27.3 (3, 3C),
26.3 (2), 23.1 (3), 12.6 (3); m/z (Cl) 379 [(M+H)+, 100%]. Found: C, 57.11; H, 8.10%. CigHgiClOg
requires C, 57.07; H, 8.19.
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(15,5/?,6/î,8i?,10^)"5-(^^/^-Butylcarbonyloxy)methyl-8-(3-chloropropyl)-9,9-diinetliyl-2,4,7-
trioxabicyclo[4,4.0]decan-10-ol (6.11b)
6 .1 1 b
C.oHn.CIO
Mol. W t; 378.89
+66.3 (c 0.3, CHCI3 ); film/cm-^ 3496, 1734; ô g  (360 MHz, CDCI3 ): 5.15 (IH, d, J 5.8,
0C H A % 0), 4.89 (IH, d, /5 .B , OCHpB^O), 4.30 (2H, apparent d, J 5.7, ŒHg), 4.21 (IH, dt, J 10.4, 5.2, 
ClOH), 4.06 (IH, t, J 3.8), 3.75-3.62 (3H, m), 3.59 (2H, t, J 5.5, CI8 H2 ), 2 . 3 2  (IH, d, J 8.1, OH), 2.00-1.58 
(4H, m), 1.21 (9H, s, tBuC=0), 1.13 (3H, s, C14Me), 0.96 (3H, s, C14Me); 8 ^ (1^0 MHz, CDCI3 ): 178.3
(0), 89.1 (2), 78.0 (1, broad signal), 74.3 (1, broad signal), 73.1 (1), 70.2 (1), 65.4 (1), 62.3 (2), 45.1 (2), 38.9 
(0), 38.5 (0), 29.3 (2), 27.2 (3, 3C), 24.0 (2), 22.6 (3), 22.2 (3, broad signal); 8 ^ (90 MHz, CDCI3 , 333 K):
178.1 (0), 89.1 (2), 78.0 (1), 74.3 (1), 73.1 (1), 70.3 (1), 65.7 (1), 62.6 (2), 44.9 (2), 38.9 (0), 38.4 (0), 29.5 
(2), 27.2 (3, 3C), 24.1 (2), 22.7 (3), 22.1 (3); m/z (CI) 379 [(M+H)+, 100%]. Found: C, 57.05; H, 8.05%. 
CigH 3 iClÜ 6  requires C, 57.07; H, 8.19.
Alcohols 6 . 1 1 a  and 6 . 1 1 b  were also generated by reduction of ketone 6 . 7  with KBH4  in the presence of 
CeCl3 *7 H2 Û. A solution of ketone 6 . 7  (1.80 g, 4.8 mmol) and CeCl3 *7 H2 0  (2.6 g, 7.1 mmol) in anhydrous 
methanol (90 ml) was stirred at rt for 15 min and then cooled to 0 °C. Solid KBH4  (740 mg, 14.1 mmol) was
added (gas evolution!). After 1.5 h acetone (1 ml) was added to the reaction mixture followed by saturated 
aqueous NaHC0 3  (50 ml). The methanol was removed in vacuo and the aqueous phase extracted with 
CH2 CI2  (3 X 50 ml). The combined extracts were washed with brine (50 ml), dried (Na2 S0 4 ) and 
concentrated in vacuo. ^H NMR spectrum of the crude product showed a 1:2 ratio of diastereoisomers by 
integration of ^H NMR signals (360 MHz, CDCI3 ) derived from the gem-dimethyl groups at 8  1.14 ppm
(major) and 1.05 ppm (minor). The undesired alcohol 6 . 1 1 b  was the major product. The crude product was 
purified by column chromatography (Si0 2  50 g, 30-50% Et2 0  in hexanes) to give a mixture of alcohols
6 . 1 1 a , b  (1.72 g, 4.56 mmol, 95%) as a colourless oil. The diastereoisomers were separated by column 
chromatography (Si0 2  150 g, hexanes-Et2 0  20—40%)
The undesired alcohol 6 . 1 1 b  was converted back to ketone 6 . 7  by Dess-Martin oxidation. 
Dess-Martin periodinane (2.7 g, 6.35 mmol) was added in one portion to a stirred solution of alcohol 6 . 1 1 b  
(1.6 g, 4.3 mmol) in CH2 CI2  (20 ml). The reaction mixture was stirred at rt for 25 min and treated with 
saturated aqueous Na2 S 2 0 g (25 ml) and saturated aqueous NaHCOg (20 ml). After 1 h the phases were 
separated and the aqueous layer was extracted with CH2 CI2  (3 x 20 ml). The combined extracts were dried 
(Na2 S0 4 ) and concentrated. The residue was purified by column chromatography (Si0 2  10 g, 10-30% Et2 0  
in hexanes) to give ketone 6 . 7  (1.61 g, 4.3 mmol, 100%).
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(l/î,5/î,6/f,8/î,10S)-5-(ï‘e/^Butylcarbonyloxy)methyl-8-(3-chloropropyl)-10-methoxy-9,9-dimethyl-2,4,7-
trioxabicyclo[4.4.0]decane (6.12)
B.1 1 a 6 . 1 2CioH3|CIOb CjgHasCIC^
Mol. W t : 378.89 Mol. W t: 392 91
A solution of alcohol 6 . 1 1 a  (4,2 g, 11.0 mmol) in THF (25 ml) was added dropwise to a stirred solution of 
sodium bis(trimethylsilyl)amide (2M in THF, 7,3 ml, 14.5 mmol) in THF (5 ml) at -78 °C, After 5 min 
methyl trifluoromethanesulfonate (2,5 ml, 22,4 mmol) was added dropwise. The reaction mixture was stirred 
at -78 °C for 20 min, treated with saturated aqueous NaHCOg (50 ml) and extracted with Et2 0  (3 x 50 ml). 
The combined organic extracts were dried (MgSO^) and concentrated in vacuo. The residue was purified by 
column chromatography (S1 0 2 , 5-20% Et2 0  in hexanes) to give methyl ether 6 . 1 2  (3,7 g, 9,41 mmol, 8 6 %) 
as a colourless oil: +54.7 (c 1,1, CHCI3 ); film/cm"^ 1732, 1162, 1112, 1040; Ôjj (400 MHz,
CDCI3 ): 4,98 (IH, d, J 6 .6 , OCT/^HgO), 4,84 (IFI, d, J 6 ,6 , OCH^H'^O), 4,48 (IH, dd, J 12,0, 1,6, 
C9//^Hb), 4,19-4,13 (2H, m, ClOH, C12H), 4,00 (IH, dd, J 12.0, 7,0, C9Hy^Hg), 3,92 (IH, dd, 710,6, 6 ,8 , 
C llH ), 3,63-3,50 (2H, m, C I8 H2 ), 3.55 (3H, s, OMe), 3,42 (IH, d, J 10.3, C13H), 3,24 (IH, d, /  9,7, 
C15H), 2,02-1.94 (IH, m, CnH ^H g), 1,80-1,68 (IH, m, 1,68-1,60 (IH, m, C16H^Hg), 1,46-
1.35 (IH, m, ClOH^Tfg), 1,22 (9H, s, ^uC=0), 1,00 (3H, s, C14Me), 0,86 (3H, s, C14Me); 8 ^ (100 MHz, 
CDCI3 ): 178.4 (0, ester C=0), 86,9 (2, OCH2 O), 79,2 (1, C13), 78,0 (1, C15), 73.3 (1, CIO or C12), 71.2 (1, 
C12 or CIO), 67,3 (1, C ll) , 63.7 (2, C9), 61.7 (3, OMe), 45.2 (2, CIS), 41.6 (0, C14), 38.8 (0, CMeg), 29,5 
(2, C17), 27,1 (3, 3C, ^Bu), 26,1 (2, C l 6 ), 23,1 (3, C14Me), 13.4 (3, C14Me); m/z (Cl) 393 [(M+H)+, 
100%], Found: (M+H)+, 393.2040. C 1 9 H3 4 CIO6  requires M, 393.2044. Found: C, 58.19; H, 8.41%. 
C i 9 H3 3 C1 0 ( 5  requires C, 58,09; H, 8,41,
( l / ï , 5 / f , 6 J Î , 8 / î , 1 0 S ) - 5 - ( / e r ^ - B u t y l c a r b o n y I o x y ) m e t l i y l - 1 0 - m e t h o x y - 9 , 9 - d i m e t h y l - 8 - ( 3 -  
p h e n y l s e l e n y l p r o p y l ) - 2 , 4 , 7 - t r i o x a b i c y c l o [ 4 . 4 . 0 ] d e c a n e  ( 6 . 1 3 )
,OMe
SePh
6.13
'C l
6,12CisHaaCK^ CgsHsgOoSe
Mol. W t: 392.91 Mol. W l; 513.53
Solid NaBFIq (610 mg, 16.1 mmol) was added in several batches to a stirred suspension of diphenyl 
diselenide (2,5 g, 8.26 mmol) in anhydrous ethanol (30 ml) to cause exothermic reaction. The reaction 
mixture was stirred at rt until a clear yellow solution was obtained. A solution of chloride 6 . 1 2  (4,2 g, 10,7 
mmol) in ethanol (30 ml) was then added via cannula and the resulting mixture was heated at reflux for 1 0  
min. The reaction mixture was cooled to rt, poured onto saturated aqueous NaHC0 3  (200 ml) and extracted 
with Et2 0  (3 X 200 ml). The combined organic extracts were washed with aqueous NaOH (2M, 100 ml) and 
brine (100 ml), dried (MgSO^) and concentrated in vacuo. The residue was purified by column 
chromatography (SiÜ2 , 10-40% Et2 0  in hexanes) to give selenide 6 . 1 3  (5.25 g, 10.2 mmol, 96%) as a 
colourless oil: ^ ^ 2 0  +7 1 . 3  1 .6 , CHCI3 ); Elm/cm-^ 1732, 1580, 1186, 1162, 1112, 1040; 8 ^ (400
107
Me
OPv O
'SePh
6.13
MHz, CDCI3 ): 7.54-7.51 (2H, in), 7.31-7.23 (3H, m), 4.99 (IH, d, J 6 .6 , OCH^H^O), 4.88 (IH, d ,7  6 .6 , 
OCH^T/gO), 4.47 (IH, dd, J 12.0, 1.6, C9H^U^), 4.20-4.16 (IH, m, ClOH collapsed by C12H), 4.18 (IH, 
dd, J 10.3, 6 .8 , C12H), 4.02 (IH, dd, J 12.1, 6.9, C9Ep,Hji), 3.97 (IH, dd, J 10.6, 6 .8 , C llH ), 3.59 (3H, s, 
OMe), 3.42 (IH, d, J 10.3, C13H), 3.23 (IH, dd, J 10.2, 1.4, C15H), 2.96 (2H, t, J 7.0, CISH^), 2.00-1.90 
(IH, m, C17/7^Hq), 1.75-1.65 (IH, m, C17H^77g), 1.65-1.57 (IH, m, C16//^Hb), 1.47-1.40 (IH, m, 
1.25 (9H, s, ^uC =0), 1.00 (3H, s, C14Me), 0.87 (3H, s, C14Me); 6 ^ (100 MHz, CDCI3 ):
178.3 (0, ester C=0), 132.7 (1, 2C), 130.3 (0), 129.0 (1, 2C), 126.7 (1), 86.9 (2, OCH2 O), 79.2 (1, C13), 78.1
(1, C15), 73.4 (1, CIO or C12), 71.2 (1, C12 or CIO), 67.3 (1, C ll) , 63.6 (2, C9), 61.7 (3, OMe), 41.6 (0, C14 
or CMeg), 38.9 (0, CMegor C14), 28.6 (2, CIS), 27.9 (2, C17 or C l 6 ), 27.1 (3, 3C, ^Bu); 27.1(2, C16 or 
C17), 23.2 (3, C14Me), 13.4 (3, C14Me); m/z (El) 514 [(M+H)+*, 33%], 357 (15), 243 (15), 193 (20), 113 
(25), 71 (100). Found; (M+H)+', 514.1830. CzgHggO^Se requires M, 514.1835. Found: C, 58.47; H, 7.48%. 
requires C, 58.48; H, 7.41.
( l / i ! , 5 / ? , 6 / ? , 8 i ? , 1 0 5 ' ) - 5 - ( ^ e r ^ B u t y l c a r b o n y l o x y ) m e t h y l - 1 0 - n i e t h o x y - 9 , 9 - d i m e t h y l - 8 - ( p r o p - 2 - e n y l ) - 2 , 4 , 7 -  
t r i o x a b i c y c l o [ 4 . 4 . 0 ] d e c a n e  ( 6 . 1 4 )
OPv
6.14CasHsePoSe C19H32Q3
Mol. Wt.: 5 1 3 5 3  Mot, W t: 356.45
Sodium metaperiodate (3.5 g, 16.8 mmol) was added in one portion to a stirred mixture of selenide 6.13 (5.20 
g, 10.1 mmol), water (60 ml) and MeOH (150 ml) at rt. The reaction mixture was stirred for 25 min then 
diluted with water (50 ml) and extracted with CH2 CI2  (3 x 50 ml). To the combined organic extracts was 
added 5 ml of triethylamine and the extracts were dried (Na2 S0 .^ ) and concentrated in vacuo. The residue
was dissolved in toluene (110 ml) and triethylamine (110 ml) and heated at reflux for 10 min . The yellow 
reaction mixture was allowed to cool to rt, poured onto saturated aqueous NaHCOg (200 ml) and extracted 
with CH2 CI2  (3 X 100 ml). The combined organic extracts were dried (Na2 S0 ^) and concentrated at rt in 
vacuo. The residue was dissolved in toluene (7 ml) and purified by column chromatography (Si0 2 , hexanes) 
until the yellow band eluted and then Et2 0 :hexaiies (5-50%) to give olefin 6.14 (3.55 g, 9.96 mmol, 98%) as 
a colourless oil: +25.9 (c 1.4, CHCI3 ); film/cm"^ 1732, 1480, 1284; ^  (400 MHz, CDCI3 ):
5.84 (IH, ddt, J 18.0, 11.4, 6 .8 , C17H), 5.08 (IH, ddm, J 5.6, 1.2, 5.04 (IH, dm, J 1.2,
CISHaHb), 4.99 (IH, d, J  6 .6 , OCTf^HgO), 4.86 (IH, d, J 6 .6 , OCR^HgO), 4.47 (IH, dd, J 12.0, 1.9, 
C9H^Hg), 4.20-4.15 (IH, m, ClOH collapsed by C12H), 4.18 (IH, dd, J 10.2, 6 .8 , C12H), 4.06 (IH, dd, J
12.0, 6 .6 , COH^Tfg), 3.99 (IH, d d ,/ 10.6, 6 .8 , C llH ), 3.57 (3H, s, OMe), 3.44 (IH, d, J 10.2, C13H), 3.30 
(IH, dd, J 10.1, 2.3, C15H), 2.19 (IH, dddt, /  14.4, 10.2, 7.1, 1.2, C16H ^E^), 2.12-2.03 (IH, m, 
ClôH^Hg), 1.23 (9H, s, ^uC =0), 1.02 (3H, s, C14Me), 0.89 (3H, s, C14Me); 5 ^  (100 MHz, CDCI3 ):
178.6 (0, ester C=0), 135.8 (1, C17), 116.7 (2, C18), 87.2 (2, OCH2 O), 79.3 (1, C13), 78.5 (1, C15), 73.5 (1, 
C12), 71.3 (1, CIO), 67.3 (1, C ll) , 63.5 (2, C9), 61.8 (3, OMe), 41.6 (0, C14), 38.9 (0, CMeg), 33.4 (2, C16),
27.2 (3, 3C, ^Bu), 23.2 (3, C14Me), 13.4 (3, C14Me); m/z (Cl) 357 [(M+H)+, 100%]. Found: (M+H)+, 
357.2277. C 1 9 H3 3 O6  requires M, 357.2276. Found: C, 64.04; H, 9.19%. C^g^^Oô requires C, 64.04; H,
9.00.
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Sharpless asymmetric dihydroxylation of alkene 6.14
.OMe
O P v O
Mol, Wt.: 504.73
+ OPv
^•^^OTBSOTBS
OH OH
6.15a 6.15b
C «H ,«0„S I
Alkene 6 . 1 4  (2 g, 5.61 mmol) and dihydroquinine 9-phenanthryl e t h e r ( 8 6  mg, 0.170 mmol) were stirred 
in ^BuOH (40 ml) until the crystals of ligand dissolved completely. After cooling to rt, water (40 ml), 
%Fe(CN)g (5.6 g, 17.1 mmol) and K2 CO3  (2.3 g, 16.7 mmol) were added and the mixture was cooled to 0
°C. Potassium osmate dihydrate (60 mg, 0.16 mmol) was added and the reaction mixture was stirred for 3 h 
at 0 then treated with saturated aqueous Na2 S0 3  (70 ml) and extracted with CH2 CI2  (3 x 100 ml). The 
combined organic extracts were washed with brine, dried (MgSO.^) and concentrated in vacuo to give the 
crude diols as an inseparable mixture (1.5:1) of diastereoisomers which were used immediately in the next 
step. The isomeric ratio was ascertained by integration of the crude mixture which revealed signals derived 
from one of the C9 protons at ô 4.82 (dd, J 12.2, 1.2, minor) and 4.60 ppm (dd, J 12.1, 1.2, minor)] in the 
NMR spectrum (360 MHz, CDCI3 ).
fg/Y-Butyldimethylsilyl chloride (1.72 g, 11.45 mmol) was added in one portion to a stirred solution 
of crude mixture of diols, triethylamine (1.6 ml, 11.0 mmol) and DMAP (70 mg, 0.58 mmol) in CH2 CI2  (25 
ml) at 0 °C. The reaction mixture was stirred at 0 °C for 1 h and at rt for 2 h. Saturated aqueous NaHC0 3  (40 
ml) was added and the resulting mixture was extracted with CH2 CI2  (3 x 100 ml). The combined organic 
extracts were dried (MgSO,^) and concentrated in  vacuo. The residue was purified by column 
chromatography (Si0 2 , 30-40% Et2 0  in hexanes) to give a mixture of 6 . 1 5 a  and 6 . 1 5 b  (2.7 g, 5.3 mmol, 
95% from the alkene). Separation by chromatography on silica gel (0-50% Et2 0  in hexanes) gave the desired
monoprotected diol 6 . 1 5 a  (1.5 g, 3.0 mmol, 53%) which crystallised on standing and the undesired 
monoprotected diol 6 . 1 5 b  (1.0 g, 2.0 mmol, 36%) as a colourless oil. TLC monitoring conditions: 50% Et2 0  
in hexanes (phosphomolybdic acid); Rf ( d i o l )  0.00 (black); Rf ( 6 . 1 5 a )  0.43 (black), ( 6 . 1 5 b )  0.31 (black).
( l / ? , 5 j R , 6 / ? , 8 / ? , 1 0 5 ) - 5 - ( t e r ^ B u t y l c a r b o n y l o x y ) m e t l i y l - 8 - { ( 2 S ) - 3 - [ ( f e / / - b u t y l d i m e t l i y I s i l y l ) o x y ] - 2 -  
h y d r o x y p r o p y l } - 1 0 - m e t h o x y - 9 , 9 - d i m e t h y l - 2 , 4 , 7 - t r i o x a b i c y c I o [ 4 . 4 . 0 ] d e c a n e  ( 6 . 1 5 a )
.OMe
O Pv O.
■OTBS
OH
.15a
Mol. Wt.: 504.73
mp 32-34 °C (hexanes-Et2 0 ); +5 8 . 0  (c 0.42, CHCI3 ); V^ax film/cm"! 3542, 2958, 1186, 1732,
1472, 1040; (400 MHz, CDCI3 ): 5.00 (IH, d, J 6 .6 , OCH^HgO), 4.86 (IH, d, J 6 .6 , OCH^HgO), 4.54
(IH, dd, J 12.0, 1.7, C9H^Hb), 4.22 (IH, ddd, J 10.5, 6.4, 1.7, ClOH), 4.17 (IH, dd, /  12.0, 6 .8 , C9Hj^Hjs),
4.14 (IH, dd, J 12.4, 6.4, C12H), 4.00 (IH, dd, J 10.6, 6 .8 , C llH ), 3.79 (IH, m, C17H), 3.62 (IH, dd, J 10.0,
5.2, C187/^Hb), 3.57 (3H, s, OMe), 3.52-3.43 (3H, m, C13H, C15H and C18HA77g), 3.12 (IH, br d, 71.6, 
OH), 1.82 (IH, ddd, J  14.5, 3.6, 2.0, C16/7^Hb), 1.44 (IH, ddd, 714.5, 10.0, 8.0, C16Ha/7b), 1.23 (9H, s.
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^BuC=0), LOO (3H, s, C14Me), 0.90 (3H, s, C14Me), 0.89 (9H, s, ^BuSi), 0.07 (6 H, s, Me2 Si); 8 ^ (100 
MHz, CDCI3 ): 178.3 (0, ester C=0), 86.9 (2, OCHgO), 78.92 (1, C13 or C15), 78.87 (1, C15 or C13), 73.1
(1, C12), 71.7 (1, C17), 71.2 (1, CIO), 67.4 (1, C ll) , 66.4 (2, CIS), 63.4 (2, C9), 61.7 (3, OMe), 41.7 (0, C14 
or CMeg), 38.8 (0, CMeg or C14), 32.2 (2, C16), 27.1 (3, 3C, ^Bu), 25.8 (3, 3C, ^BuSl), 23.1 (3, C14Me),
18.2 (0, CSi), 13.4 (3, C14Me), -5 .4  (3, 2C, SiMej); ni/z (Cl, isobutane) 505 [(M+H)+, 100%]. Found: 
(M+H)+, 505.3193. C2 5 H^ciOgSi requires M, 505.3197. Found: C, 59.29; H, 9.53%. C2 5 H^gOgSi requires 
C, 59.49; H, 9.59.
( l ^ < ! , 5 / î , 6 i f , 8 / î , 1 0 S ) - 5 - ( ^ € / ' ï - B u t y I c a r b o n y l o x y ) m e t h y l - 8 - { ( 2 J Î ) - 3 - [ ( r e / Y - b u t y l d i m e t h y l s i l y i ) o x y ] - 2 -  
h y d r o x y p r o p y l } - 1 0 - m e t I i o x y - 9 , 9 - d i m e t h y l - 2 , 4 , 7 - t r i o x a b i c y c l o [ 4 . 4 . 0 ] d e c a i i e  ( 6 . 1 5 b )
,OMe
O Pv O-
'OTBS
OH
6 .15b
Mol. W t: 504.73
+ 7 5 . 3  ( c  0 .3 , CHCI3 ); Vrnax film/cm-1 3568, 2958, 1186, 1732, 1472, 1040; 8 ^  (400 MHz,
CDCI3 ): 5.00 (IH, d, J 6 .6 , OCHy^HgO), 4.86 (IH, d, J 6.6, OCH^HgO), 4.66 (IH, dd, J 12.1, 1.3, 
C9//^Hb), 4.22-4.15 (IH, m, ClOH collapsed by C12H), 4.19 (IH, dd, J 10.3, 7.1, C12H), 4.03 (IH, dd, J
12.1, 6.9, 3.95 (IH, d d ,/ 11.0, 7.0, C llH ), 3.85-3.75 (IH, m, C17H), 3.62 (IH, dd, J 9.8, 2.4,
C15H), 3.57 (3H, s, OMe), 3.57 (IH, dd, J 9.9, 4.4, ClS/f^Hg) 3 . 4 7  (IH, d, J 10.5, C13H), 3.47 (IH, dd, /
10.0, 3.3, C 18H a% ), 3.13 (IH, br d, /4 .0 , OH), 1.45-1.33 (2H, m, CI6 H2 ), 1.23 (9H, s, ^BuC=0), 0.99 
(3H, s, C14Me), 0.90 (9H, s, ^BuSi), 0 . 8 6  (3H, s, C14Me), 0.07 (6 H, s, Me2 Si); 8 ^ (100 MHz, CDCI3 ):
178.8 (0, COO), 86.9 (2, OCH2 O), 79.4 (1, C13), 74.0 (1, C15), 73.6 (1, CIO or C12), 71.7 (1, C12 or CIO),
67.9 (1, C17), 67.8 (2, CIS), 67.3 (1, C ll) , 64.0 (2, C9), 61.8 (3, OMe), 41.3 (0, C14 or CMc3 ), 38.9 (0, 
CMeg or C14), 32.0 (2, C16), 27.1 (3, 3C, ^Bu), 25.9 (3, 3C, ^BuSi), 22.9 (3, C14Me), 18.3 (0, CSi), 1 3 . 2  (3, 
C14Me), -5.3 (3, 2C, S i M e g ) ;  m/z (Cl, isobutane) 505 [(M+H)+, 100%], 487 (8 ), 447 (10). Found: 
(M+H)+, 505.3193. C2 5 H^gOgSi requires M, 505.3197. Found: C, 59.58; H, 9.40%. C2 5 H4 gOgSi requires 
C, 59.49; H, 9.59.
( l / ? , 5 7 ? , 6 J ? , 8 i ? , 1 0 5 ) - 5 - ( / e / * / - B u t y l c a r b o n y l o x y ) n i e t l i y l - 8 - { ( 2 S ) - 3 - [ ( / e ^ / - b u t y l d i m e t h y l s i l y I ) o x y ] - 2 -  
m e t h o x y p r o p y I } - 1 0 - m e t h o x y - 9 , 9 - d i m e t I i y l - 2 , 4 , 7 " t r l o x a b l c y c l o [ 4 . 4 . 0 ] d e c a n e  ( 6 . 1 6 a )
OPv o
OTBS
6.15a
Mol. Wt,; 504.73
iMe
OPv O-
'OTBS
OMe
6.16a
A solution of alcohol 6 . 1 5 a  (525 mg, 1.04 mmol), 2,6-di-rert-butyI-4-methylpyridine (700 mg, 3.36 mmol) 
and methyl trifluoromethanesulfonate (350 jil, 3.05 mmol) in toluene (3 ml) was stirred at 70 °C (oil bath 
temperature) for 4 h and overnight at 40 °C. The reaction mixture was cooled to rt and treated with saturated 
aqueous NaHCO^ and extracted with Et2 0  (3 x 20 ml). The combined organic extracts were washed with
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aqueous HCl (2M) and brine, then dried (Na2 S0 ^) and concentrated in vacuo. The residue was purified by 
column chromatography (SiO^, 5-25% E t 2 0  in hexanes) to give methyl ether 6 . 1 6 a  (412 mg, 0,794 mmol, 
76%) as a colourless oil which solidified on standing; mp 30-32 °C (hexanes-Et2 0 ); +91.4 (c 0.3,
CHCI3 ); Vmax KBr/cm-1 2958, 1732, 1472, 1108; 0^ (400 MHz, CDCI3 ): 5.01 (IH, d, J 6 .6 , OCH^K^O), 
4.86 (IH, d, J 6 .6 , OCH^TfgO), 4.46 (IH, dd, J 10.1, 5.5, C9H^B^), 4.20-4.11 (3H, m, C9H ^% , ClOH, 
C12H), 4.00 (IH, dd, J 10.2, 6 .8 , C llH ), 3.67 (2H, d, 74.3, CI8 H2 ), 3.57 (3H, s, OMe), 3.43 (IH, d, J 10.3, 
C13H), 3.36 (3H, s, OMe), 3.35 (IH, dd, J 9.8, 1.6, C15H), 3.29 (IH, dq, J  8.1, 4.3, C17H), 1.81 (IH, ddd, J
14.2, 8.1, 1.6, C16//^Hb), 1.52 (IH, ddd, J 1 4 . 2 ,  7.6, 10.1, 4.3, C16H^77g), 1.23 (9H, s, ^uC =0), 1.00 (3H, 
s, C14Me), 0.90 (9H, s, ^BiiSi), 0.89 (3H, s, C14Me), 0.07 (6 H, s, Me2 Si); 6 ( 3  (100 MHz, CDCI3 ): 178.4 (0, 
ester C-O), 87.0 (2, OCH2 O), 79.8 (1, C17), 79.5 (1, C13), 76.2 (1, C15), 73.4 (1, CIO or C 1 2 ) ,  71.4 ( 1 ,  C12
or CIO), 67.3 (1, C ll) , 63.8 (2, C18 or C9), 63.6 (2, C9 or C18), 61.8 (3, OMe), 57.2 (3, OMe), 41.7 (0, C14 
or CMeg), 39.0 (0, CMeg or C14), 30.5 (2, C16), 27.3 (3, 3C, ^Bu), 26.1 (3, 3C, ^BuSi), 23.4 (3, C14Me),
18.4 (0, CSi), 13.5 (3, C14Me), -5 .2  (3, 2 C ,  MegSi); m/z ( C l ,  isobutane) 519 [(M+H)+, 100%], 461 ( 8 ) ,  387 
(10). Found: (M+H)+, 519.3350. C26H5i0gSi requires M, 519.3353. Found: C, 60.31; H, 9.63%. 
C26H5i0sSi requires C, 60.20; H, 9.71.
( l / ? , 5 i î , 6 i R , 8 i R , 1 0 S ' ) - 5 - ( ^ e r ^ B u t y l e a r b o n y l o x y ) m e t h y l - 8 - { ( 2 / î ) - 3 - [ ( ^ e / 7 - b u t y l d i m e t h y l s U y l ) o x y ] - 2 -  
m e t h o x y p r o p y I } - 1 0 - i i i e t h o x y - 9 , 9 - d i m e t h y l " 2 , 4 , 7 - t n o x a b i c y c I o [ 4 . 4 , 0 ] d e c a i i e  ( 6 . 1 6 b )
OPv 0 v ^ 4 ; “
iMe
OPv O.
'OTBS
OMe
OTBS
OH
6 .15b 6 .16bC2|jH4^0Si CggHgQOgSi
Mol. Wl.: 504.73
Méthylation of 6.15b (530 mg, 1.05 mmol) by the same procedure gave methyl ether 6.16b (403 mg, 0.78 
mmol, 74%) as a colourless oil: +82.5 (c 0.8, CHCI3 ); KBr/cm“  ^ 2957, 1732, 1473, 1111; ôjj
(400 MHz, CDCI3 ): 5.02 (IH, d, J 6 .6 , OCT/^HgO), 4.85 (IH, d, 7 6 .6 , O C H ^ ^ O ), 4.36-4.30 (IH, m, 
C9//^Hb), 4.23 (IH, dd,7 10.4, 7.0, C 9H ^% ), 4.23-4.18 (IH, m collapsed by signals at 4.23 and 4.21
ppm, ClOH), 4.16 (IH, dd, 7 10.2, 6.9, C12H), 3.98 (IH, dd,7 10.4, 6.9, C llH ), 3.63 (IH, dd, 7 10.8, 4.6, 
C18/7^Hb), 3.60-3.54 (IH, m, C 18H a% ), 3.56 (3H, s, OMe), 3.51 (IH, dd, 7 10.1, 1.0, C15H), 3.47 (IH, 
d, 7 10.3, C13H), 3.37 (3H, s, OMe), 3.38-3.31 (IH, m, C17H), 1.52 (IH, ddd, 7 14.3, 10.4, 1.4, CldH^Hg), 
1.40 (IH, ddd, 7 14.4, 10.4, 2.3, C16Uj^ Hb), 1.21 (9H, s,^BuC=0), 0.97 (3H, s, C14Me), 0.88 (9H, s, ^BuSi), 
0.85 (3H, s, C14Me), 0.04 (6 H, s, Me^Si); § c  (100 MHz, CDCI3 ): 178.2 (0, ester C=0), 8 6 . 8  (2, OCH2 O),
79.4 (1, C13), 77.6 (1, C17), 74.0 (1, C15), 73.5 (1, C12), 71.3(1, CIO), 67.0 (1, C ll) , 64.5 (2, C18), 63.6 (2, 
C9), 61.7 (3, OMe), 57.4 (3, OMe), 41.2 (0, C14 or CMeg), 38.8 (0, CMe^ or C14), 31.5 (2, C16), 27.1 (3, 
3C, mu), 25.8 (3, 3C, ^uSi), 23.1 (3, C14Me), 18.2 (0, CSi), 13.3 (3, C14Me), -5 .4  (3, 2C, McgSi); m/z
(Cl, isobutane) 519 [(M+H)+, 80%], 487 (60), 461 (10), 387 (10), 355 (100), 315 (15). Found: (M+H)+, 
519.3352. C2 gHg2 0 gSi requires M, 519.3353. Found: C, 60.28; H, 9.59%. C2 ^HgQ0 gSi requires C, 60.20;
H,9.71.
I l l
(liî,5/î,6/?,8i?,105)-8-{(2S)-3-[(to^-ButyldimetliyIsilyl)oxy]-2-methoxypropyl}-5-hydroxymethyl-10-
niethoxy-9,9-dimethyl-2,4,7-trioxabicydo[4.4.0]decane (6.17)
OMe
OPv O OH O
OTBS
6 .16a 6.172^1 HjgO^SI
Mol. W t; 434.64
To a solution of ester 6.16a (415 mg, 0.800 mmol) in THF (5 ml) at -80  °C was added Red-Al™ (400 |xl, 1.1 
M in THF, 0.44 mmol) dropwise over 5 min. The cooling bath was removed and the clear colourless reaction 
mixture allowed to warm to 0 °C over 30 min whereupon acetone (40 |0.1) was added and the mixture then 
poured onto ice cold aqueous NaOH (IM, 1.9 ml). Dichloromethane (2 ml) and H2 O (2 ml) were added and 
the clear colourless phases were then separated and the aqueous phase was extracted with CH2 CI2  (3 x 30 
ml). The combined organic extracts were dried (MgSO^) and concentrated in vacuo. The residue was purified 
by column chromatography (Si0 2 , 40% Et2 0  in hexanes) to give alcohol 6.17 (327 mg, 0.75 mmol, 94%) as 
a clear colourless oil: +67.4 (c 1.6, CHCI3 ); film/cm"^ 3466, 2932, 1472; Ôjj (400 MHz,
CDCI3 ): 5.02 (IH, d, 7 6.5, OCHy^HgO), 4.85 (IH, d ,7 6.5, OCH^HgO), 4.14 (IH, dd,7 10.3, 6.0, C llH ), 
4.20-3.80 (2H, m, ClOH, C12H), 3.85 (IH, br d, 7 11.7, C97/^Hb), 3.73-3.66 (IH, m, COH^Tfg), 3.65 (IH, 
dd, 7 10.8, 4.7, ClST/^Hg), 3.59 (IH, dd, 7 10.8, 4.5, C18% Hg), 3.56 (3H, s, OMe), 3.42 (IH, d ,7 10.4,
C13H), 3.36 (3H, s, OMe), 3.37-3.33 (IH, m, C15H), 3.28 (IH, dq, 7 7.6, 4.4, C17H), 2.48 (IH, br s, OH), 
1.76 (IH, ddd, 7 14.4, 7.6, 1.6, C16H^Hb), 1.49 (IH, ddd, 714.4, 9.6, 4.8, CI6 HAH5 ), 0.97 (3H, s, C14Me), 
0.89 (9H, s, ^BuSi), 0.86 (3H, s, C14Me), 0.06 (6 H, s, MejSi); 8 ^ (100 MHz, CDCI3 ): 86.7 (2, OCH2 O),
79.9 (1, C17), 79.2 (1, C13), 76.0 (1, C15), 73.3 (1, CIO or C ll  or C12), 73.2 (1, CIO or C ll  or C12), 68.0 
(1, CIO or C12), 63.9 (2 , CIS), 63.4 (2, C9), 61.7 (3, OMe), 57.0 (3, OMe), 41.7 (0, C14), 30.5 (2, C16), 25.8 
(3, 3C, ^BuSi), 23.2 (3, C14Me), 18.2 (0, CSi), 13.1 (3, C14Me), -5 .4  (3, 2C, Mc2 Si); m/z (Cl, isobutane) 
435 [(M+H)+, 100%], 403 (12), 377 (15), 345 (4), 303 (23). Found: (M+H)+, 435.2779. C2 iH 4 3 0 7 Si 
requires M, 435.2778. Found; C, 58.08; H, 9.73%. C2 iH4 2 0 7 Si requires C, 58.03; H, 9.74.
1 7 - e p i - 6 . 1 7
.OMe .OMe
OPv OH O
OTBS 'OTBS
OMeOMe
6 .16b 17-epl-6.17
eHggOgS I Cj, O j Si
Mol. W t: 518.76 Mol. W l: 434.64
Reductive cleavage of pivalate ester 6 . 1 6 b  (320 mg, 0.62 mmol) by the same procedure afforded alcohol 1 7 -  
e p i - 6 . 1 7  (264 mg, 0.61 mmol, 98%) as a clear colourless oil: +92.0 (c 1.5, CHCI3 ); film/cm"^
3466, 2930, 1470; 8 ^  (400 MHz, CDCI3 ): 5.02 (IH, d, 7 6.5, OCH^HgO), 4.83 (IH, d,7 6.5, OOA^H jP),
4.13 (IH, dd, 7 10.3, 6 .8 , C12H), 4.05 (IH, ddd, 7 10.6, 5.5, 2.5, ClOH), 3.96 (IH, dd, 7 10.6, 6.9, C llH ), 
3.89-3.81 (IH, m, C9H^Hg), 3.71-3.64 (IH, m, C9H^Hg), 3.62-3.55 (2H, m, C I8 H2 ), 3.53 (3H, s, OMe),
3.49 (IH, d, 7 10.3, C13H), 3.43 (IH, d, 7 10.4, C15H), 3.39 (3H, s, OMe), 3.37-3.30 (IH, m, C17H), 2.54 
(IH, br s, OH), 1.53-1.45 (IH, m, C16H^Hg), 1.40-1.30 (IH, ni, C16H^77g), 0.93 (3H, s, C14Me), 0.86
(9H, s, muSi), 0.82 (3H, s, C14Me), 0.02 (6 H, s, Me^Si); 8 ^ (100 MHz, CDCI3 ); 8 6 . 6  (2, OCH2 O), 79.4 (1,
112
C15), 77.8 (1, C17), 73.9 (1, C13), 73.5 (1, CIO or C12), 73.4 (1, CIO or C12), 67.4 (1, Cl 1), 64.7 (2, C18),
62.8 (2, C 9 ) ,  61.6 (3, OMe), 57.5 (3, OMe), 41.2 (0, C14), 31.2 (2, C l 6 ), 25.8 (3, 3C, ^BuSi), 23.0 (3, 
C14Me), 18.2 (0, CSi), 13.1 (3, C14Me), -5.5 (3, 2C, Me2 Si); m/z (Cl, isobutane) 435 [(M+H)+, 100%], 
403 (12), 377 (10), 345 (4), 303 (23). Found: (M+H)+, 435.2777. C2 6 H4 3 0 7 S 1 requires M, 435.2778. 
Found: C, 58.12; H, 9.68%. C2 1 1 4 4 2 0 7 8 1  requires C, 58.03; H, 9.74.
( 1 7 ? , 5 5 , 6 S , 8 7 ? , 1 0 5 ) - 8 - { ( 2 5 ) - 3 " [ ( f e r / - B u t y I d i m e t h y I s i l y l ) o x y ] - 2 " m e t h o x y p r o p y I } - 1 0 - m e t h o x y - 9 , 9 - d i m e t h y l -  
5 - { A ^ - [ ( 2 - t r i m e t h y l s i l y l ) e t h o x y c a r b o n y l ] a m i n o } - 2 , 4 , 7 - t r i o x a b i c y c l o [ 4 . 4 , 0 ] d e c a n e  ( 1 . 7 5 )  v i a  C u r t i n s  
r e a r r a n g e m e n t
5h 0 ^ 0  Y r
Y^OTBS Y^OTBS ^  I^OTBS
OMe OMe OMe
6.17 1 5 5  1.75
^glti^gOySI C^lH^OgSi UjgHgQNOgSij
Mol. \M.: 434.64 Mol. Wt.: 448.62 Mol. Wt.: 563.87
Sodium periodate (750 mg, 3.5 mmol) was added to a stirred mixture of alcohol 6 . 1 7  (280 mg, 0.65 mmol), 
cai'bon tetrachloride (5 ml), acetonitrile (5 ml) and water (7.5 ml) followed by ruthenium chloride trihydrate 
(11.3 mg, 0.043 mmol). The reaction mixture was stirred at rt for 3 h and extracted with CH2 CI2  (3 x 10 ml). 
The combined organic extracts were dried (MgS0 4 ) and concentrated in vacuo. The crude black-green 
residue was dissolved in anhydrous toluene ( 2  ml) and concentrated in vacuo three times and then 
immediately used In the next step.
The crude acid 1 . 5 5  was dissolved in anhydrous toluene (3 ml) to which freshly activated 4Â 
molecular sieves (80 mg) and anhydrous 77-ethyldiisopropylamine (0.180 ml, 1.03 mmol) were added. 2- 
Trimethylsilylethanol (0.73 ml, 5.1 mmol), dried by the addition of freshly activated 4Â molecular sieves (80 
mg), and diphenylphosphory 1 azide (0.18 ml, 0.83 mmol) were then added. The mixture was plunged into an 
oil bath at 65 °C and evolution of N2  gas was observed. After heating at 65 °C for 3 h the reaction mixture 
was quenched by the addition of saturated aqueous NaHCO^ (15 ml) and extracted with CH2 CI2  (3 x 20 ml). 
The combined organic extracts were dried (Na2 S0 4 ) and concentrated in vacuo. The residue was purified by 
column chromatography (S1 0 2 , 5-25% Et2 0  in hexane) to give carbamate 1 . 7 5  (205 rag, 0.364 mraol, 56%) 
as a pale yellow oil; +56.6 (c 0.73, CHCI3 ); (CDCl3 )/cm"i 3437, 2959, 1729, 1514, 1212;
ÔH (400 MHz, CDCI3 ): 5.51 (IH, br t, 7 9.3, ClOH), 5 . 3 2  (IH, d ,7  9.3, NH), 5.14 (IH, d, 7 6.7, OCH^HgO),
4.85 (IH, d, J 7.0, OCHaH^O), 4.25-4.15 (3H, m, C12H and O Œ 2 CH2 TMS), 3.80 (IH, dd, J  9.5, 6.9, 
C llH ), 3.63 (IH, dd, 7 11.1, 3.5, ClSTr^Hg), 3.56 (IH, dd,7 10.8, 4.0, C18Ha/7^), 3.56 (3H, s, OMe), 3.43
(IH, d, 7 10.3, C13H), 3.32 (3H, s, OMe), 3.29 (IH, d, 7 9.5, C15H), 3.18 (IH, dq, 7 7.8, 4.0, C17H), 1.84 
(IH, dd, 7  13.2, 8.0, ClôT/^Hg), 1.47 (IH, m, ddH ^T /g), 1.05-0.95 (2H, m, C T ^ T M S ) ,  0.99 (3H, s,
C14Me), 0.89 (9H, s, ^BuSi), 0.88 (3H, s, C14Me), 0.06 (6 H, s, Me2 Si), 0.05 (9H, s, Me3 Si); 5^ (90 MHz, 
CDCI3 ): 155.8 (0, O-C(O)-NH), 86.3 (2, OCH2 O), 79.7 (1, C17), 79.6 (1, C13), 76.5 (1, CIO or C15), 76.3 
(1, CIO or C15), 74.4 (1, C l2), 70.3 (1, C ll) , 63.9 (2, OCH2 CH2 TMS), 62.1 (2, C18), 61.8 (3, OMe), 56.9 
(3, OMe), 41.7 (0, C14), 29.7 (2, C16), 25.9 (3, 3C, %uSi), 23.3 (3, C14Me), 18.3 (0, CSi), 17.7 (2, CU2 SÏ),
13.4 (3, C14Me), -1 .5  (3, 3 C ,  Me^Si), -5 .4  (3, 2C, Mc2 Si); ?n/z (Cl, isobutane) 564 [(M+H)+, 20%], 536 
(100), 488 ( 2 5 ) ,  372 (25). Found: (M+H)+, 564.3385. C26%4N0gSi2 requires M, 564.3388.
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(l/f,5S,65,8/î,105)-8-{(2/?-3-[(^erM?utyldimethylsilyi)oxy]-2-methoxypropyl}-10-methoxy-9,9-dimethyI"
5-{N-[(2-trimethylsiIyl)ethoxycarbonyl]amino}-2,4,7-trioxabicyclo[4.4.0]decaiie (17-epi-1.75)
9'h"? Î ^ i
OH O
O T B S
17-epi-1.55H.„0 „S 17-epi-1.752^6^ 53^Mol. W .; 563,87
17-epl-6.17Cg, H^gOySi
Mol, w t; 434.64
Alcohol 1 7 - e p i - 6 . 1 7  (258 mg, 0.59 mmol) was converted to carbamate 1 7 - e p i - 1 . 7 5  (192 mg, 0.340 mmol, 
57%) by the same procedure +65,0 (c 0.4, CHCI3 ). (CDCl3 )/cm“  ^ 3322, 2953, 1729; 0|j (400
MHz, CDCI3 ): 5.52 (IH, br t, J 8.5, ClOH), 5.36 (IH, d, J 8.3, NH), 5.14 (IH, d, J 6.7, OCT/^HgO), 4.85 
(IH, d, J 7.0, OCHA^gO), 4.24-4.17 (2H, m, C12H and OCHy^HgCH^TMS), 4.17-4.05 (IH, m, 
OCH^/7gC%TMS), 3.80 (IH, br t, J 8.5, C llH ), 3.61-3.53 (2H, m. C l 8 % ), 3.56 (3H, s, OMe), 3.51-3.40 
(2H, m, C13H and C15H), 3.49 (3H, s, OMe), 3.31-3.25 (IH, m, C17H), 1.48-1.35 (2H, m, CI6 H2 ), 0.98 
(3H, s, C14Me), 0.98-0.93 (2H, m, CH2 TMS), 0.89 (9H, s, ^BuSi), 0.84 (3H, s, C14Me), 0.045 and 0.032 
(15H, 2 x 5 , Me^Si and Me3 Si); 6 ^ (100 MHz, CDCI3 ): 155.9 (0, N -C =0), 86.1 (2, OCH2 O), 79.6 (1, C13 
or C15), 78.3 (1, C17), 76.3 (1, CIO), 74.9 (1, C13 or C15), 74.4 (1, C12), 70.2 ( 1 , C ll) , 65.2 (2, OCH2 -  
CH2 TMS), 63.8 (2, C18), 61.8 (3, OMe), 58.1 (3, OMe), 41.3 (0, C14), 31.9 (2, C16), 25.9 (3, 3C, ^BuSl),
23.1 (3, C14-Me), 18.3 (0, CSi), 17.7 (2, CHgTMS), 13.4 (3, C14Me), -1 .6  (3, 3C, SiMeg), -5 .4  (3, 2 C ,  
SiMe2 ); m/z (FAB mode, PEG) 564 [(M+H)+]. Found: (M+H)+, 564.3384. C26Hg^N0gSÎ2 requires M, 
564.3388.
( l / ? , 5 S , 6 S , 8 / ? , 1 0 5 ) - 5 - A m i n o c a r b o n y l - 8 - { ( 2 S ) - 3 - [ ( ^ e ^ 7 - b u t y l d i n i e t h y l s i l y l ) o x y ] - 2 - m e t h o x y p r o p y l } - 1 0 -  
m e t l i o x y - 9 , 9 - d i m e t h y l - 2 , 4 , 7 - t n o x a b i c y c l o [ 4 . 4 . 0 ] d e c a n e  ( 1 . 7 4 )
o '^ o  cr^o o '^ o
^ [ •^ O T B S  ^ J ^ O T B S  Y ^ O T B S
OMe OMe OM e
6.17 1.55 1.74Cg,H^ O,SI C2 ,H,Q0 gSI C2,H,,NO,Si
Mol. W t: 434.64 Mol. Wt.: 448.62 Moi.Wt.; 447.64
Sodium periodate (50 mg, 0.24 mmol) was added to a stirred mixture of alcohol 6 . 1 7  (21 mg, 0.048 mmol), 
carbon tetrachloride (0.3 ml), acetonitrile (0.3 ml) and a solution of ruthenium chloride trihydrate in water 
(6.7 mM, 0.45 ml, 0.003 mmol). The reaction mixture was stirred at rt for 5 h and extracted with CH2 CI2  (3 x 
3 ml). The combined organic extracts were dried (MgSO^) and concentrated in vacuo. The crude black-green
residue (24 mg) was immediately used in the next step.
To crude acid 1 . 5 5  in CH2 CI2  (0.5 ml) was added 1-hydroxybenzotriazole monohydrate (6.5 mg, 
0.048 mmol) followed by a solution of 1,3-dicyclohexylcarbodÜmide in CH2 CI2  (96 mM, 0.5 ml, 0.048 
mmol) at it. The reaction mixture was stirred for 1 h and ammonia (gas) was bubbled into the reaction 
mixture for 15 min to yield a white precipitate. The solution was filtered and the solid was washed with 
CH2 CI2  (4 ml). The combined filtrate was washed with saturated aqueous NaHCO^ (3 ml), ice cooled HCl 
(O.IM, 3 ml), aqueous NaHCOg (3 ml), brine (3 ml), and then dried (MgSO^) and concentrated in vacuo. The 
residue was purified by column chromatography (Si0 2  5g, 70-100% Et2 0  in hexanes and then 0-50%
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EtOAc in Et2 Ü) to give the desired amide 1 . 7 4  (19.3 mg, 0.043 mmol, 90%) as an oil: +35.9 (c 0.85,
CHCI3 ); (CDCl3 )/cm -l 3332, 2929, 1697; dy (400 MHz, CDCI3 ): 6.65 (IH, s, N/Ï^Hg), 5.45 (IH, 
s, NHa^b),. 5.06 (IH, d, 76.5, OCHj^H^O), 4.91 (IH, d,7 6.5, 0C H ^ % 0), 4.39 (IH, d,7 8.0, ClOH), 4.24 
(IH, dd, 7 7.8, 5.4, C llH ), 4.05 (IH, dd, 7 7.7, 5.2, C12H), 3.78 (IH, dd, 7 11.1, 4.2, ClSH^Hg), 3.69 (IH, 
dd, 7 11.1, 4.1, C18Ha//b), 3.51 (3H, s, OMe), 3.51-3.46 (IH, m, C15H), 3.41-3.36 (IH, m, C17H), 3.37 
(3H, s, OMe), 3.26 (IH, d, 7 7.9, C13H), 1.85 (IH, ddd, 7 14.5, 7.7, 2.4, C16i7^Hg), 1.79-1.64 (IH, m, 
C16H a% ), 1.08 (3H, s, C14Me), 0.91 (3H, s, C14Me), 0.90 (9H, s, ^uSi), 0.07 (6 H, s, Me2 Si); Sq (100 
MHz, CDCI3 ): 170.7 (0, HgN-C^O), 87.4 (2, OCH2 O), 80.5 (1. C13), 79.7 (1, C17), 77.2 (1, C15), 73.4 (1, 
CIO), 72.7 (1, C12), 67.0 (1, br, C ll) , 63.1 (2, C18), 61.6 (3, OMe), 57.1 (3, OMe), 49.1 (0, C14), 29.9 (2, 
C16), 24.9 (3, 3C, ^BuSi), 24.5 (3, C14Me), 18.3 (0, CSi), 16.5 (3, br, C14Me), -5.317 (3, MeSi), -5.373 (3, 
MeSi); m /z  (Cl, isobutane) 448 [(M+H)+, 30%], 279 (20), 225 (100). Found: (M+H)+, 448.2729. 
C2 iH4 2 NO?Si requires M, 448.2731. Found: C, 56.40; H, 9.16; N, 3.12%. C2 iH 4 0^ 7 Si requires C, 56.35; 
H, 9.23; N, 3.13
( l / î : , 5 S , 6 S , 8 / î , 1 0 S ) - 8 - { ( 2 S ) - 3 - [ ( ^ e / 7 - B u t y l d i m e t h y I s i l y l ) o x y ] - 2 - m e t h o x y p r o p y l } - 1 0 - m e t h o x y - 9 , 9 - d i n i e t l i y l -  
5 - { A - [ ( 2 - t r i n i e t h y l s i l y l ) e t h o x y c a r b o n y l ] a i i i i n o } - 2 , 4 , 7 - t r i o x a b i c y c l o [ 4 . 4 . 0 ] d e c a n e  ( 1 . 7 5 )  v i a  H o f m a n n  
r e a r r a n g e m e n t .
.OMe
OTBS
Me
1.74G2 ,H,,N0 I^
.OMeHN
)TBS)Me
1.75GggHggNOgSlg
Mol. Wl,; 447.64 M o!.W l.:563B 7
Procedure A: Trimethylsilylethanol (0.05 ml, 0.35 mmol), silver acetate (4.1 mg, 0.025 mmol) followed by 
A-bromosuccinimide (4.5 mg, 0.025 mmol) were added to a solution of amide 1 . 7 4  (8.1 mg, 18.1 timol) in 
A,A-dimethylformamide (1 ml) at rt. The reaction mixture was stirred at rt for 24 h, treated with saturated 
aqueous NaHCOg (1 ml) and extracted with hexanes-Et2 0  (1:1) (3 x 3 ml). The combined organic extracts 
were dried (MgSO^) and concentrated in vacuo. The residue was then purified by column chromatography 
(Si0 2 , 0-30% Et2 0  in hexanes) to give carbamate 1 . 7 5  (8.9 mg, 15.9 pmol, 8 8 %) as a pale yellow oil.
Procedure B: Trimethylsilylethanol (0.05 ml, 0.35 mmol), pyridine (2 pi, 24.5 pmol) followed by 1,1- 
bis(trifluoroacetoxy)iodobenzene (Aldrich, 10.5 mg, 24.5 pmol) were added to a solution of amide 1 . 7 4  (8.5 
mg, 19.0 pmol) in acetonitrile (0.1 ml) at rt. The reaction mixture was stirred at rt for 24 h, treated with 
saturated aqueous NaHCOg (2 ml) and extracted with CH2 CI2  ( 3 x 3  ml). The combined organic extracts 
were dried (MgSO^) and concentrated in vacuo. The residue was then purified by column chromatography 
(Si0 2 , 0-30% Et2 0  in hexanes) to give carbamate 1 . 7 5  (8 . 6  mg, 15.3 pmol, 81%) as a pale yellow oil.
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(1/(,5S,65^ ,87(,10&)-8-{(2S)-3-[(^e/Y-Butyldimethylsilyl)oxy]-2-methoxypiopyl}-10-methoxy-9,9-dimethyl-
5-[A^-(methyIoxalyl)amino]-2,4,7-trioxabicyclo[4.4.0]decane (1.77)
o-T? 9  9 O ?
ifiT T  Y T hT
V  ^y^OTBS k
SiMeo SiM e,
OTBS
O
OMeMeO. :
OTBS
OMe
1.77
CjgHjgNO, (Si  ^ Cj^H^gNOgSi
Mol. Wt.; 563.87 M o i.W t: 649.92 Mol. Wt.: 505.67
To a solution of DMAP (233 mg, 1.68 mmol) and methyl oxalyl chloride (140 |l i1 , 1.53 mmol) in CH2 CI2  (2
ml) was added to carbamate 1 . 7 5  (178 mg, 0.316 mmol) and the reaction mixture was stirred at rt for 6  d. The 
solution was then diluted with Et2 0  (5 ml) and quickly washed with ice-cooled ammonia solution (O.IM, 10
ml) and then washed quickly with ice-cooled aqueous HCl solution (O.IM, 10 ml) and finally washed with 
saturated aqueous NaHCOg (10 ml). The organic phase was then dried (Na2 S 0 ^) and concentrated in vacuo 
to give the fairly pure A-Teoc amide 1 . 7 6  as a pale yellow oil (201 mg, 0.309 mmol, 98%) which was used 
crude in the next reaction. A-Teoc amide 1 . 7 6  was unstable towards column chromatography but a sample 
isolated in low yield (34%) gave the following spectroscopic data:
MeO. ,OMe
OTBS
OMe
1.76
Mol. Wl.: 649.92
[a ]o 2 0  +30.9 (c 1.1, CHCI3 ); v^ax (film)/cm-l 2955, 2919, 2856, 1748, 1715, 1253; 6 ^  (400 MHz, 
CDCI3 ): 6.12 (IH, d, J 10.4, ClOH), 5.13 (IH, d, J 6.7, OC^^HgO), 4.97 (IH, d, 76.7, O C H ^^O ), 4.88 
(IH, dd, J 10.4, 7.2, C llH ), 4.39-4.36 (2H, m, OC//2 CH2 TMS), 4.32 (IH, dd, J 10.6, 7.2, C12H), 3.90 (3H, 
s, OMe), 3.66 (IH, dd, J 11.3, 3.3, ClST/^Hg), 3.59 (3H, s, OMe), 3.49 (IH, dd, J 11.3, 3.3, Cim p^H s),
3.47 (IH, d, J  10.3, C13H), 3.31 (3H, s, OMe), 3.23 (IH, d, J 9.9, C15H), 3.14 (IH, dq, J 9.0, 3.0, C17H), 
1.90 (IH, dd, J 14.0, 10.0, C16H^Hq), 1.41 (IH, ddd, 7 14.0, 10.2, 3.1, C16H^77^), 1.16-1.10 (2H, m, 
CH2 TMS), 0.97 (3H, s, C14Me), 0.90 (9H, s, ^BuSi), 0.89 (3H, s, C14Me), 0.074 (6 H, s, Me2 Si), 0.070 (9H, 
s, Me3 Si); (90 MHz, CDCI3 ): 163.0 (0), 161.1 (0), 152.3 (0), 87.5 (2, OCHgO), 79.2 (1, C13), 78.7 (1, 
C17), 76.9 (1, CIO), 76.3 (1, C15), 74.8 (1, C12), 67.3 (2, CH2 CH2 TMS), 66.7 (1, C ll) , 61.4 (2, CIS), 61.2 
(3, OMe), 56.5 (3, OMe), 52.9 (3, OMe), 41.7 (0, C14), 30.0 (2, C16), 25.9 (3, 3C, ^BuSi), 23.1 (3, C14Me),
18.3 (0, CSi), 17.3 (2, CH2 TMS), 13.1 (3, C14Me), -1.7 (3, 3C, Meg Si), -5 .40 (3, MeSi), -5.46 (3, MeSi); 
m/z (Cl, isobutane) 650 [(M+H)+, 100%], 578 (70), 506 (50), 490 (50), 403 (70). Found: (M+H)+, 650.3393. 
C2 9 H5 6 NO 1 1  Si2  requires M, 650.3392. Found: C, 55.38; H, 9.52; N 2.24%. C2 pHggO^Si2  requires C,
55.38; H, 9.47; N, 2.48.
A solution of TBAF (0.76 g, 2.4 mmol) and acetic acid (0.5 ml, 8 . 8  mmol) in CH2 CI2  (9.5 ml) was added to 
the A-Teoc amide 1 . 7 6  and immediate gas evolution was observed. The reaction mixture was stirred for 4 
min and then immediately diluted with CH2 CI2  (10 ml), and washed with water (3 x 10 ml). The organic 
phase was dried (MgSO^) and concentrated in vacuo. The residue was then purified by column 
chromatography (Si0 2 , 50-70% Ft2 0  in hexanes) to give 1 . 7 7  (116 mg, 0.230 mmol, 73%) as a white solid:
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°  9 C 9MeO te
O
C„„H..NO„S OTBSOMe
mp 136-138 °C (hexanes-ether); +56.2 (c 0.8, CHCI3 ); (CHCl3 )/cm  ^ 3401, 3019, 2956,
2884, 1720; ô g  (360 MHz, CDCI3 ): 7.53 (IH, d, J 9.2, NH), 5.71 (IH, t, J 9.5, ClOH), 5.16 (IH, d, J 7.0, 
OCH^HgO), 4.88 (IH, d, 7 7.0, OCH^/^gO), 4.23 (IH, dd,7 10.1, 6 .6 , C12H), 3.93 (IH, dd, J  9.5, 6.7, 
C llH ), 3.93 (3H, s, OMe), 3.57 (IH, dd, J 10.8, 4.4, ClST/^Hg), 3.57 (3H, s, OMe), 3.52 (IH, dd,7 11.0,
4.1, CISH^H^), 3.43 (IH, d, J 10.2, C13H), 3.30 (IH, dd, J  9.6, 0.9, C15H), 3.27 (3H, s, OMe), 3.12 (IH, 
dq, /  8.2,4.1, C17H), 1.82 (IH, ddd, J 14.3, 7.5, 1.4, ClO/f^Hg), 1.47 (IH, ddd,7 14.5, 9.9, 4.2, ClOH^Tf^),
1.00 (3H, s, C14Me), 0.88 (12H, s, ^BuSi and C14Me), 0.05 (6 H, s, Me2 Si); 5^ (90 MHz, CDCI3 ): 160.2 (0, 
C(0)), 156.4 (0, C(0)), 86.4 (2, OCH2 O), 79.7 (1, C17), 79.4 (1, C13), 76.7 (1, C15), 74.2 (1, C l2), 74.0 (1,
CIO), 69.9 (1, C ll) , 62.7 (2, CIS), 61.7 (3, OMe), 56.8 (3, OMe), 53.9 (3, OMe), 41.6 (0, C14), 29.7 (2, 
C16), 25.8 (3, 3C, ^BuSi), 23.3 (3, C14Me), 18.2 (0, CSi), 13.5 (3, C14Me), -5.5 (3, 2C, Me2 Si); m/z (Cl,
isobutane) 506 [(M+H)+, 100%], 474 (25), 448 (20), 444 (10), 374 (15). Found: (M+H)+, 506.2782. 
^23^44^0^81 requires M, 506.2785. Found: C, 54.09; H, 8.29; N 2.69%. C23H^3N0gSi requires C, 54.63;
H, 8.57; N, 2.77.
The structure and relative stereochemistry of 1.77 was confirmed by X-ray crystallography with Mo X-rays 
on a CAD4 d i f f r a c t o m e t e r . C r y s t a l  data (1.77) C23H^3N0c)Si, M = 505.67, orthorhombic, a = 
9.824(2), b = 12.368(2), c = 22.340(6) K u =  2934(1) Â ^ ,  T = 293 K, space group Z  =  4, | l i ( M o -
Kg() 0.13 mm~l, 10536 reflections measured, 3588 unique = 0.052) used in refinement. /?1[2369 with
I>2a(I)] = 0.083, w7?2(all data) = 0.27. The absolute structure could not be determined from the X-ray data. 
The results for 1.77 reflect the poor quality of the crystals. The atoms of the C 15 side-chain show large
values and some atypical bond lengths which suggest positional disorder. CCDC reference number 207/406. 
See http://www.rsc.org/suppdata/pl/a9/a909898d/ for crystallographic files in .cif format.
17-epi-1.77
Acylation of carbamate 17-epi-1.75 (190 rag, 0.337 mmol) by the same procedure described above gave the 
A-Teoc amide 17-epi-1.76 in 50% yield:
Cleavage of N-Ttoc amide 17-epi-1.76 by the same procedure described above gave recovered carbamate 17- 
epi-1.75 (29 mg, 0.052 mmol, 15%) and 17-epi-1.77 (106 mg, 0.230 mmol, 63%) as an oil:
MeO .OMe
iTBS
OMe
Mil. Wt.: 649.92
[alD^4 + 7 4  2  (c 1 .1 , CHCI3 ); v,„ax (CDCl3 )/cm-^ 2954, 2922, 2857, 1749, 1715, 1252, 1109, 1026, 837, 
775; 5h (400 MHz, CDCI3 ): 6.13 (IH, d, J 10.4, ClOH), 5.13 (IH, d, J 6.7, OC/f^HgO), 4.96 (IH, d, 76.7,
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OCHA^gO), 4.89 (IH, dd,J 10.4, 7.3, C llH ), 4.40-4.35 (2H, m, OCH2 CH2 TMS), 4.32 (IH, dd, J 10.6, 7.3, 
C12H), 3.89 (3H, s, OMe), 3.62 (IH, dd, J 10.8, 4.5, ClST/^Hg), 3.59 (3H, s, OMe), 3.55 (IH, dd,7 10.8,
4.4, C18H^% ), 3.53-3.50 (2H, m, 710.3, C13H and C15H), 3.34 (3H, s, OMe), 3.23-3.18 (IH, m, C17H), 
1.52 (IH, dd, J 14.5, 9.4, ClôT/^Hg), 1.41 (IH, ddd, J 14.6, 9.4, 2.3, C l^ R pR gX  1.15-1.10 (2H, m, 
C //2 TMS), 1.00 (3H, s, C14Me), 0.89 (9H, s, ^BuSi), 0.85 (3H, s, C14Me), 0.073 (9H, s, MegSi), 0.044 (6 H, 
s, Me2 Si); 0^ (90 MHz, CDCI3 ): 162.9 (0), 161.1 (0), 152.6 (0), 87.5 (2, OCH2 O), 79.1 (1, C13 or C15),
77.8 (1, C17), 77.2 (1, CIO), 75.6 (1, C15 or C13), 74.8 (1, C12), 67.6 (2, CH2 CH2 TMS), 66.3 (1, C ll) , 64.5 
(2, C18), 61.8 (3, OMe), 57.2 (3, OMe), 52.9 (3, OMe), 41.5 (0, C14), 32.3 (2, C16), 25.9 (3, 3C, ^BuSi),
23.1 (3, C14Me), 18.3 (0, CSi), 17.3 (2, CH2 TMS), 13.2 (3, C14Me), -1 .6  (3, 3C, Me^Si), -5.38 (3, MeSi), 
-5.40 (3, MeSi); m/z (Cl, isobutane) 650 [(M+H)+, 55%], 622 (70), 578 (60), 506 (35), 474 (45), 458 (25), 
403 (70), 371 (45). Found; (M+H)+, 650.3387. C2 9 H5 6 N O nSi2 requires M, 650.3392.
MeO, .O M e
■OTBS
OMe
Mol. Wl.; 505.67
[a]o23 +70.6 (C 1.5, CHCI3 ); Vmax 3330, 2954, 2930, 2857, 1717, 1529, 1111, 1026, 836,
777; ÔH (360 MHz, CDCI3 ): 7.56 (IH, d, J 9.1, NH), 5.73 (IH, t, J 9.4, ClOH), 5.18 (IH, d, J 7.0, 
OC//^HbO), 4.87 (IH, d ,7 7.0, O C H ^^O ), 4.25 (IH, dd,7 10.3, 6 .8 , C12H), 3.96-3.90 (IH, m, C llH ),
3.92 (3H, s, OMe), 3.60-3.52 (2H, m, CI8 H2 ), 3.58 (3H, s, OMe), 3.52-3.46 (2H, m, C13H and C15H), 3.27 
(3H, s, OMe), 3.22-3.17 (IH, m, C17H), 1.51-1.38 (2H, m, 016% ), 1.00 (3H, s, C14Me), 0.88 (9H, s, 
muSi), 0.87 (3H, s, C14Me), 0.04 (6 H, s, MejSi); 5^ (90 MHz, CDCI3 ): 160.3 (0, C(0)), 156.4 (0, C(0)),
86.3 (2, OCH2 O), 79.5 (1, C13 or C15), 78.0 (1, C17), 75.2 (1, C13 or C15), 74.4 (1, C12), 74.1 (1, CIO),
70.0 (1, C ll) , 64.8 (2, C18), 61.8 (3, OMe), 57.7 (3, OMe), 53.9 (3, OMe), 41.3 (0, C14), 31.7 (2, C16), 25.9 
(3, 3C, ^BuSi), 23.2 (3, C14Me), 18.2 (0, C-Si), 13.5 (3, C14Me), -5.5 (3, 2C, Me2 -Si); m/z (Cl, isobutane) 
506 [(M+H)+, 100%], 476 (15), 474 (10), 448 (10), 391 (7). Found: (M+H)+, 506.2785. C2 3 % 4 N 0 9 Si 
requires M, 506.2785.
Formation of adduct 6.18
_ 0 ..^ S n M e 3  MeO 
SePh
22Cl yHagOSeSn 
M o i.W t: 444.06
\^ O T B S  
1 .7 7  OMeCaKiaNOgSI 
Mol. W t: 505.67
.OMe
SePh
'OTBS6.18 T
QîûPsiNOgSeSt OMe 
M oi.W t: 754.88
To a solution of stannane 2.2 (170 mg, 0.383 mmol) and 4Â MS in THF (2.5 ml) at -80  °C was added BuLi 
(265 |il, 1.43 M solution in hexane, 0.370 mmol) and the bright yellow solution stirred at -80  °C for 15 min. 
TMEDA (57 |a.l, 0.378 mmol) was added and after 10 min at -80  °C, a solution of ester 1.77 (73 mg, 0.144 
mmol) and 4Â MS in THF (2.25 ml) was quickly added. After stirring for 1 h maintaining the temperature 
below -6 0  °C, the mixture was poured into brine (3 ml), and extracted with CH2 CI2  ( 2 x 5  ml). The 
combined extracts were dried (Na2 S0 ^) and concentrated to give a yellow oil which was purified by column 
chromatography (Si0 2 , PhMe;hexanes:BtOAc, 100:0:0, 0:95:5, 0:75:25, 0:50:50) to give (2/?,37?,47?)-3,4-
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dihydro-2 ,3-dimethyl-4-phenylselenylmethyl-2//-pyran (77 mg, 0.274 mmol, 74%) and the coupling product 
6 . 1 8  (44 mg, 0.058 mmol, 41% based on the fragment 1 . 7 7 )  as a colourless oil: +29.0 (c 0.9,
CHCI3 ); V^ax (C H C y/cm -l 3054, 2974, 2933, 2878, 1640, 1578, 1477, 1454, 1437, 1382, 1237, 1091, 
736, 690; 6 ^  (400 MHz, CDCI3 ): 7.43-7.40 (2H, m), 7.20-7.10 (3H, m), 6.21 (IH, dd. J 2.4, 6.2, C6 H),
4.40 (IH, dt, J 1.7, 6.2, C5H), 3 . 9 2  (IH, dq, J 1.7, 6 .6 , C2H), 2.78 (IH, dd, 7 9.1, 11.8, CH^Hg), 2.73 (IH, 
dd, 7 7.2, 11.8, CU^Hb), 2.65-2.57 (IH, m, C4H), 1.83-1.75 (IH, m, C3H), 1.14 (3H, d ,7  6 .6 , C2Me), 0.72 
(3H, d, 7.0, C3Me); §c (100 MHz, CDCI3 ): 143.8 (1, C6 ), 132.6 (1, 2C), 130.0 (0), 129.0 (1, 2C), 126.8 (1),
101.9 (1, C5), 75.3 (1, C2), 37.0 (1, C4), 34.0 (1, C3), 31.0 (2, C H g S e ) ,  1 8 . 2  (3, C2Me), 5.1 (3, 
C3Me).Found: (M+H)-^, 282.0522. Ci^H^gOSe requiresM, 282.0523.
Acyl dihydropyran 6 . 1 8 :  _  21.2 (c 0.5, CHCI3 ); v , .^ a x  (CHCl3 )/cm"l 3319, 2928, 1671, 1106, 1023,
826; ÔH (400 MHz, CDCI3 ): 7.56 (IH, d, 7 9.5, NH), 7.55-7.51 (2H, m), 7.31-7.28 (3H, m), 7.14 (IH, t, 7
1.8, C5H), 5.68 (IH, t, 7 9.3, ClOH), 5.16 (IH, d, 7 6.9, OCT/^HgO), 4.88 (IH, d, 7 6.9, OCHaH^O), 4.23
(IH, dd, 7 6.4, 9.9, C12H), 4.09 (IH, dq, 7 1.2, 6.5, C2H), 3.95 (IH, dd, 7  6.5, 9 . 3 ,  C llH ), 3 . 5 7  (3H, s, 
OMe), 3.57 (IH, dd, 7 4.1, 10.9, CISH^Hb), 3.50 (IH, dd, 7 3.8, 11.0, CISHaH^), 3.42 (IH, d, 7 10.0,
C13H), 3.31 (IH, br d, 7 9.3, C15H), 3.26 (3H, s, OMe), 3.10-3.16 (IH, m, C17H), 2.98-2.94 (2H, m, 
CH2 Se), 2.85 (1 H, dddd, 7 2.5, 5.7, 8.1, 10.6, C4H), 2.07-1.99 (IH, m, C3H), 1.83 (IH, ddd, 7 1.4, 8.0, 14.1, 
C167/aHb), 1.57-1.47 (IH, m, C16HA%), 1.39 (3H, d,7 6.5, C2Me), 1.01 (3H, s, C14Me), 0.90 (3H, s, 
C14Me), 0.88 (9H, s, ^BuSi), 0.82 (3H, d, 7 7.0, C3Me), 0.04 (6 H, s, MezSi); 5^ (100 MHz, CDCI3 ): 179.6 
(0), 160.7 (0), 148.0 (0), 133.2 (1, 2C), 129.3 (1, 2C), 129.1 (0), 127.4 (1), 125.0 (1, C5), 86.4 (2, OCHgO),
79.7 (1, C13 or C17), 79.4 (1, C17 or C13), 77.2 (1, C2 or C15), 76.8 (1, C15 or C2), 74.1 (1, C12), 73.8 (1, 
CIO), 69.6 (1, C ll) , 62.3 (2, C18), 61.7 (3, OMe), 56.9 (3, OMe), 41.4 (0, C l4), 39.0 (1, C4), 33.1 (1, C3), 
29.5 (2, C16 or CHjSe), 29.4 (2, CH^Se or C16), 25.9 (3, 3C, ^BuSi), 23.5 (3, C14Me), 18.3 (0, CSi), 18.2
(3, C2Me), 13.9 (3, C14Me), 5.9 (3, C3Me), -5 .30 (3, MeSi), -5.33 (3, MeSi); m/z (Cl, isobutane) 756 
[(M+H)+, 30%], 698 (20), 598 (100), 540 (60). Found: (M+H)+, 756.3047. Cg^HggNO^SeSi requires M,
756.3045.
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Acylation of dihydropyran 2.2 (135 mg, 0.304 mmol) by the procedure described above gave (2/?,3/?,4/?)-3,4- 
dihydro-2,3-dimethyl-4-phenylselenylmethyl“2/7-pyran ( 6 6  mg, 0.235 mmol, 77%) and the coupling product
1 7 - e p i - 6 . 1 8  (36 mg, 0.048 mmol, 39% based on the right half fragment 1 7 - e p i - 1 . 7 7 )  as a colourless oil: 
+16.0 (c 1.0, CHCI3 ); v^ax (CHCl3 )/cm"l 3366, 2928, 2855, 1727, 1670, 1104, 1024, 836;
(400 MHz, CDCI3 ): 7.63 (IH, d, J 8.7, NH), 7.52-7.45 (2H, m). 7.30-7.20 (3H, m), 7.15 (IH, t, J 1.8, C5H), 
5.67 (IH, t, J 9.2, ClOH), 5.14 (IH, d, J 7.0, OCH^^B^O), 4.85 (IH, d, 7 6.9, OCHaH^O), 4.21 (IH, dd, 7
6.5, 10.2, C12H), 4.06 (IH, dq, 7 1.3, 6.5, C2H), 3.93 (IH, dd, 7 6 .6 , 9.5, C llH ), 3.54 (3H, s, OMe), 3.52- 
3.43 (4H, m, C I8 FI2 , C15FI, C13H), 3.23-3.14 (IH, m, C17H), 3.19 (3H, s, OMe), 2.90-2.84 (2H, m, 
CH2 Se), 2.84-2.77 (IH, m, C4H), 2.10-1.92 (IH, m, C3H), 1.50-1.40 (IH, m, C16/7aHb), 1.30-1.18 (IH, 
m, CI6 HA//5 ), 1.34 (3H, d,7 6.5, C2Me), 0.97 (3H, s, C14Me), 0.84 (9H, s, OBuSi), 0.83 (3H, s, C14Me),
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0.73 (3H, d, J 7.0, C3Me), 0.00 (6 H, s, 6 ^  (400 MHz, CgDg): 7.49 (IH, d, J 9.0, NH), 7.35-7.32
(2H, m), 7.16 (IH, t, J 1.9, C5H), 6.97-6.91 (3H, m), 5.81 (IH, t, J 9.5, ClOH), 4.68 (IH, d, J 6.9, 
OCT/^HgO), 4.57 (IH, d, 76.9, O C H A^O ), 4.19 (IH, dd, 76.9, 10.4, C12H), 3.53-3.40 (5H, m), 3.38 (3H,
s, OMe), 3.38-3.36 (IH, m), 3.19 (3H, s, OMe), 2.98 (IH, 7 10.4, C13H), 2.59-2.51 (2H, m), 2.50-2.44 (IH, 
m), 1.61-1.53 (IH, m, C167f^Hg), 1.48-1.40 (2H, m, C3H and C16Uj^ Hb ), 0.95 (3H, d,7 6.7, C2Me), 0.91
(9H, s, 'BuSi), 0.85 (3H, s, C14Me), 0.82 (3H, s, C14Me), 0.55 (3H, d, 7 7.0, C3Me), 0.004 (3H, s, MeSi), 
-0.003 (3H, s, MeSi); (100 MHz, CgDg); 179.4 (0), 160.5 (0), 147.2 (0), 131.9 (1, 2C), 128.1 (1, 2C),
126.6 (0), 126.0 (1), 122.4 (1, C5), 84.9 (2, OCHgO), 77.9 (1, C13), 77.0 (1), 75.0 (1), 73.8 (1), 73.7 (1,
C12), 72.7 (1, CIO), 68.9 (1), 63.5 (2, C18), 60.0 (3, OMe), 56.6 (3, OMe), 40.1 (0, C14), 37.7 (1), 32.0 (1),
31.0 (2, C16), 28.2 (2, CH2 Se), 24.8 (3, 3C, ^BuSi), 21.6 (3, C14Me), 17.2 (0, CSi), 16.7 (3, C2Me), 12.2 (3, 
C14Me), 4.5 (3, C3Me), -6.47 (3, MeSi), -6 .52 (3, MeSi); m/z (CI, isobutane) 756 [(M+H)+, 20%], 598 
(100), 540 (20). Found: (M+H)+, 756.3049. CggHggNOgSeSi requires M, 756.3045.
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To a solution of acyldihydropyran 6 . 1 8  (30.0 mg, 39.7 pmol) in THF (2.5 ml) a t—95 °C was added dropwise 
LiBH(^-Bu) 3  (0.1 ml, 1.0 M solution in THF, 0.1 mmol). After 10 min at -95 °C the mixture was treated 
with brine (1 ml) and extracted with CH2 CI2  ( 2 x 4  ml). The combined organic extracts were dried (Na2 S 0 ^) 
and concentrated in vacuo. The residue was immediately dissolved in CH2 CI2  (2 ml) and MeOH (0.2 ml). 
Camphorsulfonic acid (3.0 mg, 0.012 mmol) was added and the solution stirred at rt for 1.5 h. Solid K2 CO3
(25 mg, 0.18 mmol) was added slowly during 1 0  min after which the mixture was poured into saturated 
aqueous NaHCOg (2 ml) and extracted with CH2 CI2  ( 3 x 5  ml). The combined organic extracts were dried 
(Na2 S0 4 ) and concentrated in vacuo, to give the crude diastereoisomeric acetals as a colourless oil which
were used immediately in the next step.
A yellow solution of benzoyl chloride (15 pi, 0.129 mmol), DMAP (10 mg, 0.082 mmol) and N,N- 
diisopropyletliylamine (80 pi, 0.459 mmol) in CH2 CI2  (0.5 ml) and 4Â MS was added to a stirred solution of 
the crude acetals in CH2 Cl2 (T 5  ml). The reaction mixture was stirred for 1 h at rt before MeOH (0.5 ml) was 
added. After 10 min the mixture was poured into brine (3 ml) and extracted with CH2 CI2  ( 3 x 5  ml). The 
combined organic extracts were dried (Na2 S0 4 ) and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (5 g) eluting with 50% hexanes-Et2 Û in hexanes to give 26 mg (29.1
pmol, 73% over 3 steps) of a mixture of the two diastereoisomers at C7 in the ratio 6:1 (determined by 
integration of signals derived from C12H [^H NMR (400 MHz, C^Dg): 5 4.24 (dd, major) and 4.17 (dd, 
minor)]. The mixture was purified by column chromatography on silica gel (5 g) eluting with 10-20% Et2 0  
in CH2 CI2  to give diastereoisomer 6 . 1 9  (16 mg, 17.9 pmol, 45%) along with an impure mixture of 6 . 1 9  and 
its C7-epimer ( 8  mg, 8.95 pmol, 23%). Data for benzoate 6 . 1 9 :  [ct]j3 ^  ^ +50.0 (c 0.55, CHCI3 ); 
(CHCl3 )/cm -l 3358, 2929, 2856, 1732, 1706, 1524, 1471, 1263, 1123, 1032, 836; ô g  (400 MHz, CgDg):
8.23 (2H, ddm, J 1.6, 8.3), 7.41 (2H, ddm, J 1.6, 8.1), 7.31 (IH, d, /9 .6 ,  NH), 7.10-6.97 and 6.95-6.85 (6 H, 
2 m), 5.87 (IH, s, C7H), 5.86 (IH, t, J 9.7, ClOH), 4.50 (IH, d, J 7.0, OCH^HgO), 4.44 (IH, d, J 7.0, 
OCHaT/^O), 4.24 (IH, dd, /  6 .6 , 10.2, C12H), 3.95 (IH, dd, /  2.6, 11.7, ClSH^Hg), 3.86 (IH, dd, /  2.4,
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11.7, CISHaT/^)’ 3.71 (IH, dd,7 6.7, 9.5, C llH ), 3.49 (IH, dq, J 2.3, 6.7, C2H), 3.46 (IH, br d, J  8 .8 ,
C15H), 3.42-3.38 (IH, m, C17H), 3.32 (3H, s, OMe), 3.21 (3H, s, OMe), 3.05 (IH, d, J 10.1, C13H), 2.85 
(3H, s, OMe), 2.78 (2H, dd, 7 7.9, SeCHs), 2.41-2.31 (IH, m, C4H), 2.20 (IH, dd, 7 3.5, 8.1, 2.09
(IH, ddd, 7  0.8, 5.6, 10.6, C16H^Uq), 1.69 (IH, t, 7 13.0, 1.66-1.57 (IH, m, C16% 7/g), 1.52-
1.48 (IH, m, C3H), 0.99 (3H, s, C14Me), 0.96 (9H, s, ^BuSi), 0.89 (3H, s, C14Me), 0.80 (3H, d, 7 6 .6 , 
C2Me), 0.77 (3H, d, 7 7.1, C3Me), 0.101 (3H, s, MeSi), 0.091 (3H, s, MeSi); 0^ (100 MHz, CgDg): 165.3
(0), 164.0 (0), 132.0 (1), 131.5 ( 1 ), 129.7 (0), 129.0 (0), 128.9 (1, 2C), 128.0 (1, 2C), 127.4 (1, 2C), 125.6 (1, 
2C), 98.0 (0, C6 ), 85.2 (2, OCH^O), 78.0 (1, C13 or C17), 77.9 (1, C17 or C13), 75.1 (1, C15), 73.7 (1, C12),
72.9 (1, 07 or CIO), 71.4 (1, CIO or C7), 70.3 (1, C ll) , 69.4 (1, C2), 61.0 (2, C18), 59.9 (3, OMe), 55.1 (3, 
OMe), 46.7 (3, OMe), 40.4 (0, C14), 34.2 (1, C3), 33.8 (1, C4), 30.8 (2, CH2 Se), 30.0 (2, C5), 28.5 (2, C l 6 ),
24.9 (3, 3C, 'BuSi), 22.2 (3, C14Me), 17.3 (0, CSi), 16.8 (3, C2Me), 12.5 (3, C14Me), 3.4 (3, C3Me), -6.39  
(3, MeSi), -6.49 (3, MeSi); m/z (FAB mode) 916 [(M+Na)+, 4%], 914 (2), 758 (1), 628 (1), 479 (4). Found: 
(M+Na)***, 916.3547. C^^H^yNO^%SeSiNarequires M, 916.3547.
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Acyldihydropyran 1 7 - e p i - 6 . 1 8  (30.0 mg, 39.7 |rmol) was converted to 1 7 - e p i - 6 . 1 9  (14 mg, 15.7 [Xmol, 40%) 
by the procedure described above: +61.4 (c 0.7, CHCI3 ); (CHCl3 )/cm“  ^ 3359, 2929, 2856,
1732, 1706, 1523, 1471, 1263, 1124, 1030, 836; ô g  (400 MHz, CgDg): 8.21 (2H, ddm, J 1.5, 8.0), 7.45 (2H, 
ddm, /  1.5, 8.0), 7.36 (IH, d, J 9.6, NH), 7.05-6.88 (6 H, m), 5.96 (IH, t, J 9.7, ClOH), 5.91 (IH, s, C7H), 
4.54 (IH, d, J  7.3, OCH^HbO), 4.52 (IH, d, J 7.5, OCHaH^O), 4.27 (IH, dd, J 6.9, 10.2, C12H), 3.73 (IH, 
dd, 7 7.0, 9.6, C llH ), 3.70 (IH, dd, 7 9.4, 10.0, C15H), 3.67 (IH, dd, 7 4.6, 9.9, CISHaH^), 3.62-3.57 (IH, 
m, C18HAHg) 3.58 (3H, s, OMe), 3.51 (IH, dq,7 2.3, 6 .6 , C2H), 3.51-3.43 (IH, m, C17H), 3.20 (3H, s, 
OMe), 3.01 (IH, 7 10.3, C13H), 2.86 (IH, dd, 7 7.1, 12.0, ScCT/aHb), 2.86 (3H, s, OMe), 2.79 (IH, dd, 7
8 .6 , 12.1, SeCHA^s), 2.44-2.35 (IH, m, C4H), 2.26 (IH, dd, 7 3.5, 13.1, C5/7aHb), 1.77 (IH, t, 7 13.0, 
C5 H a 7 / 5 ), 1.65 (IH, dd, 7 10.2, 14.2, C16HaHb), 1.67-1.50 (IH, m, C3H), 1.46 (IH, br dd,7 9.3, 13.8, 
C16Ha7/b), 0.95 (9H, s,^BuSi), 0.92 (3H, s, C14Me), 0.88 (3H, s, C14Me), 0.81 (3H, d, 7 6.4, C2Me), 0.80 
(3H, d, 7 7.1, C3Me), 0.063 (3H, s, MeSi), 0.061 (3H, s, MeSi); 8 ^ (100 MHz, C^D^): 165.4 (0), 146 (0),
132.0 (1), 131.7 (1, 2C), 129.4 (0), 128.9 (1, 2C), 128.1 (1, 2C), 127.3 (1, 2C), 125.8 (1), 124.5 (1), 98.0 (0, 
C6 ), 84.9 (2, OCH2 O), 77.8 (1, C13), 76.8 (1, C17), 74.6 (1, C15), 73.8 (1, C12), 72.9 (1, CIO), 71.4 (1, C7),
70.4 (1, C ll) , 69.5 (1, C2), 63.9 (2, CIS), 60.0 (3, OMe), 56.8 (3, OMe), 46.7 (3, OMe), 40.1 (0, C14), 34.1 
(1, C4), 33.8 (1, C3), 32.2 (2, C16), 30.9 (2, CH2 Se), 30.3 (2, C5), 24.9 (3, 3C, ^BuSi), 21.9 (3, C14Me), 17.3
(0, CSi), 16.8 (3, C2Me), 12.4 (3, C14Me), 3.3 (3, C3Me), -6.3 (3, MeSi), -6 .4  (3, MeSi); m/z (FAB mode) 
916 [(M+Na)+, 28%], 914 (16), 758 (6 ), 329 (24). Found: (M+Na)+, 916.3548. C^^Hg-yNOiiSeSiNa 
requires M, 916.3547.
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Sodium periodate (30 mg, 0.14 mmol) was added in one portion to a solution of the diastereoisomerically 
pure selenide 6.19 (10 mg, 11.2 |xmol) in Me0 H/H2 0 /CH2 Cl2  (3:1:1, 3.5 ml), After 30 min the mixture was 
diluted with Et2 0  (10 ml) and EtgN (0.5 ml) and washed with H2 O ( 2 x 5  ml), dried (Na2 S0 ^) and 
concentrated in vacuo to give the selenoxide as a colourless oil which was dissolved in toluene ( 2  ml) 
whereupon Et^N (2 ml, 14.3 p.mol) was added. After refluxing for 5 min, the reaction mixture was poured 
into saturated aqueous NaHCOg (5 ml) and extracted with Et2 Û ( 2 x 1 0  ml). The organic extracts were dried 
(Na2 SO^) and concentrated in vacuo to give a pale yellow oil which was dissolved in MeOH (3 ml) to which
was added aqueous LiOH (0.3 ml, 1.0 M, 0.3 mmol). After 30 min at rt the mixture was concentrated, the 
residue was dissolved in Et2 0  (5 ml), washed with H2 O ( 2 x 2  ml) and brine (2 ml), dried (Na2 S 0 ^), and
concentrated in vacuo to give 18-0-TBS mycalamide B as a yellow oil which was used immediately in the
next step.
TBAF (22 mg, 70 (imol) was added to a solution of 18-O-TBS mycalamide B in THE (1 ml) and 
after 1 h at rt the reaction mixture was diluted with Et2 0  (5 ml) and washed with saturated aqueous NaHCOg 
(2 ml). The aqueous phase was extracted with CH2 CI2  ( 2 x 5  ml) and the combined organic layers dried 
(Na2 S0 4 ) and concentrated in vacuo to give an oil which was purified by column chromatography on silica 
gel (1 g) eluting with hexanes:EtOAc:NEtg (100:0:1, 75:25:1, 50:50:1, 25:75:1, 0:100:1) to give mycalamide 
B (1.5) (4,5 mg, 8.69 pmol, 78% over 4 steps): (CHCl3 )/cm“l 3359, 2971, 2933, 1686, 1522, 1468,
1382, 1193, 1109, 1075, 1032. 959, 879, 789; §h (400 MHz, CDCI3 ): 7.54 (IH, d, J  9.6, NH), 5.83 (IH, t, J
9.6, ClOH), 5.14 (IH, d, J 7.0, OC^f^HgO), 4.88 (IH, d , i  6.7, OCU j^ HqO), 4.88 (IH, br s, =C7fy^Hg), 4.75 
(IH, br s, =CBjs,Hb \  4.31 (IH, d, J2.0, C7H), 4.24 (IH, dd, J 6 .8 , 10.2, C12H), 4.06 (IH, dq, J 2.8, 6.5, 
C2H), 3.90 (IH, d, 7 2.1, C70H), 3.81 (IH, dd, 7 6 .8 , 9.6, C llH ), 3.72-3.65 (IH, m, ClSTf^Hg), 3.58 (3H, 
s, OMe), 3.54-3.48 (IH, m, CI8 HA//5 ), 3.46 (IH, d, 710.4, C13H), 3.48-3.42 (IH, m hidden, C15H), 3.32 
(3H, s, OMe), 3.27 (3H, s, OMe), 3.25-3.18 (IH, m, C17H), 2.39 (IH, d, 7 14.0, CS/Z^Hg), 2.30 (IH, dq, 7
2.8, 7.1, C3H), 2.26 (IH, dm, 7 13.9, C5H^% ), 1.60-1.54 (2H, m, C16f%), 1.23 (3H, d, 76.6, C2Me), 1.04 
(3H, d, 7 7.2, C3Me), 1.01 (3H, s, C14Me), 0.89 (3H, s, C14Me); 6 ^  (400 MHz, CgDg): 7.58 (IH, d, 7 9.8, 
NH), 5.83 (IH, t ,7  9.9, ClOH), 4.71 (IH, t, 7 1.8, 4.66 (IH, t, 71.9, ^CH^ZZg), 4.56 (IH, d,77.0,
OC/Z^HgO), 4.53 (IH, d ,7  6.9, OCH^/ï^O), 4.24 (IH, dd,7 7.0, 10.6, C12H), 4.16 (IH, s, C7H), 4.07 (IH, 
br s, C70H), 3.85-3.77 (IH, m, CIST/^Hb), 3.80 (IH, dq,7 1.8, 6 .6 , C2H), 3.74-3.68 (IH, m, ClSH^TZg),
3.69 (IH, dd, 7 7.0, 10.0, C llH ), 3.40 (IH, dd, 7 5.6, 6.1, C15H), 3.33-3.28 (IH, m, C17H), 3.22 (3H, s, 
C130Me), 3.15 (3H, s, C60Me), 3.03 (3H, s, C170Me), 2.94 (IH, d, 7 10.5, C13-H), 2.60 (IH, d, 7 14.0, 
C5-77^Hb), 2.40 (IH, dt,7 1.8, 14.0, CSB^^H^), 2.33 (IH, br s, C180H), 1.86 (IH, dq, 7 1.7, 7.0, C3H),
1.59-1.55 (2H, m, ClOHg), 0.92 (3H, d, 7 7.0, C3Me), 0.81 (3H, d collapsed by C14Me, 7 6 .6 , C2Me), 0.80 
(3H, s, C14Me), 0.76 (3H, s, C14Me); 5^ (100 MHz, CgDg): 171.1 (0, C8 ), 144.6 (0, C4), 109.6 (2, =CH2 ),
99.2 (0, C6 ), 85.1 (2, OCHjO), 77.7 (1, C13 or C l7), 77.5 (1, C17 or C13), 74.4 (1, C15), 73.9 (1, C12), 72.9
(1, CIO), 70.9 (1, C l  or C ll) , 70.7 (1, C ll  or C7), 68.1 (1, C2), 62.6 (2, C18), 60.0 (3, C130Me), 55.2 (3, 
C170Me), 47.0 (3, C60Me), 40.4 (1, C3), 40.3 (0, C14), 32.9 (1, C5), 29.3 (2, C16), 21.5 (3, CMMe^q),
16.5 (3, C2Me^^), 11.9 (3, C14Me), 11.0 (3, C3Me); m/z (FAB mode) 540 [(M+Na)+, 100%], 507 (20), 486 
(25), 176 (32). Found: (M+Na)+, 540.2790. Cg^H^gNOioNa requires M, 540.2785.
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17-ne/;ï-Mycalamide B
o 9Meo
■OMe
SePh 
17-epi-6.19
C 44H67NO 1 iSeSi 
Mol. W t: 893.05
ITBS
OMe
OMe 0
17-epl-Mycalamlde B (17-epi-1.5)
C.îcH.nNOi OMe
Selenide 1 7 - e p i - 6 . 1 9  (14 mg, 15.7 jimol) gave I7-epi-mycalamide B ( 1 7 - e p i - l . S )  (6.3 mg, 12.2 p,mol, 78% 
over 4 steps) by the procedure described above: (CHCl3 )/cm“  ^ 3356, 2971, 2933, 1686, 1524, 1468,
1382, 1194, 1109, 1074, 1033. 959, 878, 790; Ôjj (400 MHz, CgDg): 7.48 (IH, d, J 9.9, NH). 5.94 (IH, t, J
9.9, ClOH), 4.75-4.70 (2H, m, =CH2 ), 4.57 (IH, d, J 6.9, OCH^HgO), 4.54 (IH, d, J 6.9, OCH^/f^O), 4.23
(IH, dd, J 6.9, 10.2, C12H), 4.17 (2H, s, C7H and C70H), 3.82 (IH, dq. J 2.6, 6 .6 , C2H), 3.65 (IH, dd, J 7.1,
9.7, C llH ), 3.61-3.55 (2H, m, ClSHg), 3.51 (IH, d, 79.3, C15H), 3.32 (3H, s, C130Me), 3.27-3.18 (IH, m,
C17H), 3.21 (3H, s, C60Me), 3.06 (3H, s, C170Me), 2.96 (IH, d, J 10.4, C13H), 2.60 (IH, d, J 13.9, 
C5/7^Hb), 2.42 (IH, br d, 713.9, C5H^//^), 1.88 (IH, dq, 7 2.6, 7.1, C3H), 1.65 (IH, dd,7 8.2, 14.8, 
C16//^Hj3), 1.50 (IH, brs,C 180H ), 1.27 (IH, ddd.72.8, 10.0, 14.3, ClOH^Tf^), 0.90 (3H, d, 7 7.1, C3Me), 
0.83 (3H, s, C14Me), 0.81 (3H, d, 7 6 .6 , C2Me), 0.77 (3H, s, C14Me); 5^ (100 MHz, CgD^): 171.1 (0, C8 ),
145.0 (0, C4), 109.4 (2, =CH2 ), 99.1 (0, C6 ), 85.0 (2, OCH2 O), 78.3 (1, C17), 77.8 (1, C13), 75.9 (1, C15),
73.8 (1, C12), 72.8 (1, CIO), 71.1 (1, C7), 70.1 (1, C ll) , 68.0 (1, C2), 62.6 (2, CIS), 60.0 (3, C130Me), 55.6 
(3, C170Me), 47.1 (3, C60Me), 40.3 (1, C3), 40.1 (0, C14), 33.0 (1, C5), 31.5 (2, C16), 21.7 (3, C14Me),
16.5 (3, C2Me), 12.1 (3, C14Me), 11.1 (3, C3Me); m/z (FAB mode) 540 [(M+Na)+, 100%], 508 (20), 486 
(25). Found: (M+Na)"*", 540.2789. C25H^3N02QNa requires M, 540.2785.
10.5 Synthesis of analogues of pederin
( 2 5 , 4 / ? , 6 / î ) - 4 - ( f e / t - B u t y l d i m e t h y l s i l y l o x y ) - 6 - ( 3 - c l î l o r o p r o p y l ) - 5 , 5 - d i n i e t h y l - t e t r a h y d r o - p y r a n - 2 -  
c a r b o x a m i d e  ( 7 . 1 ) .
OTBS
CiTHaaCINOaSi 
ivbl. Wt.: 345.96
OTBS
Cl7.1CtTHaiCINOsSi 
Mol. W t: 364.00
To a solution of nitrile 5 . 3  (14.3 g, 41.3 mmol) in EtOH (100 ml) and CH2 CI2  (50 ml) at 0°C, was added a 
solution of K2 CO3  (107.3 g, 776 mmol) in water (50 ml) followed by H2 O2  (148 ml, 30% aqueous solution, 
930 mmol) and n-tetrabutylammonium hydrogen sulfate (2.80 g, 8.3 mmol) causing strong gas evolution. 
The reaction mixture was stirred at rt (using a water bath) for 7 days while H2 O2  (50 ml, 30% aqueous 
solution, 310 mmol) was added every 24 h. Saturated aqueous Na2 S2 0 3  (150 ml) was added dropwise until 
effervescence ceased. The phases were separated and the aqueous phase was extracted with CH2 CI2  (3 x 150 
ml). The combined organic extracts were dried (MgSO^), and concentrated in vacuo. The residue was 
purified by column chromatography (S1 0 2 , hexanes/Et2 0  0-50%) to give amide 7 . 1  (9.73 g, 26.7 mmol, 
65%) as a white solid and recovered nitrile 5 . 3  (2.16 g, 6.25 mmol, 15 %) : mp 90-92°C (hexanes);
+19.4 (c 0.9, CHCI3 ); Vmax film/cm"l 3482, 3313, 3204, 2956, 2857, 1694, 1586, 1471, 1388, 1256, 1086;
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8 h  (400 MHz, CDCI3 ): 6.35 (IH, br s, NH^Hg), 5.49 (1 H, br s, NH^f/g) 4.35 (IH, t, J 4.9, C ll-H ), 3.59 
(IH, ddd, J  10.7, 6 .6 , 3.0, C18 Tf^Hg), 3.55 (IH, ddd,7 10.7, 6.5, 2.8, J  10.7, 6.5, 2.8, C18 3.45
(IH, dd, J  8.9, 4.0, C13-H), 3.22 (IH, dd, J  10.7, 1.8, C15-H), 2.22 (IH, dt, J 13.4, 4.4, C12-7/^Hg), 2.10- 
1.96 (IH, m, C17-//^Hg), 1.90-1.60 (4H, m, C12-H^//g, C16-H2_ C17-H^77g), 0.92 (3H, s, C14-Me), 0.91 
(9H, s, ^BuSi), 0.89 (3H, s, C14-Me), 0.11 (3H s, Si-Me), 0.06 (3H, s. Si-Me); 6 ( 3  (100 MHz, CDCI3 ):
174.3 (0, CIO), 81.0 (1, C15), 72.8 (1, C13), 70.8 (1, C ll) , 44.9 (2, C l 8 ), 38.3 (0, C14), 30.3 (2, 2C, C12 and 
C17), 2 6 . 2  (2, C l 6 ), 25.8 (3, 3C, ^BuSi), 24.3 (3, C14-Me), 18.0 (0, C-Si), 15.7 (3, C14-Me), -4 .2  (3, Me-Si), 
-5 .0  (3, Me-Si); m/z (Cl, Isobutane) 366 (35), 364 [(M+H)+, 100%], 308 (7), 306 (21), 234 (30), 232 (100), 
174 (20); Found : (M+H)+, 364.2073. C i7 H3 5 0 3 NSiCl requires M, 364.2075; Found: C, 56.04; H, 9.39; 
N, 3.84. C i7 H3 4 ClN0 3 Si requires C, 56.09; H, 9.41; N, 3.85.
A ^ - { [ ( 2 S , 4 / ? , 6 i ? ) - 4 - ( ^ e r / - B u t y l d i m e t h y l s i l y l o x y ) - 6 - ( 3 - c h I o r o p r o p y l ) - 5 , 5 - d i m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ] -
( S ) - m e t h o x y - m e t h y I } - o x a l a m i c  a c i d  m e t h y l  e s t e r  ( 7 . 5 )
a n d
A ^ - { [ ( 2 5 , 4 i ? , 6 7 ? ) " 4 - ( r e r / - B u t y I d i m e t l i y l s i l y l o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i m e t h y l - t e t r a l i y d r o - p y r a n - 2 - y l ] -  
( / ? ) - m e t h o x y - m e t h y l } - o x a l a m i c  a c i d  m e t h y l  e s t e r  ( 7 . 4 )
OTBS
7.1G17 Hal CIN Si Mol.Wt.; 364.00
MeO
O MeO
7.5C21 HjoCINQiSI Mol.Wt: 466.08
OTBS MeO,
O MeO
7.4CatH^dCINOsSI Mol. Wl.:466.08
OTBS
To a solution of amide 7 . 1  (1.06 g, 2.9 mmol) in CH2 CI2  (50 ml) was added in one portion freshly purchased 
Me^OBF^ (1.76 g, 11.9 mmol, 4.1 eq). After 4.5 h at rt, the mixture was poured onto saturated aqueous 
NaHCOg (50 ml) and extracted with CH2 CI2  (3 x 25 ml), dried (MgSO^) and concentrated in vacuo to give
7 . 2  as a colourless oil which was used immediately in the following step.
To a solution of crude methyl imidate 7 . 2  in CH2 CI2  (50 ml) at 0 °C was added pyridine (1.1 ml, 13.6 mmol)
followed immediately by methyl oxalyl chloride (350 jal, 3.8 mmol). After 10 min at 0 °C, the mixture was 
poured into saturated aqueous NaHCOg (20 ml) and extracted quickly with CH2 CI2  (3 x 40 ml), dried 
(MgSO^) and concentrated in vacuo to give 7 . 3  as a colourless oil which was used immediately in the next 
step.
To a solution of crude A-acylimidate 7 . 3  in toluene (40 ml) at rt was added RhCllPhgPjg (135 mg, 0.15 
mmol). The mixture was cooled to -75 °C and freshly prepared catecholborane^^^ (5.8 ml, 2.9 mmol, 0.5 M 
solution in THF) was added. The reaction mixture was stirred at -70  °C for 2 h  and poured into saturated 
aqueous NaHCOg (20 ml) and extracted with CH2 CI2  (3 x 40 ml). The combined organic extracts were dried 
(MgSO^), and concentrated in vacuo to give a yellow oil which was purified by column chromatography 
(Si0 2 , 10-30% EtOAc in hexanes) to give 7 . 5  (620 mg, 1.33 mmol, 46%) as a colourless oil which 
crystallised on standing and 7 . 4  (112 mg, 0.24 mmol, 8.3 %) as a colourless oil (dr = 5.5:1).
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A ^ - { [ ( 2 S ' , 4 / f , 6 / ï ) - 4 - ( ^ e / ^ - B i i t y l d i n i e t h y I s i l y l o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ] -  
( S ) - m e t h o x y - m e t h y I } - o x a l a m i c  a c i d  m e t h y l  e s t e r  ( 7 . 5 )
o  MeO
MeO. OTBS
7.5C21 KioClNQsSi 
M oLW k 466.08
mp 40-42°C (hexanes); [aJ^^O +2 1.4 (c 1.0, CHC^); füm/cm-l 3403, 3359, 2953, 2857, 1713,
1518, 1471, 1361, 1295, 1210; ôjj (400 MHz, CDCI3 ); 7.48 (IH, d, J 9.7, NH), 5.21 (IH, dd, J 9.8, 6.7, 
CIO-H), 3.93 (3H, s, OMe), 3.84 (IH, dt, J7 .1 , 5.5, C ll-H ), 3.54 (IH, dd, J 8.3, 4.0, C13-H), 3.48 (2H, t, J
6 .6 , CI8 -H2 ), 3.40 (3H, s, OMe), 3.17 (IH, dd, J 11.0, 1.4, C15-H), 1.91-1.79 (3H, m), 1.70-1.48 (3H, m), 
0.92 (3H, s, C14-Me), 0.90 (9H, s, ^BuSi), 0.85 (3H, s, C14-Me), 0.055 (3H, s, Si-Me), 0.049 (3H, s, S i-  
Me); Ôc (100 MHz, CDCI3 ): 160.5 (0), 157.2 (0), 80.9 (1, CIO), 79.8 ( 1 ,  C15), 72.6 ( 1 ,  C13), 70.0 (1, br
signal, C ll) , 56.8 (3, OMe), 53.8 (3, OMe), 45.1 (2, C18), 38.4 (0, C 1 4 ) ,  30.3 (2, C12 or C16 or C17), 29.9 
(2, C12 or C16 or C17), 26.0 (2, C12 or C16 or C17), 25.7 (3, 3C, ^BuSi), 24.5 (3, C14-Me), 18.0 (0, C-Si),
16.5 (3, br signal, C14-Me), -4 .4  (3, Me-Si), -5 .0  (3, Me-Si); m/z (CI, Isobutane) 366 (35), 364 [(M+H)+, 
100%], 308 (7), 306 (21), 234 (30), 232 (100), 174 (20); m/z (FAB, Nal) 490 (40), 488 [(M+Na)+, 100%], 
304 (15), 302 (45); Found : (M+Na)+, 488.2212. C2 iH^oOgNSiClNa requires M, 488.2211.
A - { [ ( 2 S , 4 j R , 6 J Î ) - 4 - ( / e / ^ B u t y l d i m e t h y l s i l y l o x y ) - 6 - ( 3 - c l i l o r o p r o p y l ) - 5 , 5 " d i m e t h y l - t e t r a h y d r o - p y r a n - 2 - y I ] -  
( 7 ? ) - m e t h o x y - m e t h y l } - o x a l a m i c  a c i d  m e t h y l  e s t e r  ( 7 . 4 )
Ô  M'ëÔ'
P I B SM eO .
M o  17 + 1 3 . 5  (c 0.5, CHCI3 ); film/cm-1 3404, 3358, 2954, 2857, 1713, 1518, 1471, 1361, 1295,
1210; ÔH (400 MHz, CDCI3 ): 7.84 (IH, d ,  J 9.7, NH), 5.10 (IH, dd, J 9.9, 3.4, CIO-H), 3.93 (3H, s, OMe),
3.87-3.82 (IH, m (5 lines). Cl 1-H), 3.68 (IH, dd, J 6.0, 3.6, C13-H or C15-H), 3.58 (2H, dd, J 6 .6 , 6.2, C18- 
Hg), 3.50 (IH, dd, J 11.7, 2.4, C15-H or C13-H), 3.41 (3H, s, OMe), 2.14-1.93 (2H, m), 1.82-1.73 (IH, m), 
1.63-1.54 (3H, m), 1.02 (3H, s, C14-Me), 0.90 (9H, s, ^BuSi), 0.87 (3H, s, C14-Me), 0.06 (3H, s, Si-Me), 
0.04 (3H, s, Si-Me); (100 MHz, CDCI3 ): 160.9 (0), 1 5 6 . 8  (0), 82.8 ( 1 , CIO), 81.1(1, C13 or C15), 73.4 
(1, C15 or C13), 68.7 (1, C ll) , 57.4 (3, OMe), 54.2 (OMe), 45.4 (2, C18), 38.3 (0, C14), 31.4 (2, C12 or C16 
or C17), 30.2 (2, C12 or C16 or C17), 30.0 (2, C12 or C16 or C17), 26.2 (3, 3C, ^BuSi), 25.7 (3, C14-Me),
19.6 (0, br signal, C14-Me), 18.3 (0, C - S i ) ,  -4.1 (3, Me-Si), -4 .7  (3, Me-Si); m/z (FAB, Nal) 490 (40), 488 
[(M-t-Na)+, 100%]; Found : (M+Na)+, 488.2210. C2 iH4 o0 6 NSiClNa requires M, 488.2211.
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A ^ - { ( 2 S , 4 7 f , 6 i ? ) - 4 - ( t o ^ - B u t y l d i m e t l i y I s i l y l o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i m e t h y l - t e t r a l i y d r o - p y r a n - 2 - y l ] -  
( i î ) - m e t h o x y - m e t h y l } - 2 - ( ( 4 5 , 5 i ? , 6 / f ) - 5 , 6 - d i m e t h y l - 4 " p h e i i y l s e I a n y I m e t h y l - 5 , 6 - d i h y d r o - 4 / f - p y r a n - 2 - y I ) - 2 -  
o x o - a c e t a m i d e  ( 7 . 6 )  
a n d
A ^ - { [ ( 2 S , 4 j R , 6 j f f ) - 4 - ( t e r t - B u t y l d i m e t h y l s i l y l o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ] -  
( / ? ) - m e t h o x y - m e t h y l } - 2 , 2 - b i s - ( ( 4 5 , 5 / ? , 6 / f ) - 5 , 6 - d i m e t l i y I - 4 - p l i e n y l s e l a n y I m e t h y l - 5 , 6 - d i h y d r o - 4 i ? - p y r a n -  
2 - y l ) - 2 - h y d r o x y - a c e t a m i d e  ( 7 . 7 )
O MeO = H
SePh
2 3CggHwOSeSn 
Mol. W t: 570.30
O MeO
.OTBS
SePh
O TBS
O MeO
Cl
7.4CaiHjoCINOsSi 
Mol. W l: 466.08
OTBS
C3,HMCINCbSeSi 
M ol.W t: 7 1 5 2 9
C^oH^gCI NO 78628! 
M d.W l,: 996.55
To a solution of stannane 2 . 3  (257 mg, 0.45 mmol) in THF (3 ml) at -90  °C was added dropwise nBuLi (200 
pi, 0.454 mmol, 2.27 M solution in hexanes) and the bright yellow solution stirred while maintaining the 
temperature between -85 and -90  °C for 15 min. Formation of the lithiated dihydropyran was checked by 
TLC (AI2 O3 , hexanes). TMEDA ( 6 8  pi, 0.45 mmol) was added and after 10 min at -  90 °C, a solution of
ester 7 . 4  (63 mg, 0.135 mmol) in THF (1.5 ml) was quickly added using a wide bore cannula. The light 
yellow solution was allowed to gradually warm up to -40®C over 3 h and then poured into brine (5 ml) and 
extracted with CH2 CI2  (3 x 10 ml). The combined extracts were dried (Na2 S0 q) and concentrated in vacuo 
to give a yellow oil which was purified by chromatography (Si0 2 , PhMe and then 0-30% Et2 0  in hexanes) to 
give coupling product 7 . 6  (45.0 mg, 0.063 mmol, 45% based on the right half fragment 7 . 4 )  as a colourless 
oil along with byproduct 7 . 7  (46.0 mg, 0.046 mmol, 34%) as a white powder.
A ^ - { ( 2 5 , 4 7 ? , 6 / î : ) - 4 - ( ï e / Y - B u t y l d i m e t h y l s i l y l o x y ) - 6 - ( 3 - c h l o r o p r o p y I ) - 5 , 5 - d i m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ] -  
( / f ) - m e t h o x y - m e t h y l } - 2 - ( ( 4 5 , 5 i ? , 6 j R ) - 5 , 6 - d i m e t h y l - 4 - p h e i i y l s e l a n y l m e t h y l - 5 , 6 - d i h y d r o - 4 j H - p y r a n - 2 - y I ) - 2 -  
o x o - a c e t a m i d e  ( 7 . 6 )
O MeO
.OTBS
SePh
7.6C34H&tC!NOcSe3 
Mol. W t: 715.29
[a ]D 20_ i84  (c 0.8, CHCI3 ); v,nax 3394, 3311, 2932, 2857, 1667, 1580, 1500, 1381, 1253, 1074,
878, 837, 776, 738, 584; ô g  (400 MHz, CDCI3 ): 7.70 (IH, d, J 9 . 8 ,  NH), 7.54-7.40 (2H, m, Harom), 7.30- 
7.25 ( 3 H ,  m, Harom), 7.04 (IH, t, J  1.9, C5-H), 5.08 (IH, dd, J 6.2, 3.6, CIO-H), 4.10 (IH, dq, J 6.5, 1.3, C2- 
H), 3.85-3.80 (IH, m, 5 lignes, C ll-H ), 3.68 (IH, dd, 7 6.1, 3.6, C13-H), 3.64-3.57 (2H, m, CI8 -H2 ), 3.14 
(IH, dd, J 9.6, 2.4, C15-H), 3.40 (3H, s, OMe), 2.99 (IH, d, J 12.1, Se-CT/^Hg), 2.94 (IH, d ,J  12.1, Se-
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2.90-2.83 (IH, m, C4-H), 2.12-1.90 and 1.79-1.43 (7H, 2 x m, C3-H, CI2 -H2 , C I6 -H2  and C17- 
H2 ), 1.38 (3H, d, J 6.5, C2-Me), 1.01 (3H, s, C14-Me), 0.90 (9H, s, ^Bu-Si), 0.88 (3H, s, C14-Me), 0.85 (3H, 
d, J 7.0, C3-Me), 0.06 (3H, s, Me-Si), 0.04 (3H, s, Me-Si); 6 ^ (100 MHz, CDCI3 ); 180.5 (0), 160.8 (0),
148.2 (0, C6 ), 133.1 (1, 2C, Carom), 129.2 (1, 20, Carom), 129.2 (0, Carom), 127.3 (1, Carom), 124.2 (1, 
C5), 81.9 (1, CIO), 80.5 (1, C15), 76.7 (1, C2), 73.1 (1, C13), 68.5 (1, C ll) ,  56.9 (3, OMe), 45.4 (2, C18),
39.0 (1, C4), 37.9 (0, C14), 33.2 (1, C3), 31.1 (2, C12 or C16 or C17), 29.5 (2, Se-CH2 ), 29.4 (2, C12 or C16 
or C17), 25.8 (3, 3C, ^Bii-Si), 25.5 (3, C14-Me), 25.2 (2, C12 or C16 or C17), 19.2 (3, C14-Me), 18.2 (3, C2- 
Me), 17.8 (0, C-Si), 5.9 (3, C3-Me), -4 .4  (3, Me-Si), -5 .0  (3, Me-Si); m/z (FAB, Nal) 743 (5), 742 (10), 741 
(20), 740 (50), 739 (45), 738 [(M+Na)+, 100%], 736 (50), 737 (25), 736 (55), 735 (20), 734 (15), 733 (5), 
584 (4), 583 (6 ), 582 (18), 581 (16), 580 (32), 579 (2), 578 (2); Found : (M+Na)+ 738.2465. 
C3 4 H5 4 Ü 6 SeSiCINNa requires M, 738.2473.
7V-{[(2S,4if,6/î)-4-(tert-Butyldimethylsilyloxy)-6-(3-chloropropyl)-5,5-dimethyl-tetrahydro-pyran-2-yl]- 
(7î)-niethoxy"methyl}-2,2-bis-((4S,5/?,6/?)-5,6-dlmetliyl-4-phenylselanylmethyl-5,6-dihydro-4jF/-pyran" 
2-yl)-2-hydroxy-acetamide (7.7)
0  MeÔ'
.OTBS
PhSe-
mp 38-40°C (hexanes); +35.9 (c 0.3, CHC^); fUni/cm-l 3393, 2931, 1686, 1514, 1471,
1381, 1253, 1100, 879, 837, 776, 737, 584; ô g  (400 MHz, CDCI3 ): 7.50-7.46 (4H, m, Harom), 7.30-7.23 
(6 H, m, Harom), 7.06 (IH, d, J 9.7, NH), 5.27 (IH, dd, J  9.7, 6.2, CIO-H), 5.09 (IH, t, 71.5, C5-H), 4.99 (IH, 
t, 71.8, C5'-H), 4.50 (IH, s, C7-H), 4.02 (IH, dq, 7 6.5, 1.3, C2-H), 3.97 (IH, dq, 7 6 .6 , 1.3, C2'-H), 3.70-3.64 
(2H, m, C ll-H  and C13-H), 3.60-3.46 (2H, m, CI8 -H2 ), 3.40 (3H, s, OMe), 3.31 (IH, dd, 7 7.9, 4.5, C15-H), 
2.93-2.79 (4H, m, Se-CH2  and Se'-CH2 ), 2.75-2.68 (IH, m, C4-H), 2.68-2.60 (IH, m, C4-H), 2.07-1.95 and 
1.95-1.85 and 1.78-1.52 (8 H, 3 x m, C3-H, C3’-H, CI2 -H2 , CI6 -H2  and CI7 -H2 ), 1.26 (3H, d, 7 6.5, C2- 
Me), 1.24 (3H, d, 7  6.5, C2'-Me), 0.90 (3H, s, C14-Me), 0.87 (9H, s, ^Bu-Si), 0.834 (3H, s, C14-Me), 0.831 
(3H, d, 7 6 .8 , C3-Me), 0.79 (3H, d, 7 6.9, C3'-Me), 0.05 (3H, s, Me-Si), -0 .04  (3H, s, Me-Si); 6 ^ (100 MHz, 
CDCI3 ): 171.1 (0), 151.4 (0, C6 ), 150.4 (0, C6 '), 132.7 (1, 2C, Carom), 132.6 (1, 2C, Carom), 129.9 (0, 
Carom), 129.1 (0, Carom), 129.1 (1, 2C, Carom), 127.0 (1, 2C, Carom), 126.9 (1, 2C, Carom), 101.2 (1, 2C, 
C5 and C5'), 81.7 (1, CIO), 79.2 (1, C15), 77.0 (1, C7), 77.0 (1, C2), 76.6 (1, C2'), 72.5 (1, C ll  or C13), 72.2 
( 1 , C ll  or C13), 56.3 (3, OMe), 45.2 (2, C18), 38.8 (0, C14), 37.5 (1, C4), 37.4 (1, C4'), 33.9 (1, C3), 33.6 
(1, C3'), 30.9 (2, C12 or C16 or C17), 30.7 (2, 2C, Se-CH2  and Se'-CH2 ), 30.1 (2, C12 or C16 or C17), 26.3 
(2, C12 or C16 or C17), 25.8 (3, 3C, ^Bu-Si), 23.8 (3, C14-Me), 18.3 (3, C2-Me), 18.2 (3, C2'-Me), 18.0 (0, 
C-Si), 14.5 (3, br s, C14-Me), 5.7 (3, C3-Me), 5.4 (3, C3'-Me), -4.1 (3, Me-Si), -5.1 (3, Me-Si); m/z (FAB, 
Nal) 1026 (5), 1025 (7), 1024 (20), 1023 (30), 1022 (60), 1021 (55), 1020 [(M+Na)’^ , 100%], 1019 (55), 
1018 (90), 1017 (45), 1016 (47), 1015 (20), 1014 (20), 1013 (5), 1012 (5), 8 6 6  (4), 865 (6 ), 864 (13), 863 
(12), 862 (20), 861 (7), 860 (12), 859 (5), 858 (5); Found : (M+Na)+ 1020.2986. 
C48H72O7N80Se2Si^5ciNa requires M, 1020.2994 and C4gH72Û7N78Se^()SeSi37ciNa requires M,
1020.2973.
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( 5 ) - B e n z o i c  a c i d  ( { [ ( 2 5 , 4 / f , 6 / ï ) - 4 - ( ^ < ? r ^ - b u t y l d i m e t h y l s i l a n y l o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i n i e t h y l -  
t e t r a l i y d r o - p y r a n - 2 - y l ] - ( / ? ) - m e t h o x y - m e t h y l } - c a r b a m o y l ) - ( ( 2 / ? , 4 / ? , 5 / ? , 6 7 f ) - 2 - m e t h o x y - 5 , 6 - d i m e t h y l - 4 -  
p h e i i y l s e l a n y l m e t h y I - t e t r a h y d r o - p y r a n - 2 - y l ) - m e t h y l  e s t e r  ( 7 . 8 a )  
a n d
( / ? ) - B e n z o i c  a c i d  ( { [ ( 2 5 , 4 i ? , 6 / ? ) - 4 - ( t e r t - b u t y l d i m e t h y I s i l a i i y l o x y ) - 6 - ( 3 - c h I o r o p r o p y I ) - 5 , 5 - d i n i e t h y I -  
t e t r a h y d r O “p y r a n - 2 - y I ] - ( i 2 ) - m e t h o x y - m e t h y I } - c a r b a m o y I ) - ( ( 2 i ? , 4 / 2 , 5 / ? , 6 7 ? ) " 2 - m e t h o x y - 5 , 6 - d i m e t h y l - 4 -  
p h e n y l s e l a n y I m e t h y I - t e t r a h y d r o - p y r a i i - 2 - y I ) - m e t h y l  e s t e r  ( 7 . 8 b )
SePh (tj H
" ^ 9  H OTBS
Cl
7.6
CjtHs^CINOgSeSI 
Mol, Wt.: 715 2 9
OM e O MeO
,OTBS
)Bz
■SePh
7.8a
OMe O MeO
.OTBS
O B z
S e P h
7.8bC4aH64CINafeSaSI 
Mol. W t.:853.46
C^aHôiCINQiSeSI 
Mol.Wt.: 853.46
To a solution of acyl dihydropyran 7.6 (35 mg, 48.9 |xmol) in THF (3 ml) at -90  °C was added LiBH(5 -Bu) 3
(0.125 ml, 1.0 M solution in THF, 0.125 mmol) over 3 min. After 10 min maintaining the temperature 
between -85  and -90°C the mixture was treated with brine (1 ml) and extracted with CH2 CI2  ( 3 x 5  ml). The 
combined organic extracts were dried (Na2 S 0 ^) and concentrated in vacuo to give the corresponding 
alcohols as a pale yellow oil. The cmde alcohols were immediately dissolved in CH2 CI2  (2.5 ml) and MeOH
(0.25 ml). Camphorsulfonic acid (4.0 mg, 17.0 pmol) was added and the solution stirred at rt. After 3 h at rt 
solid K2 CO3  (35 mg, 0.24 mmol) was added slowly over 10 min. The reaction mixture was stirred for 
another 2 0  min and then poured onto saturated aqueous NaHCÛ3  ( 2  ml) and extracted with CH2 CI2  ( 3 x 5  
ml). The combined organic extracts were dried (Na2 S0 4 ) and concentrated in vacuo, to give the
diastereoisomeric acetals as a pale yellow oil which were used immediately in the next step. ^H NMR (400 
Mhz, CDCI3 ) spectroscopy confirmed complete addition of methanol on the dihydropyran ring and the ratio
of the C7-diastereomers (c.a. dr = 3:2) was determined by integration of the N-H (IH, d) at 5 -  7.70 ppm 
(major) and 5= 1.59  ppm (minor). A solution of benzoyl chloride (200 |il, 1.71 mmol), DMAP (125 rag, 1.02 
mmol), DIPEA (1 ml, 5.70 mmol) and 4Â MS (5) was prepared in CH2 CI2  (19 ml). To the crude acetal
alcohols was added 2 ml of the above solution and the reaction mixture was stirred at rt for 15 h before 
MeOH was added (1 ml). After 20 min the mixture was poured into brine (2 ml) and extracted with CH2 CI2  
( 3 x 5  ml). The combined organic extracts were dried (Na2 S0 4 ) and concentrated in vacuo. The residue was 
purified by column chromatography (Si0 2 , PhMe and then 0-40% Et2 Û in hexanes) to give a mixture of 
diastereoisomers 7 . 8 a : 7 . 8 b  (30 mg, 0.035 mmol, 72%). ^H NMR (400 MHz, CDCI3 ) spectroscopy confirmed 
the ratio of the C7-diastereomers to be dr = 2:1 which was determined by integration of the C7-H (IH, s) at 5 
= 5.73 ppm (minor) and 5 = 5.46 ppm (major). Benzoates 7 . 8 a  and 7 . 8 b  were separated and purified by 
HPLC using a HiCHROM column (NC100-7C18-250 SPl, Nucleosil 100-7C18, 25 cm-10 mm) eluting with 
MeCN. Retention time were recorded to be 16.3-18.4 min (major) and 18.4-20.6 min (minor) to afford 
benzoate 7 . 8 a  (10.6 mg, 12.42 p.mol, 25%) as a colourless oil, and benzoate 7 . 8 b  (6.7 mg, 7.85 |imol, 16%) 
as a white solid.
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( 5 ) - B e n z o i c  a c i d  ( { [ ( 2 : $  , 4 / ( , 6 ^ ) - 4 - ( ^ e f Y - b u t y l d i m e t h y l s i i a n y l o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 . d i m e t h y i -  
t e t r a h y d r O " p y r a i i - 2 - y l ] - ( / < ! ) - m e t h o x y - i i i e t h y l } - c a r b a m o y l ) - ( ( 2 / f , 4 7 ? , 5 / ? , 6 J ? ) - 2 - m e t h o x y - 5 , 6 - d i m e t h y I - 4 -  
p h e n y l s e I a i i y l m e t h y l - t e t r a h y d r o - p y r a i i - 2 - y l ) - m e t h y l  e s t e r  ( 7 . 8 a )
OMe 0= ÏÏ MeO ^ OTBS
OBz A -
^ S e P h
7 . 8 a
CigHwCINOgSeSI 
Mol. Wl.: 853.46
X
[aJo^O +53.0 (c 0.4, CHCI3 ); film/cm-^ 3305, 2955, 2927, 2854, 1720, 1671, 1548, 1455, 1381,
1271, 1095; ô g  (400 MHz, CDCI3 ): 8.10 (2H, dd, 7 8.3, 1.4, Harom), 7.59 (IH, tt, 77.5, 1.2, Harom), 7.54-
7.49 (2H, m, Harom), 7.49-7.44 (2H, m, Harom), 7.30-7.24 (4H, m, 3 x Harom and NH), 5.46 (IH, s, C7-H), 
5.11 (IH, dd, J 9.7, 4.3, CIO-H), 3.98 (IH, dq, J 6 .6 , 2.1, C2-H), 3.80 (IH, app q ,7  4.1, C ll-H ), 3.63 (IH, 
dd, J 5.2, 3.8, C13-H), 3.63-3.50 (2H, C I 8 -H2 ), 3.42 (3H, s, OMe), 3.39 (IH, dd, J 11.5, 2.3, C15-H), 3.21 
(3H, s, OMe), 2.94 (IH, dd, J  12.0, 6.4, Se-CH^Hg), 2.84 (IH, dd, J 12.0, 9.4, Se-CH^T/g), 2.40-2.34 (IH,
m, C4-H), 2.20-2.09 (IH, m), 2.09-2.95 (3H, m), 1.90-1.80 (IH, m, C3-H), 1.80-1.68 (2H, m), 1.65-1.45 (2H, 
m), 1.21 (3H, d, J 6 .6 , C2-Me), 1.01 (3H, s, C14-Me), 0.90 (9H, s, ^Bu-Si), 0.88 (3H, s, C14-Me), 0.79 (3H, 
d, 7 7.1, C3-Me), 0.04 (3H, s, Si-Me), 0.02 (3H, s, Si-Me); (100 MHz, CDCI3 ): 167.3 (0), 165.4 (0),
133.4 (1, Carom), 132.6 (1, 2C, Carom), 130.3 (0, Carom), 130.1 (1, 2C, Carom), 129.3 (0, Carom), 129.1 (1, 
2C, Carom), 128.4 (1, 2C, Carom), 126.9 (1, Carom), 98.9 (0, C6 ), 81.5 (1, CIO), 80.7 (1, C15), 7 3 . 2  (1, 
C13), 72.2 (1, C7), 70.8 (1, C2), 68.1 (1, br signal, C ll) , 57.1 (3, OMe), 48.0 (3, OMe), 45.2 (2, C18), 37.8 
(0, C14), 35.0 (1, C3 or C4), 34.9 (1, C3 or C4), 32.1 (2, Se-CH2 ), 31.0 (2, C5 or C12 or C16 or C17), 30.7 
(2, C5 or C12 or C16 or C17), 30.5 (2, C5 or C12 or C16 or C17), 25.9 (3, 3C, ^Bu-Si), 25.8 (3, C14-Me),
25.5 (2, C5 or C12 or C16 or C17), 19.3 (3, br signal, C14-Me), 18.4 (3, C2-Me), 18.0 (0, C-Si), 4.2 (3, C3- 
Me), -4 .4  (3, Me-Si), -5.1 (3, Me-Si); m/z (FAB, Nal) 878 (50), 876 [(M+Na)+, 100%], 874 (50), 720 (10), 
718 (15), 439 (10), 413 (10); Found : (M+Na)+ 876.3152. C4 2 Hg4 0 gNClSeSiNa requires M, 876.3153.
( S ) - B e n z o i c  a c i d  ( { [ ( 2 S  , 4 f i , 6 i f ) - 4 - ( t o 7 - b u t y l d i m e t h y l s i I a n y I o x y ) - 6 - ( 3 - c h I o r o p r o p y l ) - 5 , 5 - d i m e t h y l -  
t e t r a h y d r o - p y r a n - 2 - y l ] - ( / ? ) - m e t h o x y - i i i e t h y l } “ C a r b a m o y I ) - ( ( 2 j f î , 4 / ? , 5 / ? , 6 / î ) - 2 - m e t h o x y - 5 , 6 - d i m e t l i y I - 4 -  
p h e n y I s e I a n y I m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ) - m e t h y l  e s t e r  ( 7 . 8 b )
OM e O MeO
SePh
OBz
7.8b
C42H64CINOeSeSI 
Mol. Wl.: 853/^6
,OTBS
mp 92-94°C (hexanes/Et2 0 ); +56.0 (c 0.3, CHCI3 ); film/cm  ^ 3431, 3358, 3070, 2955, 2930,
2 8 5 6 ,  1729, 1697, 1508, 1473, 1451, 1270, 1071; 5^  (400 MHz, CDCI3 ): 8.11 (2H, dd, 7 8.5, 1.3, Harom), 
7.62 (IH, tt, 7 7.5, 1.0, Harom), 7.51-7.46 (4H, m, Harom), 7.29-7.24 (3H, m, Harom), 7.14 (IH, d, 7 9.6, 
NH), 5.73 (IH, s, C7-H), 5.16 (IH, dd, 7 9.6, 3.3, CIO-H), 3.86 (IH, dq, 7 6.5, 2.0, C2-H), 3.72 (IH, app q, 7
4.0, C ll-H ), 3.65 (IH, dd, 7  5.6, 3.6, C13-H), 3.45 (3H, s, OMe), 3.41 (3H, s, OMe), 3.37 (IH, dd, 7  11.4,
2.2, C15-H), 3.24 (IH, d d d ,  7  10.8, 7.5, 5.4, C18-H^Hb), 3.15 (IH, dt, 7  10.7, 6.0, C18-Ha% ), 2.87 (IH,
129
dd, J 11.9, 8.0, Se-CH^K^), 2.83 (IH, dd,7 12.1, 7.2, 2.39-2.23 (2H, m), 2.10-1.93 (3H, m),
1.87-1.42 (5H, m), 1.04 (3H, d, J 6.5, C2-Me), 0.98 (3H, s, C14-Me), 0.88 (9H, s, ^u-S i), 0.83 (3H, s, C14- 
Me), 0.70 (3H, d, J 6.9, C3-Me), 0.03 (3H, s, Si-Me), 0.02 (3H, s, Si-Me); (100 MHz, CDCI3 ): 166.9
(0), 164.8 (0), 133.6 (1, Carom), 132.7 (1, 2C, Carom), 130.3 (0, Carom), 129.9 (1, 2C, Carom), 129.2 (0, 
Carom), 129.1 (1, 2C, Carom), 128.6 (1, 2C, Carom), 126.9 (1, Carom), 98.9 (0, C6 ), 81.6 (1, CIO), 80.7 (1, 
C15), 73.1 (1, C7), 72.9 (1, C l3), 70.2 (1, C2), 68.3 (1, br signal, C ll) , 57.0 (3, OMe), 49.1 (3, OMe), 45.0 
(2, CIS), 37.8 (0, C14), 35.1 (1, C3 or C4), 34.9 (1, C3 or C4), 32.4 (2, Se-CHg), 31.2 (2, C5 or C12 or C16
or C17), 30.1 (2, C5 or C12 or C16 or C17), 29.7 (2, C5 or C12 or C16 or C17), 25.8 (3, 3C, %u-Si), 25.6 (3, 
C14-Me), 25.5 (2, C5 or C12 or C16 or C17), 19.5 (3, br signal, C14-Me), 18.1 (3, C2-Me), 17.9 (0, C-Si),
4.2 (3, C3-Me), -4 .4  (3, Me-Si), -5.1 (3, Me-Si); m/z (FAB, Nal) 878 (60), 876 [(M+Na)+, 100%], 874 
(50), 715 (15), 536 (10); Found : (M+Na)+ 876.3168. C 2^ H6 4 0 8 NClSeSiNa requires M, 876.3153
A - { [ ( 2 S , 4 / ? , 6 / ? ) - 4 - ( ^ e / ' A B u t y l d i m e t h y l s U y I o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ] -
( S ) - m e t h o x y - m e t h y I ) - 2 ~ ( ( 4 i S , 5 / î , 6 / î ) - 5 , 6 - d i m e t h y i - 4 - p h e n y l s e l a n y l m e t h y l - 5 , 6 - d i h y d r o - 4 / 7 - p y r a n - 2 - y l ) - 2 -  
o x o - a c e t a m i d e  ( 7 . 9 )
SnBuj,
SePh
2 3Cï6H4 4 0 SeSn 
Mol. W t: 570.30
MeO.
O MeO
7 SOziH^oCINOeSi 
M ol.W t; 466.08
OTBS
Cl
O MeO
.OTBS
laR i
7.9C a i Hs4CIN QjSeSI 
M ol.W t.: 715.29
To a solution of stannane 2 . 3  (430 mg, 0.754 mmol) in THF (5 ml) at -80  °C was added dropwise n-BuLi 
(330 |t1, 0.754 mmol, 2.29 M solution in hexane) and the bright yellow solution stirred while maintaining the 
temperature in between -75  and -80  °C for 15 min. TMEDA (114 p.1, 0.754 mmol) was added and after 10 
min at -  80 °C, a solution of ester 7 . 5  (135 mg, 0.290 mmol) in THF (2.5 ml) pre-cooled to -78"C, was 
quickly added using a wide bore cannula. The light yellow solution was allowed to gradually warm up to 
-40°C over 1 h and then poured into brine (5 ml) and extracted with CH2 CI2  (3 x 10 ml). The combined 
extracts were dried (Na2 S 0 ^) and concentrated in vacuo to give a yellow oil which was purified by 
chromatography (Si0 2 , PhMe and then 0-30% Et2 0  in hexanes) to give coupling product 7 . 9  (129 mg, 0.180 
mmol, 62% based on the right half fragment 7 . 5 )  as a colourless oil.
-26.7 (c 0.75, CHCI3 ); v^ax film/cm-^ 3319, 2930, 2857, 1668, 1505, 1472, 1384, 1255, 1073; Sjj 
(400 MHz, CDCI3 ): 7.49-7.45 (2H, m, Harom), 7.42 (IH, d, J 9.6, NH), 7.25-7.20 (3H, m, Harom), 7.05 (IH, 
br t, J 2 . 0 ,  C5-H), 5.14 (IH, dd, J 9.8, 6.5, CIO-H), 4.04 (IH, dq, J 6.5, 1.0, C2-H), 3.80 (IH, app q, J 5.6, 
C ll-H ), 3.50 (IH, dd, 7 8.1, 3.9, C13-H), 3.47-3.37 (2H, m (7 lines), CI8 -H2 ), 3.33 (3H, s, OMe), 3.14 (IH, 
d, J 9.7, C15-H), 2.93 (IH, d, J 14.0, Se-CT/^Hg), 2.91 (IH, d, J 13.8, Se-CHy^Tf^), 2.84-2.77 (IH, m, C4- 
H), 2.00-1.93 (IH, m, C3-H), 1.86-1.77 and 1.65-1.45 (6 H, 2 x m, CI2 -H2 , CI6 -H2  and CH-Hg), 1.32 (3H, 
d, J 6.5, C2-Me), 0.89 (3H, s, C14-Me), 0.86 (9H, s, ^Bu-Si), 0.80 (3H, s, C14-Me), 0.76 (3H, d, J 7.0, C3- 
Me), 0.004 (3H, s, Me-Si), 0.000 (3H, s, Me-Si); 8 ^ dOO MHz, CDCI3 ): 180.2 (0), 161.5 (0), 148.2 (0, C6 ),
133.0 (1, 2C, Carom), 129.2 (1, 2C, Carom), 129.2 (0, Carom), 127.3 (1, Carom), 124.2 ( 1 , C5), 80.5 (1, 
CIO), 79.8 (1, C15), 76.7 (1, C2), 72.7 (1, C13), 69.7 (1, C ll) , 56.6 (3, OMe), 45.4 (2, C l 8 ) ,  39.0 ( 1 ,  C4),
38.4 (0, C14), 3 3 . 2  (1, C3), 30.7 (2, C12 or C16 or C17), 29.7 (2, C12 or C16 or C17), 29.5 (2, S e - C H g ) ,  26.0 
(2, C12 or C16 or C17), 25.7 (3, 3C, ^Bu-Si), 24.7 (3, C14-Me), 18.1 (3, C2-Me), 18.0 (0, C-Si), 16.9 (3, 
C14-Me), 5.9 (3, C3-Me), -4.3 (3, Me-Si), -4 .4  (3, Me-Si); m/z (FAB, Nal) 743 (5), 742 (10), 741 (20), 740
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(50), 739 (45), 738 [(M+Na)+, 100%], 736 (50), 737 (25), 736 (55), 735 (20), 734 (15), 733 (5), 584 (4), 583
(6 ), 582 (18), 581 (16), 580 (32), 579 (2), 578 (2), 554 (20), 553 (10), 552 (40), 551 (10), 550 (25), 549 (10), 
548 (10); m/z (FAB, Nal) 738 [(M+Na)+, 100%], 736 (50), 552 (40), 550 (10), 394 (30), 231 (90); Found : 
(M+Na)+ 738.2476. Cg^Hg^OgSeSiClNa requires M, 738.2473.
( S ) -  B e n z o i c  a c i d  ( { [ ( 2 5 , 4 / ? , 6 i ? ) - 4 - ( ^ e / t - b u t y l d i n i e t h y l s i l y l o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i m e t h y l -
t e t r a h y d r o - p y r a n - 2 - y l ] - ( 5 ) - m e t h o x y - m e t l i y l } - c a r b a m o y l ) - ( ( 2 j [ î , 4 i î , 5 . K , 6 i î ) - 2 - m e t l i o x y - 5 , 6 - d i m e t h y l - 4 -  
p h e n y I s e l a n y l i n e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ) - m e t h y l  e s t e r  ( 7 . 1 0 a )  
a n d
( S ) - B e n z o i c  a c i d  ( { [ ( 2 5 , 4 7 ? , 6 / f ) - 4 - ( t e r t - b u t y l d i m e t h y l s i l y l o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i m e t h y l -
t e t r a h y d r o - p y r a n - 2 - y l ] - ( 5 ) - m e t h o x y - m e t h y l } - c a r b a m o y l ) - ( ( 2 j R , 4 i ? , 5 / î , 6 7 î ) - 2 - m e t h o x y - 5 , 6 - d i m e t h y l - 4 -  
p l i e n y l s e l a n y l m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ) - n i e t h y l  e s t e r  ( 7 . 1 0 b )
OMe 0  MeOOMe O MeO0M,(
,OTBS.OTBS ,OTBS
lePh OBz
SePh■SePh
7.9CsiHaCINOeSeSI 
Mol. W l; 7-15.29
7.10aC.,2 Ha,CINOflSeSI 
Mot.Wt.; 653.46
7 .10bC.gHg.CINOgSeSi 
Mol. Wl,: 853.46
To a solution of acyl dihydropyran 7 . 9  (35 mg, 48.9 |imol) in THF (3 ml) at -90  °C was added LiBH(j-Bu) 3
(0.125 ml, 1.0 M solution in THF, 0.125 mmol) over 10 min. After 10 min maintaining the temperature 
between -80 and -85°C, the mixture was treated with brine (1 ml) and extracted with CH2 CI2  ( 3 x 5  ml). The 
combined organic extracts were dried (Na2 S 0 .^ ) and concentrated iti vacuo to give the corresponding 
alcohols as a pale yellow oil. The crude alcohols were immediately dissolved in CH2 CI2  (2.5 ml) and MeOH
(0.25 ml). Camphorsulfonic acid (4.0 mg, 17 p.mol) was added and the solution stirred at rt for 1 h before 
another batch of camphorsulfonic acid (4.0 mg, 0.017 mmol) was added. After 1.5 h at rt solid K2 CO3  (16
mg, 0.11 mmol) was added slowly over 10 min. The reaction mixture was stirred for another 20 min and then 
poured onto saturated aqueous NaHC0 3  (2 ml) and extracted with CH2 CI2  ( 3 x 5  ml). The combined organic 
extracts were dried (Na2 S0 ^) and concentrated in vacuo, to give the diastereoisomeric acetals as a pale
yellow oil which were used immediately in the next step. A solution of benzoyl chloride (200 p i ,  1.71 mmol), 
DMAP (125 mg, 1.02 mmol), DIPEA (1.0 ml, 5.70 mmol) and 4Â MS (5) was prepared in CH2 CI2  (19 ml).
To the crude acetal alcohols was added 2 ml of the above solution and the reaction mixture was stirred at rt 
for 15 h before MeOH was added (1 ml). After 20 min the mixture was poured into brine (2 ml) and extracted 
with CH2 CI2  ( 3 x 5  ml). The combined organic extracts were dried (Na2 S0 q) and concentrated in vacuo. The 
residue was purified by column chromatography (Si0 2 , PhMe and then 0-30% Et2 Ü in hexanes) to give 
7 . 1 0 a  (25.1 mg, 29.4 pmol, 60% over 3 steps) and 7 . 1 0 b  (6.3 mg, 7.4 pmol, 15%). The diastereomeric ratio 
between 7 . 1 0 a  and 7 . 1 0 b  is dr = 4:1).
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( S ) - B e n z o i c  a c i d  ( { [ ( 2 S  , 4 / f , 6 / ï ) - 4 - ( ^ e / ’^ - b u t y l d i m e t h y l s i l y I o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i m e t h y l -  
t e t r a h y d r o - p y r a n - 2 - y l ] - ( 5 ) - m e t h o x y - m e t l i y l } - c a r b a n i o y l ) - ( ( 2 7 ? , 4 7 f , 5 / ? , 6 i ? ) - 2 “m e t h o x y “5 , 6 " d i m e t h y l " 4 -  
p h e n y l s e l a i i y l m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ) - r a e t h y l  e s t e r  ( 7 . 1 0 a )
OMe 0  MeO
OTBS
^ S e P h
7 .1 0 a
C4 2 HQ4O  NOgSeSi 
Mol. Wt.; 853.46
[a lla is +(50.0 (c 1.2, CHCI3 ); film/cm-1 3431, 3359, 3070, 2955, 2930, 2856, 1730, 1697, 1508,
1472, 1451, 1269, 1097, 1071; 6 ^  (400 MHz, CDCI3 ): 8.08 (2H, dd, J 8.4, 1.3, Harom), 7.60 (IH, tt, 77.5,
1.2, Harom), 7.52-7.44 (4H, m, Harom), 7.29-7.21 (3H, m, Harom), 6.81 (IH, d, J 9.6, NH), 5.57 (IH, s, C7- 
H), 5.26 (IH, dd, J 9.6, 5.6, CIO-H), 3.93 (IH, dq, J 6.4, 2.1, C2-H), 3.81 (IH, app q, J 5.4, C ll-H ), 3.55-
3.50 (3H, m, C13-H and CI8 -H2 ), 3.42 (3H, s, OMe), 3.30 (IH, dd, J  10.5, 2.0, C15-H), 3.25 (3H, s, OMe),
2.92 (IH, dd, J 12.0, 6.5, Se-CH^Hg), 2.84 (IH, dd, J 12.0, 9.3, S e-C H ^ ^ ), 2.38-2.27 (IH, m, C4-H), 2.00 
(IH, dd, J 13.6, 3.6, C5-7/^Hg), 1.94-1.81 (3H, m), 1.72 (IH, t , /  13.3, C5-H^% ), 1.69-1.48 (4H, m),1.17 
(3H, d, J 6 .6 , C2-Me), 0.90 (9H, s, ^Bu-Si), 0.822 (3H, s, C14-Me), 0.818 (3H, s, C14-Me), 0.77 (3H, d, J
7.0, C3-Me), 0.04 (6 H, s, Si-Me2 ); 5^ (100 MHz, CDCI3 ): 167.6 (0), 165.2 (0), 133.5 (1, Carom), 132.5 (1, 
2C, Carom), 130.3 (0, Carom), 130.0 (1, 2C, Carom), 129.1 (0, Carom), 129.0 (1, 2C, Carom), 128.5 (1, 2C, 
Carom), 126.8 (1, Carom), 98.6 (0, C6 ), 80.6 (1, CIO), 79.7 (1, C15), 73.0 (1, C13), 72.7 (1, C7), 70.6 (1, 
C2), 69.9 (1, br signal, C ll) , 56.3 (3, OMe), 48.5 (3, OMe), 45.6 (2, C I S ) ,  38.2 (0, C14), 35.1 (1, C4), 34.9 
(1, C3), 32.0 (2, Se-CH2 ), 30.9 (2, C5), 30.8 (2, C12 or C16 or C17), 29.7 (2, C12 or C16 or C17), 26.1 (2,
C12 or C16 or C17), 25.8 (3, 3C, ^Bu-Sl), 24.9 (3, C14-Me), 18.3 (3, C2-Me), 17.9 (0, C-Si), 17.2 (3, br 
signal, C14-Me), 4.3 (3, C3-Me), -4 .5  (3, Me-Si), -5 .0  (3, Me-Si); m/z (FAB, Nal) 878 (60), 876 
[(M+Na)+, 100%], 874 (50), 792 (15), 790 (30), 788 (16), 660 (10), 658 (20), 656 (10), 538 (30), 536 (70), 
534 (35); Found : (M+Na)+ 876.3155. C4 2 Hg4 0 gNClSeSiNa requires M, 876.3153
( / Î ) -  B e n z o i c  a c i d  ( { [ ( 2 5 , 4 ; R , 6 j ( ) - 4 - ( t e / t - b u t y I d i m e t h y l s i l y l o x y ) - 6 - ( 3 - c h l o r o p r o p y l ) - 5 , 5 - d i m e t h y l -  
t e t r a h y d r o - p y r a n - 2 - y l ] - ( 5 ) - m e t h o x y - m e t h y l } - c a r b a n i o y l ) - ( ( 2 7 ? , 4 j ? , 5 j R , 6 / ? ) - 2 - m e t h o x y - 5 , 6 - d i m e t h y l - 4 -  
p b e n y l s e l a i i y l m e t l i y l - t e t r a h y d r o - p y r a n - 2 - y I ) - m e t h y l  e s t e r  ( 7 . 1 0 b )
OM e O MeO
,OTBS
OBz
■SePh
7.10b
C42 HG4CI NOgSeSf 
Mot. WL: 853,46
[aJo^O +64.0 {c 0.3, CHCI3 ); füm/cm-l 3431, 3358, 3070, 2955, 2930, 2856, 1729, 1697, 1508,
1473, 1451, 1270, 1071; 6 jj (400 MHz, CDCI3 ): 8.10 (2H, dd, J  7.2, 1.2, Harom), 7.61 (IH, tt, J 7.2, 1.2, 
Harom), 7.50-7.44 (4H, m, Harom), 7.27-7.23 (3H, m, Harom), 7.17 (IH, d, J9 .5 , NH), 5.58 (IH, s, C7-H),
5.20 (IH, dd, J  9.5, 5.3, CIO-H), 3.93 (IH, dq, J 6.5, 2.0, C2-H), 3.83-3.80 (IH, m, C ll-H ), 3.56-3.53 (3H, 
m, C13-H and ClS-Hg), 3.43 (3H, s, OMe), 3.41 (3H, s, OMe), 3.29-3.22 (IH, d, J 9.9, C15-H), 2.87 (IH, 
dd, J 12.0, 8.2, Se-CT/^Hg), 2.83 (IH, dd, J 12.0, 7.3, Se-CH^% ), 2.32-2.23 (IH, m, C4-H), 2.02-1.80 (4H,
m), 1.80-1.55 (5H, m), 1.11 (3H, d, J 6.5, C2-Me), 1.00 (3H, s, C14-Me), 0.91 (9H, s, ^Bu-Si), 0.89 (3H, s.
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C14-Me), 0.76 (3H, d, J 7.0, C3-Me), 0.04 (6 H, s, Si-Mej); 5^ (100 MHz, CDCI3 ): 167.4 (0), 165.2 (0),
133.4 (1, Carom), 132.5 (1, 2C, Carom), 130.2 (0, Carom), 129.9 (1, 2C, Carom), 129.4 (0, Carom), 129.1 (1, 
2C, Carom), 128.5 (1, 2C, Carom), 126.9 (1, Carom), 99.1 (0, C6 ), 80.7 (1, CIO), 80.1 (1, C15), 73.6 (1, C7),
72.9 (1, C13), 70.6 (1, C2), 70.4 (1, br signal, Cl l ) ,  56.8 (3, OMe), 49.5 (3, OMe), 45.7 (2, C18), 38.1 (0, 
C14), 35.1 (1, C3 or C4), 35.0 (1, C3 or C4), 32.2 (2, Se-CHj), 31.1 (2, C5 or C12 or C16 or C17), 30.5 (2,
C5 or C12 or C16 or C17), 29.9 (2, C5 or C12 or C16 or C17), 29.7 (2, C5 or C12 or C16 or C17), 25.8 (3, 
4C, ^Bu-Si and C14-Me), 25.3 (3, C14-Me), 18.1 (3, C2-Me), 18.0 (0, C-Si), 4.2 (3, C3-Me), -4.5 (3, Me-Si), 
-5 .0  (3, Me-Si); m/z (FAB, Nal) 878 (60). 876 [(M+Na)+, 100%], 874 (50), 792 (15), 790 (30), 788 (16), 
660 (10), 658 (20), 656 (10), 538 (30), 536 (70), 534 (35); Found ; (M+Na)+ 876,3159. 
C4 2 H6 4 0 gNClSeSiNa requires M, 876.3153
A - { [ ( ( 2 S , 4 7 ? , 6 M : ) - 6 - ( 3 - C h l o r o p r o p y I ) - 4 - h y d r o x y - 5 , 5 - d i m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ] - ( 5 ' ) - m e t h o x y -  
m e t l i y l } - ( 2 S ) - 2 - h y d r o x y - 2 - ( ( 2 5 , 5 / ï , 6 / ? ) - , 2 - m e t h o x y - 5 , 6 - d i i i i e t h y l - 4 - m e t h y l e n e - t e t r a l i y d r o - p y r a n - 2 - y l ) -  
a c e t a n i i d e  ( 2 . 8 )
OMe o MeO OMe 0  MeO
.OH,OTBS
)Bz
■SePh 7.10aC«Hs4CIN0 8 SeSi 
Mol. W .; 853.46
C23H4C/CIN07 
Mol. W t: 478.02
Sodium periodate (24 mg, 0.112 mmol) was added in one portion to a solution of the diastereoisomerically 
pure selenide 7.10a (11 mg, 12.9 jimol) in MeOH/H2 0 /CH2 Cl  ^(3:1:1, 3.5 ml). After 30 min the mixture was 
diluted with Et2 0  (5 ml) and EtgN (0.5 ml) and washed with H2 O ( 3 x 2  ml), dried (Na2 SÛ4 ) and 
concentrated in vacuo to give the selenoxide as a colourless oil which was dissolved in toluene (2.4 ml) 
whereupon EtgN (2.4 ml, 17.2 |0 .mol) was added. After refluxing for 2 min, the bright yellow reaction 
mixture was poured into saturated aqueous NaHCOg (3 ml) and extraeted with Et2 0  ( 3 x 3  ml). The organic 
extracts were dried (Na2 SÛ4 ) and concentrated in vacuo to give a pale yellow oil which was dissolved in
MeOH (3 ml) to which was added aqueous LiOH (0.3 ml, 1.0 M, 0.3 mmol). After 30 min at rt the mixture 
was concentrated, the residue was dissolved in Et2 Û (5 ml), washed with H2 O ( 2 x 2  ml) and brine (2 ml), 
dried (Na2 SÜ 4 ), and concentrated in vacuo to give a yellow oil which was used immediately in the next step. 
To a solution of the crude residue in THF (1 ml) was added TBAF«3 H2 Ü (17 mg, 53.9 p.mol) and 4Â MS (5). 
After 15 h at rt the reaction mixture was diluted with Et2 Ü (5 ml) and washed with saturated aqueous 
NaHCOg (3 ml). The aqueous phase was extracted with CH2 CI2  ( 3 x 3  ml) and the combined organic layers 
dried (Na2 S0 4 ) and concentrated in vacuo to give a yellow oil which was purified by column 
chromatography on silica gel (1 g) eluting with PhMe:hexanes:Et2 0 :Et0 Ac:NEtg (100:0:0:0:1 then 
0:100:0:0:1-» 0:0:100:0:1 -»  0:0:50:50:1) to give C18-chloride-pederin-analogue 2.8 (4.1 mg, 8.58 nmol, 
67% over 4 steps).
+40 (c 0.3, CgDg); Vj^ x^ filni/cm-1 3477, 3392, 2935, 2367, 1685, 1500, 1114, 1092; 5^ (400 
MHz, CgDg): 7.44 (IH, d, J 7.8, NH), 5.26 (IH, t, J 8.2, ClOH), 4.77 (IH, t, J 1.9, =CH^Hg), 4.71 (IH, t,7
2.0, ^CH^Hg), 4.03 (IH, s, C7H), 3.87-3.81 (2H, m, C2H and C llH ), 3.60-3.53 (IH, m, C18^^Hg), 3.56 
(3H, s, OMe), 3.24-3.16 (IH, m, C13H), 3.20 (3H, s, OMe), 2.82-2.73 (3H, m, C5-H^Hg, C15H and C18- 
Ha-^5 ), 2.42 (IH, d, J 14.1, Cg.H^Hg), 1.94 (IH, dq, 77.0, 2.4, C3H), 1.86-1.67 (3H, m), 1.56-1.44 (IH, 
m), 1.32-1.22 (2H, m), 1.00 (3H, d, 76.5, C2Me), 0.98 (3H, d, 7 7.0, C3Me), 0.80 (3H, s, C14Me), 0.62 (3H, 
s, C14-Me), 0.20 (2H, br s, 2 x OH); 5^ (90 MHz, CgDg): 171.8 (0, C=0), 145.8 (0, C4), 108.5 (2, = 0% ),
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98.2 (0, C6 ), 83.6 (1, C7), 78.9 (1, CIO), 73.0 (1, C15), 72.3 (1, C2 or Cl l ) ,  70.9 (1, C13), 68.0 (1, C2 or 
C ll) , 67.1 (2, C18), 55.5 (3, OMe), 47.7 (3, OMe), 40.6 (1, C3), 37.4 (0, C14), 33.4 (2, C5), 30.0 (2, C12 or 
C16 or C17), 24.3 (2, C12 or C16 or C17), 23.8 (2, C12 or C16 or C17), 20.9 (3, C14-Me), 16.6 (3, C2~Me),
10.6 (3, 2C, C3-Me and C14-Me); m/z (FAB mode) 464 [(M-HCl+Na)+, 100%]; Found: (M-HCl+Na)+, 
464.2621. C23HggN0-yNa requires M, 464.2624.
i V - { [ ( 2 5 , 4 / ? , 6 / ? ) - 6 - ( 3 - C h l o r o - p r o p y l ) - 4 - h y d r o x y - 5 , 5 - d i m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ] - ( S ) - m e t h o x y -
m e t h y l } - ( 5 ) - 2 - h y d r o x y - 2 - ( ( 2 S , 4 / ? S , 5 / î , 6 i ? ) - 2 - m e t h o x y - 4 , 5 , 6 - t r i i i i e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ) - a c e t a m i d e
( 2 . 9 )
^  OMe o MeO ^
2.8CzsH^cPINO? 
Mol. W t: 476.02
OMe o  MeO
2.9CasKtiCINO? 
Mol. W l : 480.03
Adams catalyst (PtO^.xH^O, 4.0 mg) was added to a solution of olefin 2.8 (3.0 mg, 6.27 /traol) in fresly
distilled benzene (3 ml). Gaseous hydrogen was bubbled into the solution for 5 min until giving a black 
suspension which was stirred under H2  atmosphere at room temperature for 3 days. The reaction was 
monitored by NMR (360 Mhz, CgDg) spectroscopy by observing the disappearance and appearance of 
the following signals :
Disappearance of :
4.77 (IH, t, J1.9, =C//^Hb) 
4.71 (IH, t, 7 2.0, =CHA%))
3.56 (3H, s, OMe)
3.20 (3H, s, OMe)
2.42 (IH, d, J14.1,C 5 Ha/ / b)
Appearance
3.58 (3H, s, OMe) of major diastereomer
3.23 (3H, s, OMe) of major diastereomer
3.57 (3H, s, OMe) of minor diastereomer
3.29 (3H, s, OMe) of minor diastereomer
After 3 d, the reaction mixture was filtered through celite and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel ( 1  g) eluting with Et2 0 :EtOAc ( 1 :1 ) to give a mixture of the 
two diastereomers in the ratio 7:3 (3,0 mg, 6.25 /imol, 99%),. The diastereomeric ratio was determined by 
integration of the signal derived from C7-H (IH, s) at 5 = 3.96 ppm (major) and 4.02 ppm (minor).
film/cm-1 3469, 3392, 2930, 1726, 1688, 1501, 1459, 1272, 1119, 1087, 582.
The ^H NMR spectroscopic data is described bellow without the integration, or assignment using the 
abréviations Ma for major diastereoisomer, mi for minor diastereoisomer.
ÔH (400 MHz, C^Dg): 7.45 (d, J 7.6, NH, Ma+mi), 5.28-5.22 (m, ClOH, Ma+mi), 4.30-4.16 (m), 4.02 (s, 
C7H, mi), 3.96 (s, C7H, Ma), 3.93-3.82 (m), 3.73-3.69 (m)3.58 (3H, s, OMe, Ma), 3.57 (3H, s, OMe, mi),
3.29 (3H, s, OMe, mi), 3.23 (3H, s, OMe, Ma), 3.26-3.15 (m), 2.83-2.74 (m), 2.10-2.05 (app dd), 1.90-1.62 
(m), 1.53-1.45 (m), 1.35-1.20 (m), 1.14 (app d, Me), 1.03 (app d. Me), 0.90 (app d, Me), 0.79 (app s. Me), 
0.72 (app dd, mi), 0.61 (s. Me, Ma).
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The NMR spectroscopy data is described bellow using the abréviations B for big signals, s for small 
signals.
ÔC (90 MHz, CgDg): 172.00 (B), 166.23 (s), 98.29 (B), 97.57 (s), 84.31 (B), 84.37 (s), 78.92 (B), 78.86 (s),
73.00 (B), 73.0 (s), 72.33 (B), 72.28 (s), 70.90 (B), 69.11 (s), 66.99 (B), 66.95 (s), 6 6 . 6 8  (s), 62.61 (B), 55.58 
(B), 55.49 (s), 47.07 (B), 47.61 (s), 37.43 (B), 37.84 (s), 36.46 (B), 36.00 (s), 31.67 (B), 31.10 (s), 30.01 (B),
30.01 (s), 29.46 (B), 29.11 (s), 29.04 (B), 28.87 (s), 28.34 (s), 27.94 (s), 24.33 (B), 24.30 (s), 23.86 (B), 22.79 
(s), 22.00 (s), 20.84 (B), 19.78 (B), 18.02 (s), 17.19 (s), 17.09 (B), 14.16 (s), 12.92 (s), 11.81 (B), 10.57 (s), 
9.81 (s)
m/z (FAB, Nal) 469 (10), 468 (15), 467 (25), 466 [(M-HCI+Na)+, 100%], 464 (8 ), 434 (10), 415 (5), 414 
(27), 413 (100), 411 (5).
Found: (M-HCl+Na)+ 466.2782. C23H^iN0yNa requires M, 466.2781.
( S ) - B e n z o i c  a c i d  ( { [ ( 2 S , 4 / î , 6 J ? ) - 6 - ( 3 - b e n z o y l p r o p y l ) " 4 - ( ï ^ r t - b u t y l d i m e t h y l s i l y l o x y ) - 5 , 5 - d i m e t h y l -  
t e t r a h y d r o - p y r a n - 2 - y l ] - ( 5 ) - m e t h o x y - n i e t l i y l } - c a r b a m o y l ) - ( ( 2 / ? , 4 R , 5 j R , 6 j i ? ) - 2 - m e t h o x y - 5 , 6 - d i m e t h y l - 4 -  
p I i e n y l s e l a n y I n i e t h y l - t e t r a h y d r o - p y r a i i - 2 - y l ) - m e t h y l  e s t e r  ( 7 . 1 1 )
.OTBS.OTBS
OBz OBz
SePh SePh
C4 gHe 4Ci NO f)S eS i 
Mol. Wt.: 853.46
OM e MelOMe Mel
.OTBS.OTBS
OBzOBz
SePhSeP h NH.7 .1 1
OM e O MeiOMe O Mei
7.12
C42 Hg, N^OgSe Si 
(vbI.WI.: 850,03
7.13
0/fz Hcg N2O oSe Si 
Mol. Wt.: 834 03
C49HtoN2 C1)SgSI 
Mol. Wt: 933.13
F o r m a t i o n  o f  a z i d e
Sodium azide (20 mg, 0.308 mmol) was added to the chloride 7 . 1 0 a  (23.0 mg, 26.9 pmol) in DMF (1 ml) and 
the mixture was refluxed for 2 min. Although the reaction could not be followed by TLC (azide product and 
starting chloride have the same rf), the reaction mixture was concentrated in vacuo using a water bath at 50°C
for 5 min and completion of the reaction was confirmed by NMR spectroscopy on the residue. The 
residue was then dissolved in CH2 CI2  (3 x 1 ml) and filtered through cotton plug. The filtrate was then 
concentrated in vacuo and the corresponding azide 7 . 1 2  was used immediately in the following step.
R e d u c t i o n  o f  a z i d e  t o  a m i n e  ;
To the crude azide 7 . 1 2  in THF (0.5 ml) was added triphenylphosphine (40 mg, 0.153 mmol) at rt. After 12 h, 
water (0.05 ml, 28 mmol) was added and the reaction mixture was stirred at rt for another 18 h. The reaction 
mixture was then diluted with CH2 CI2  (3 ml), dried (Na2 S0 4 ) and then concentrated in vacuo to give the
corresponding crude amine 7 . 1 3  as a pale yellow oil.
A c y l a t i o n  o f  t h e  a m i n e .
A solution of benzoyl chloride (30 p.1, 0.26 mmol), pyridine (41 p.1, 0.52 mmol) in CH2 CI2  (5 ml) at 0°C was 
prepared. To the crude amine 7 . 1 3 ,  0.5 ml of the above solution was added and the reaction mixture was
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allowed to stir at 0°C for 3 h, before MeOH (0.5 ml) was added. After 10 min, PhMe (2 ml) was added and 
CH2 CI2  was removed by quick distillation in vacuo. The residue was purified by column chromatography 
(Si0 2 , PhMe:hexanes:Et2 Ü;NEt3  100:0:0:1 —> 0:100:0:1 0:50:50:1) to give benzamide 7 . 1 1  (19.7 mg,
0.021 mmol, 78% over 3 steps).
( 5 ) - B e n z o i c  a c i d  ( { [ ( 2 5  , 4 i î , 6 / î ) - 6 - ( 3 - a z i d o p r o p y I ) - 4 - ( ^ e / ^ b u t y l d i m e t h y I s i I y l o x y ) - 5 , 5 - d i m e t h y l -  
t e t r a h y d r o - p y r a n - 2 - y l ] - ( S ) - m e t h o x y - m e t h y l } - c a r b a m o y l ) - ( ( 2 J Î , 4 7 ? , 5 7 f , 6 i ? ) - 2 - m e t h o x y - 5 , 6 - d i m e t h y l - 4 -  
p h e n y l s e i a n y I m e t h y I - t e t r a l i y d r o - p y r a n - 2 - y l ) - m e t h y l  e s t e r  ( 7 . 1 2 )
OM e 0  M0 Os ^ O  = II 1 H .O T B S
OBz ^  0 ^ V
SePh
7 .1 2
C4aH64N4C^SeSi
Mol. Wl: 860.03
NMR and NMR of the crude azide 7 . 1 2  still containing a little amount of DMF is reported here and 
structural assignments was deduced from the chloride 7 . 1 0 a  assignments.
ÔH (360 MHz, CDCI3 ): 8.08 (2H, dd, J 8.2, 1.1, Harom), 7.61 (IH, tt, J 7.3, 1.3, Harom), 7.51-7.45 (4H, m, 
Harom), 7.31-7.22 (3H, m, Harom), 6.81 (IH, d, J 9.7, NH), 5.56 (IH, s, C7-H), 5.25 (IH, dd, J 9.7, 5.1, 
CIO-H), 3.92 (IH, dq, J 6 .6 , 2.1, C2-H), 3.84 (IH, app q, J 5.6, C ll-H ), 3 . 5 2  (IH, dd, J 7.4, 3.6, C13-H),
3.41 (3H, s, OMe), 3.30-3.23 (3H, m, C I8 -H2  and C15-H), 3.25 (3H, s, OMe), 2.92 (IH, dd, J 12.2, 6 .6 , Se- 
C//^Hb), 2.83 (IH, dd,7 12.1, 9.3, Se-CHy^7/g), 2.38-2.27 (IH, m, C4-H), 2.00 (IH, dd, J 13.5, 3.6, C5- 
H^Hg), 1.87-1.39 (8 H, m), 1.15 (3H, d, 7 6 .6 , C2-Me), 0.90 (9H, s, ^Bu-Si), 0.81 (3H, s, C14-Me), 0.80 (3H, 
s, C14-Me), 0.76 (3H, d, J  7.0, C3-Me), 0.03 (6 H, s, Si-Me^); 6 ^ (100 MHz, CDCI3 ): 167.6 (0), 165.2 (0),
133.5 (1, Carom), 132.5 (1, 2C, Carom), 131.5 (0, Carom), 130.3 (1, 2C, Carom), 129.2 (0, Carom), 129.1 (1, 
2C, Carom), 128.5 (1, 2C, Carom), 126.8 (1, Carom), 98.8 (0, C6 ), 80.7 (1, CIO), 79.9 (1, C15), 73.2 (1, 
C13), 72.7 (1, C l), 70.6 (1, C2), 69.7 (1, br signal, Cl l ) ,  56.3 (3, OMe), 51.7 (2, C l 8 ), 48.5 (3, OMe), 38.2 
(0, C14), 35.1 (1, C4), 34.9 (1, C3), 32.0 (2, Se-CH^), 30.9 (2, C5), 30.8 (2 , C12 or C16 or C17), 29.7 (2, 
C12 or C16 or C17), 26.1 (2, C12 or C16 or C17), 25.9 (3, C14-Me), 25.8 (3, 3C, ^Bu-Si), 18.3 (3, C2-Me),
17.9 (0, C-Si), 17.7 (3, C14-Me), 4.3 (3, C3-Me), -4.5 (3, Me-Si), -5 .0  (3, Me-Si).
( 5 )  - B e n z o i c  a c i d  (  { [  (  2 5 , 4 / ( , 6 / ( ) - 6 - ( 3 - a m i n o p r o p y l ) - 4 - ( i ( e / 7 - b n t y l d i m e t h y l s i I y i o x y ) - 5 , 5 - d i m e t h y i -
t e t r a h y d r o - p y r a n - 2 - y l ] - ( 5 ) - m e t h o x y - m e t h y l ] - c a r b a m o y l ) - ( ( 2 / f , 4 f ? , 5 i ? , 6 i î ! ) - 2 - m e t l i o x y - 5 , 6 - d i m e t h y l - 4 -  
p h e i i y I s e l a n y I m e t h y l - t e t r a h y d r o - p y r a n - 2 - y l ) - r a e t h y l  e s t e r  ( 7 . 1 3 )
OMe Q Mel
SePh
OBz
.OTBS
NH.
Data of the amine were obtained on a previous experiment on a 26.9 jimol scale of the chloride 7 . 1 0 a ,  from 
which the amine was isolated and purified by column chromatography (Si0 2 , 0-25% MeOH in CH2 CI2 ) to
give the amine (14 mg, 16.8 p,mol, 63%) as a colourless oil.
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M g  +50.0 (c 1.4, CHCI3 ); fili-n/cm-l 3350, 2955, 2925, 2854, 1729, 1697, 1508, 1460, 1270,
1094; Sjj (400 MHz, CDCI3 ): 8.06 (2H, dd, J 8.4, 1.2, Harom), 7.60 (IH, tt, J 7.4, 1.1, Harom), 7.52-7.44 
(4H, m, Harom), 7.29-7.21 (3H, m, Harom), 7.01 (IH, br d, J 9.4, NH), 5.59 (IH, s, C7-H), 5.25 (IH, dd, J
9.5, 5.2, CIO-H), 3.91 (IH, dq, J  6 .6 , 2.1, C2-H), 3.87 (IH, app q, J  5.0, C ll-H ), 3.52 (IH, dd, J 7.4, 3.6, 
C13-H), 3.45-3.39 (IH, m collapsed by OMe, C15-H or 3.43 (3H, s, OMe), 3.30-3.24 (2H, ra),
3.27 (3H, s, OMe), 2.92 (IH, dd, J  12.0, 6.4, Se-CH^Hg), 2.84 (IH, dd, J 12.0, 9.2, Se-CR^H^), 2.77-2.40 
(2H, br signal, NH2 ), 2.36-2.26 (IH, m, C4-H), 2.00 (IH, dd, J 13.7, 3.8, C5-//^Hg), 1.90-1.35 (8 H, m), 1.16
(3H, d, J 6.5, C2-Me), 0.90 (9H, s, ^Bu-Si), 0.83 (3H, s, C14-Me), 0.80 (3H, s, C14-Me), 0.76 (3H, d, J 7.0, 
C3-Me), 0.04 (6 H, s, Si-Mej); 5^ (100 MHz, CDCI3 ): 167.8 ( 0 ) ,  165.2 (0), 133.6 (1, Carom), 132.5 (1, 2C,
Carom), 130.4 (0, Carom), 130.0 (1, 2C, Carom), 129.1 (0, Carom), 129.0 (1, 2C, Carom), 128.6 (1, 2C, 
Carom), 126.8 (1, Carom), 98.9 (0, C6 ), 80.7 (1, CIO), 80.4 (1, C15), 73.4 (1, C7), 72.8 (1, C13), 70.5 ( 1 , 
C2), 69.6 (1, br signal, C ll) , 56.3 (3, OMe), 48.6 (3, OMe), 41.6 (2, CIS), 38.2 (0, C14), 35.2 (1, C4), 34.9 
(1, C3), 32.1 (2, Se-CH2 ), 30.9 (2, C5), 30.8 (2, C12 or C16 or C17), 29.7 (2, C12 or C16 or C17), 29.3 (2, 
C12 or C16 or C17), 25.8 (3, 3C, ^Bu-Si), 22.7 (3, C14-Me), 18.4 (3, C2-Me), 18.0 (0, C-Si), 14.1 (3, C14- 
Me), 4.3 (3, C3-Me), -4 .5  (3, Me-Si), -5 .0  (3, Me-Si); m/z (FAB mode) 835 [(M+H)+, 100%], 833 (60), 
770 (50), 530 (20), 442; Found : (M+H)+ 835.3834. C4 2 H5 7 0 gN2 SiSe requires M, 835.3832.
( S ) - B e n z o i c  a c i d  ( { [ ( 2 S , 4 / ? , 6 J Ï ) - 6 - ( 3 - b e n z o y I p r o p y i ) " 4 - ( f e r A b u t y l d i m e t h y I s i l y l o x y ) - 5 , 5 - d i m e t l i y l -  
t e t r a l i y d r o - p y r a i î - 2 - y l ] - ( S ) - m e t h o x y - m e t h y l } - c a r b a m o y l ) - ( ( 2 i î , 4 i ? , 5 / î , 6 i î ) - 2 - m e t l i o x y - 5 , 6 - d i m e t h y l - 4 -  
p h e n y I s e I a n y l m e t h y l - t e t r a h y d r o - p y r a n - 2 -  
y l ) - m e t h y l  e s t e r  ( 7 . 1 1 )
_  OM e 0  MeOV  ' + A  1 'j+ OTBS
4 4 Ï B Z  H T V 0
^ S e P h  I7.11 ^ - ' ^ N ^ P hC^gHToNaOgSeSI H
Mol. Wl.: 938.13
[a]g23 +64.0 (c 0.5, CHCI3 ); füm/cm-l 3368, 2955, 2929, 2856, 1735, 1726, 1701, 1696, 1686,
1655, 1648, 1508, 1500, 1490, 1476, 1466, 1459, 1450, 1438, 1271, 1096, 1072, 585, 576; Ôg (400 MHz, 
CDCI3 ): 8.03 (2H, dd, J 7.2, 1.1, Harom), 7.84 (2H, dd, J7.1, 1.3, Harom), 7.60 (IH, t, 7 7.4, Harom), 7.50-
7.43 (5H, m, Harom), 7.39 (2H, t, J 7.3, Harom), 7.30-7.21 (3H, m, Harom), 6 . 8 8  (IH, t, 7, 4.4, C18-NH),
6.70 (IH, d, J 9.7, N9-H), 5.57 (IH, s, C7-H), 5.32 (IH, dd, J  9.6, 6.0, CIO-H), 3.89 (IH, dq, 7 7.0, 2.1, C2- 
H), 3.84 (IH, app q, 7 5.0, C ll-H ), 3.52-3.26 (4H, m, C13-H, C15-H, C18-H2), 3.41 (3H, s, OMe), 3.24 (3H, 
s, OMe), 2.87 (IH, dd, 7 12.0, 6 .8 , Se-C//^Hg), 2.81 (IH, dd, 7 12.0, 9.0, Se-CH^T/^), 2.34-2.25 (IH, m, 
C4-H), 2.00 (IH, dd, 7 13.5, 3.6, C5-H^Hg), 1.91-1.42 (8 H, m, C3-H, C5-H^//g, C12-H2, C16-H2, C17-
H2), 1.15 (3H, d, 7 6 .6 , C2-Me), 0.87 (9H, s, ^Bu-Si), 0.82 (3H, s, C14-Me), 0.80 (3H, s, C14-Me), 0.74 (3H, 
d, 7 7.0, C3-Me), 0.030 (3H, s, Si-Me), 0.028 (3H, s, Si-Me); (90 MHz, CDCI3 ); 167.7 (0), 167.4 (0),
165.3 (0), 134.9 (0, Carom), 133.8 ( 1 , Carom), 132.5 (1, 2C, Carom), 131.0 (1, Carom) 130.3 (0, Carom),
129.9 (1, 2C, Carom), 129.0 (0, 2C, Carom), 128.8 (0, Carom), 128.6 (1, 2C, Carom), 128.3 (1, 2C, Carom),
127.0 (1, 2C, Carom), 126.8 (1, Carom), 98.8 (0, C6 ), 80.2 (1, 2C, br signal, CIO and C13 or C15), 73.8 (1, 
C l), 72.6 (1, C13 or C15), 70.6 (1, C2), 70.4 (1, br signal, Cl l ) ,  56.3 (3, OMe), 48.7 (3, OMe), 40.1 (2, 
CIS), 38.4 (0, C14), 35.2 (1, C4), 34.9 (1, C3), 32.0 (2, Se-CH^), 31.0 (2, C5), 30.7 (2 , C12 or C16 or C17),
26.4 (2, C12 or C16 or C17), 26.0 (2, C12 or C16 or C17), 25.7 (3, 3C, ^Bu-Si), 24.7 (3, br signal, C14-Me),
18.3 (3, C2-Me), 17.93 (3, C14-Me), 17.84 (0, C-Si), 4.2 (3, C3-Me), -4 .5  (3, Me-Si), -5 .0  (3, Me-Si); m/z 
(FAB, Nal) 965 (5), 964 (15), 963 (40), 962 (55), 961 [(M+Na)+, 100%], 960 (35), 959 (55), 958 (25), 957
137
(20), 804 (20), 803 (50), 802 (100); Found : (M+Na)+ 961.3929. QgH-yoOgN2 SiSeNa requires M, 
931.3920.
N - [ 3 - ( ( 2 7 f , 4 1 ? , 6 5 ) - 4 - H y d r o x y - 6 - { [ ( 2 5 ) - 2 - h y d r o x y - 2 - ( ( 2 i R , 5 / ü , 6 7 ? ) - 2 - m e t h o x y - 5 , 6 - d i m e t h y l - 4 - m e t h y I e i i e -  
t e t r a h y d r o - p y r a n - 2 - y l ) - a c e t y l a m i n o ] - ( S ) - m e t h o x y “ m e t h y l } - 3 , 3 - d i m e t h y l - t e t r a h y d r o - p y r a n ”2 - y l >  
p r o p y l j - b e n z a m i d e  ( 2 . 1 0 )
OMe o MeOOMe o MeO
OH,OTBS
OBz
SePh Ph
2.107 .11C^gHToNjOgSeSi 
Mo!. Wt.- 938.13
CoohlieN^ a 
Mol. Wl,: 562.69
Ph
Sodium periodate (20 mg, 0.96 mmol) was added in one portion to a solution of the diastereoisomerically 
pure selenide 7.11 (9 mg, 9.6 pmol) in Me0 H/H2 0 /CH2 Cl2  (3:1:1, 3 ml). After 30 min the mixture was 
diluted with Et2 Û (5 ml) and EtgN (0.5 ml) and washed with H2 O ( 3 x 2  ml), dried (Na2 S 0 ^) and 
concentrated in vacuo to give the selenoxide as a colourless oil which was dissolved in toluene ( 2  ml) 
whereupon Et^N (2 ml, 14.3 pmol) was added. After refluxing for 2 min, the bright yellow reaction mixture 
was poured into saturated aqueous NaHCO^ (3 ml) and extracted with Et2 0  ( 3 x 3  ml). The organic extracts 
were dried (Na2 SO^) and concentrated in vacuo to give a pale yellow oil which was dissolved in MeOH (3
ml) to which was added aqueous LiOH (0.3 ml, 1.0 M, 0.3 mmol). After 30 min at rt the mixture was 
concentrated, the residue was dissolved in Et2 0  (5 ml), washed with H2 O ( 2 x 2  ml) and brine (2 ml), dried 
(Na2 SO^), and concentrated in vacuo to give a yellow oil which was used immediately in the next step. To a 
solution of the crude residue in THF (1 ml) was added TBAF*3 H2 Û (14 mg, 44.4 pmol) and 4Â MS (4). 
After 4 h at rt the reaction mixture was diluted with Et2 0  (5 ml) and washed with saturated aqueous 
NaHCOg (3 ml). The aqueous phase was extracted with CH2 CI2  ( 3 x 3  ml) and the combined organic layers 
dried (Na2 S0 ^) and concentrated in vacuo to give a yellow oil which was purified by column 
chromatography on silica gel (1 g) eluting with CH2 Cl2 :MeOH:NEtg (100:0:1 —> 95:5:1) to give C18- 
benzamide-pederin-analogue 2.10 (4.2 mg, 7.46 |imol, 78% over 4 steps) as a white solid.
mp 61-63°C (hexanes/Et2 0 ); [a]i)21 +45.3 (c 0.3, CgDg); Vj^ x^ filn-^cm-^ 3373, 2967, 2929, 1672, 1651, 
1533, 1309, 1122, 1073, 1041, 715, 694, 576; 6 ^  (400 MHz, CgDg): 7.77-7.73 (2H, m, Harom), 7.34 (IH, 
d, J 9.7, N9-H), 7.05-7.02 (3H, m, Harom), 6.23 (IH, t, J 5.2, C18-NH), 5.52 (IH, dd, J 9.6, 8.0, CIO-H), 
4.73 (IH, t, J 1.7, =C/7^Hb), 4.68 (IH, t, 71.8, =CH^% ), 4.28 (IH, s, C7-H), 3.83 ( lH ,/6 .5 , 2.7, C2-H), 
3.76 (IH, ddd, J  8.0, 6.0, 3.2, Cl 1-H), 3.35 (IH, dd, J 10.4, 4.6, C13-H), 3.32-3.22 (3H, m, CI8 -H2  and C15- 
H), 3.28 (3H, s, OMe), 3.12 (3H, s, OMe), 2.68 (IH, d, J 14.2, CS-Z/^Hg), 2.56 (IH, dt, 7 14.2, 1.8, C5- 
Hy^ ZZg), 2.00 (IH, ddd, 713.4, 4.3, 3.2, C12-Z/^Hb), 1.90 (IH, dq, 77.0, 2.6, C3-H), 1.87-1.82 (IH, m), 1.62 
(IH, ddd, 7 13.5, 10.5, 6.0, C12-HA77g), 1.52-1.45 (IH, m), 1.31-1.14 (4H, m), 0.915 (3H, d, 77.0, C3-Me), 
0.911 (3H, d, 7 6.5, C2-Me), 0.81 (6 H, s, CM-Meg); 6 ^ (90 MHz, C^Dg): 170.8 (0, C=0), 166.0 (0, C=0),
145.4 (0, C4), 134.2 (0, Carom), 131.1 (1, Carom), 131.0 (1, Carom), 130.4 (1, Carom), 129.8 (1, 2C, 
Carom), 108.9 (2, =CH2 ), 99.0 (0, C6 ), 78.4 (1, CIO or C15), 78.3 (1, C15 or CIO), 72.8 (1, C l), 71.4 (1,
C ll) , 70.6 (1, C13), 68.2 (1, C2), 54.7 (3, OMe), 47.8 (3, OMe), 40.5 (1, C3), 39.3 (2, C18), 37.3 (0, C14),
33.4 (2, C5), 29.1 (2, C12 or C16 or C17), 25.9 (2, C12 or C16 or C l7), 25.5 (2, C12 or C16 or C17), 22.1 (3, 
C2-Me or C3-Me), 16.6 (3, C2-Me or C3-Me), 12.6 (3, br signal, C14-Me), 10.8 (3, C14-Me); m/z (FAB, 
Nal) 585 [(M+Na)+, 70%], 481 (15), 176 (50); Found: (M+Na)+, 585.3157. C3 QH^gN2 0 gNa requires M,
585.3152.
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